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More than 30 members of the diverse amphidinolide family of biologically active 
macrolides have been isolated over last three decades. From this family, amphidinolides 
C and F stand among the most complex and densely functionalized affiliates. Recently, 
we  have  accomplished  the  first  total  synthesis  of  amphidinolide  F.  The  all-carbon 
framework of amphidinolide C has been synthesized.  
  During endeavor toward the total syntheses of amphidinolides F / C, we have 
uncovered a “hidden symmetry element” present in the northern and southern domains of 
amphidinolides F / C. The southern C1-C8 and northern C18-C25 tetrahydrofuran segments 
were derived from a common intermediate. A scalable silver-catalyzed isomerization / 
cyclization on propargyl-benzoate / diol furnished the common intermediate in multigram quantity. The common intermediate provided access to over half of carbon backbone of 
the macrocycle as well as majority of stereochemistry present in amphidinolides F / C. 
  Two strategically different techniques have been developed for the C9-C11 diene 
preparation. A metal-catalyst free Weinreb amide-vinyl lithium coupling / methylenation 
sequence furnished the diene motif. Alternately, diastereoselective addition of a dienyl 
iodide derived 2-lithio-1,3-diene species to an α-oxy aldehyde installed the C9-C11 diene 
and secured the C8 stereochemistry in single operation. The dienyl iodide was prepared 
via a regioselective hydrostannylation on an enyne. 
  A challenging alkylation between an α-branched sulfone and an α-silyloxy iodide 
generated  the  all-carbon  frameworks  of  amphidinolides  F  /  C.  An  efficient  oxidative 
desulfurization incorporated the carbonyl moiety at C15. The protecting group on C18 
alcohol was found to have significant effect on the sulfone-iodide alkylation / oxidative 
desulfurization  sequence.  Installation  of  chelating  ethoxyethyl  ether  on  C18  alcohol 
helped the successful incorporation of C15 ketone and solved the deprotection problem in 
advanced stage of synthesis.  
  A detailed analytical and computational study on proline sulfonamide-catalyzed 
aldol reactions has been performed. The pKa value of a proline sulfonamide catalyst was 
determined experimentally via NMR titration technique. Computational study revealed 
the  origin  of  enhanced  stereoselectivity  by  proline  sulfonamide  catalysts  over  parent 
proline. The non-classical hydrogen bonding interactions were found to be responsible 
for improved diastereoselectivity. 
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CHAPTER I: BACKGROUND OF AMPHIDINOLIDES C AND F 
 
1.1 Introduction to Amphidinolides 
 
Dinoflagellates are marine microorganisms that produce marine toxins and have 
been extensively studied by isolation chemists with a broad range of interests.
1 In search 
of finding new chemically interesting and biologically relevant secondary metabolites 
from  symbiotic  marine  dinoflagellates,  Kobayashi  and  co-workers  have  uncovered  a 
series  of  natural  products,  widely  known  as  amphidinolides.
2 More  than  30  different 
amphidinolides have been isolated since their initial discovery in 1986.
3 Amphidinolide 
natural products encompass the dense array of sensitive functionalities embedded within 
the  largely  conserved  macrocyclic  scaffold.  Their  12-29  membered  macrolactone 
frameworks  are  ornamented  with  rather  scarce  structural  components.  The  non-
thermodynamic s-cis-1,3-diene entities, the exo-methylene moieties, the delicate allylic 
epoxides, the vicinally located one-carbon branches are some of the interesting structural 
features  present  in  many  members  of  this  enthralling  class  of  natural  products.  Few 
amphidinolides  are  comprised  with  rather  unusual  epoxides,  tetrahydrofurans  and 
tetrahydropyrans in the macrocyclic skeletons.   
 
  Apart from intriguing molecular frameworks, almost all amphidinolides possess 
highly promising biological profiles.
4 Few of them even extend to exceptional level of 
cytotoxicity against a series of cancer cell lines. Unfortunately, natural resources of these 
active  constituents  are  extremely  limited  and  often  demand  cumbersome  purification 
techniques.  Inadequate  natural  supply  of  these  bioactive  materials  severely  disables 
further investigation on their biological synopsis and pharmaceutical promise. To secure 
regular  availability  in  need,  the  synthetic  community  worldwide  has  devoted  much 
attention to this fascinating class of natural products over the last two decades. These 
tremendous  efforts  resulted  in  the  synthesis  of  several  amphidinolides  including 
amphidinolides  A,
5 B,
6 E,
7 G  and  H,
8 J,
9 K,
10 P,
11 T,
12 V,
13 W,
14 X,
15 Y
16 (Figure  1.1). 
Some of these works resulted in the stereochemical reassignments. Many non-natural 
analogues also have been synthesized for screening purposes.  
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Figure 1.1. Synthesized Amphidinolides 
 
  
 
1.2 Isolation, Structure Elucidation and Bioactivity of Amphidinolides C 
C2 and F 
 
Dinoflagellates of the genus Amphidinium possess resilient biosynthetic tools for 
mixed polyketide production.
4g These unicellular entities live in symbiosis with marine 
Okinawan Amphiscolops flatworms, but could be cultivated in laboratory under suitable 
seawater conditions. During investigation for the bioactive ingredients of marine source, 
Kobayashi and co-workers isolated a 25-membered macrolide, known as amphidinolide 
C (1.14) from the genus Amphidinium (Y-5, Y-56, Y-59 and Y-71 stains), which were 
collected from internal cells of Amphiscolops species (Figure 1.2).
17 The Amphidinium 
species was also mass cultured in laboratory and the harvested cells was purified by 
exhaustive extractions and HPLC technique to produce amphidinolide C (0.0015% yield) 
as colorless amorphous solid. More recently, amphidinolide F (1.16), an amphidinolide C 
congener was sequestered from Amphidinium species, which possesses same macrocyclic 
core as amphidinolide C, but contains different side chain.
18 The host invertebrate A. 
magniviridis  was  collected  at  Zanpa,  Okinawa  and  the  concomitant  dinoflagellate 
Amphidinium sp. was mass cultured unialgally at 25 °C for two weeks in a see water 
medium. Amphidinolide F (1.16) was isolated in 0.00001% yield (wet weight) from the 
cultured  alga  after  meticulous  purifications.  A  new  affiliate  to  this  subfamily, 
amphidinolide  C2 ( 1.15)  was  also  sequestered  from  the  Y-71  stain  of  Amphidinium 
species.
19 Only 1.8 milligram of amphidinolide C2 (1.15) was collected from 1300 liters 
of Amphidinium culture with 0.00015% isolated yield. 
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Figure 1.2. Structures of Amphidinolides C, C2, F and U 
 
  Given  the  fact  that  none  of  these  natural  products  (1.14-1.16)  was  crystalline 
solid, comprehensive NMR studies, degradation techniques and derivatization methods 
were  exploited  to  determine  the  building  of  these  structures.
17,18,19  The  relative 
stereochemistry  of  amphidinolide  C  (1.14)  was  established  by  extensive  NOESY, 
TCOSY experiments and careful analysis of the coupling constant (J) values. Elucidation 
of the absolute configuration at all secondary alcoholic centers was accomplished by 
modified Mosher ester analysis. A degradation experiment and comparison study was 
utilized  for  determination  of  the  absolute  stereochemistrty  on  the  southern 
tetrahydrofuran  unit.  The  stereochemical  assignment  of  amphidinolide  C2 ( 1.15)  was 
  
 
based on derivatization technique. Interestingly, the relative and absolute configuration of 
amphidinolide F (1.16) was not unambiguously assigned. The stereochemical assignment 
of amphidinolide F was based on analogy to amphidinolide C and the fact that both were 
isolated from the same microorganism.  
  All  the  affiliates  of  this  subfamily ( 1.14-1.16)  possess  impressive  level  of 
cytotoxicity against a range of cancer cell lines. Among these, amphidinolide C (1.14) is 
the most potent member. Amphidinolide C exhibits remarkable antineoplasticity against 
murine  lymphoma  L1210  and  human  epidermoid  carcinoma  KB  cells  in  vitro  in 
nanomolar  range  (IC50  values  5.8  and  4.6  ng/mL  respectively).  Interestingly,  almost 
identical  amphidinolide  C2 ( 1.15)  with  an  additional  acetoxy  moiety  on  C29  displays 
modest activity (IC50 values 0.8 and 3.0 µg/mL respectively). Amphidinolide F (1.16) 
containing the same macrocyclic core as amphidinolide C with different side arm exhibits 
250-700  times  diminished  activity.  Another  member  of  the  family,  amphidinolide  U 
(1.17) that retains the same side chain as amphidinolide C, differ in the macrocyclic core 
also reveals much reduced potency.
20 These observations suggest that the 25-membered 
macrolactone ring might be essential for cytotoxicity, and the side chain could affect the 
potency of cytotoxic activity significantly. 
 
 
 
 
 
  
 
1.3 Synthetic Efforts Toward Amphidinolides C, C2 and F 
 
Interesting structural architecture and biological potency of amphidinolides C, C2 
and  F  (1.14-1.16)  have  generated  substantial  attention  from  the  synthetic  community 
worldwide,
21-25, 27-31 particularly by the research groups of Roush, Spilling, Pagenkopf, 
Williams and our own laboratory. Interestingly, while the first member of this subfamily, 
amphidinolide C (1.14) was isolated back in 1988; endeavors toward the total syntheses 
of these attractive natural products have adopted sudden acceleration in recent times. 
More than five communications have been published on various fragment synthesis since 
we initiated the program toward total syntheses of amphidinolides C / F in 2008. Despite 
these sizable endeavors neither amphidinolide C nor F has been successfully synthesized 
in more than 20 years since their isolation. Very recently, we have accomplished the first 
enantioselective total synthesis of amphidinolide F (1.16).
21 
To simplify, the all carbon framework of amphidinolides C / F could be divided in 
three major segments - 1) southern tetrahydrofuran domain, 2) northern tetrahydrofuran 
domain,  and  3)  western  diene  segment.  Each  domain  individually  contains  adequate 
structural complexity. The synthetic efforts toward these three different domains would 
be discussed chronologically in three different sections. 
 
 
 
 
  
 
1.3.1 Synthetic Efforts Toward Southern Tetrahydrofuran Domain 
 
1.3.1.1 The Roush Group 
 
  In  2008,  Roush  and  co-workers  reported  their  synthetic  studies  toward  the 
southern tetrahydrofuran segment of amphidinolides C / F (Scheme 1.1).
22 A Lewis acid-
promoted diastereoselective [3+2]-annulation between crotylsilane 1.18 and glyoxalate 
1.19 was employed to set all stereochemistry within the southern tetrahydrofuran unit 
1.20. The C7, C8 anti-diol moiety was introduced via Brown allyl-boration reaction in 
moderate yield and diastereoselectivity.  
  In a second-generation approach, the group established a kinetically controlled 
hetero  Michael  sequence  on  α,β-unsaturated  ester  1.26  to  introduce  the  2,5-trans 
stereochemistry present in the tetrahydrofuran, which was finally elaborated to the C1-C9 
fragment  1.28  of  amphidinolides  C  /  F.  No  further  advancement  toward  the  total 
syntheses of these natural products has been reported to date by this group. 
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Scheme 1.1. Roush’s Effort Toward Southern Tetrahydrofuran Domain 
 
  
 
1.3.1.2 The Mohapatra Group 
 
  In the next year, Mohapatra and co-workers revealed their synthetic effort toward 
the C1-C9 segment 1.35 of amphidinolides C / F (Scheme 1.2).
23 The C4-methyl moiety 
was introduced via diastereoselective alkylation directed by the C6 stereochemistry. A 
tandem Sharpless asymmetric dihydroxylation (AD) / SN2 cyclization installed the trans-
disposed tetrahydrofuran in 1.32. The C7, C8 anti-diol unit was incorporated via Sharpless 
asymmetric epoxidation followed by Lewis acid-mediated epoxide ring opening reaction. 
Thus, the C1-C9 subunit 1.35 of amphidinolides C / F was prepared in 19-linear steps 
starting from lactone 1.29. 
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Scheme 1.2. Mohapatra’s Strategy for the Preparation of C1-C9 Subunit 
   
 
1.3.1.3 The Spilling Group 
 
Recently, Spilling and co-workers communicated a short synthesis of the C1-C9 
fragment of amphidinolides C / F (Scheme 1.3).
24 The group exploited a nickel-catalyzed 
Tamaru reaction to secure the C4 and C6 stereochemistry. The major diastereomer 1.38 
from this moderately selective transformation (1:6 dr) revealed to have the undesired 
relative  stereochemistry.  A  cross-metathesis  on  the  desired  isomer  1.39  produced  the 
homologated α,β-unsaturated ester 1.41. Similar to Roush second-generation synthesis, 
Spilling exploited a base-induced intramolecular hetero Michael reaction to set the trans-
relationship  across  the  ether  linkage  in  1.42  /  1.43.  Extensive  silyl-migration  ensued 
under the reaction conditions and the requisite primary alcohol 1.43 was obtained in 
modest yield over 3 steps from lactol 1.36.  
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Scheme 1.3. Spilling’s Tamaru / Michael Sequence to C1-C9 Segment 
   
 
1.3.1.4 The Ferrié and Figadère Group 
 
  In 2010, Ferrié and Figadère revealed an efficient approach toward the southern 
tetrahydrofuran subunit of amphidinolides C / F (Scheme 1.4).
25 The group efficiently 
implemented their own chemistry
26 for rapid construction of the C1-C9 skeleton 1.50. A 
vinylogous Mukaiyama aldolization between silyloxyfuran 1.45 and α-oxy aldehyde 1.44 
generated the unsaturated γ-lactone 1.46 in moderate diastereoselectivity (3:1 dr). A face 
selective hydrogenation on lactone 1.46 employed the C4-methyl moiety with correct 
relative  stereochemistry.  The  two-carbon  homologation  was  accomplished  via  a  C-
glycosylation  reaction  with  oxazolidinethione  1.49  to  deliver  the  trans-disposed 
tetrahydrofuran 1.50 in complete diastereoselectivity. Finally, a moderately regioselective 
hydrostannylation  catalyzed  by  a  Molybdenum  complex  produced  the  internal  vinyl 
stannane 1.52 as major isomer. No further advancement toward the total syntheses of 
these natural products has been reported to date by this group. 
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Scheme 1.4. Ferrié and Figadère’s Approach to Southern Tetrahydrofuran Domain 
 
1.3.2 Synthetic Studies Toward Northern Tetrahydrofuran Portion 
 
1.3.2.1 The Roush Group 
 
  The Roush group first communicated their synthetic studies toward the northern 
segment  of  amphidinolide  F  in  2004  (Scheme  1.5).
27 Similar  to  the  preparation  of 
southern tetrahydrofuran unit, a chelation controlled [3+2]-annulation between allylsilane 
1.53  and  ethyl  glyoxalate  1.19  secured  all  the  stereochemistry  around  northern 
   
 
tetrahydrofuran  segment.  The  annulated  adduct  1.54  was  homologated  to  β-hydroxy 
ketone 1.57 over an extended 11 linear steps. The C12, C13 anti-relationship in 1.58 was 
incorporated via Evans-Tischenko reduction of the β-hydroxy ketone 1.57. Installation of 
the  diene  side  chain  of  amphidinolide  F  (1.16)  was  accomplished  via  a  Stille  cross-
coupling sequence in modest overall yield (43% over 3 steps).  
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Scheme 1.5. Roush Synthesis of C11-C29 Fragment of Amphidinolide F 
 
 
   
 
1.3.2.2 The Mohapatra Group 
 
  Mohapatra’s strategy toward northern tetrahydrofuran unit of amphidinolides C / 
F was significantly different from their previous approach to southern tetrahydrofuran 
domain (Scheme 1.6).
28 A Lewis acid-catalyzed regiospecific opening of allyl epoxide 
1.63  with  alcohol  1.62  followed  by  ring  closing  metathesis  (RCM)  constructed  the 
northern tetrahydrofuran skeleton 1.64. The diene sidearm was installed via a Horner-
Wadsworth-Emmons (HWE) olefination. The bis-allylic alcohol at C29 was introduced 
via Nozaki-Hiyama-Kishi (NHK) coupling in a non-stereoselective fashion; their trials 
for stereoselective generation of the hydroxyl moiety were ineffective. Thus, the group 
accomplished synthesis of the C19-C34 segment of amphidinolide C in 14 linear steps.  
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Scheme 1.6. Mohapatra’s Ring Closing Metathesis (RCM) Strategy 
   
 
1.3.2.3 The Armstrong Group 
 
  In 2009, Armstrong and co-workers revealed their effort toward C19-C29 fragment 
1.72 of amphidinolide F (1.16) (Scheme 1.7).
29 The notable feature of their synthesis 
included  a  Sharpless  mono-dihydroxylation  on  dienoate  1.68  to  produce  diol  1.69  in 
moderate enantioselectivity (73% ee). An iodocyclization sequence was employed for 
construction  of  the  trans-disposed  tetrahydrofuran  1.70.  The  diene  side  chain  was 
introduced  via  an  E-selective  Wittig  olefination  on  an  α-oxy  aldehyde.  Thus, 
Armstrong’s  short  synthesis  of  C19-C29  segment  of  amphidinolide  F  experienced  few 
stereoselectivity issues.  
 
CO2Et EtO2C
AD-mix-α
CH3SO2NH2
t-BuOH/H2O
85%, 73% ee
O
OH
H
H
EtO2C
I
CO2Et CO2Et EtO2C
OH
HO
I2, NaHCO3
CH3CN
85%, 3:1 dr
3 steps
O
OTBS
H
H
EtO2C
OH
1) DMP CH2Cl2
2) Me2=CHCH2PBu3
+Br-
n-BuLi, DMSO, toluene
43% (2 stpes), 87:13  E:Z
O
OTBS
H
H
EtO2C
1.68
1.72 1.71
1.70 1.69
23
24
20 23
24
20
23
25 25
26
 
 
Scheme 1.7. Armstrong Synthesis of C19-C29 Fragment of Amphidinolide F 
 
 
   
 
1.3.2.4 The Spilling Group 
 
  Soon after the disclosure of southern tetrahydrofuran segment synthesis, Spilling 
and co-workers revealed their progress toward the northern tetrahydrofuran subunit of 
amphidinolides  C  and  F  (Scheme  1.8).
30 The  group  exploited  an  efficient  palladium-
catalyzed  cyclization  protocol  to  generate  the  2,5-trans-tetrahydrofuran  1.74  in  good 
yield and diastereoselectivity. The E-vinylphosphonate 1.74 was converted to β-keto-
phosphonate 1.75 through a 3-step oxidation sequence. Finally, the Horner-Wadsworth-
Emmons (HWE) olefination and subsequent Felkin-Anh reduction mounted the diene 
sidearm and set the C24 alcohol stereochemistry of amphidinolide F (1.16). The identical 
method was utilized to install the diene side chain of amphidinolide C (see Chapter VI).  
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Scheme 1.8. Spilling’s Strategy to Northern Subunit of Amphidinolide F 
   
 
1.3.2.5 The Pagenkopf Group 
 
  Pagenkopf’s venture toward the northern tetrahydrofuran unit of amphidinolide C 
(1.14) revolved around execution of the chemistry developed by the group for synthesis 
of trans-tetrahydrofuran motif (Scheme 1.9).
31 The group utilized a well-designed cobalt 
catalyst  1.78  and  molecular  oxygen  as  terminal  oxidant  to  promote  the  Mukaiyama 
aerobic cyclization on alkenol 1.77. The 2,5-trans-tetrahydrofuran 1.79 was obtained in 
excellent yield (97% crude yield), which was converted to aldehyde 1.80 under Swern 
conditions. The enyne 1.81 for the diene sidearm of amphidinolide C was prepared in 10 
steps with 43% overall yield. A substrate controlled diastereoselective alkynylation on 
aldehyde 1.80 delivered the propargyl alcohol 1.82, but displayed an inherent preference 
for the undesired C24 stereoisomer. After Mitsunobu inversion, reduction of the enyne 
1.83  by  treatment  of  Red-Al  furnished  the  requisite  diene  1.84.  Thus,  Pagenkopf’s 
exertion resulted into the first stereoselective synthesis of C18-C34 northern segment of 
amphidinolide C.  
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Scheme 1.9. Pagenkopf’s Endeavor Toward Amphidinolide C 
 
 
 
 
 
 
 
 
   
 
1.3.3 Synthetic Studies Toward Diene Segment 
 
  Although sizable amount of research have been conducted targeting syntheses of 
both northern and southern domain of amphidinolides C and F; surprisingly, no effort 
toward the western diene sector of amphidinolides C / F has been documented. It should 
be mentioned that few other affiliates of the amphidinolide family, e.g. amphidinolides B, 
G, H also possess similar s-cis-diene motif in the macrocyclic scaffold (see Figure 1.1). A 
wealth of research has been directed for synthesis of such kind of highly substituted 
stereo-defined 1,3-diene unit, including effort by our own laboratory. In this section, few 
approaches  toward  the  related  diene  motif  of  amphidinolides  B,  H  and  G  would  be 
discussed. 
 
1.3.3.1 The Crews Group 
 
  In 2005, the Crews group described their first-generation synthesis of C13-C18 
fragment of amphidinolide B1 (Scheme 1.10).
32a Notable steps in the sequence included 
construction of the allenic acetate 1.87 via a 3-step homologation procedure, although in 
a modest overall yield (31%). An iodide-mediated SN2′ reaction exclusively delivered the 
E-dienyl iodide 1.88 in excellent yield.  
Soon  after,  the  group  published  a  second-generation  approach  for  the  dienyl 
iodide  synthesis.
32b  The  enyne  1.92  was  prepared  via  a  Horner-Wadsworth-Emmons  
(HWE) olefination with moderate selectivity (6:1 E:Z). The alkyne moiety on 1.92 was 
   
 
then regioselectively silylstannylated to deliver the vinyl stannane 1.93. Final desilylation 
of the vinyl silane 1.93 followed by iodination produced the dienyl iodide 1.94. Thus, 
Crews’ strategy to western sector of amphidinolide B1 provided two distinct routes for 
related diene construction. 
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Scheme 1.10. Crews’ Strategies to Diene Motif of Amphidinolide B1 
 
 
   
 
1.3.3.2 The Carter Group 
 
  The carter group has dedicated significant energy for construction of the diene 
motif present in amphidinolide B series (Scheme 1.11).
33 A scale dependent Sakurai-type 
coupling between allyl silane 1.95 and ketone 1.96 furnished the homoallylic alcohol 
1.97. SOCl2 mediated dehydration of tertiary alcohol 1.97 furnished the required 1,3-
diene 1.98 along with a seperable non-conjugated isomer 1.99. In a second-generation 
approach, the group utilized an efficient Wittig olefination on α,β-unsaturated aldehyde 
1.100 for stereoselective generation of the amphidinolide B diene 1.102. 
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Scheme 1.11. Carter’s Diene Synthesis for Amphidinolide B 
   
 
1.3.3.3 The Fürstner Group 
 
  In 2009, the Fürstner group revealed a Stille cross-coupling protocol for assembly 
of the diene moiety present in amphidinolides B, G and H (Scheme 1.12).
6b The report 
disclosed an efficient cross-coupling reaction between vinyl stannane 1.103 and vinyl 
iodide  1.104  to  furnish  the  diene  1.105  in  excellent  yield  (82%)  without  any  alkene 
isomerization. The authors pointed out that this particular combination of halogen-free 
ingredients was essential for the efficacy of the coupling event. A high catalyst loading 
(70  mol%  Pd-catalyst)  and  excess  of  one  of  the  coupling  partner  (up  to  2.0  equiv. 
stannane) was required for high efficiency of the transformation.  
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Scheme 1.12. Fürstner’s Cross-coupling Protocol to Diene 
 
 
 
 
 
 
   
 
1.3.3.4 The Nishiyama Group 
 
  Very recently, Nishiyama and co-workers disclosed divergent total syntheses of 
amphidinolides B, H and G.
34 The group employed a metal free pathway for construction 
of the diene motif 1.109 (Scheme 1.13). The alkynone 1.108 was prepared via a coupling 
between aldehyde 1.107 and alkyne 1.106 followed by oxidation. A Michael addition and 
subsequent methylenation on alkynone 1.108 afforded the diene 1.109.  
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Scheme 1.13. Nishiyama’s Endeavor Toward Diene Unit of Amphidinolides B, G and H  
 
 
 
 
   
 
1.4 Conclusion 
 
  Previous work toward the total syntheses of amphidinolides C / F has mainly 
revolved around the synthesis of the two discrete domains - northern tetrahydrofuran 
domain and southern tetrahydrofuran domain. A wealth of research has been directed for 
efficient  generation  of  substituted  tetrahydrofurans.  Despite  these  sizable  efforts, 
questions  still  lingered  around  efficient  preparation  of  the  C9-C11  1,3-diene  unit  of 
amphidinolides C / F, combination of individual subunits, formation of the 25-membered 
macrocycle,  manipulation  of  the  C15,  C18  sensitive  1,4-diketone  moiety  and  finally 
protection  /  deprotection  issues  in  these  poly-oxygenated  natural  products.  In  the 
subsequent chapters, I would articulate our synthetic efforts, which have culminated into 
the first total synthesis of amphidinolide F (1.16). 
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CHAPTER II: SYNTHESIS OF WESTERN DIENE SEGMENT:  
A MODEL STUDY 
 
2.1 Retrosynthetic Analysis 
 
More than 30 members of the diverse amphidinolide family of biologically active 
macrolides have been isolated over last three decades.
1 From this family, amphidinolides 
C,  C2  and  F  (1.14-1.16)  stand  among  the  most  complex  and  densely  functionalized 
affiliates  (Figure  2.1).  These  natural  products  (1.14-1.16)  contain  eleven  stereogenic 
centers embedded within a 25-membered macrocyclic scaffold and include two trans-
disposed  tetrahydrofuran  rings  in  northern  and  southern  halves  of  the  macrocycle,  a 
sensitive 1,4-diketone motif and a highly substituted non-thermodynamic diene unit at 
C9-C11. In addition, amphidinolide C (1.14) side chain comprises an interesting bis allylic 
alcohol moiety at C29. It is easily noticed that all the three members of this subfamily 
(1.14-1.16) share the same macrocyclic core, but differ in the C24 side chain extension.  
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Figure 2.1. Structural Diversities in Amphidinolides C, C2 and F 
   
Engrossed  by  potent  cytotoxic  activity  and  the  fascinating  structural  features 
present  in  amphidinolides  C  /  F,  we  initiated  a  research  program  targeting  the  total 
syntheses of these natural products. Our retrosynthetic disconnection for amphidinolide F 
(1.16) is depicted in Scheme 2.1. The 25-membered macrocycle was envisioned to arise 
from seco-acid 2.1 via macrolactonization protocol. The key disconnection at C14-C15 
would break down the all-carbon skeleton of the natural product 1.16 into almost two 
equal  halves  2.2  and  2.3  with  similar  complexity.  In  forward  sense,  sulfone-iodide 
alkylation followed by oxidative desulfurization should couple the two key fragments and 
would  install  the  C15  ketone  via  an  umpolung  strategy.
2 We  noticed  considerable 
“hidden”  symmetry  within  the  tetrahydrofuran  portions  of  fragments  2.2  and  2.3. 
Specifically, the C1-C8 portion and the C18-C25 contain nearly identical functionalization, 
oxidation state and stereochemical information. This observation led us to propose that 
sulfone 2.2 and iodide 2.3 subunits might be accessible via a common intermediate 2.4. 
Ketone 2.4 could provide access to over half the carbon backbone of the macrocycle as 
well as the majority of the stereochemistry present in amphidinolides C / F. 
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Scheme 2.1. Retrosynthetic Disconnection 
 
2.2 Synthesis of the C7-C20 Western Segment  
 
  On  the  very  outset,  we  were  curious  to  see  if  the  sulfone-iodide  coupling  / 
oxidative  desulfurization  sequence  could  be  implemented  in  this  complex  chemical 
environment  (see  Scheme  2.1).  It  should  be  mentioned  that  the  coupling  involved 
alkylation  between  an  α-branched  sulfone  2.2  to  a  sterically  encumbered  α-silyloxy 
iodide 2.3. To test this strategy, we decided to perform a model coupling between iodide 
2.6 and sulfone 2.7 (Scheme 2.2). We were also interested in developing practical and 
   
efficient route to access the western segment of amphidinolides C / F. In this context, the 
most imperative issue was construction of the C9-C11 highly substituted s-cis-1,3-diene 
motif present in several amphidinolide natural products (see Figures 2.1 and 1.1). Despite 
the considerable synthetic attention, proportionally limited success has been achieved for 
accessing the key diene motif - likely due to the challenging nature of the metal-mediated 
cross coupling reaction (e.g. Suzuki or Stille reaction), commonly envisioned to construct 
these  sensitive  dienes.
3 The  transition  metal-catalyzed  s-cis-1,3-diene  formation  often 
required high catalyst loading (up to 100 mol%) and experienced alkene isomerization in 
few occasions. Consequently, we have invested considerable energy to develop alternate 
pathways for construction of such kind of scaffold. Our initial strategy was to introduce 
the C12, C13 trans-stereochemistry via stereoselective epoxide ring opening on the dienyl 
epoxide 2.8. The dienyl epoxide 2.8 was envisioned to arise via a coupling between vinyl 
iodide 2.9 and Weinreb amide 2.10 followed by methylenation of the intermediate enone.  
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Scheme 2.2. Retrosynthetic Analysis for the C7-C20 Fragment 
 
2.2.1 Preparation of Weinreb Amide 2.10 and Dienyl Iodide 2.9 
 
Syntheses of the Weinreb amide 2.10 and dienyl iodide 2.9 are shown in Scheme 
2.3. The Weinreb amide 2.10 was readily accessible from the known Ley ester 2.11,
 4 
which in turn was prepared from D-mannitol in 2 steps. Ley has shown that the diacetal 
derivatives of glyceraldehyde were significantly more robust than traditional acetonide 
analogues. We did find that the order of addition (LDA was added to the ester 2.11) for 
the key epimerization of equatorial ester 2.11 into axial ester 2.12 was critical to the 
success of the experiment - use of the alternate order of addition led to a significant 
reduction in yield (<20%).  
   
Synthesis of the dienyl iodide 2.9 commenced with known alcohol 2.13.
5 A one-
pot operation involving oxidation followed by Wittig olefination furnished the conjugated 
ester 2.15 as single geometrical isomer. DIBAL-H reduction of ester 2.15 followed by 
silyl protection of the exposed alcohol delivered the requisite dienyl iodide 2.9. 
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Scheme 2.3. Synthesis of Weinreb Amide and Dienyl Iodide 
 
2.2.2 Attempted Triene-based Strategy to C7-C14 Fragment 
 
With the two subunits in hand, we set out to explore the Weinreb amide / dienyl 
lithium coupling (Scheme 2.4). Halogen-metal exchange on vinyl iodide 2.9 followed by 
addition of the Weinreb amide 2.10 smoothly delivered the enone 2.16. Methylenation 
employing the Petasis reagent
6 did provide the intermediate triene; however, some E / Z 
isomerization appeared to occur under the reaction conditions (approximately 4:1 E / Z). 
While careful monitoring of the reaction could minimize this ratio, the isomers were not 
   
separable by standard chromatographic methods. In hope of separating the mixture, the 
TBS ether was removed using HF•Pyr. to furnish triene alcohol 2.17. Unfortunately, the 
alkene isomers were again inseparable. Next, Sharpless asymmetric epoxidation (SAE) as 
described in the amphidinolide B series
7 was screened on alkene 2.17. However, none of 
the desired product 2.18 was identified; rather a complex mixture of several compounds 
was  observed.  Given  these  unexpected  hurdles,  it  became  clear  that  an  alternate 
combination of the reaction sequence was required. 
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Scheme 2.4. Attempted Triene Route  
   
2.2.3 Modified Approach to C7-C14 Diene Segment  
 
After the unproductive endeavors to incorporate the C12, C13 stereochemistry on 
triene  2.17,  we  sought  introduction  of  these  moieties  prior  to  diene  formation  as  a 
reasonable substitute (Scheme 2.5). Accordingly, the first goal was preparation of the 
vinyl iodide 2.21 with the C12, C13 substituents. The C12 and C13 stereochemistry could be 
generated via standard anti-aldol protocol (e.g. Masamune reaction) and the vinyl iodide 
functionality could be incorporated using Negishi’s carbometalation chemistry on alkyne 
2.22.  
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Scheme 2.5. Revised Strategy to the Diene Segment  
 
 
 
   
2.2.3.1 Preparation of Alkyne 2.22 
 
Synthesis  of  vinyl  iodide  2.21  commenced  with  the  Masamune  anti-aldol 
reaction
8 between the known ester 2.23
8 and aldehyde 2.24
9 to provide the aldol adduct in 
reasonable diastereoselectivity, which was subsequently converted to bis-TBS ether 2.25 
(Scheme 2.6). The chiral auxiliary was removed by the treatment of DIBAL-H and the 
exposed  primary  alcohol  was  then  oxidized  to  aldehyde  2.26.  Subsequent  Ohira-
Bestmann  (2.27)
10 reaction  on  aldehyde  2.26  delivered  the  requisite  alkyne  2.22  and 
hence, set the stage for introduction of the vinyl iodide functionality. This efficient 5-step 
sequence supplied the C10-C14 segment 2.22 in 56% overall yield. 
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Scheme 2.6. Rapid Synthesis of the Alkyne  
 
 
   
2.2.3.2 Attempts Toward Vinyl Iodide 2.21 
 
After  devising  a  straightforward  route  to  alkyne  2.22,  our  focus  shifted  to 
incorporation of the vinyl iodide functionality on it (Scheme 2.7). We first intended to 
implement Negishi’s zirconium-catalyzed (Cp2ZrCl2 2.30) regioselective carbometalation 
technique  to  incorporate  the  vinyl  iodide  moiety.
11 To  our  surprise,  alkyne  2.22  was 
unusually inert under Negishi’s carboalumination conditions. In fact, all our attempts to 
carboaluminate  alkyne  2.22  under  modified  Negishi  or  Wipf  conditions
12 failed  to 
provide  the  desired  vinyl  iodide  2.21.  Carbometalation  with  finely  tuned  zirconium 
complexes (2.31 or 2.32) as described by Lipshutz
13 also could not promote to the desired 
addition product 2.21. We initially attributed the inert nature of this particular alkyne 2.22 
to the steric bulkiness (by two large TBS groups in addition to propargyl α-branching) 
around the triple bond, but realized that this was not the only responsible factor as the 
diol 2.28 again failed to deliver the anticipated vinyl iodide 2.29.  
The  next  available  alternative  was  the  analogous  carbostanylation
14 on  alkyne 
2.22 followed by iodination. Interestingly, carbostanylation on alkyne 2.22 delivered the 
undesired addition adduct 2.33 as sole regioisomer. The regiochemistry of vinyl stannane 
2.33  was  confirmed  by  careful  investigation  of  the  coupling  constant  value  (J).  The 
olefinic proton in stannane 2.33 displayed a clear quartet at 6.26 ppm with a coupling 
constant of 6.5 Hertz. The alkene proton on the required regioisomer 2.34 should exhibit 
a smaller J value (~1 Hertz) due to its long distant nature (4 bond vs 3 bond coupling). 
   
Extensive scrutiny for carbometalation on alkyne 2.22 and the unrewarding outcomes 
from it led us to change our strategy for accessing the vinyl iodide 2.21. 
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Scheme 2.7. Attempts Toward the Vinyl Iodide  
 
2.2.3.3 Successful Preparation of the Vinyl Iodide  
 
Finding difficulty in installing the vinyl iodide later, we decided to switch the 
order of events (Scheme 2.8). The plan was to install the vinyl iodide moiety prior to 
introduction of the C12, C13 substituents. The synthesis commenced with the Sharpless 
asymmetric epoxidation (SAE)
 15 on our premade dienyl alcohol 2.35 to furnish the allyl 
epoxide 2.36 in good yield and enantioselectivity (87% yield, 95% ee). The primary 
alcohol was then protected as silyl ether 2.37. The major challenge in this sequence was 
   
selective opening of the epoxide at C12 with inversion by a methyl nucleophile. Despite 
the wealth of research on the reactivity of allyl electrophiles,
16 surprisingly few examples 
of  this  type  of  transformation  have  been  reported.
17 Furthermore,  no  example  of 
performing this transformation on an allyl epoxide / vinyl iodide (e.g. 2.37) has been 
disclosed. 
  The  appropriate  conditions  for  the  stereoselective  epoxide-opening  event  were 
thoroughly investigated (see the table). We quickly realized that the temperature had a 
major  influence  in  the  regio-  and  stereocontrol  of  the  AlMe3  mediated  epoxide  ring 
opening. At higher temperature (-35 ºC), the regiocontrol of the epoxide opening was 
poor  and  significant  erosion  at C 12  stereochemistry  was  observed  (Entry  1).  Cooling 
down  the  reaction  to  -50  ºC  boosted  the  diastereoselectivity  as  well  as  yield  by 
suppressing formation of the regioisomeric alcohol (Entry 2). A significant enhancement 
in diastereo-control (20:1 dr) was recorded when the reaction was conducted at -78 ºC 
(Entry  3).  Unfortunately,  stereoselectivity  of  the  transformation  was  largely  scale 
dependent and a drop in diastereoselectivity (1.7:1 dr) was observed in more than a gram 
scale reaction (Entry 4). Reducing the amount of Me3Al (from 3.0 to 2.2 equiv.) slightly 
improved the diastereomeric ratio (Entry 6). It was interesting to notice that the initial 1.8 
equivalent of Me3Al was not sufficient and additional 0.4 equivalent was necessary to 
drive the reaction to completion. Addition of Me3Al in two equal batches (1.1+1.1 equiv.) 
further enhanced the stereoselectivity (6.3:1). It should be mentioned that addition of 2.2 
equivalent Me3Al at a time diminished the diastereomeric ratio. Next, we screened the 
concentration  effect  in  the  epoxide-opening  event.  A  slight  increase  in 
   
diastereoselectivity  was  observed  at  higher  concentration  (Entry  8).  The  optimum 
diastereocontrol (10.2:1 dr) was accomplished performing the reaction at -90 ºC and at 
higher concentration (Entry 9). Use of different methyl nucleophile (MeMgBr) led to 
decomposition of the starting epoxide (Entry 5).  
We reasoned that the first equivalent of Me3Al was necessary for activating (by 
its Lewis acidic nature) the vinyl iodide / allyl epoxide 2.37, while the second equivalent 
was promoting the epoxide-opening event. Again, the epoxide opening could operate in 
two possible ways, either SN1 or SN2. If SN2 controlled the opening, the desired alcohol 
2.39 would predominate; while the SN1 was responsible for the erosion at C12 center. We 
believed that lowering the temperature and increasing the concentration favored the SN2 
displacement. Final silyl protection of the secondary alcohol completed synthesis of the 
vinyl iodide segment 2.21. 
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Entry  Reagent (eqv.)  Temp.  [Conc.]  Scale  dr  yield 
1  AlMe3 (3.0)  -35 ºC  0.10 M  <100 mg  1.5:1  53% 
2  AlMe3 (3.0)  -50 ºC  0.10 M  <100 mg  3.5:1  72% 
3  AlMe3 (3.0)  -78 ºC  0.10 M  <100 mg  20:1  95% 
4  AlMe3 (3.0)  -78 ºC  0.10 M  >1.0 g  1.7:1  96% 
5  MeMgBr (2.0)  -78 ºC  0.10 M  <100 mg  -  Decomp. 
6  AlMe3 (1.8+0.4)  -78 ºC  0.10 M  >1.0 g  4.4:1  93% 
7  AlMe3 (1.1+1.1)  -78 ºC  0.10 M  >1.0 g  6.3:1  97% 
8  AlMe3 (1.1+1.1)  -78 ºC  0.12 M  >1.0 g  7.2:1  95% 
9  AlMe3 (1.1+1.1)  -90 ºC  0.13 M  1.5 g  10.2:1  98% 
 
Scheme 2.8. Synthesis of Vinyl Iodide 2.21 
   
2.2.3.4 Preparation of Iodide Subunit: Efficient Synthesis of the C9-C11 
Diene 
 
  With  the  two  subunits  in  hand,  we  set  out  to  explore  the  crucial  coupling  / 
olefination sequence (Scheme 2.9). After some experimentation, we found that halogen-
metal exchange on vinyl iodide 2.21 by the treatment of n-BuLi, followed by addition to 
Weinreb amide 2.10 at -78 ºC cleanly generated the enone 2.40 in excellent yield (94%). 
Selection of the organometallic reagent was critical for the success of this coupling event; 
more hindered halogen-exchanging reagent (e.g. t-BuLi or sec-BuLi) resulted in poor 
yields. Next, methylenation of enone 2.40 under Petasis conditions
6 proved optimal to 
deliver the diene 2.41 in excellent yield (89%). Alternate methylenation conditions (e.g. 
Wittig, Lombardo) were ineffective to furnish the desired diene 2.41. Thus, this two steps 
sequence provided an efficient and practical route to this kind of s-cis diene, which was 
commonly viewed to form via metal-mediated cross coupling protocol (e.g. Suzuki or 
Stille coupling).
3 The s-cis configuration of the diene unit was confirmed by the observed 
nOe enhancement. Finally, selective desilylation of C14 TBS ether followed by iodination 
generated the key C7-C14 iodide subunit 2.6. 
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Scheme 2.9. Preparation of the Iodide Subunit 
 
2.2.4 Synthesis of the Sulfone Subunit 
 
  After successful construction of the diene subunit 2.6, the next objective was to 
prepare the sulfone counterpart 2.7 for alkylation (Scheme 2.10). Synthesis of sulfone 2.7 
commenced  with  the  known  iodide  2.42,
18 which  was  prepared  from  commercially 
available Roche’s ester in 3 steps. Halogen-metal exchange and subsequent addition of 
the organolithium species 2.43 to known aldehyde 2.44
19 generated alcohol 2.45 as an 
inconsequential mixture of diastereomers at C18. The alkyl lithium intermediate 2.43 was 
stabilized by chelation with the adjacent O-benzyl group. TPAP oxidation
20 followed by 
careful  ketalization  of  the  resultant  C18  ketone  under  Noyori  conditions
21 smoothly 
   
delivered the dimethyl ketal 2.47. Other ketalization conditions were either ineffective or 
led to decomposition of ketone 2.46. The benzyl ether was removed by the treatment of 
Freeman’s  LiDBB  reagent
22 and  the  exposed  alcohol  was  converted  to  sulfide  2.48. 
Finally,  TPAP-mediated  exhaustive  oxidation  of  sulfide  2.48  provided  the  C15-C20 
sulfone subunit 2.7 in excellent yield. The solvent (MeCN) played an important role as it 
facilitated the catalyst turnover during the exhaustive oxidation. 
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Scheme 2.10. Synthesis of the Sulfone Subunit 
 
 
 
   
2.2.5 Sulfone-iodide Alkylation  
 
  Preparation of the two key subunits (2.6 and 2.7) set the stage for crucial sulfone / 
iodide alkylation event (Scheme 2.11). The coupling between an α-branched sulfone 2.7 
and  an  α-silyloxy  iodide  2.6  retains  substantial  synthetic  challenge  due  to  the  steric 
congestion  around  the  partaking  centers  in  alkylation.  Not  surprisingly,  only  one 
precedent for this kind of sterically demanding alkylation was found in the literature.
23 
We intended to employ this strategy in our original convergent approach (see scheme 2.1) 
to adjoin the two key subunits for construction of the all-carbon frameworks present in 
amphidinolides C / F. Therefore, we invested substantial effort to explore this critical 
alkylation. After extensive experimentation, we discovered that treatment of the sulfone 
2.7  (2.2  equiv.  with  respect  to  iodide  2.6)  with  LHMDS  (1.0  equiv.  with  respect  to 
sulfone 2.7) and subsequent addition of iodide 2.6 in presence of HMPA afforded the 
C14-C15  coupled  material  2.49  in  excellent  yield  (86%).  Ratio  of  sulfone  to  iodide, 
equivalent  of  base  with  respect  to  sulfone  and  temperature  proved  instrumental  for 
success  of  this  crucial  coupling.  Alternative  bases  (e.g.  LDA,  KHMDS)  were  either 
ineffective or provided significantly lower yield. Generation of coupled sulfone 2.49 set 
the stage for the next crucial oxidative desulfurization event.  
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Scheme 2.11. The Sulfone-Iodide Alkylation 
 
2.2.6 Oxidative Desulfurization 
 
With sufficient coupled material in hand, we set out to explore the key oxidative 
desulfurization sequence. One-flask oxidative removal of phenyl sulfone to install ketone 
moiety was first invented by Little and co-workers back in 1980.
24 Several modifications 
have  been  made  to  improve  the  efficiency  of  this  transformation.
25 Surprisingly, 
application of this interesting methodology in bioactive molecule synthesis is not highly 
documented.  Our  laboratory  has  utilized  this  reaction  in  an  azaspiracid  fragment 
synthesis (Scheme 2.12).
26 The Arjona group has employed this transformation during 
their synthetic endeavor toward baconipyrones A and B.
27 Probably the most complex 
application of oxidative desulfurization in natural product synthesis to date was reported 
by  Paquette  and  co-workers  in  their  polycavernoside  A  synthesis  to  produce  a  1,2-
diketone  moiety.
28 We  were  interested  to  explore  this  transformation  in  our  synthetic 
sequence to incorporate the crucial C15 ketone functionality. 
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Scheme 2.12. Applications of Oxidative Desulfurization in Synthesis 
 
The high steric demand around the sulfone moiety in our system 2.49 complicated 
the oxidation (Scheme 2.13). After some experimentation, we were pleased to find that 
oxidation of sulfone 2.49 under LDA / DMPU / bis-TMS peroxide conditions installed 
the C15-ketone 2.5 although in modest isolated yield {51% (87% borsm)}. The freshly 
distilled DMPU played an important role in success of the reaction and worked superior 
than HMPA. Alternate bases (e.g. LHMDS, NaHMDS, KHMDS) were ineffective for 
this  transformation.  Use  of  n-BuLi  as  base  led  to  complete  decomposition. 
   
Mechanistically,  a  strong  base  (here  LDA)  first  deprotonates  the  C15  proton  and  the 
resulting carbanion 2.56 nucleophilically attacks the bis-TMS peroxide to produce the 
geminal siloxy-sulfone intermediate 2.57. An attack by external nucleophile initiates the 
collapse, displacing the sulfone to install the ketone. This one-pot operation actually led 
to  umpolung  of  the  C15  center  where  the  nucleophilic  sulfone  transformed  into  an 
electrophilic carbonyl moiety. This two-step sequence (sulfone alkylation / oxidation) 
circumvents any problematic furan formation (between C15 and C18) and can be viewed 
as a viable alternative to traditional dithiane chemistry.
29 
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Scheme 2.13. Oxidative Desulfurization to Install the C15 Ketone 
   
2.3 Conclusion 
 
In conclusion, synthesis of the western C7-C20 segment of amphidinolides C and F 
has  been  accomplished  in  13  linear  steps  starting  from  the  known  alcohol  2.13.  A 
diastereoselective ring opening of vinyl iodide / allyl epoxide 2.37 provided access to the 
C12,  C13  anti-stereochemistry  and  the  vinyl  iodide  2.21  was  prepared  in  multigram 
quantity. An efficient Weinreb amide coupling / methylenation sequence was employed 
to construct the key C9-C11 diene unit. The sulfone alkylation efficiently coupled the C7-
C14 and C15-C20 subunits. Finally, an oxidative desulfurization event incorporated the C15 
ketone. This critical model study verified many of the key steps that would be utilized in 
our real synthesis and laid a solid platform for our endeavor toward the total syntheses of 
amphidinolides C and F. 
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2.5 Experimental 
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Axial  Ester  2.12:  To  a  stirred  solution  of  equatorial  ester  2.11
1 (1.01  g,  4.31 
mmol) in THF (16.0 mL) at -78 ºC was added LDA
2 (5.0 mL, 5.00 mmol, 1 M in THF / 
hexanes). After 30 min, t-BuOH (861 mg, 1.10 mL, 11.6 mmol) was slowly added to the 
yellow  reaction  mixture  with  the  evolution  of  gas.  After  30  min,  the  reaction  was 
quenched with sat. aq. NH4Cl (10 mL) and the aqueous layer was extracted with Et2O (3 
X 50 mL). The combined organic layer was washed with brine (30 mL) and the dried 
(MgSO4) extract was concentrated in vacuo. The residue was passed through a small plug 
of silica gel, eluting with 50% Et2O / hexanes (100 mL). The solvent was removed in 
vacuo and the yellow solid was purified by recrystallization from hexane to give axial 
ester 2.12
1 (444 mg, 1.89 mmol, 44%) as white solid. 
1H NMR (400 MHz, CDCl3) δ 
4.12-4.17 (m, 2H), 3.97-4.02 (m, 1H), 3.81 (s, 3H), 3.32 (s, 3H), 3.31 (s, 3H), 1.37 (s, 
3H), 1.32 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 171.1, 99.6, 98.7, 68.1, 57.6, 52.0, 
50.1, 48.2, 18.0, 17.7 ppm. 
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Weinreb Amide 2.10: To a stirred solution of ester 2.12 (1.01 g, 4.32 mmol) in 
THF / H2O (1:1, 22.0 mL) at rt was added LiOH•H2O (201 mg, 4.79 mmol). After 4 h, 
the solution pH was adjusted to 4 with aq. HCl (4.0 mL, 1M) and the aqueous layer was 
extracted with EtOAc (6 X 30 mL). The combined organic layer was washed with brine 
(30 mL) and the dried (MgSO4) extract was concentrated in vacuo to give the crude acid 
2.58.  
The crude acid 2.58 was redissolved in CH2Cl2 (21.0 mL) and Me(OMe)NH•HCl 
(500 mg, 5.10 mmol), Et3N (511 mg, 0.71 mL, 5.10 mmol), EDCI (978 mg, 5.10 mmol) 
and DMAP (103 mg, 0.851 mmol) were added sequentially at rt. After 24 h, the reaction 
mixture was concentrated in vacuo and the residue was dissolved in EtOAc / water (2:1, 
90 mL). The aqueous layer was extracted with EtOAc (3 X 50 mL) and combined organic 
layer  was  washed  with  sat.  aq.  NaHCO3,  water  and  brine  (25  mL  each).  The  dried 
(MgSO4) extract was concentrated in vacuo and purified by flash chromatography over 
silica gel, eluting with 40-50% EtOAc / hexanes, to give Weinreb amide 2.10 (897 mg, 
3.41 mmol, 79%) as white solid. Mp. 49-50 ºC; [α]D
23 = -87.7 (c = 1.02, CHCl3); IR: 
   
 
(neat)  3586,  3515,  2986,  2943,  2829,  1668,  1467,  1369  cm
-1; 
1H  NMR  (400  MHz, 
CDCl3) δ 4.78 (s br, 1H), 4.11-4.15 (m, 1H), 3.90 (dd, J = 11.2, 4.4 Hz, 1H), 3.78 (s, 3H), 
3.38 (s, 3H), 3.35 (s, 3H), 3.22 (s br, 3H), 1.39 (s, 3H), 1.37 (s, 3H) ppm; 
13C NMR (100 
MHz, CDCl3) δ 170.8, 100.1, 99.2, 67.2, 61.4, 59.5, 48.9, 48.2, 32.1, 18.1, 17.9 ppm; 
HRMS (CI+) calcd. for C11H22NO6 (M+H) 264.1447, found 264.1448. 
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Ester 2.15: To a stirred solution of alcohol 2.13
3 (9.01 g, 45.5 mmol) in CH2Cl2 
(180.0 mL) at rt was added MnO2 (79.2 g, 910 mmol). After 12 h, the black solid was 
removed by filtration (20.0 mL CH2Cl2 wash) to give the solution of crude aldehyde 2.59. 
  To a stirred solution of the crude aldehyde 2.59 in CH2Cl2 (200 mL) was added 
ylide 2.14 (22.8 g, 68.2 mmol). After 12 h, the reaction was concentrated in vacuo and 
Et2O (75 mL) was added to the residue. The solid formed was removed by filtration. The 
filtrate was concentrated in vacuo and purified by flash chromatography over silica gel, 
eluting with 5-10% Et2O / pentane, to give ester 2.15
4 (10.7 g, 42.4 mmol, 93%) as light 
yellow oil. IR: (neat) 3058, 2992, 2949, 2918, 1714, 1621, 1434, 1288, 1173, 1016, 975, 
788 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 7.37 (d, J = 15.6 Hz, 1H), 6.94 (br s, 1H), 5.98 
(d, J = 15.6 Hz, 1H), 3.78 (s, 3H), 2.02 (d, J = 1.0 Hz, 3H) ppm; 
13C NMR (176 MHz, 
   
 
CDCl3)  δ  167.4,  144.6,  144.0,  117.9,  93.6,  51.8,  19.7  ppm;  HRMS  (ES+)  calcd.  for 
C7H9O2I (M+) 251.9647, found 251.9642. 
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Alcohol 2.60: To a stirred solution of ester 2.15 (8.68 g, 34.4 mmol) in CH2Cl2 
(106.0 mL) at -78 ºC was added DIBAL-H (103.0 mL, 103 mmol, 1 M in CH2Cl2). The 
reaction  was  allowed  to  warm  to  -30  ºC  over  3  h  and  then  quenched  with  sat.  aq. 
Rochelle’s  salt  (75  mL)  and  stirred  vigorously  for  1  h  to  get  two  clear  layers.  The 
aqueous layer was extracted with Et2O (3 X 100 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by chromatography over silica gel, eluting with 20-50 
% Et2O / pentane, to give alcohol 2.60
4 (7.40 g, 33.0 mmol, 96%) as colorless oil. IR: 
(neat) 3324, 2915, 2856, 1575, 1435, 1378, 1298, 1158, 1094, 997, 961, 748 cm
-1; 
1H 
NMR (400 MHz, CDCl3) δ 6.393 (br s, 1H) 6.390 (d, J = 15.6 Hz, 1H), 5.94 (dt, J = 15.6, 
5.7 Hz, 1H), 4.22 (t, J = 5.6 Hz, 2H), 2.00 (d, J = 0.84 Hz, 3H) ppm; 
13C NMR (700 
MHz,  CDCl3)  δ  144.5,  131.9,  128.8,  84.0,  63.3,  20.1  ppm;  HRMS  (EI+)  calcd.  for 
C6H9OI (M+) 223.9698, found 223.9703. 
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TBS Ether 2.9: To a stirred solution of alcohol 2.60 (523 mg, 2.33 mmol) in 
DMF (3.5 mL) at 0 
oC were sequentially added imidazole (278 mg, 4.08 mmol), TBS 
chloride (457 mg, 3.03 mmol) and DMAP (70.6 mg, 0.583 mmol). After 2 h, the reaction 
was quenched with sat. aq. NH4Cl (25 mL) and the aqueous layer was extracted with 
Et2O (3 X 50 mL). The dried (MgSO4) extract was concentrated in vacuo and purified by 
flash chromatography over silica gel, eluting with 5-10% Et2O / pentane, to give TBS 
ether 2.9
4 (781 mg, 2.31 mmol, 99%) as colorless oil. IR: (neat) 2954, 2928, 2856, 1471, 
1379, 1300, 1256, 1129, 1073, 963, 834, 776 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 6.36 
(dt, J = 15.5, 1.6 Hz, 1H), 6.32 (br s, 1H), 5.85 (dt, J = 15.5, 4.9 Hz, 1H) 4.22 (dd, J = 
4.9, 1.5 Hz, 2H), 1.98 (d, J = 0.96 Hz, 3H), 0.93 (s, 9H), 0.09 (s, 6H) ppm; 
13C NMR 
(100 MHz, CDCl3) δ 144.7, 130.3, 129.5, 82.9, 63.4, 25.9, 20.1, 18.4, -5.2 ppm; HRMS 
(EI+) calcd. for C12H23OSiI (M+) 338.0563, found 338.0561. 
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Enone 2.16: To a stirred solution of vinyl iodide 2.9 (355 mg, 1.05 mmol) in dry 
THF (4.0 mL) at -78 °C was added n-BuLi (0.39 mL, 0.975 mmol, 2.5 M in hexanes) 
dropwise. After 1.5 h, a solution of Weinreb amide 2.10 (230 mg, 0.875 mmol) in THF 
(4.0  mL)  was  added  dropwise  to  the  reaction.  After  another  1.5  h,  the  reaction  was 
quenched with sat. aq. NH4Cl (5 mL) and diluted with CH2Cl2 (30 mL) and H2O (5 mL). 
The aqueous layer was extracted with CH2Cl2 (3 X 30 mL) and the dried (MgSO4) extract 
was concentrated in vacuo and purified by flash chromatography over silica gel, eluting 
with  5-10%  EtOAc  /  hexanes,  to  give  enone  2.16  (309  mg,  0.745  mmol,  85%)  as 
colorless oil. [α]D
23 = -58.9 (c = 1.00, CHCl3); IR: (neat) 2992, 2954, 2921, 2856, 1682, 
1634, 1586 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 6.52 (s, 1H), 6.40 (d, J = 15.7 Hz, 1H), 
6.28 (dt, J = 15.7, 4.4 Hz, 1H), 4.35 (d, J = 3.4 Hz, 2H), 4.14-4.21 (m, 2H), 3.90 (dd, J = 
10.9, 4.2 Hz, 1H), 3.34 (s, 3H), 3.23 (s, 3H), 2.33 (s, 3H), 1.39 (s, 3H), 1.32 (s, 3H), 0.95 
(s, 9H), 0.11 (s, 6H) ppm; 
13C NMR (100 MHz, CDCl3) δ 198.1, 151.8, 136.8, 133.0, 
123.1, 100.0, 99.0, 74.9, 63.4, 57.5, 50.3, 48.3, 25.9, 18.4, 18.0, 17.8, 14.5, -5.2 ppm; 
HRMS (EI+) calcd. for C21H38O6Si (M+) 414.2438, found 414.2435. 
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  Triene 2.61: To a stirred solution of enone 2.16 (150 mg, 0.362 mmol) in toluene 
(2.0 mL) was added Petasis reagent
5 (1.14 mL, 1.48 mmol, 1.3 M in toluene) in a sealed 
tube and heated at 70 °C in dark. After 3 h, the reaction was diluted with pentane (5.0 
mL) and the precipitated solid was filtered off (rinse with 3 X 5 mL pentane). The solvent 
was evaporated in vacuo and purified by flash chromatography over silica gel, eluting 5-
15% Et2O / pentane with 1% Et3N, to give sequentially triene 2.61 {90.0 mg, 0.218 
mmol, 60% (76% borsm)} as light yellow oil followed by recovered enone 2.16 (35.6 
mg, 0.086 mmol, 24%). [α]D
23 = -7.7 (c = 1.01, CHCl3); IR: (neat) 2992, 2959, 2927, 
2850, 1462, 1374, 1260, 1146, 1118 cm
-1; 
1H NMR (400 MHz, CDCl3, two isomers) δ 
6.79 (d, J = 15.7 Hz, 1H (minor isomer)), 6.31 (d, J = 15.6 Hz, 1H (minor isomer)), 5.89 
(s, 1H), 5.80 (dt, J = 15.6, 5.4 Hz, 1H), 5.50 (s, 1H (major isomer)), 5.49 (s, 1H (minor 
isomer)), 5.09 (s, 1H (major isomer)), 5.07 (s, 1H (minor isomer)), 4.66 (dd, J = 11.3, 3.6 
Hz, 1H (major isomer)), 4.62 (dd, J = 11.3, 3.4 Hz, 1H (minor isomer)), 4.29 (d, J = 3.7 
Hz, 2H), 3.80-3.88 (m, 1H), 3.64-3.69 (m, 1H), 3.41 (s, 3H), 3.37 (s, 3H), 1.91 (s, 3H), 
1.43 (s, 3H), 1.39 (s, 3H), 0.94 (s, 9H (major isomer)), 0.93 (s, 9H (minor isomer)), 0.10 
(s, 6H (major isomer)), 0.08 (s, 6H (minor isomer)) ppm; 
13C NMR (100 MHz, CDCl3) δ 
142.8,  142.3,  136.8,  135.9,  134.4,  130.4,  128.9,  127.88,  127.81,  126.5,  116.5,  116.0, 
   
 
100.9, 100.0, 73.8, 73.5, 65.6, 63.8, 48.6, 48.3, 25.9, 21.0, 18.4, 18.3, 18.0, 17.9, 14.2, -
5.1 ppm; HRMS (CI+) calcd. for C22H40O5Si (M+) 412.2645, found 412.2653. 
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Alcohol 2.17: To a stirred solution of TBS ether 2.61 (80.1 mg, 0.194 mmol) in 
THF (0.80 mL) in a plastic bottle was added HF•Pyr. (0.49 mL, 0.588 mmol, 1.2 M in 
pyridine) at rt. After 36 h, the reaction mixture was diluted with EtOAc (20 mL) and 
quenched with sat. aq. NaHCO3 (7.5 mL). The aqueous layer was extracted with EtOAc 
(4 X 15 mL) and combined organic layer was washed with H2O and brine (20 mL each). 
The  dried  extract  (MgSO4)  was  concentrated  in  vacuo  and  purified  by  flash 
chromatography over silica gel, eluting 15-20% EtOAc / hexanes, to give alcohol 2.17 
(56 mg, 0.188 mmol, 97%) as light yellow oil. [α]D
23 = -11.2 (c = 1.00, CHCl3); IR: 
(neat) 3460, 2992, 2932, 2829, 1739, 1674, 1625, 1456, 1369 cm
-1; 
1H NMR (400 MHz, 
CDCl3, two isomers) δ 6.78 (d, J = 15.7 Hz, 1H (minor isomer)), 6.33 (d, J = 15.7 Hz, 1H 
(major isomer)), 5.85-5.98 (m, 2H), 5.53 (s, 1H (major isomer)), 5.49 (s, 1H (minor 
isomer)), 5.10 (s, 1H (major isomer)), 5.07 (s, 1H (minor isomer)), 4.65 (dd, J = 11.0, 3.6 
Hz, 1H), 4.26 (d, J = 5.6 Hz, 2H), 3.81-3.88 (m, 1H), 3.67 (dd, J = 10.9, 3.6 Hz, 1H), 
3.40 (s, 3H), 3.36 (s, 3H), 1.92 (s, 3H), 1.43 (s, 3H), 1.39 (s, 3H) ppm; 
13C NMR (100 
   
 
MHz, CDCl3) δ 142.7, 142.3, 136.6, 136.2, 135.6, 129.8, 129.6, 128.8, 128.2, 127.5, 
116.9, 116.3, 100.9, 100.0, 73.6, 73.4, 65.5, 65.4, 63.9, 63.7, 48.7, 48.3, 21.0, 18.3, 17.9, 
14.1 ppm; HRMS (CI+) calcd. for C16H26O5 (M+) 298.1780, found 298.1772. 
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Aldol Adduct 2.25: To a stirred solution of ester 2.23
6 (1.20 g, 2.50 mmol) in 
CH2Cl2 (13.0 mL) was added Et3N (705 mg, 0.98 mL, 7.00 mmol) dropwise at rt and 
then cooled it down to -78 °C. A solution of (Cyx)2BOTf (6.5 mL, 6.5 mmol, 1M in 
hexane) was added dropwise over 30 min . After 3 h, aldehyde 2.24
7 (871 mg, 5.00 
mmol) in CH2Cl2 (5.0 mL) was added dropwise to it. After an additional 1 h at -78 °C, 
the reaction was warmed to 0 °C. After another 2.5 h, pH 7 buffer solution (22 mL) and 
30% H2O2 (6 mL) were added to the solution. After vigorous stirring for 12 h at rt, the 
reaction mixture was concentrated in vacuo and partitioned between H2O (25 mL) and 
CH2Cl2 (50 mL). The aqueous layer was extracted with CH2Cl2 (3 X 30 mL) and the 
combined organic layer was washed with H2O (30 mL). The dried (MgSO4) extract was 
concentrated in vacuo and then high vacuum was applied for 2 h. The residue was passed 
   
 
through a small plug of silica gel (50 g), eluting with 100% EtOAc (150 mL) to get crude 
aldol adduct 2.62. 
The crude adduct 2.62 was redissolved in CH2Cl2 (6.5 mL) and were added 2,6-
lutidine (738 mg, 0.80 mL, 5.00 mmol) followed by TBSOTf (1.26 g, 1.10 mL, 5.00 
mmol) at 0 ºC. After 3 h, the reaction mixture was quenched with sat. aq. NaHCO3 (10 
mL)  and  diluted  with  CH2Cl2  (50  mL)  and  H2O  (20  mL).  The  aqueous  layer  was 
extracted with CH2Cl2 (4 X 50 mL) and the combined organic layer was washed with 
H2O and brine (25 mL each). The dried (MgSO4) extract was concentrated in vacuo and 
purified by chromatography over silica gel, eluting with 3-8 % EtOAc / hexanes, to give 
bis-TBS ether 2.25 {1.40 g, 1.82 mmol, 73%, (10:1 dr)} as dense colorless oil. [α]D
23 = -
19.7 (c = 1.01, CHCl3); IR: (neat) 2954, 2927, 2883, 2856, 1745, 1598, 1472, 1456, 1331, 
1255, 1157, 1097, 1009, 852, 781, 732, 699, 661 cm
-1; 
1H NMR (300 MHz, CDCl3) δ 
7.36-7.39 (m, 2H), 7.17-7.30 (m, 4H), 7.09-7.14 (m, 2H), 6.88 (s, 2H), 6.80 (d, J = 7.0 
Hz, 2H), 5.73 (d, J = 5.5 Hz, 1H), 4.84 (d, J = 16.3 Hz, 1H), 4.48 (d, J = 16.3 Hz, 1H), 
4.04-4.12 (m, 1H), 3.90 (q, J = 5.1 Hz, 1H), 3.48-3.57 (m, 2H), 2.62-2.71 (m, 1H), 2.44 
(s, 6H), 2.31 (s, 3H), 1.19 (d, J = 6.9 Hz, 3H), 1.08 (d, J = 7.2 Hz, 3H), 0.87 (s, 18H), 
0.07 (s, 3H), 0.06 (s, 3H),  0.006 (s, 3H), 0.001 (s, 3H) ppm; 
13C NMR (100 MHz, 
CDCl3) δ 172.3, 142.4, 140.4, 138.5, 138.3, 133.1,  132.1,  128.3, 128.2,  128.0,  127.7, 
127.2, 126.4, 77.8, 74.7, 65.1, 56.7, 48.1, 43.7, 25.9, 25.8,  22.9, 20.9, 18.3, 18.1, 14.5, 
12.5,  -4.3,  -4.8,  -5.4,  -5.5  ppm;  HRMS  (ES+)  calcd.  for  C42H65O6Si2Na  (M+Na) 
790.3969, found 790.3943. 
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Alcohol 2.63: To a stirred solution of ester 2.25 (1.74 g, 2.27 mmol) in CH2Cl2 
(22.0 mL) at -78 °C was added DIBAL-H (5.23 mL, 5.23 mmol, 1M in CH2Cl2). After 3 
h, the reaction was quenched with aq. Rochelle’s salt (0.5 M, 30 mL) and diluted with 
Et2O (60 mL). The mixture was warmed to rt and stirred vigorously for 45 min to get two 
clear layers. The aqueous layer was extracted with Et2O (3 X 50 mL) and the dried 
(MgSO4) extract was concentrated in vacuo and purified by chromatography over silica 
gel, eluting with 10-15 % Et2O / pentane, to give alcohol 2.63 (657 mg, 1.89 mmol, 83%) 
as colorless oil. [α]D
23 = +5.9 (c = 0.81, CHCl3); IR: (neat) 3417, 2954, 2927, 2883, 2850, 
1472, 1462, 1255, 1097, 1031, 835, 775 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 3.72-3.80 
(m, 2H), 3.55-3.67 (m, 3H), 2.97 (dd, J = 7.1, 4.5 Hz, 1H), 1.90-1.99 (m, 1H), 1.05 (d, J 
= 7.1 Hz, 3H), 0.916 (s, 9H), 0.914 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H), 0.09 (s, 6H) ppm; 
13C NMR (100 MHz, CDCl3) δ 77.3, 65.1, 64.6, 37.1, 25.9, 25.8, 18.2, 18.0, 14.0, -4.3, -
4.9,  -5.43,  -5.47  ppm;  HRMS  (CI+)  calcd.  for  C17H40O3Si2  (M+)  349.2594,  found 
349.2593. 
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Aldehyde 2.26: To a stirred solution of alcohol 2.63 (420 mg, 1.20 mmol) in 
CH2Cl2 (10.0 mL) at 0 ºC was added DMP (1.01 g, 2.40 mmol) in one portion. After 5 
min,  the  reaction  was  warmed  to  rt.  After  another  1.5  h,  the  reaction  mixture  was 
quenched with sat. aq. NaHCO3 (10 mL) and diluted with Et2O (30 mL). The aqueous 
layer was extracted with Et2O (2 X 30 mL). The dried (MgSO4) extract was concentrated 
in vacuo and purified by flash chromatography over silica gel, eluting 2-3 % Et2O / 
pentane, to give aldehyde 2.26 (399 mg, 1.15 mmol, 96 %) as colorless oil. [α]D
23
 = +29.4 
(c = 1.00, CHCl3); IR: (neat) 2948, 2921, 2888, 2856, 1723, 1472, 1260, 1108, 835, 775 
cm
-1; 
1H NMR (400 MHz, CDCl3) δ 9.76 (d, J = 1.6 Hz, 1H), 4.05 (td, J = 6.1, 3.7 Hz, 
1H), 3.60 (d, J = 6.1 Hz, 2H), 2.59 (qdd, J = 7.0, 3.8, 1.6 Hz, 1H), 1.13 (d, J = 7.0 Hz, 
3H), 0.90 (s, 18H), 0.10 (s, 6H), 0.06 (s, 6H) ppm; 
13C NMR (100 MHz, CDCl3) δ 203.6, 
74.0, 64.6, 49.8, 25.8, 25.7, 18.2, 18.0, 9.4, -4.3, -5.0, -5.5 ppm; HRMS (ES+) calcd. for 
C17H39O3Si2 (M+H) 347.2438, found 347.2425. 
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Alkyne 2.22: To a stirred solution of Ohira-Bestmann reagent 2.27
8 (693 mg, 3.60 
mmol) in THF (20.0 mL) at -78 °C was added NaOMe solution (7.2 mL, 3.60 mmol, 
0.5M in THF) dropwise over 30 min. A solution of aldehyde 2.26 (359 mg, 1.03 mmol) 
in THF (7.0 mL) was added dropwise to the solution and slowly warmed to 0 ºC over 2 h. 
The reaction was quenched with sat. aq. NH4Cl (10 mL) and diluted with Et2O (25 mL) 
and the aqueous layer was extracted with Et2O (3 X 50 mL). The dried (MgSO4) extract 
was purified by chromatography over silica gel, eluting with 1-2% Et2O / pentane, to give 
alkyne 2.22 (341 mg, 0.995 mmol, 96%) as colorless oil. [α]D
23 = +4.2 (c = 1.63, CHCl3); 
IR: (neat) 3308, 2954, 2927, 2888, 2856, 1472, 1456, 1358, 1255, 1129, 1086, 1026, 
1004, 955, 835, 781, 666, 634 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 3.73 (dd, J = 9.3, 5.9 
Hz, 1H), 3.61-3.65 (m, 1H), 3.57 (dd, J = 9.3, 5.4 Hz, 1H), 2.73-2.80 (m, 1H), 2.03 (d, J 
= 2.5 Hz, 1H), 1.21 (d, J = 7.2 Hz, 3H), 0.92 (s, 18H), 0.09 (s, 9H), 0.08 (s, 3H) ppm; 
13C 
NMR (100 MHz, CDCl3) δ 85.7, 75.2, 69.5, 65.2, 29.6, 25.9, 25.8, 18.3, 18.1, 16.9, -4.1, 
-4.8, -5.3 ppm; HRMS (CI+) calcd. for C18H39O2Si2 (M+H) 343.2489, found 343.2486. 
 
   
 
OTBS
OTBS
Bu3Sn
OTBS
Me
OTBS
2.22 2.33
H
 
 
Vinyl Stannane 2.33: To a stirred suspension of CuCN (52.0 mg, 0.584 mmol) in 
THF (4.0 mL) at -78 °C was added n-BuLi (0.48 mL, 1.18 mmol, 2.5 M in hexanes). The 
mixture was slowly warmed to -40 °C for 15 min, then re-cooled to -78 °C and Bu3SnH 
(340 mg, 0.31 mL, 1.16 mmol) was added. After 15 min, a solution of alkyne 2.22 (50.2 
mg, 0.146 mmol) in THF (4.0 mL) was added to the reaction. After another 30 min, 
DMPU (413 mg, 0.39 mL, 3.22 mmol) was added. After additional 30 min, MeI (414 mg, 
0.18 mL, 2.92 mmol) was added and allowed to warm to rt. After 14 h, the reaction was 
quenched with sat. aq. NH4Cl (4 mL) and diluted with Et2O (15 mL). The aqueous layer 
was extracted with Et2O (3 X 15 mL) and the dried (MgSO4) extract was concentrated in 
vacuo and purified by flash chromatography over silica gel, eluting with pentane (100 
mL), to give vinyl stannane 2.33 (78.1 mg, 0.121 mmol, 83%) as colorless oil. [α]D
23 = -
7.4 (c = 1.02, CHCl3); IR: (neat) 2954, 2921, 2856, 1462, 1255, 1118, 1086, 1004, 830, 
775 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 6.26 (q, J = 6.5 Hz, 1H), 3.59-3.65 (m, 2H), 
3.45 (dd, J = 9.6, 5.8 Hz, 1H), 2.48-2.55 (m, 1H), 1.73 (d, J = 6.5 Hz, 3H), 1.46-1.54 (m, 
6H), 1.29-1.38 (m, 6H), 1.01 (d, J = 7.1 Hz, 3H), 0.89-1.02 (m, 15H), 0.91 (s, 18H), 0.09 
(s, 3H), 0.08 (s, 3H), 0.04 (s, 6H) ppm; 
13C NMR (100 MHz, CDCl3) δ 146.2, 134.7, 
77.2, 65.4, 45.5, 29.2, 27.5, 26.06, 26.03, 20.2, 18.4, 18.2, 16.2, 13.6, 10.6, -3.9, -4.6, -
   
 
5.33,  -5.35  ppm;  HRMS  (CI+)  calcd.  for  C31H69O2Si2Sn  (M+H)  649.3858,  found 
649.3827. 
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Epoxide 2.36: To a stirred suspension of 4Å mol sieves (2.50 g) in dry CH2Cl2 
(30.0 mL) at -35 
oC was added Ti(Oi-Pr)4 (563 mg, 0.59 mL, 1.97 mmol) followed by 
(+)-DET (605 mg, 0.50 mL, 2.96 mmol). The resulting mixture was stirred for 1 h and 
then TBHP (5.40 mL, 29.6 mmol, 5.5 M in decane) was added. After 1 h, a solution of 
allyl alcohol 2.60 (2.21 g, 9.86 mmol) in CH2Cl2 (30.0 mL) was added dropwise over 45 
min. After 16 h at -35 
oC, the reaction was quenched with sat. aq. NaHCO3 (20 mL) and 
diluted with Et2O (50 mL). The resulting solution was passed through a celite pad and the 
aqueous layer was extracted with Et2O (3 X 60 mL) and the combined organic layer was 
washed with H2O and brine (50 mL each). The dried (MgSO4) extract was concentrated 
in  vacuo  and  purified  by  flash  chromatography  over  silica  gel,  eluting  with  15-20% 
EtOAc  /  hexanes,  to  give  epoxide  2.36  (2.06  g,  8.58  mmol,  87%)  as  white  solid. 
Enatiomeric excess was determined by chiral HPLC {4.6 X 250 mm, Daicel AD column, 
96:4 hexanes / i-PrOH, 0.5 mL min
-1, retention times 33.2 min (major) and 36.2 (minor)} 
to be 95% ee. Mp. 47-48 ºC; [α]D
23 = -20.3 (c = 1.61, CHCl3); IR: (neat) 3390, 3046, 
2981, 2921, 2867, 1603, 1434, 1380, 1293, 1233, 1151, 1069, 1031, 999, 879, 786 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 6.45 (s, 1H), 3.96 (d, J = 12.6 Hz, 1H), 3.67-3.73 (m, 1H), 
   
 
3.55 (d, J = 2.0 Hz, 1H), 3.16 (dt J = 3.9, 2.9 Hz, 1H), 2.14 (s br, 1H), 1.75 (d, J = 0.88 
Hz, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 143.4, 80.1, 61.0, 58.2, 57.1, 19.0 ppm; 
HRMS (EI+) calcd. for C6H9O2I (M+) 239.9648, found 239.9639. 
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  TBS Ether 2.37: To a stirred solution of alcohol 2.36 (1.95 g, 8.12 mmol) in 
DMF (12.0 mL) at 0 
oC were added imidazole (967 mg, 14.2 mmol), TBS chloride (1.59 
g, 10.5 mmol) and DMAP (245 mg, 2.03 mmol) sequentially. After 1 h, the reaction was 
quenched with sat. aq. NH4Cl (20 mL) and diluted with Et2O (50 mL). The aqueous layer 
was extracted with Et2O (2 X 50 mL) and the dried (MgSO4) extract was concentrated in 
vacuo and purified by flash chromatography over silica gel, eluting with 4-8% EtOAc / 
hexanes, to give TBS ether 2.37 (2.85 g, 8.04 mmol, 99%) as colorless oil. [α]D
23 = -11.1 
(c = 1.07, CHCl3); IR: (neat) 2954, 2921, 2888, 2856, 1472, 1456, 1374, 1353, 1255, 
1151, 1102, 1059, 1004, 960, 879, 824, 775, 666 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 
6.42 (s, 1H), 3.87 (dd, J = 12.0, 3.1 Hz, 1H), 3.74 (dd, J = 12.0, 4.2 Hz, 1H), 3.44 (d, J = 
1.8, 1H), 3.07-3.09 (m, 1H), 1.76 (d, J = 1.0 Hz, 3H), 0.92 (s, 9H), 0.10 (s, 3H), 0.09 (s, 
3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 143.9, 79.4, 62.6, 58.5, 57.4, 25.8, 19.1, 18.3, -
5.3 ppm; HRMS (CI+) calcd. for C12H24OSiI (M+H) 355.05906, found 355.05960. 
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  Alcohol 2.39: To a stirred solution of epoxide 2.37 (1.53 g, 4.32 mmol) in CH2Cl2 
(34.0 mL) at -90 
oC was added Me3Al (343 mg, 0.46 mL, 4.75 mmol). After 45 min, 
another portion of Me3Al (343 mg, 0.46 mL, 4.75 mmol) was added. After another 1 h, 
the reaction mixture was quenched with sat. aq. Rochelle’s salt (50 mL) and diluted with 
CH2Cl2 (50 mL). The resulting mixture was stirred vigorously at rt for 15 min to get two 
clear  layers.  The  aqueous  layer  was  extracted  with  CH2Cl2  (3  X  60  mL)  and  the 
combined organic layer was washed with brine (30 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
5-10% EtOAc / hexanes, to give alcohol 2.39 {1.57 g, 4.24 mmol, 98% (10.2:1 dr)} as 
colorless oil. [α]D
23 = +9.4 (c = 1.00, CHCl3); IR: (neat) 3564, 3466, 2954, 2927, 2856, 
1472, 1456, 1255, 1113, 1091, 879, 835, 775, 672 cm
-1; 
1H NMR (300 MHz, CDCl3) δ 
6.03 (s, 1H), 3.71 (dd, J = 9.5, 2.8 Hz, 1H), 3.53-3.60 (m, 1H), 3.48 (dd, J = 9.5, 6.5 Hz, 
1H), 2.57 (dq, J = 7.3, 7.0 Hz, 1H), 2.36 (d, J = 3.9 Hz, 1H), 1.86 (d, J = 0.9 Hz, 3H), 
1.03 (d, J = 7.0 Hz, 3H), 0.92 (s, 9H), 0.09 (s, 6H) ppm; 
13C NMR (100 MHz, CDCl3) δ 
149.7, 76.6, 73.2, 65.0, 45.9, 25.8, 20.8, 18.2, 15.6, -5.3, -5.4 ppm; HRMS (CI+) calcd. 
for C13H28O2ISi (M+H) 371.0904, found 371.0887. 
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  Bis-TBS Ether 2.21: To a stirred solution of alcohol 2.39 (644 mg, 1.73 mmol) in 
CH2Cl2 (11.0 mL) were added 2,6-lutidine (406 mg, 0.44 mL, 3.80 mmol) followed after 
5 min by TBSOTf  (921 mg, 0.80 mL, 3.47 mmol) at 0 
oC. The reaction was allowed to 
warm up to rt. After 2 h, the reaction was quenched with sat. aq. NaHCO3 (10 mL) and 
diluted with Et2O (30 mL). The aqueous layer was extracted with Et2O (2 X 30 mL) and 
the combined organic layer was washed with H2O and brine (20 mL each). The dried 
(MgSO4) extract was concentrated in vacuo and purified by flash chromatography over 
silica gel, eluting with 1% EtOAc / hexanes, to give bis-TBS ether 2.21 (822 mg, 1.69 
mmol, 98%) as colorless oil. [α]D
23 = +14.5 (c = 1.05, CHCl3); IR: (neat) 2954, 2921, 
2883, 2850, 1472, 1396, 1358, 1244, 1102, 1059, 950, 933, 841, 770, 666 cm
-1; 
1H NMR 
(400 MHz, CDCl3) δ 5.98 (s, 1H), 3.58 (dt, J = 6.8, 4.7 Hz, 1H), 3.48 (dd, J = 9.9, 4.8 Hz, 
1H), 3.39 (dd, J = 9.9, 7.0 Hz, 1H), 2.74 (qd, J = 7.1, 4.5 Hz, 1H), 1.83 (s, 3H), 1.09 (d, J 
= 7.1 Hz, 3H), 0.91 (s, 9H), 0.90 (s, 9H), 0.07 (s, 6H), 0.05 (s, 6H) ppm; 
13C NMR (100 
MHz, C6D6) δ 148.9, 77.6, 75.8, 65.4, 45.5, 25.9, 25.8, 22.2, 18.2, 18.0, 15.8, -4.3, -4.9, -
5.4, -5.6 ppm; HRMS (CI+) calcd. for C19H42O2ISi2 (M+H) 485.1768, found 485.1777. 
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  Enone 2.40: To a stirred solution of vinyl iodide 2.21 (400 mg, 0.826 mmol) in 
THF (6.5 mL) at -78 
oC was added n-BuLi (0.30 mL, 0.757 mmol, 2.5 M in hexanes) 
dropwise. After 2 h at -78 
oC, a solution of Weinreb amide 2.10 (181 mg, 0.688 mmol) in 
THF (6.5 mL) was added dropwise over 15 min. After another 1.5 h, the reaction was 
quenched with sat. aq. NH4Cl (10 mL) and the aqueous layer was extracted with Et2O (3 
X 30 mL). The dried (MgSO4) extract was concentrated in vacuo and purified by flash 
chromatography over silica gel, eluting with 5-8% EtOAc / hexanes, to give enone 2.40 
(362 mg, 0.646 mmol, 94%) as colorless oil. [α]D
23 = -37.0 (c = 1.01, CHCl3); IR: (neat) 
2954, 2927, 2856, 1685, 1609, 1472, 1374, 1249, 1146, 1113, 1037, 835, 775 cm
-1; 
1H 
NMR (400 MHz, CDCl3) δ 6.55 (s, 1H), 4.23 (dd, J = 6.1, 4.4 Hz, 1H), 4.10 (dd, J = 
11.2, 6.1 Hz, 1H), 3.90 (dd, J = 11.2, 4.4 Hz, 1H), 3.69-3.73 (m, 1H), 3.50 (dd, J = 10.2, 
5.1 Hz, 1H), 3.44 (dd, J = 10.2, 6.3 Hz, 1H), 3.34 (s, 3H), 3.30 (s, 3H), 2.58 (qd, J = 7.1, 
4.6 Hz, 1H), 2.23 (d, J = 0.96, 3H), 1.39 (s, 3H), 1.33 (s, 3H), 1.14 (d, J = 7.1, 3H), 0.90 
(s, 9H), 0.89 (s, 9H), 0.074 (s, 3H), 0.070 (s, 3H), 0.045 (s, 3H), 0.042 (s, 3H) ppm; 
13C 
NMR (100 MHz, CDCl3) δ 197.2, 163.3, 121.1, 100.1, 99.2, 76.2, 75.1, 65.2, 58.9, 49.7, 
48.3, 46.4, 25.9, 25.8, 19.4, 18.2, 18.0, 17.99, 17.93, 16.0, -4.2, -4.9, -5.34, -5.38 ppm; 
HRMS (ES+) calcd. for C28H56O7Si2Na (M+Na) 583.3462, found 581.3470. 
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  Diene 2.41: To a stirred solution of enone 2.40 (225 mg, 0.401 mmol) in toluene 
(3.0 mL) in a sealed tube was added Petasis reagent
5 (0.92 mL, 1.20 mmol, 1.3 M in 
toluene) and heated to 80 
oC in dark. After 4 h, the reaction was diluted with pentane (5.0 
mL) and the precipitated solid was filtered off (rinse with 3 X 5 mL pentane). The solvent 
was  evaporated in vacuo and  the  residue  was  purified  by  flash  chromatography  over 
silica gel, eluting 3-4% EtOAc / hexanes, to give diene 2.41 (199 mg, 0.356 mmol, 89%) 
as colorless oil. [α]D
23 = -2.0 (c = 1.00, CHCl3); IR: (neat) 2948, 2927, 2850, 1472, 1374, 
1249, 1151, 1113, 1042, 830, 781 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 5.67 (s, 1H), 5.46 
(s, 1H), 4.99 (s, 1H), 4.59 (dd, J = 11.3, 3.5 Hz, 1H), 3.81 (t, J = 11.1 Hz, 1H), 3.65-3.70 
(m, 2H), 3.46 (d, J = 5.8 Hz, 2H), 3.41 (s, 3H), 3.36 (s, 3H), 2.46 (qd, J = 7.1, 4.2 Hz, 
1H), 1.77 (d, J = 1.1, 3H), 1.44 (s, 3H), 1.39 (s, 3H), 1.08 (d, J = 7.1, 3H), 0.90 (s, 18H), 
0.08 (s, 6H), 0.04 (s, 6H) ppm; 
13C NMR (100 MHz, CDCl3) δ 143.0, 142.1, 123.6, 
114.3, 100.9, 100.1, 76.4, 73.7, 65.9, 65.5, 48.6, 48.3, 45.3, 25.99, 25.92, 18.3, 18.1, 17.9, 
16.8, 16.0, -4.1, -4.8, -5.35, -5.39 ppm; HRMS (ES+) calcd. for C29H58O6Si2Na (M+Na) 
581.3670, found 581.3646. 
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  Alcohol 2.64: To a stirred solution of bis-TBS ether 2.41 (156 mg, 0.279 mmol) 
in THF (3.0 mL) in a plastic bottle at 0 ºC was added HF•Pyr. stock solution
9 (1.2 mL). 
After 30 min, the reaction was warmed to rt. After 6 h, the reaction was recooled to 0 ºC 
and another portion of HF•Pyr. (0.60 mL) was added. After 20 min, the reaction was 
warmed to rt. After additional 2 h, the reaction was quenched with sat. aq. NaHCO3 (5 
mL) and the aqueous layer was extracted with EtOAc (3 X 30 mL). The dried (MgSO4) 
extract was concentrated in vacuo and purified by flash chromatography over silica gel, 
eluting with 20-25% EtOAc / hexanes, to give alcohol 2.64 (113 mg, 0.254 mmol, 91%) 
as colorless oil. [α]D
23 = -26.0 (c = 1.01, CHCl3); IR: (neat) 3490, 2953, 2929, 2883, 
2855, 2832, 1470, 1462, 1372, 1252, 1147, 1116, 1042, 874, 835, 777 cm
-1; 
1H NMR 
(400 MHz, CDCl3) δ 5.74 (s, 1H), 5.44 (s, 1H), 5.01 (s, 1H), 4.59 (dd, J = 10.9, 3.7 Hz, 
1H), 3.77-3.84 (m, 2H), 3.69 (dd, J = 10.8, 3.8 Hz, 1H), 3.50-3.59 (m, 2H), 3.40 (s, 3H), 
3.36 (s, 3H), 2.49 (dq, J = 6.8, 6.7 Hz, 1H), 1.80 (t, J = 6.3, 1H), 1.78 (d, J = 1.2 Hz, 3H), 
1.43 (s, 3H), 1.39 (s, 3H), 1.08 (d, J = 7.0, 3H), 0.92 (s, 9H), 0.11 (s, 3H), 0.09 (s, 3H) 
ppm; 
13C NMR (100 MHz, CDCl3) δ 142.8, 141.9, 123.4, 115.2, 100.8, 100.0, 75.0, 73.8, 
65.5, 64.2, 48.6, 48.3, 46.0, 25.8, 18.2, 18.1, 17.8, 16.6, 14.8, -4.4, -4.6 ppm; HRMS 
(ES+) calcd. for C23H44O6SiNa (M+Na) 467.2805, found 467.2802. 
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  Iodide  2.6:  To  a  stirred  solution  of  alcohol  2.64  (85.1  mg,  0.191  mmol)  in 
benzene (3.0 mL) at 0 ºC were added imidazole (39.0 mg, 0.574 mmol), PPh3 (126 mg, 
0.478 mmol) and I2 (97.3 mg, 0.382 mmol) sequentially. After 10 min, the reaction was 
warmed to rt. After 1 h, the reaction was quenched with sat. aq. Na2S2O3 (5 mL) and the 
aqueous layer was extracted with EtOAc (3 X 20 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
10-15% EtOAc / hexanes, to give iodide 2.6 (91.1 mg, 0.164 mmol, 86%) as colorless oil. 
[α]D
23 = +4.0 (c = 1.02, CHCl3); IR: (neat) 2949, 2929, 2883, 2859, 2824, 1458, 1372, 
1252, 1147, 1116, 1042, 835, 773 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 5.79 (s, 1H), 5.48 
(s, 1H), 5.03 (s, 1H), 4.61 (dd, J = 11.3, 3.4 Hz, 1H), 3.84 (dd, J = 11.2, 11.0 Hz, 1H), 
3.70 (dd, J = 10.8, 3.7 Hz, 1H), 3.63 (dt, J = 6.5, 4.5 Hz, 1H), 3.42 (s, 3H), 3.37 (s, 3H), 
3.18 (dd, J = 10.0, 4.2 Hz, 1H), 3.14 (dd, J = 10.0, 6.6 Hz, 1H), 2.59-2.66 (m, 1H), 1.79 
(d, J = 1.1 Hz, 3H), 1.44 (s, 3H), 1.40 (s, 3H), 1.05 (d, J = 7.0, 3H), 0.92 (s, 9H), 0.12 (s, 
3H), 0.08 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 142.7, 140.9, 124.3, 114.9, 100.9, 
100.1, 74.6, 73.8, 65.8, 48.7, 48.3, 46.9, 25.8, 18.2, 18.0, 17.9, 16.5, 15.3, 11.4, -4.2, -4.7 
ppm; HRMS (ES+) calcd. for C23H43O5ISiNa (M+Na) 577.1822, found 577.1810. 
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  Alcohol 2.45: To a stirred solution of iodide 2.42
10 (1.20 g, 4.13 mmol) in Et2O 
(50.0 mL) at -78 ºC suspended with 4Å mol. sieves (2.50 g) was added t-BuLi (5.8 mL, 
9.30 mmol, 1.6 M in pentane). After 15 min, the reaction was warmed to rt for 30 min 
and recooled to -78 ºC. The aldehyde 2.44
11 (1.15 g, 4.96 mmol) in Et2O (20.0 mL) was 
cannulated to it and stirred at same temperature for 45 min. The reaction was warmed to 
rt for 45 min and then quenched with sat. aq. NH4Cl (30 mL). The mol. sieves was 
filtered off and the aqueous layer was extracted with EtOAc / Et2O (1:1, 3 X 70 mL). The 
combined organic layer was washed with brine (50 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
8-15% EtOAc / hexanes, to give diastereomeric alcohol 2.45 {1.17 g, 2.96 mmol, 72% 
(1:1 dr)} as colorless oil. [α]D
23 = -2.7 (c = 1.00, CHCl3); IR: (neat) 3466, 2941, 2886, 
2867,  1454,  1092,  1069,  878,  734,  676  cm
-1; 
1H  NMR  {400  MHz,  CDCl3  (two 
diastereomers)} δ 7.29-7.36 (m, 5H (2 diastereomers)), 4.538 (s, 2H (1 diastereomer)), 
4.531 (s, 2H (1 diastereomer)), 3.89-4.01 (m, 3H (2 diastereomers)), 3.72 (d, J = 2.8 Hz, 
1H (1 diastereomer), 3.66 (d, J = 2.6 Hz, 1H (1 diastereomer)), 3.32-3.40 (m, 2H (2 
diastereomers)),  2.01-2.08  (m,  1H  (2  diastereomers)),  1.59-1.74  (m,  3H  (2 
diastereomers)),  1.46-1.55  (m,  1H  (2  diastereomers)),  1.27-1.33  (m,  1H  (2 
diastereomers)),  1.07-1.18  (m,  21H  (2  diastereomers)),  1.00  (d,  J  =  6.8  Hz,  3H  (2 
   
 
diastereomers)) ppm; 
13C NMR (100 MHz, CDCl3) δ 138.6, 128.3, 127.5, 127.4, 76.5, 
75.6, 73.0, 72.9, 69.7, 69.5, 63.0, 42.3, 42.1, 39.4, 38.8, 30.4, 30.2, 18.0, 17.9, 17.3, 11.8 
ppm; HRMS (ES+) calcd. for C23H42O3SiNa (M+Na) 417.2801, found 417.2805. 
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  Ketone 2.46: To a stirred solution of diastereomeric alcohol 2.45 (940 mg, 2.38 
mmol) in CH2Cl2 (40.0 mL) at 0 ºC were sequentially added 4Å mol. sieves (2.50 g), 
NMO (558 mg, 4.76 mmol) and TPAP (42.1 mg, 0.119 mmol). After 5 min, the reaction 
was warmed to rt. After 3 h, the solid was filtered off (rinsed with EtOAc / hexanes (30 
mL,  1:1))  and  the  solvent  was  removed  in vacuo.  The  residue  was  purified  by  flash 
chromatography over silica gel, eluting with 8-12% EtOAc / hexanes, to give ketone 2.46 
(910 mg, 2.31 mmol, 97%) as colorless oil. [α]D
23 = +0.45 (c = 1.32, CHCl3); IR: (neat) 
2959, 2943, 2867, 1718, 1456, 1364, 1108, 884, 743, 683 cm
-1; 
1H NMR (400 MHz, 
CDCl3) δ 7.29-7.38 (m, 5H), 4.50 (s, 2H), 3.97 (t, J = 6.3 Hz, 2H), 3.37 (dd, J = 9.1, 5.4 
Hz, 1H), 3.29 (dd, J = 9.1, 6.7 Hz, 1H), 2.66 (dd, J = 16.0, 5.2 Hz, 1H), 2.63 (t, J = 6.3 
Hz, 2H), 2.36-2.44 (m, 1H), 2.33 (dd, J = 16.0, 7.6 Hz, 1H), 1.04-1.12 (m, 21H), 0.96 (d, 
J = 6.5 Hz, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 209.5, 138.5, 128.3, 127.5, 127.4, 
75.0,  72.9,  59.2,  48.0,  46.2,  29.5,  17.9,  17.1,  11.9  ppm;  HRMS  (CI+)  calcd.  for 
C23H41O3Si (M+H) 393.2825, found 393.2834. 
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  Ketal 2.47: To a stirred solution of ketone 2.46 (380 mg, 0.967 mmol) in CH2Cl2 
(0.55 mL) at -78 ºC was added MeOTMS (408 mg, 0.54 mL, 3.87 mmol) followed by 
TMSOTf (21.5 mg, 17.5 µL, 96.7 µmol). After 36 h at -78 ºC, the reaction was quenched 
with pyridine (0.30 mL) and the resulting mixture was poured into sat. aq. NaHCO3 (10 
mL). The aqueous layer was extracted with CH2Cl2 (3 X 50 mL) and the dried (MgSO4) 
extract was concentrated in vacuo. The residue was purified by flash chromatography 
over silica gel, eluting with 6-10% of EtOAc / hexanes, to give ketal 2.47 (352 mg, 0.802 
mmol, 83%) as colorless oil. [α]D
23 = +3.9 (c = 1.24, CHCl3); IR: (neat) 2937, 2894, 
2867, 1462, 1151, 1086, 1059, 884, 732, 688 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 7.26-
7.37 (m, 5H), 4.52 (s, 2H), 3.68-3.79 (m, 2H), 3.37 (dd, J = 8.9, 5.9 Hz, 1H), 3.29 (dd, J 
= 8.9, 6.4 Hz, 1H), 3.178 (s, 3H), 3.172 (s, 3H), 1.93-2.06 (m, 3H), 1.75 (dd, J = 14.8, 4.8 
Hz, 1H), 1.42 (dd, J = 14.8, 7.5 Hz, 1H), 1.07-1.13 (m, 21H), 1.05 (d, J = 6.8 Hz, 3H) 
ppm; 
13C NMR (100 MHz, CDCl3) δ 138.8, 128.2, 127.4, 127.3, 102.2, 75.9, 72.9, 59.2, 
47.7,  47.6,  36.4,  29.8,  18.1,  18.0,  11.9  ppm;  HRMS  (ES+)  calcd.  for  C25H46O4SiNa 
(M+Na) 461.3063, found 461.3047. 
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  Alcohol 2.65: To a stirred solution of benzyl ether 2.47 (264 mg, 0.601 mmol) in 
THF (6.0 mL) at -78 ºC was added freshly prepared LiDBB solution
12 (10.5 mL, 4.20 
mmol, 0.4 M in THF) in one portion. After 5 min, the reaction was quenched with sat. aq. 
NH4Cl (7 mL). The resulting mixture was diluted with EtOAc (50 mL) and H2O (7 mL) 
and the aqueous layer was extracted with EtOAc (3 X 30 mL). The dried (MgSO4) extract 
was concentrated in vacuo and purified by flash chromatography over silica gel, eluting 
with 10-15% of EtOAc / hexanes, to give alcohol 2.65 (189 mg, 0.542 mmol, 90%) as 
colorless oil. [α]D
23 = -9.5 (c = 1.01, CHCl3); IR: (neat) 3444, 2943, 2888, 2861, 1151, 
1086, 1059, 884, 638 cm
-1; 
1H NMR (300 MHz, CDCl3) δ 3.72-3.78 (m, 2H), 3.56 (ddd, 
J = 11.0, 7.7, 4.2 Hz, 1H), 3.40 (ddd, J = 11.0, 6.6, 4.8 Hz, 1H), 3.22 (s, 3H), 3.19 (s, 
3H), 3.08 (dd, J = 7.7, 4.8 Hz, 1H), 2.01-2.06 (m, 2H), 1.88-1.99 (m, 1H), 1.79 (dd, J = 
14.6, 8.5 Hz, 1H), 1.49 (dd, J = 14.6, 4.1 Hz, 1H), 1.06-1.15 (m, 21H), 0.95 (d, J = 6.8 
Hz, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 102.2, 68.6, 59.4, 47.9, 39.0, 36.5, 32.1, 
18.9, 18.0, 11.9 ppm; HRMS (ES+) calcd. for C18H40O4SiNa (M+Na) 371.2594, found 
371.2599. 
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  Sulfide 2.48: To a stirred solution of alcohol 2.65 (184 mg, 0.527 mmol) in THF 
(1.2 mL) at 0 ºC were added Ph2S2 (231 mg, 1.05 mmol) followed by PBu3 (243 mg, 0.30 
mL, 1.21 mmol). After 10 min, the reaction was warmed to rt. After 5 h, the solvent was 
removed in vacuo and the residue was directly loaded onto silica gel and purified by flash 
chromatography, eluting with 2-5% EtOAc / hexanes, to give sulfide 2.48 (230 mg, 0.521 
mmol, 99%) as colorless oil. [α]D
23 = +2.0 (c = 1.05, CHCl3); IR: (neat) 2941, 2890, 
2863, 1454, 1092, 1061, 882, 734, 688 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 
7.5 Hz, 2H), 7.26-7.30 (m, 2H), 7.16 (t, J = 7.2 Hz, 1H), 3.65-3.75 (m, 2H), 3.178 (s, 
3H), 3.171 (s, 3H), 3.14 (dd, J = 12.7, 5.4 Hz, 1H), 2.75 (dd, J = 12.7, 7.6 Hz, 1H), 1.92-
1.99 (m, 3H), 1.78 (dd, J = 14.7, 5.7 Hz, 1H), 1.53 (dd, J = 14.7, 7.0 Hz, 1H), 1.13 (d, J = 
6.6 Hz, 3H), 1.05-1.11 (m, 21H) ppm; 
13C NMR (100 MHz, CDCl3) δ 137.3, 128.8, 
128.7, 125.5, 102.0, 59.2, 47.7, 41.4, 39.1, 36.4, 29.6, 20.4, 18.0, 11.9 ppm; HRMS (CI+) 
calcd. for C24H44O3SiS (M+) 440.2781, found 440.2772. 
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  Sulfone  2.7:  To  a  stirred  solution  of  sulfide  2.48  (205  mg,  0.465  mmol)  in 
CH3CN (2.5 mL) were sequentially added 4Å mol. sieves (300 mg), NMO (164 mg, 1.39 
mmol) and TPAP (17.1 mg, 46.5 µmol) at rt. After 6 h, another portion of TPAP (8.5 mg, 
23.3 µmol) was added.  After additional 12 h, the reaction was diluted with EtOAc / 
hexanes (5 mL, 1:1) and passed through a small plug of silica gel (rinsed with 50 mL 
EtOAc / hexanes (1:1)). The solvent was removed in vacuo and the residue was purified 
by flash chromatography over silica gel, eluting with 15-20% EtOAc / hexanes, to give 
sulfone 2.7 (204 mg, 0.432 mmol, 93%) as a colorless oil. [α]D
23 = +0.55 (c = 1.09, 
CHCl3); IR: (neat) 2941, 2890, 2859, 1462, 1443, 1318, 1306, 1147, 1084, 1046, 882, 
750, 688 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 7.92-7.94 (m, 2H), 7.63-7.67 (m, 1H), 
7.55-7.59 (m, 2H), 3.73 (dd, J = 14.3, 2.5 Hz, 1H), 3.56-3.67 (m, 2H), 3.08 (s, 3H), 3.04 
(s, 3H), 2.84 (dd, J = 14.3, 9.5 Hz, 1H), 2.15-2.20 (m, 1H), 1.75-1.82 (m, 1H), 1.70 (dd, J 
= 14.6, 9.0 Hz, 1H), 1.42-1.52 (m, 2H), 1.18 (d, J = 6.6 Hz, 3H), 1.04-1.08 (m, 21H) 
ppm; 
13C NMR (100 MHz, CDCl3) δ 139.9, 133.4, 129.1, 128.0, 101.7, 61.4, 59.1, 47.6 
(2  carbons),  39.9,  36.1,  25.3,  21.5,  18.0,  11.9  ppm;  HRMS  (ES+)  calcd.  for 
C24H44O5SiSNa (M+Na) 495.2576, found 495.2560. 
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  Coupled  Sulfone  2.49:  To  a  stirred  solution  of  sulfone  2.7  (54.5  mg,  0.115 
mmol) in THF (0.40 mL) at -78 ºC was added LHMDS (104 µL, 104 µmol, 1M in THF). 
After  30  min,  the  reaction  was  warmed  to  0  ºC  and  treated  with  HMPA  (100  µL) 
followed by a solution of iodide 2.6 (32.0 mg, 57.7 µmol) in THF (0.40 mL). After 1 h, 
the reaction was warmed to rt. After 6 h, the reaction was quenched with sat. aq. NH4Cl 
(5 mL) at 0 ºC and diluted with EtOAc (20 mL). The aqueous layer was extracted with 
EtOAc (3 X 20 mL) and the dried (MgSO4) extract was concentrated in vacuo. The 
residue was purified by flash chromatography over silica gel, eluting with 10-25% EtOAc 
/ hexanes, to sequentially give coupled sulfone 2.49 {44.5 mg, 49.4 µmol, 86%, (2-3:1 
dr)} as colorless oil followed by recovered sulfone 2.7 (25.7 mg, 54.3 µmol). [α]D
23 = -
21.5 (c = 1.00, CHCl3); IR: (neat) 2945, 2890, 2863, 2832, 1462, 1439, 1372, 1299, 1252, 
1143, 1112, 1084, 1042, 878, 835, 773, 734, 688 cm
-1; 
1H NMR {400 MHz, CDCl3 (two 
diastereomers)}  δ  7.87-7.91  (m,  2H  (2  diastereomers)),  7.61-7.66  (m,  1H  (2 
diastereomers)), 7.52-7.59 (m, 2H (2 diastereomers)), 5.76 (s, 1H (1 diastereomer)), 5.61 
(s, 1H (1 diastereomer)), 5.46 (s, 1H (2 diastereomers)), 5.00 (s, 1H (1 diastereomer)), 
4.98 (s, 1H (1 diastereomer)), 4.55-4.61 (m, 1H (2 diastereomers)), 4.21 (td, J = 6.6, 2.9 
   
 
Hz, 1H (1 diastereomer)), 4.08 (td, J = 8.8, 3.4 Hz, 1H (1 diastereomer)), 3.87-3.94 (m, 
1H  (1  diastereomer)),  3.78-3.84  (m,  1H  (2  diastereomers)),  3.63-3.75  (m,  2H  (2 
diastereomers)), 3.52-3.56 (m, 1H (1 diastereomer)), 3.43 (s, 3H (1 diastereomer)), 3.40-
3.42  (m,  1H,  (1  diastereomer)),  3.41  (s,  3H,  (1  diastereomer)),  3.37  (s,  3H,  (1 
diastereomer)), 3.36 (s, 3H, (1 diastereomer)), 3.19-3.21 (m, 1H (1 diastereomer)), 3.19 
(s, 3H (1 diastereomer)), 3.16 (s, 3H (1 diastereomer)), 3.04 (s, 3H (1 diastereomer)), 
2.98 (s, 3H  (1 diastereomer)), 2.55 (q, J = 7.1 Hz, 1H (1 diastereomer)), 2.41 (qd, J = 
7.0, 2.8 Hz, 1H (1 diastereomer)), 2.33 (qd, J = 6.9, 2.9 Hz, 1H (1 diastereomer)), 2.14-
2.21 (m, 2H (2 diastereomers)), 1.97-2.07 (m, 1H (2 diastereomers)), 1.09-194 (m, 1H (2 
diastereomers)), 1.82 (s, 3H (1 diastereomer)), 1.76 (s, 3H (1 diastereomer)), 1.58-1.74 
(m,  2H  (2  diastereomers)),  1.41-1.47  (m,  1H  (2  diastereomers)),  1.46  (s,  3H  (1 
diastereomer)), 1.43 (s, 3H (1 diastereomer)), 1.40 (s, 3H (1 diastereomer)), 1.39 (s, 3H 
(1  diastereomer)),  1.30-1.37  (m,  1H  (2  diastereomers)),  1.26  (d,  J  =  12.8  Hz,  3H  (1 
diastereomer)), 1.05-1.16 (m, 27 H (2 diastereomers)), 0.90 (s, 9H (1 diastereomer)), 0.89 
(s, 9H (1 diastereomer)), 0.16 (s, 3H (1 diastereomer)), 0.12 (s, 3H (1 diastereomer)), 
0.098 (s, 3H (1 diastereomer)), 0.090 (s, 3H (1 diastereomer)) ppm; 
13C NMR (100 MHz, 
CDCl3) δ 142.8, 142.6, 141.7, 141.0, 139.9, 139.2, 133.3, 129.1, 129.0, 128.57, 128.51, 
124.2, 123.3, 116.0, 115.2, 102.0, 101.8, 100.9, 100.1 (2 peaks), 73.9, 73.6, 72.2, 72.1, 
65.8, 65.7, 65.4, 65.0, 59.3, 59.2, 48.7 (2 peaks), 48.34, 48.31, 47.96, 47.94, 47.8, 47.7, 
47.6, 46.9, 46.2, 38.9, 36.9, 36.5, 34.0, 29.7, 29.4, 29.3, 28.3, 28.1, 27.4, 25.9, 25.8, 
18.46, 18.43, 18.3, 18.1, 18.06, 18.04, 17.95, 17.91, 17.8, 16.4, 14.5, 12.0, 11.9, -4.1, -
   
 
4.30,  -4.38,  -4.4  ppm;  HRMS  (ES+)  calcd.  for  C47H86O10Si2SNa  (M+Na)  921.5378, 
found 921.5389. 
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  Ketone 2.5: To a stirred solution of diisopropylamine (7.0 µL, 47.8 µmol) in THF 
(0.30 mL) at -78 ºC was added n-BuLi (20. 0 µL, 47.8 µmol, 2.5 M in hexanes). After 15 
min, the reaction was warmed to 0 ºC and stirred for 10 min. The reaction was recooled 
to -20 ºC and treated with DMPU (106 mg, 0.10 mL, 0.827 mmol). A solution of sulfone 
2.49 (21.5 mg, 23.9 µmol) in THF (0.30 mL) was added via cannula. After 15 min, neat 
TMSOOTMS (26.0 µL, 0.119 mmol) was added to the reaction in one portion. After 
additional 30 min, the reaction was slowly warmed to rt over 1 h and another portion of 
TMSOOTMS (13.0 µL, 59.7 µmol) was added. After 1 h, the reaction was quenched with 
sat. aq. NH4Cl (2 mL) and diluted with EtOAc (10 mL). The aqueous layer was extracted 
with EtOAc (3 X 10 mL) and the dried (MgSO4) extract was concentrated in vacuo. The 
residue was purified by flash chromatography over silica gel, eluting with 5-25% EtOAc / 
hexanes with 2% Et3N, to sequentially give ketone 2.5 {9.4 mg, 12.2 µmol, 51% (87% 
borsm)} as colorless oil followed by recovered sulfone 2.49 (8.9 mg, 9.9 µmol, 41%). 
   
 
[α]D
23 = -5.0 (c = 0.61, CHCl3); IR: (neat) 2949, 2890, 2863, 2828, 1715, 1462, 1372, 
1252, 1147, 1116, 1046, 878, 835, 777, 676 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 5.57 (s, 
1H), 5.46 (s, 1H), 4.98 (s, 1H), 4.58 (dd, J = 11.4, 3.4 Hz, 1H), 4.27-4.30 (m, 1H), 3.80 
(dd, J = 11.3, 10.9 Hz, 1H), 3.71 (td, J = 7.3, 3.0 Hz, 2H), 3.64 (dd, J = 10.8, 3.7 Hz, 1H), 
3.41 (s, 3H), 3.35 (s, 3H), 3.14 (s, 3H), 3.08 (s, 3H), 2.58-2.69 (m, 3H), 2.43 (qd, J = 7.0, 
3.5 Hz, 1H), 2.23 (dd, J = 14.5, 8.8 Hz, 1H), 1.92 (t, J = 7.4 Hz, 2H), 1.78 (d, J = 0.9 Hz, 
3H), 1.40-1.45 (m, 1H), 1.43 (s, 3H), 1.38 (s, 3H), 1.06-1.14 (m, 24H), 1.01 (d, J = 7.0, 
3H), 0.90 (s, 9H), 0.11 (s, 3H), 0.06 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 212.1, 
142.8, 142.4, 123.8, 114.8, 101.5, 100.9, 100.1, 73.6, 70.1, 65.7, 59.3, 48.6, 48.3, 48.0, 
47.9, 47.4, 46.7, 41.9, 36.7 (2 carbons), 25.8, 18.3, 18.2, 18.0 (2 carbons), 17.1, 14.7, 
11.9, -4.5, -4.9 ppm; HRMS (ES+) calcd. for C41H80O9Si2Na (M+Na) 795.5239, found 
795.5221. 
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CHAPTER III: APPROACH TOWARD NORTHERN AND 
SOUTHERN TETRAHYDROFURN DOMAINS:  
A COMMON INTERMEDIATE STRATEGY  
 
3.1 Retrosynthetic Strategy for the Common Intermediate 
 
During our model study for the western diene sector of amphidinolides C / F, we 
have developed an efficient route for accessing the C9-C11 s-cis-diene and established a 
coupling  /  oxidation  strategy  that  would  be  employed  in  the  total  syntheses  of  these 
natural products. With these successful endeavors, our focus shifted to the northern and 
southern tetrahydrofuran domains of the macrocyclic core of amphidinolides C and F. It 
has  been  proposed  in  prior  chapter  that  both  the  C1-C8  and  C18-C25  tetrahydrofuran 
segments could arise from the common intermediate 2.4 (see Chapter II, Scheme 2.1). 
Thus, the immediate target was to devise a tactic for synthesizing the common ketone 
intermediate 2.4 (Scheme 3.1). The ketone 2.4 was envisioned to come from the enol-
benzoate 3.1. We planned to employ a gold-catalyzed isomerization / cyclization protocol 
on propargyl-benzoate / diol 3.2 to build the dihydrofuran intermediate 3.1. The diol 3.2 
could arise from alkyne 3.3 and vinyl iodide 3.4 via Sonogashira cross-coupling followed 
by Sharpless asymmetric dihydroxylation. 
 
   
O
TBSO
TBSO
O
ODMB
H H
Common
intermediate (2.4)
HO
TBSO
HO OBz
ODMB
Au-catalyzed
isomerization /
cyclization
OBz
ODMB
TBSO
I
+
Sonogashira
coupling / 
dihydroxylation
3.2 3.4 3.3
O
TBSO
HO
BzO
ODMB
H H
3.1
 
 
Scheme 3.1. Retrosynthetic Strategy for the Common Intermediate  
 
3.2 Synthesis of Propargyl-benzoate / Diol 3.2 
 
  Preparation of the propargyl-benzoate / diol 3.2 is shown in Scheme 3.2. The 
synthesis commenced with known alcohol 3.5,
1 which was prepared in two steps from 
commercially  available  D-malic  acid.  Oxidation  of  the  primary  alcohol  under  Swern 
conditions
2 followed by treatment with the Ohira-Bestmann reagent 2.27
3 delivered the 
alkyne 3.7 in good yield. The benzylidine acetal was removed under acidic conditions to 
furnish the diol 3.8 and attempts were made to selectively protect the primary alcohol as 
3,4-dimethoxy benzyl (DMB) ether. Benzylation selectivity was marginal as the steric 
discrimination between the primary alcohol and the secondary propargyl alcohol was 
minimal.
4 Benzoylation of the crude mixture produced the desired propargyl benzoate 3.3 
   
in modest yield (36% isolated yield in 2 steps). Nevertheless, the alkyne 3.3 obtained 
from the reaction was sufficient to move forward in the sequence. The alkyne 3.3 and the 
known vinyl iodide 3.4
5 were subjected to Sonogashira cross-coupling conditions
6 and 
the  enyne  3.10  was  obtained  in  reasonable  yield.  Finally,  Sharpless  asymmetric 
dihydroxylation
7 on  enyne  3.10  smoothly  delivered  the  diol  3.2  in  good  diastereo-
selectivity and set the platform for the crucial isomerization / cyclization sequence. 
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Scheme 3.2. Preparation of Propargyl-benzoate / Diol 3.2 
 
   
3.3 Isomerization-cyclization to Dihydrofuran 
 
3.3.1 Precedent for Gold- and Silver-catalyzed Dihydrofuran Formation 
 
2,5-Dihydrofurans and their derivatives are important building blocks frequent in 
many  bioactive  materials.
8  Consequently,  their  efficient  generation  has  attracted 
extensive synthetic effort over years.
9 On this context, dihydrofuran formation by gold- 
or  silver  catalysis  on  alkynol  precursor  constitutes  a  rich  history  (Scheme  3.3).  This 
interesting reactivity largely arises from finely tunable alkyne-activation by gold or silver 
catalysts under mild conditions. In 1991, Shigemasa and co-workers first described a 
silver (I)-catalyzed dihydrofuran formation on propargyl acetate / alcohols to deliver the 
dihydrofurans in moderate to good yield.
10 The stereogenicity of the propargyl acetate 
3.11 was completely transferred into product dihydrofuran 3.12. In another report, the 
Krause group disclosed an efficient 2,5-dihydrofuran generation from α-hydroxyallenes 
via gold (III) catalysis.
11 The cyclization was carried out at room temperature and the 
dihydrofuran product was obtained in good yield. Very recently, Gagosz and co-workers 
revealed a one-flask, Au-catalyzed rearrangement / cyclization protocol on propargyl-
benzoate  /  alcohol  to  access  the  2,5-dihydrofurans  in  excellent  yield  and 
stereoselectivity.
12  Despite  the  sizable  methodological  advancement,  only  limited 
applications of this chemistry has been documented.
13 We sought to further explore this 
interesting transformation in natural product synthesis. 
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Scheme 3.3. Precedents for Au- or Ag-catalyzed Dihydrofuran Generation 
 
3.3.2 Optimization for Dihydrofuran Formation  
 
Initially, we intended to build on Gagosz’s newly developed efficient technique
12 
to access the desired dihydrofuran 3.1 (Scheme 3.4). We were aware that the presence of 
1,2-diol moiety in our highly oxygenated system could complicate the cyclization. In 
fact, all our attempts to facilitate this transformation on 3.2 either under gold or silver 
catalysts  failed  to  generate  the  desired  2,5-dihydrofuran  3.1.  We  suspected  that  a 
vulnerable protecting group like 3,4-dimethoxy benzyl (DMB) ether on the alcohol could 
be  problematic.  The  electron  rich  nature  of  DMB  ether  might  interfere  with  highly 
   
electrophilic  gold  or  silver  catalysts.  Thus,  the  more  robust  and  less  electron  rich  p-
methoxy benzyl (PMB) ether was installed on the alcohol moiety. While different gold 
catalysts again failed to provide the requisite dihydrofuran, we were excited to find that 
treatment of propargyl benzoate 3.17 with AgBF4 in hot benzene
10 furnished the desired 
product 3.18 although in modest yield (30%). This outcome encouraged us to mount an 
electron-deficient pivaloyl unit on the alcohol and the desired 2,5-dihydrofuran 3.20 was 
obtained  in  much  improved  yield  (70%).  Use  of  dry  and  deoxygenated  benzene  was 
critical to success of this transformation. The reaction was performed in a dark room - 
metallic silver was precipitated out in presence of light leading to much diminished yield 
(~25%).  This  transformation  was  routinely  performed  on  5-gram  scale  and  provided 
sufficient quantities of 3.20. The functionalized dihydrofuran 3.20 could be diversified to 
variety  of  fully  substituted  tetrahydrofuran  and  might  serve  as  a  building  block  for 
various  trans-disposed  furan-containing  natural  products.
14 The  furan  compound  3.21 
was obtained as noteworthy by-product (15%) and plausible mechanism for its formation 
would be discussed in the next section. 
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Scheme 3.4. Optimization on the One-flask Isomerization-cyclization  
 
   
3.3.3 Proposed Mechanism for the Dihydrofuran and Furan By-product 
Formation  
 
  The  gold-  or  silver-catalyzed  one-flask  isomerization  /  cyclization  of  doubly 
propargyl ester / alcohol constitutes an interesting class of transformation. The product 
dihydrofuran  could  be  easily  diversified  to  the  building  blocks  for  various 
tetrahydrofuran  containing  natural  /  non-natural  biologically  active  molecules.  Its 
generation  is  proportionally  interesting  from  the  mechanistic  perspective.  To  justify 
formation of the dihydrofuran 3.20 and the furan by-product 3.21, a detailed mechanistic 
scenario has been proposed (Scheme 3.5).  
Initially, the cylindrical alkyne would be coordinated by the silver (I) species and 
the activated alkyne 3.22 could be intramolecularly attacked by two possible nucleophiles 
from either terminus. Nucleophilic attack by the benzoate ester (6-endo-dig cyclization) 
would  produce  the  stabilized  carbocationic  intermediate  3.23.  Fragmentation  of  the 
allylic  C-O  bond  would  complete  the  1,3-benzoate  migration  forming  the  allene 
intermediate 3.24 stereospecifically. The regenerated Ag (I) catalyst from isomerization 
event  could  take  part  in  another  allene  activation  and  the  nucleophilic  attack  by  the 
proximal  alcohol  to  allene  (5-endo-trig  cyclization)  should  deliver  the  vinyl  silver 
intermediate 3.25. It should be mentioned that this unfavorable 5-endo-trig ring closure 
(by  Baldwin’s  rule
15)  has  been  witnessed  in  many  gold  /  silver-catalyzed  cyclization 
processes.
16 This proposed mechanism justified the regioselective 1,3-shift of benzoate 
ester  moiety  and  the  inversion  of  configuration  of  the  alcohol  initially  bearing  the 
benzoyl  moiety.  Final  proto-demetallation  should  release  the  desired  trans-2,5-
   
dihydrofuran 3.20 as major product and would regenerate the catalyst for next catalytic 
cycle.  
On the other hand, direct nucleophilic attack by the distal alcohol (5-endo-dig 
cyclization) on activated alkyne 3.22 would generate the vinyl silver intermediate 3.26, 
which after proto-demetallation should produce 2-hydroxy-1,2-dihydrofuran intermediate 
3.27. Finally, silver (I)-mediated dehydration would discharge the furan by-product 3.21. 
Thus, the two significant products (3.20 and 3.21) of this transformation resulted from the 
initial attack by two competitive nucleophiles on the activated alkyne. While beyond the 
scope of this thesis, subsequent improvement in this transformation could be attained by 
employing a more nucleophilic benzoate ester (e.g. p-methoxy benzoate) to suppress the 
formation of furan by-product.  
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Scheme 3.5. Plausible Mechanism for the Silver-catalyzed Cyclization  
 
   
3.4 Preparation of Common Intermediate 3.30  
 
  After success in synthesis of key enol-benzoate precursor 3.20, our focus shifted 
to convert it to the common ketone intermediate 3.30 (Scheme 3.6). First, the secondary 
alcohol in dihydrofuran 3.20 was protected as silyl ether 3.28. The bis-silyl ether 3.28 
was  treated  with  MeLi•LiBr  (2.0  equiv.)  at  -78  ºC  and  then  quenched  with  aqueous 
ammonium  chloride  to  deliver  the  C5-ketone  3.30  in  good  yield.  Some  pivaloyl-
deprotected ketone (~10%) was obtained under the reaction conditions (see experimental 
section).  Use  of  MeLi  instead  of  MeLi•LiBr  led  to  significant  pivaloyl  removal. 
Incorporation  of  the  ketone  completed  our  successful  endeavor  toward  the  common 
intermediate 3.30 in 10 steps. All individual steps were scaled up to prepare ketone 3.30 
in more than 5-gram quantity.  
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Scheme 3.6. Synthesis of Common Intermediate 3.30 
   
3.5 Elaboration of the Common Intermediate 3.30 to C1-C8 Southern 
Tetrahydrofuran Segment 
 
3.5.1 Introduction of C4-Methyl Moiety 
 
With  sufficient  amount  of  common  intermediate  3.30  in  hand,  we  set  out  to 
elaborate  it  to  the  southern  C1-C8  tetrahydrofuran  segment  of  amphidinolides  C  /  F 
(Scheme 3.7). The immediate task in hand was incorporation of the C4-methyl moiety to 
dihydrofuran scaffold 3.28. We expected to directly trap the enol-benzoate 3.28-derived 
enolate 3.29 with methyl iodide to generate the C4-methyl derivative. Unfortunately, the 
C6-stereochemical influence appeared to be the dominant stereo-controlling element in 
alkylation - yielding the undesired C4-methyl configuration 3.31 as major isomer. We 
were able to exploit this C6-directing effect to our advantage to establish the desired C4-
methyl stereochemistry. First, the ketone 3.30 was converted to corresponding enone 3.33 
and  then  the  exo-methylene  moiety  in  3.33  was  hydrogenated  using  Wilkinson’s 
catalyst
17 to  provide  the  correct  stereochemical  combination  3.32  in  good  yield  and 
diastereoselectivity (89%, 10:1 dr). Fortunately, no erosion at C6-center was identified 
during the methylenation event (notice there are two deprotonation sites - C4 and C6). The 
relative  stereochemistry  of  C4-methyl  moiety  was  established  via  nOe  analysis.  A 
convincing nOe enhancement (2.5%) was observed between the C3-proton and C4-methyl 
in the desired product 3.32. This nOe signal was absent in 3.31; instead, the C4-methyl 
was showing nOe enhancement the C2-protons (1.2% nOe).  
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Scheme 3.7. Incorporation of the C4-Methyl Moiety 
 
 
 
 
 
 
   
3.5.2 Completion of the Synthesis of Southern Tetrahydrofuran Subunit 
 
  After incorporation of the C4-methyl group by the aid of C5-ketone, the next task 
in hand was a quick deoxygenation to furnish the fully functionalized C1-C8 southern 
tetrahydrofuran subunit 3.35 (Scheme 3.8). We intended to utilize the Myers’ modified 
Wolff-Kishner  reduction  conditions  to  serve  this  purpose.
18 This  two-step,  one-flask 
method combines a t-butyldimethylsilylhydrazone (TBS-hydrazone) formation followed 
by  low  temperature  Wolff-Kishner  reduction  for  removal  of  the  carbonyl  oxygen. 
Therefore,  the  1,2-bis(t-butyldimethylsilyl)hydrazine  was  prepared  and  treated  with 
ketone  3.32  in  presence  of  catalytic  Sc(OTf)3.  While  the  TBS-hydrazone  generation 
proceeded smoothly (checked by TLC mass spectrometry), the t-BuOK mediated Wolff-
Kishner reduction proved problematic mainly leading to decomposition of the hydrazone 
derivative 3.34. Alternately, the two-step, two-flask tosylhydrazone formation / hydride 
reduction  technique  was  attempted.  Once  again,  the  hydrazone  derivative  3.36  was 
formed  easily,  but  remained  inert  under  various  reduction  conditions  {e.g. 
NaB(OAc)3H}. Finally, we were able to circumvent this problem by utilizing a traditional 
three-step Barton-MaCombie deoxygenation protocol.
19 The ketone was first reduced to 
alcohol 3.37 and subsequently converted to thioate derivative 3.38. Lastly, n-Bu3SnH-
mediated  radical  reduction  cleanly  delivered  the  desired  product  3.35.  Use  of 
deoxygenated toluene was necessary for the efficiency of this transformation; significant 
reduction in yield was recorded in regular dry toluene. This efficient three-step sequence 
delivered the deoxygenated tetrahydrofuran 3.35 in 80% overall yield.  
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Scheme 3.8. Deoxygenation of C5-Ketone 
 
 
 
 
    
3.6 Synthesis of Northern C18-C25 Tetrahydrofuran Fragment 
 
Synthesis of the C18-C25 northern tetrahydrofuran segment 3.41 again resumed 
with  the  common  intermediate  3.30  (Scheme  3.9).  We  employed  our  previously 
optimized three-step Barton-MaCombie sequence
19 for removal of the C22 ketone and the 
deoxygenated  tetrahydrofuran  3.41  was  obtained  in  excellent  overall  yield  (86%).  It 
should be mentioned that, an additional complicacy arose by an undesired silyl migration 
during the thioate formation under basic conditions {e.g. (Imid)2C=S, DMAP, CH2Cl2}. 
We  avoided  this  unanticipated  problem  simply  by  heating  the  alcohol  3.39  with 
thiocarbonyldiimidazole at elevated temperatures (non-basic conditions). Such kind of 
silyl migration was also observed under basic conditions during deoxygenation of the C5-
ketone in C1-C8 subunit synthesis, but to a lesser extent.  
 
Im2C=S
PhMe, 100 ºC
99%
O
OTBS
O
H H
3.40
NaBH4
MeOH
95%, 1.7:1 dr
OTBS
O H H
PivO
O
3.30
O
OTBS
OH
PivO
H H
3.39
S N
N
O
OTBS
PivO
H H
3.41
Bu3SnH
AIBN, PhMe
95 ºC
91%
OTBS
22
22
22
22
OTBS
PivO
OTBS
OTBS
O
O
O
PivO
H H
Silyl-migration occured
under basic conditions
22 Si
OTBS
18 25
3.42
 
 
Scheme 3.9. Deoxygenation of C22 Ketone 
    
3.7 An Improved Route to Enyne 3.43 
 
  After devising a scalable sequence to diol 3.19, we intended to design a shorter 
route to access the cyclization precursor (Scheme 3.10). The enyne 3.43 was previously 
made in 8 linear steps (total steps count 11) in multigram quantity. The Sonogashira 
cross-coupling
6 was utilized as key step to construct the enyne skeleton. In a second-
generation strategy, we planned to introduce the propargyl alcohol via an asymmetric 
alkynylation  between  known  aldehyde  3.45
20  and  enyne  3.46
21  (Scheme  3.10). 
Accordingly, the TBS ether 3.46 was prepared in one step from commercially available 
enyneol 3.47.
22 A one-flask Carreira asymmetric alkynylation / protection
23 furnished the 
requisite propargyl benzoate 3.43 in a modest 35% yield and in good enantioselectivity 
(89%  ee).  The  enantiomeric  excess  was  determined  via 
19F  NMR  analysis  after 
derivatization  of  the  intermediate  propargyl  alcohol  to  a  Mosher  ester.  Thus,  our 
improved second-generation approach produced the enyne intermediate 3.43 in a notable 
two linear steps (total steps count 4). 
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Scheme 3.10. Our Improved Second-generation Synthesis of Enyne 3.43 
 
3.8 Conclusion 
 
  The silver-catalyzed isomerization / cyclization of the propargyl-benzoate / diol 
3.19 to dihydrofuran 3.20 was accomplished. An efficient and scalable 10-step sequence 
was devised to provide the common ketone 3.30 intermediate in multigram quantity. The 
common intermediate was further elaborated to the southern C1-C8 and northern C18-C25 
tetrahydrofuran segments. A second-generation synthesis of the propargyl benzoate / diol 
precursor 3.19 was accomplished in as low as three steps. Gram scale synthesis of both 
    
the northern and southern tetrahydrofuran fragments laid a solid base for the completion 
of the total syntheses of amphidinolides C and F. 
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3.10 Experimental 
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Alkyne 3.7: To a stirred solution of oxalyl chloride (8.88 g, 6.1 mL, 70.0 mmol) 
in CH2Cl2 (154.0 mL) at -78 ºC was cannulated a solution of DMSO (11.43 g, 10.4 mL, 
146.3 mmol) in CH2Cl2 (77.0 mL). After 15 min, a solution of alcohol 3.5
1 (12.36 g, 63.6 
mmol) in CH2Cl2 (77.0 mL) was cannulated to it. After 45 min, Et3N (32.20 g, 44.7 mL, 
318.2 mmol) was added. After 10 min, the cooling bath was removed and the reaction 
was quenched with H2O (150 mL).  The aqueous layer was extracted with CH2Cl2 (3 X 
300 mL) and the dried (MgSO4) extract was concentrated in vacuo to give the crude 
aldehyde 3.6. 
To a stirred solution of Ohira-Bestmann reagent 2.27
2 (18.30 g, 95.4 mmol) in 
THF (320.0 mL) at -78 ºC was added NaOMe (191.0 mL, 95.5 mmol, 0.5 M in THF) 
over 30 min. A solution of crude aldehyde 3.6 in THF (160.0 mL) was cannulated to it 
and was slowly warmed to 0 ºC over 2.5 h. The reaction was quenched with sat. aq. 
NH4Cl (150 mL) and the aqueous layer was extracted with CH2Cl2 (3 X 300 mL). The 
    
dried (MgSO4) extract was concentrated in vacuo and purified by flash chromatography 
over silica gel, eluting with 5-15% EtOAc / hexanes, to give alkyne 3.7 (8.02 g, 42.6 
mmol, 67%) as colorless oil. [α]D
23 = +29.0 (c = 1.02, CHCl3); IR: (neat) 3287, 2967, 
2931, 2857, 1455, 1399, 1303, 1119, 1097, 1007, 760 cm
-1; 
1H NMR (700 MHz, CDCl3) 
δ 7.52-7.54 (m, 2H), 7.35-7.40 (m, 3H), 5.54 (s, 1H), 4.69 (dt, J = 11.5, 2.4 Hz, 1H), 4.30 
(ddd, J = 11.7, 4.9, 1.3 Hz, 1H), 3.99 (td, J = 12.1, 2.5 Hz, 1H), 2.57 (d, J = 2.1 Hz, 1H), 
2.27-2.33 (m, 1H), 1.80-1.83 (m, 1H) ppm; 
13C NMR (176 MHz, CDCl3) δ 137.8, 129.1, 
128.3, 126.2, 101.6, 81.6, 73.8, 67.2, 66.6, 31.9 ppm; HRMS (EI+) calcd. for C12H12O2 
(M+) 188.08373, found 188.08406. 
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Diol 3.8: To a stirred solution of benzylidine acetal 3.7 (21.9 g, 116.5 mmol) in 
MeOH  (445  mL)  at  rt  was  added  p-TSA•H2O  (222  mg,  1.16  mmol).  After  3  h,  the 
reaction  was  quenched  with  Et3N  (2.0  mL).  The  solvent  was  removed  in vacuo  and 
purified by flash chromatography over silica gel, eluting with 40-80% EtOAc / hexanes, 
to give diol 3.8 (10.9 g, 108.8 mmol, 93%) as colorless oil. [α]D
23 = +36.1 (c = 1.01, 
CHCl3); IR: (neat) 3292, 2957, 2891, 2115, 1643, 1434, 1337, 1185, 1047, 965, 887 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 4.66-4.69 (m, 1H),4.02-4.06 (m, 1H), 3.88-3.91 (m,1H), 
3.05 (d, J = 5.0 Hz, 1H), 2.54 (d, J = 2.1 Hz, 1H), 2.30 (br s, 1H), 2.04-2.08 (m, 1H), 
    
1.95-1.99 (m, 1H) ppm; 
13C NMR (176 MHz, CDCl3) δ 84.1, 73.4, 61.5, 60.3, 38.6 ppm; 
HRMS (EI+) calcd. for C5H8O2 (M+)100.0524, found 100.0523.  
 
3.8
OH OH
3.48
OH DMBO
3.3
OBz DMBO
 
 
Benzoate  3.3:  To  a  stirred  solution  of  diol  3.8  (240  mg,  2.39  mmol)  and 
DMBOC(NH)CCl3 (899 mg, 2.87 mmol) in THF (20.0 mL) at rt was added PPTS (61.0 
mg, 0.239 mmol). After 48 h, the reaction was quenched with sat. aq. NaHCO3 (15 mL) 
and the aqueous layer was extracted with Et2O / EtOAc (1:1, 3 X 30 mL). The dried 
(MgSO4) extract was concentrated in vacuo to give crude DMB ether 3.48. 
  To a stirred solution of the crude 3.48 in pyridine (10.0 mL) at rt were added 
DMAP (29.0 mg, 0.239 mmol) followed by benzoyl chloride (1.01 g, 0.83 mL, 7.19 
mmol). After 2.5 h, the reaction was quenched with sat. aq. NaHCO3 (20 mL) and the 
aqueous layer was extracted with Et2O (3 X 50 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
20-40% EtOAc / hexanes, to give benzoate ester 3.3 (306 mg, 0.863 mmol, 36%) as 
colorless oil. [α]D
23 = +37.8 (c = 1.02, CHCl3); IR: (neat) 3270, 2933, 2859, 1722, 1593, 
1516, 1451, 1265, 1157, 1095, 1026, 712 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 8.04-8.06 
    
(m, 2H), 7.59 (tt, J = 7.4, 1.3 Hz, 1H), 7.45 (t, J = 7.7 Hz, 2H), 6.90 (d, J = 1.7 Hz, 1H), 
6.86 (dd, J = 8.1, 1.7 Hz, 1H), 6.78 (d, J = 8.1 Hz, 1H), 5.81 (ddd, J = 7.9, 6.4, 2.1 Hz, 
1H), 4.46 (dd, J = 28.0, 11.5 Hz, 2H), 3.90 (s, 3H), 3.85 (s, 3H), 3.65-3.71 (m, 2H), 2.51 
(d, J = 2.1 Hz, 1H), 2.28-2.32 (m, 1H), 2.21-2.26 ( m, 1H) ppm; 
13C NMR (176 MHz, 
CDCl3) δ 165.3, 149.0, 148.5, 133.2, 130.6, 129.77, 129.72, 128.4, 120.2, 111.0, 110.7, 
81.0, 73.9, 73.0, 65.3, 61.7, 55.88, 55.82, 35.0 ppm; HRMS (EI+) calcd. for C21H22O5 
(M+) 354.1467, found 354.1458.  
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Enyne 3.10: To a stirred solution of PdCl2(PPh3)2 (12.1 mg, 16.9 µmol) in THF 
(2.0 mL) at rt was added CuI (10.0 mg, 50.8 µmol). A solution of alkyne 3.3 (120 mg, 
0.339  mmol)  and  vinyl  iodide  3.4
3 (112  mg,  0.375  mmol)  in  THF  (2.0  mL)  was 
cannulated to it. Et3N (680 mg, 0.95 mL, 6.78 mmol) was added dropwise over 5 min. 
After 1.5 h, the reaction was quenched with sat. aq. NH4Cl (15 mL) and the aqueous layer 
was extracted with Et2O (3 X 30 mL). The dried (MgSO4) extract was concentrated in 
vacuo and purified by flash chromatography over silica gel, eluting with 10-20% EtOAc / 
hexanes, to give enyne 3.10 (119 mg, 0.226 mmol, 67%) as colorless oil. [α]D
23 = +6.5 (c 
= 1.00, CHCl3); IR: (neat) 2954, 2930, 2856, 1723, 1516, 1463, 1452, 1265, 1107, 1027, 
836 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 8.04-8.06 (m, 2H), 7.58 (tt, J = 7.4, 1.3 Hz, 1H), 
7.44-7.46 (m, 2H), 6.90 (d, J = 1.9 Hz, 1H), 6.86 (dd, J = 8.1, 1.9 Hz, 1H), 6.79 (d, J = 
    
8.1 Hz, 1H), 6.22 (dt, J = 15.8, 4.1 Hz, 1H), 5.94 (td, J = 6.7, 1.4 Hz, 1H) 5.79 (ddd, J = 
15.7, 4.1, 2.1 Hz, 1H), 4.46 (dd, J = 25.5, 11.5 Hz, 2H), 4.23 (ddd, J = 4.1, 2.2, 0.4 Hz, 
2H), 3.90 (s, 3H), 3.86 (s, 3H), 3.65-3.71 (m, 2H), 2.28-2.32 (m, 1H), 2.21-2.26 (m,1H), 
0.92 (s, 9H), 0.07 (s, 6H) ppm; 
13C NMR (176 MHz, CDCl3) δ 165.4, 149.0, 148.5, 
143.6, 133.0, 130.7, 129.9, 129.7, 128.3, 120.2, 111.0, 110.7, 107.7, 86.4, 83.9, 73.0, 
65.6,  62.7,  62.5,  55.87,  55.82,  35.3,  25.8,  18.3,  -5.3  ppm;  HRMS  (ES+)  calcd.  for 
C30H40O6SiNa (M+Na) 547.2492, found 547.2483.  
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Diol 3.2: To a stirred solution of AD-mix-β (182 mg) in t-BuOH / H2O (4.0 mL, 
1:1) at rt was added MeSO2NH2 (12.7 mg, 0.133 mmol). After 15 min, the mixture was 
cooled down to 0 ºC and transferred to a flask containing the enyne 3.10 (70.2 mg, 0.133 
mmol) at 0 ºC. After 40 h, the reaction was quenched with solid Na2SO3 (200 mg) and the 
aqueous layer was extracted with EtOAc (4 X 20 mL). The combined organic layer was 
washed with brine (20 mL). The dried (MgSO4) extract was concentrated in vacuo and 
purified by flash chromatography over silica gel, eluting with 20-50% EtOAc / hexanes, 
to give diol 3.2 (60.9 mg, 0.109 mmol, 82%) as colorless oil. [α]D
23 = +24.2 (c = 1.00, 
CHCl3); IR: (neat) 3474, 2953, 2930, 2857, 1723, 1601, 1516, 1464, 1266, 1107, 1027, 
837, 713 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 8.02-8.04 (m, 2H), 7.59 (tt, J = 7.4, 1.3 Hz, 
    
1H), 7.43-7.46 (m, 2H), 6.89 (d, J = 1.9 Hz, 1H), 6.85 (dd, J = 8.0, 1.9 Hz, 1H), 6.78 (d, J 
= 8.0 Hz, 1H), 5.83 (ddd, J = 7.5, 6.1, 1.5 Hz, 1H), 4.42-4.48 (m, 3H), 3.89 (s, 3H), 3.85 
(s, 3H), 3.80 (dd, J = 10.3, 4.8 Hz, 1H), 3.75 (dd, J = 10.3, 4.5 Hz, 1H), 3.63-3.71 (m, 
3H), 2.79-2.85 (br m, 1H), 2.65-2.69 (br m, 1H), 2.26-2.31 (m, 1H), 2.20-2.25 (m, 1H), 
0.89 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 165.3, 149.0, 
148.5, 133.2, 130.5, 129.7, 128.3, 120.3, 111.0, 110.7, 83.6, 83.5, 73.9, 73.0, 65.3, 63.6, 
63.4,  61.9,  55.87,  55.84,  35.0,  25.8,  18.2,  -5.4,  -5.5  ppm;  HRMS  (ES+)  calcd.  for 
C30H42O8SiNa (M+Na) 581.2547, found 551.2550.  
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Benzoate  3.50:  To  a  stirred  solution  of  diol  3.8  (517  mg,  5.16  mmol)  and 
PMBOC(NH)CCl3 (1.75 g, 6.19 mmol) in THF (43 mL) at rt was added PPTS (130 mg, 
0.516 mmol). After 42 h, the reaction was quenched with sat. aq. NaHCO3 (25 mL) and 
the aqueous layer was extracted with Et2O / EtOAc (1:1, 3 X 50 mL). The dried (MgSO4) 
extract was concentrated in vacuo to give crude PMB ether 3.49. 
  To a stirred solution of the crude 3.49 in pyridine (21.5 mL) at rt were added 
DMAP (62.5 mg, 0.516 mmol) followed by benzoyl chloride (2.17 g, 1.80 mL, 15.5 
    
mmol). After 2.5 h, the reaction was quenched with sat. aq. NaHCO3 (40 mL) and the 
aqueous layer was extracted with Et2O (3 X 75 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
20-40% EtOAc / hexanes, to give benzoate ester 3.50 (687 mg, 2.11 mmol, 41%) as 
colorless oil. [α]D
23 = +34.6 (C = 1.00, CHCl3); IR: (neat) 3289, 2932, 2861, 1723, 1612, 
1513, 1451, 1266, 1249, 1175, 1095, 1069, 820, 712 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 
8.05-8.07 (m, 2H), 7.59 (tt, J = 7.4, 1.2 Hz, 1H), 7.45-7.48 (m, 2H), 7.26 (d, J = 8.6 Hz, 
2H), 6.85 (d, J = 8.6 Hz, 2H), 5.80 (ddd, J = 7.6, 6.2, 2.1 Hz, 1H), 4.46 (dd, J = 29.3, 
11.5 Hz, 1H), 3.79 (s, 3H), 3.64-3.71 (m, 2H), 2.51 (d, J = 2.1 Hz, 1H), 2.27-2.32 (m, 
1H), 2.21-2.25 ( m, 1H) ppm; 
13C NMR (176 MHz, CDCl3) δ 165.3, 159.1, 133.2, 130.1, 
129.8, 129.3, 128.3, 113.7, 81.0, 73.9, 72.7, 65.2, 61.8, 55.2, 35.0 ppm; HRMS (ES+) 
calcd. for C20H20O4Na (M+ Na) 347.1259, found 347.1251.  
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Enyne 3.51: To a stirred solution of PdCl2(PPh3)2 (46.2 mg, 0.066 mmol) in THF 
(7.0 mL) at rt was added CuI (37.5 mg, 0.197 mmol). A solution of alkyne 3.50 (428 mg, 
1.32 mmol) and vinyl iodide 3.4
3 (433 mg, 1.45 mmol) in THF (7.0 mL) was cannulated 
to it. Et3N (2.01 g, 2.8 mL, 19.8 mmol) was added dropwise over 5 min. After 2.5 h, the 
reaction was quenched with sat. aq. NH4Cl (30 mL) and the aqueous layer was extracted 
with  Et2O  (3  X  60  mL).  The  dried  (MgSO4)  extract  was  concentrated  in vacuo  and 
    
purified by flash chromatography over silica gel, eluting with 5-15% EtOAc / hexanes, to 
give enyne 3.51 (445 mg, 0.899 mmol, 68%) as colorless oil. [α]D
23 = +6.2 (c = 1.00, 
CHCl3); IR: (neat) 2954, 2930, 2856, 1723, 1612, 1513, 1301, 1253, 1103, 1069, 836, 
712 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 8.05-8.07 (m, 2H), 7.58 (tt, J = 7.4, 1.3 Hz, 1H), 
7.43-7.47 (m, 2H), 7.26 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.7 Hz, 2H), 6.23 (dt, J = 15.7, 
4.1 Hz, 1H), 5.92 (td, J = 6.7, 1.4 Hz, 1H), 5.79 (ddd, J = 15.7, 4.1, 2.1 Hz, 1H), 4.46 (dd, 
J = 16.1, 11.5 Hz, 2H), 4.23 (dd, J = 4.1, 2.1 Hz, 2H), 3.78 (s, 3H), 3.62-3.72 (m, 2H), 
2.18-2.33 (m, 2H), 0.92 (s, 9H), 0.08 (s, 6H) ppm; 
13C NMR (176 MHz, CDCl3) δ 165.4, 
159.1, 143.5, 133.0, 130.3, 130.0, 129.7, 129.2, 128.3, 113.7, 107.8, 86.4, 83.9, 72.7, 
65.5, 62.7, 62.6, 55.2, 35.3, 25.8, 18.3, -5.3 ppm; HRMS (ES+) calcd. for C29H39O5Si 
(M+H) 495.2567, found 495.2558.  
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Diol 3.17: To a stirred solution of AD-mix-β (1.52 g) in t-BuOH / H2O (26.0 mL, 
1:1) at rt was added MeSO2NH2 (85.5 mg, 0.899 mmol). After 15 min, the mixture was 
cooled down to 0 ºC and transferred to a flask containing the enyne 3.51 (445 mg, 0.899 
mmol) at 0 ºC. After 36 h, the reaction was quenched with solid Na2SO3 (1.6 g) and the 
aqueous layer was extracted with EtOAc (4 X 50 mL). The combined organic layer was 
washed with brine (50 mL). The dried (MgSO4) extract was concentrated in vacuo and 
    
purified by flash chromatography over silica gel, eluting with 20-50% EtOAc / hexanes, 
to give diol 3.17 (423 mg, 0.800 mmol, 89%) as colorless oil. [α]D
23 = +18.7 (c = 1.10, 
CHCl3); IR: (neat) 3431, 2954, 2930, 2856, 1723, 1612, 1513, 1452, 1256, 1104, 836, 
712 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 8.02-8.04 (m, 2H), 7.59 (tt, J = 7.4, 1.3 Hz, 1H), 
7.44-7.47 (m, 2H), 7.25 (d, J = 8.6 Hz, 2H), 6.84 (d, J = 8.6 Hz, 2H), 5.81 (ddd, J = 7.6, 
6.1, 1.5 Hz, 1H), 3.81 (dd, J = 10.3, 4.8 Hz, 1H), 3.79 (s, 3H), 3.76 (dd, J = 10.2, 4.7 Hz, 
1H), 3.62-3.72 (m, 3H), 2.79 (d, J = 5.2 Hz, 1H), 2.66 (d, J = 6.3 Hz, 1H), 2.26-2.30 (m, 
1H), 2.20-2.24 (m, 1H), 0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H) ppm; 
13C NMR (176 
MHz, CDCl3) δ 165.3, 159.2, 130.2, 129.8, 129.7, 129.2, 128.3, 113.8, 83.7, 83.5, 74.0, 
72.7, 65.3, 63.6, 63.4, 62.0, 55.2, 35.1, 25.8, 18.2, -5.50, -5.54 ppm; HRMS (ES+) calcd. 
for C29H40O7SiNa (M+Na) 551.2441, found 551.2439.  
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Dihydrofuran 3.18: To a stirred solution of diol 3.17 (313 mg, 0.592 mmol) in 
dry and deoxygenated C6H6 (6.0 mL) was added AgBF4 (11.5 mg, 0.059 mmol) and 
heated to 80 ºC in dark. After 1.45 h, the reaction was cooled down to rt and the solvent 
was reduced to 1.0 mL in vacuo. The residue was purified by flash chromatography over 
silica gel, eluting with 20-30% EtOAc / hexanes, to give the dihydrofuran 3.18 (93.9 mg, 
0.177 mmol, 30%) as colorless oil. [α]D
23 = +11.0 (c = 1.14, CHCl3); IR: (neat) 3471, 
    
2957, 2929, 2856, 1746, 1612, 1513, 1250, 1192, 1084, 836, 778  cm
-1; 
1H NMR (400 
MHz, CDCl3) δ 8.08-8.11 (m, 2H), 7.64 (tt, J = 7.4, 1.3 Hz, 1H), 7.48-7.52 (m, 2H), 7.28 
(d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.6 Hz, 2H), 6.07 (t, J = 1.7 Hz, 1H), 5.11-5.16 (m, 1H), 
4.95 (dt, J = 5.6, 1.7 Hz, 1H), 4.47 (s, 2H), 3.81 (s, 3H), 3.72-3.82 (m, 3H), 3.60-3.66 (m, 
2H), 1.92-2.02 (m, 2H), 0.91 (s, 9H), 0.098 (s, 3H), 0.095 (s, 3H) ppm; 
13C NMR (100 
MHz, CDCl3) δ 163.5, 159.1, 144.4, 133.8, 130.5, 130.0, 129.3, 128.8, 128.6, 113.7, 
113.2, 82.1, 80.3, 72.7, 71.3, 66.4, 63.9, 55.2, 36.7, 25.9, 18.3, -5.3 ppm; HRMS (ES+) 
calcd. for C29H41O7Si (M+H) 529.2622, found 529.2632. 
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Benzoate 3.44: To a stirred solution of benzylidine acetal 3.7 (5.34 g, 28.3 mmol) 
in MeOH (108.0 mL) at rt was added p-TSA•H2O (54.0 mg, 0.283 mmol). After 3 h, the 
reaction was quenched with Et3N (425 mg, 0.60 mL, 4.20 mmol) and the solvent was 
removed in vacuo to give crude diol 3.8. 
To a stirred solution of crude 3.8 in CH2Cl2 / pyridine (81.0 mL, 2.5:1) at 0 ºC 
was added pivaloyl chloride (3.76 g, 3.9 mL, 31.2 mmol). After 1.5 h, DMAP (343 mg, 
    
2.83 mmol) followed by benzoyl chloride (4.98 g, 4.1 mL, 35.4 mmol) were added and 
the  reaction  was  warmed  to  rt.  After  2.5  h,  the  reaction  was  quenched  with  sat.  aq. 
NaHCO3 (75 mL) and the aqueous layer was extracted with Et2O (3 X 200 mL). The 
dried (MgSO4) extract was concentrated in vacuo and purified by flash chromatography 
over silica gel, eluting with 5-10% EtOAc / hexanes, to sequentially give benzoate ester 
3.44 (4.99 g, 17.3 mmol, 61%) as colorless oil followed by bis-pivaloyl ester 3.53 (1.45 
g, 5.40 mmol, 19%). Benzoate ester 3.44: [α]D
23 = +35.3 (c = 1.02, CHCl3); IR: (neat) 
3291, 3264, 2972, 2933, 2898, 2871, 1727, 1481, 1450, 1271, 1155, 1092, 1065, 1026, 
711 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 8.06-8.09 (m, 2H), 7.59 (tt, J = 7.4, 1.2 Hz, 1H), 
7.44-7.48 (m, 2H), 5.74 (td, J = 6.7, 2.1 Hz, 1H), 4.30 (td, J = 6.3, 2.0 Hz, 2H), 2.55 (d, J 
= 2.1 Hz, 1H), 2.23-2.38 (m, 2H), 1.21 (s, 9H) ppm; 
13C NMR (100 MHz, CDCl3) δ 
178.3, 165.2, 133.3, 129.8, 129.5, 128.4, 80.3, 74.4, 61.3, 60.0, 38.7, 33.9, 27.1 ppm; 
HRMS (CI+) calcd. for C17H21O4 (M+H) 289.1440, found 289.1434. 
Bis-pivaloyl ester 3.53: [α]D
23 = +49.0 (c = 1.00, CHCl3); IR: (neat) 3269, 2974, 2935, 
2909,  2874,  1733,  1481,  1461,  1398,  1366,  1282,  1038,  cm
-1; 
1H  NMR  (400  MHz, 
CDCl3) δ 5.46 (td, J = 6.9, 2.1 Hz, 1H), 4.20 (td, J = 6.5, 1.4 Hz, 2H), 2.47 (d, J = 2.1 Hz, 
1H) 2.10-2.22 (m, 2H), 1.23 (s, 9H), 1.21 (s, 9H) ppm; 
13C NMR (100 MHz, CDCl3) δ 
178.3, 177.0, 80.5, 73.8, 60.3, 59.9, 38.7, 33.7, 27.1, 26.9 ppm; HRMS (EI+) calcd. for 
C15H24O4 (M+) 268.1674, found 268.1661. 
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Diol 3.8: To a stirred solution of bis-pivaloyl ester 3.53 (2.02 g, 7.52 mmol) in 
MeOH (50.0 mL) at rt was added LiOH•H2O (237 mg, 5.64 mmol). After 20 h, the 
reaction was quenched with Dowex-50W-X8 resin (7.1 g). After 15 min, the solid resin 
was removed by filtration. The filtrate was concentrated in vacuo and purified by flash 
chromatography over silica gel, eluting with 40-80% EtOAc / hexanes, to give diol 3.8 
(701 mg, 7.00 mmol, 93%) as colorless oil.  
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Enyne 3.43: To a stirred solution of PdCl2(PPh3)2 (995 mg, 1.41 mmol) in THF 
(163.0 mL) at rt was added CuI (810 mg, 4.25 mmol). A solution of alkyne 3.44 (8.17 g, 
28.3 mmol) and vinyl iodide 3.4
3 (9.30 g, 31.1 mmol) in THF (163.0 mL) was cannulated 
to it. Et3N (43.0 g, 60.0 mL, 424.9 mmol) was added dropwise over 15 min. After 2.5 h, 
the reaction was quenched with sat. aq. NH4Cl (150 mL) and the aqueous layer was 
extracted with Et2O (3 X 300 mL). The dried (MgSO4) extract was concentrated in vacuo 
and  purified  by  flash  chromatography  over  silica  gel,  eluting  with  10-15%  EtOAc  / 
hexanes, to give enyne 3.43 (10.11 g, 22.0 mmol, 78%) as colorless oil. [α]D
23 = +6.3 (c = 
    
1.02, CHCl3); IR: (neat) 2949, 2929, 2851, 1731, 1466, 1267, 1155, 1104, 952, 832, 711 
cm
-1; 
1H NMR (400 MHz, CDCl3) δ 8.07-8.10 (m, 2H), 7.59 (tt, J = 7.4, 1.3 Hz, 1H), 
7.44-7.48 (m, 2H), 6.27 (dt, J = 15.7, 4.0 Hz, 1H), 5.88 (dt, J = 1.5, 6.6 Hz, 1H), 5.80 
(ddt, J = 15.7, 2.1, 1.9 Hz, 1H), 4.29 (t, J = 6.3 Hz, 2H), 4.23 (dd, J = 4.0, 2.1 Hz, 1H), 
2.23-2.37 (m, 2H), 1.21 (s, 9H), 0.92 (s, 9H), 0.08 (s, 6H) ppm; 
13C NMR (100 MHz, 
CDCl3) δ 178.4, 165.3, 143.9, 133.2, 129.8, 129.7, 128.4, 107.5, 85.4, 84.4, 62.7, 62.2, 
60.3,  38.7,  34.2,  27.1,  25.8,  18.3,  -5.4  ppm;  HRMS  (ES+)  calcd.  for  C26H38O5SiNa 
(M+Na) 481.2386, found 481.2398. 
 
OBz
OBz
OTBS
OH
OH
OTBS
PivO
PivO
3.43 3.19  
 
Diol 3.19: To a stirred solution of AD-mix-β (30.53 g) in t-BuOH / H2O (660.0 
mL, 1:1) at rt was added MeSO2NH2 (2.10 g, 22.0 mmol). After 15 min, the mixture was 
cooled down to 0 ºC and transferred to a flask containing the enyne 3.43 (10.11 g, 22.0 
mmol) at 0 ºC. After 40 h, the reaction was quenched with solid Na2SO3 (35.0 g, 277.5 
mmol) and the aqueous layer was extracted with EtOAc (4 X 400 mL). The combined 
organic  layer  was  washed  with  brine  (250  mL).  The  dried  (MgSO4)  extract  was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
10-40% EtOAc / hexanes, to give diol 3.19 (9.44 g, 19.2 mmol, 87%) as colorless oil. 
[α]D
23 = +17.0 (c = 1.00, CHCl3); IR: (neat) 3460, 2954, 2927, 2856, 1723, 1478, 1265, 
    
1146, 1097, 841, 786, 715 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 8.06-8.08 (m, 2H), 7.61 
(tt, J = 7.4, 1.1 Hz, 1H), 7.47 (t, J = 7.8 Hz, 2H), 5.78 (td, J = 6.7, 1.3 Hz, 1H), 4.48 (td, J 
= 5.3, 1.4 Hz, 1H), 4.24-4.38 (m, 2H), 3.71-3.85 (m, 3H), 2.81-2.83 (m, 1H), 2.71 (d, J = 
6.0 Hz, 1H), 2.23-2.38 (m, 1H), 1.22 (s, 9H), 0.90 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 178.4, 165.2, 133.3, 129.8, 129.5, 128.4, 84.3, 82.7, 73.9, 
63.6, 63.4, 61.5, 60.1, 38.7, 34.0, 27.1, 25.8, 18.2, -5.50, -5.54 ppm; HRMS (ES+) calcd. 
for C26H40O7SiNa (M+Na) 515.2441, found 515.2419. 
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  Dihydrofuran 3.20: To a stirred solution of diol 3.19 (5.30 g, 10.7 mmol) in dry 
C6H6 (105.0 mL) was added AgBF4 (210 mg, 1.07 mmol) and heated to 80 ºC in dark. 
After 1.45 h, the reaction was cooled down to rt and the solvent was reduced to 15 mL in 
vacuo. The residue was quickly passed through a short silica gel column, eluting with 10-
20% EtOAc / hexanes, to sequentially give the furan by-product 3.21 (762 mg, 1.60 
mmol, 15 %) followed by dihydrofuran 3.20 (3.70 g, 7.51 mmol, 70%) as colorless oil. 
Dihydrofuran 3.20: [α]D
23 = +10.5 (c = 1.02, CHCl3); IR: (neat) 3513, 2956, 2925, 2855, 
1750, 1727, 1260, 1158, 1112, 1084, 835, 777 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 8.09 
(d, J = 8.2 Hz, 2H), 7.64 (td, J = 7.4, 1.0 Hz, 1H), 7.50 (t, J = 7.7 Hz, 2H), 6.09 (t, J = 1.7 
Hz, 1H), 4.97 (dt, J = 5.6, 1.9 Hz, 1H), 4.27 (dt, J = 11.1, 6.2 Hz, 1H), 4.21 (dt, J = 11.1, 
    
6.5 Hz, 1H), 3.84 (td, J = 6.3, 2.0 Hz, 1H), 3.80 (dd, J = 9.8, 6.5 Hz, 1H), 3.75 (dd, J = 
9.8, 6.1 Hz, 1H), 1.97-2.05 (m, 2H), 1.22 (s, 9H), 0.92 (s, 9H), 0.108 (s, 3H), 0.104 (s, 
3H); 
13C NMR (176 MHz, CDCl3) δ 178.6, 163.4, 144.7, 133.9, 130.0, 128.74, 128.70, 
112.5, 81.8, 80.6, 71.2, 63.9, 61.0, 38.7, 35.5, 27.2, 25.9, 18.3, -5.3; HRMS (ES+) calcd. 
for C26H40O7SiNa (M+Na) 515.2441, found 515.2409. 
Furan by-product 3.21: [α]D
23 = +42.3° (c = 1.02, CHCl3); IR (neat) 2957, 2932, 2857, 
1727, 1452, 1264, 1153, 1097, 837, 778 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 8.06 (dd, J 
= 8.4, 1.3 Hz, 2H), 7.57 (tt, J = 7.4, 1.3 Hz, 1H), 7.44 (dd, J = 8.3, 7.4, Hz, 2H), 6.38 (d, J 
= 3.1 Hz, 1H), 6.22 (dd, J = 8.0, 6.3 Hz, 1H), 6.21 (d, J = 3.1 Hz, 1H), 4.65 (s, 2H), 4.21 
(ddd, J = 11.2, 7.4, 5.7 Hz, 1H), 4.14 (dt, J = 11.2, 6.1 Hz, 1H), 2.48-2.53 (m, 1H), 2.39-
2.44 (m, 1H), 1.21 (s, 9H), 0.90 (s, 9H), 0.088 (s, 3H), 0.084 (s, 3H) ppm; 
13C NMR (176 
MHz, CDCl3) δ 178.3, 165.5, 154.7, 151.1, 133.0, 130.0, 129.7, 128.3, 109.8, 107.9, 
66.3, 60.4, 58.2, 38.7, 31.8, 27.1, 25.8, 18.3,  -5.24, -5.26 ppm; HRMS (ES+) calcd. for 
C26H38O6SiNa (M+Na) 497. 2335, found 497.2313. 
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  Bis-TBS Ether 3.28: To a stirred solution of alcohol 3.20 (3.70 g, 7.51 mmol) in 
CH2Cl2  (83.0  mL)  at  -78  ºC  were  added  2,6-lutidine  (3.21  g,  3.5  mL,  30.0  mmol) 
followed by TBSOTf (3.97 g, 3.5 mL, 15.0 mmol). After 3 h, the reaction was quenched 
    
with sat. aq. NaHCO3 (50 mL) and the aqueous layer was extracted with Et2O (3 X 100 
mL).  The  dried  (MgSO4)  extract  was  concentrated  in  vacuo  and  purified  by  flash 
chromatography over silica gel, eluting with 5-10% EtOAc / hexanes, to give bis-TBS 
ether 3.28 (3.87 g, 6.38 mmol, 85%) as colorless oil. [α]D
23 = +17.0 (c = 1.00, CHCl3); 
IR: (neat) 2956, 2925, 2886, 2855, 1750, 1731, 1466, 1260, 1155, 1088, 839, 777 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 8.08-8.09 (m, 2H), 7.63-7.66 (m, 1H), 7.50-7.52 (m, 2H), 
6.11 (t, J = 1.5 Hz, 1H), 5.07-5.09 (m, 1H), 4.98 (dt, J = 5.7, 1.5 Hz, 1H), 4.20-4.27 (m, 
2H), 3.85 (td, J = 6.6, 1.2 Hz, 1H), 3.78 (dd, J = 9.8, 7.5 Hz, 1H), 3.65 (dd, J = 9.7, 5.8 
Hz, 1H), 1.97-2.04 (m, 2H), 1.22 (s, 9H), 0.94 (s, 9H), 0.84 (s, 9H), 0.114 (s, 3H), 0.112 
(s, 3H), 0.05 (s, 3H), -0.03 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.6, 163.1, 
144.9, 133.7, 129.9, 129.0, 128.6, 111.8, 81.8, 81.4, 72.9, 64.2, 61.1, 38.7, 35.5, 27.2, 
26.0, 25.7, 18.4, 18.0, -4.1, -5.21, -5.24, -5.3 ppm; HRMS (ES+) calcd. for C32H55O7Si2 
(M+H) 607.3486, found 607.3475. 
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  Ketone 3.30: To a stirred solution of enol benzoate 3.28 (4.93 g, 8.12 mmol) in 
Et2O (86.0 mL) at -78 ºC was added MeLi•LiBr (7.4 mL, 16.2 mmol, 2.2 M in Et2O) 
dropwise. After 1.5 h, the reaction was quenched with sat. aq. NH4Cl (50 mL) and the 
aqueous layer was extracted with Et2O (3 X 100 mL). The dried (MgSO4) extract was 
    
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
5-20% EtOAc / hexanes, to sequentially give ketone 3.30 (3.30 g, 6.57 mmol, 81%) 
followed by keto-ol 3.54 (306 mg, 0.731 mmol, 9%) as colorless oils. Ketone 3.30: [α]D
23 
= -56.3 (c = 1.03, CHCl3); IR: (neat) 2954, 2927, 2883, 2856, 1761, 1734, 1472, 1358, 
1287, 1255, 1157, 1091, 835, 781 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 4.64-4.71 (m, 1H), 
4.25 (t, J = 6.3 Hz, 2H), 4.15 (br s, 1H), 4.03 (ddd, J = 8.9, 5.3, 1.7 Hz, 1H), 3.74 (t, J = 
9.2 Hz, 1H), 3.55 (dd, J = 9.6, 5.3 Hz, 1H), 2.56 (dd, J = 18.0, 6.3 Hz, 1H), 2.25 (ddd, J = 
18.0, 9.0, 1.0 Hz, 1H), 1.99-2.06 (m, 2H), 1.22 (s, 9H), 0.90 (s, 9H), 0.85 (s, 9H), 0.086 
(s, 3H), 0.084 (s, 3H), 0.07 (s, 3H), 0.02 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 
216.8, 178.4, 80.1, 74.9, 74.7, 63.0, 61.0, 43.6, 38.7, 35.5, 27.2, 25.9, 25.7, 18.3, 17.8, -
4.4, -5.2, -5.3, -5.4 ppm; HRMS (ES+) calcd. for C25H51O6Si2 (M+H) 503.3224, found 
503.3199. 
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  Ketone 3.31. To a stirred suspension of LiBr (104 mg, 1.19 mmol) in Et2O (3.2 
mL) at -78 ºC was added MeLi (0.68 mL, 1.08 mmol, 1.6 M in Et2O). A solution of enol-
benzoate 3.28 (330 mg, 0.543 mmol) in Et2O (5.0 mL, pre-cooled) was cannulated to it. 
After 3 h, DMPU (1.06 g, 1.0 mL, 8.27 mmol) was added followed by MeI (2.28 g, 1.0 
mL, 16.0 mmol). After 2 h, the reaction was quenched with sat. aq. NH4Cl (10 mL) and 
    
the aqueous layer was extracted with Et2O (3 X 30 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
2-6% EtOAc / hexanes, to give ketone 3.31 {206 mg, 0.398 mmol, 73% (5:1 dr)} as 
colorless oil. [α]D
23 = -87.1 (c = 1.00, CHCl3); IR (neat) 2956, 2930, 2858, 1761, 1731, 
1472, 1256, 1154, 1082, 836, 778 cm
-1; 
1H NMR (700 MHz, CDCl3) 4.68 (ddd, J = 10.2, 
7.3, 3.7 Hz, 1H), 4.27-4.30 (m, 1H), 4.22-4.25 (m, 1H), 4.09 (d, J = 1.6 Hz, 1H), 4.02-
4.05 (m, 1H), 3.73 (t, J = 9.2 Hz, 1H), 3.56 (dd, J = 9.5, 5.4 Hz, 1H), 2.55 (pen, J = 7.4 
Hz, 1H), 1.81-1.85 (m, 1H), 1.72-1.77 (m, 1H), 1.22 (s, 9H), 1.09 (d, J = 7.4 Hz, 3H), 
0.90 (s, 9H), 0.84 (s, 9H), 0.086 (s, 3H), 0.084 (s, 3H), 0.07 (s, 3H), 0.01 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 218.9, 178.5, 78.3, 76.7, 73.9, 63.0, 61.3, 45.6, 38.7, 29.9, 
27.2,  25.9,  25.8,  18.3,  17.9,  9.6,  -4.3,  -5.2,  -5.3,  -5.4  ppm;  HRMS  (ES+)  calcd.  for 
C26H53O6Si2 (M+H) 517.3381, found 517.3388.  
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  Enone 3.33: To a stirred solution of ketone 3.30 (1.91 g, 3.79 mmol) in THF 
(40.0 mL) at -78 ºC was added LDA
4 (7.6 mL, 7.60 mmol, 1 M in THF / hexanes) and 
warmed to -50 ºC over 15 min. After 35 min, DMPU (4.86 g, 4.6 mL, 37.9 mmol) was 
added followed by a solution of Eschenmoser’s salt (3.51 g, 18.9 mmol) in THF (40.0 
mL). The reaction was slowly warmed to -10 ºC over 50 min and quenched with sat. aq. 
    
NaHCO3 (30 mL) and the aqueous layer was extracted with Et2O (3 X 100 mL). The 
dried (MgSO4) extract was concentrated in vacuo and purified by flash chromatography 
over silica gel, eluting with 4-10% EtOAc / hexanes, to give enone 3.33 (1.38 g, 2.68 
mmol, 71%) as colorless oil. [α]D
23 = -117.6 (c = 1.00, CHCl3); IR: (neat) 2953, 2929, 
2883, 2855, 1731, 1645, 1474, 1256, 1158, 1112, 1084, 835, 781 cm
-1; 
1H NMR (700 
MHz, CDCl3) δ 6.12 (d, J = 2.8 Hz, 1H), 5.34 (d, J = 2.4 Hz, 1H), 5.08 (ddd, J = 8.6, 5.9, 
2.8 Hz, 1H), 4.30-4.33 (m, 2H), 4.29 (d, J = 1.3 Hz, 2H), 4.06 (ddd, J = 9.0, 5.3, 1.5 Hz, 
1H), 3.75 (dd, J = 9.4, 9.1 Hz, 1H), 3.54 (dd, J = 9.5, 5.2 Hz, 1H), 2.16-2.21 (m, 1H), 
1.93-1.98 (m, 1H), 1.22 (s, 9H), 0.91 (s, 9H), 0.78 (s, 9H), 0.093 (s, 3H), 0.090 (s, 3H), 
0.04 (s, 3H), -0.03 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 205.6, 178.5, 145.1, 
116.8, 80.3, 74.9, 74.7, 63.0, 60.5, 38.7, 34.8, 27.2, 25.9, 25.6, 18.3, 17.8, -4.4, -5.3, -5.4, 
-5.5 ppm; HRMS (ES+) calcd. for C26H50O6Si2Na (M+Na) 537.3044, found 537.3033. 
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  Methyl Ketone 3.32: To a stirred solution of enone 3.33 (1.28 g, 2.48 mmol) in 
toluene (45.0 mL) was added (Ph3P)3RhCl (230 mg, 0.248 mmol) at rt and a hydrogen 
balloon was fitted to it. After 30 h, the reaction was directly loaded onto column and 
purified by flash chromatography over silica gel, eluting with 6-10% EtOAc / hexanes, to 
give methyl ketone 3.32 {1.14 g, 2.20 mmol, 89%(10:1 dr)} as colorless oil. [α]D
23 = -
    
31.0 (c = 1.00, CHCl3); IR: (neat) 2959, 2932, 2878, 2856, 1761, 1728, 1462, 1287, 1255, 
1151, 1118, 1069, 841, 775 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 4.26-4.39 (m, 3H), 4.16 
(ddd, J = 10.4, 8.6, 3.4 Hz, 1H), 4.07 (ddd, J = 9.4, 5.1, 1.6 Hz, 1H), 3.74 (t, J = 9.4 Hz, 
1H), 3.54 (dd, J = 9.4, 5.1 Hz, 1H), 2.08-2.21(m, 2H), 1.93-2.02 (m, 1H), 1.22 (s, 9H), 
1.09 (d, J = 6.9 Hz, 3H), 0.90 (s, 9H), 0.85 (s, 9H), 0.089 (s, 3H), 0.086 (s, 3H), 0.07 (s, 
3H), 0.009 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 218.0, 178.4, 81.3, 80.0, 74.3, 
62.8, 60.9, 48.1, 38.7, 34.2, 27.2, 25.9, 25.8, 18.3, 17.7, 9.6, -4.5, -4.8, -5.3, -5.4 ppm; 
HRMS (ES+) calcd. for C26H53O6Si2 (M+H) 517.3381, found 517.3359. 
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Alcohol 3.37: To a stirred solution of ketone 3.32 (1.10 g, 2.12 mmol) in MeOH 
(40.0 mL) at 40 ºC was added NaBH4 (81.0 mg, 2.12 mmol). After 1 h, another portion of 
NaBH4  (40.5  mg,  1.06  mmol)  was  added.  After  additional  30  min,  the  reaction  was 
quenched with sat. aq. NH4Cl (20 mL) and the aqueous layer was extracted with EtOAc 
(4 X 40 mL). The dried (MgSO4) extract was concentrated in vacuo and purified by flash 
chromatography  over  silica  gel,  eluting  with  5-15%  EtOAc  /  hexanes,  to  give 
diastereomeric  alcohol  3.37  {1.01  g,  1.95  mmol,  92%  (1.3:1  dr)}  as  colorless  oil. 
Analytically  pure  samples  of  the  individual  diastereomers  could  be  obtained  via 
chromatography over silica gel, eluting with 5-15% EtOAc / hexanes, to give sequentially 
    
the major diastereomer followed by the minor diastereomer. 3.37 Major isomer: [α]D
23 = -
44.2 (c = 1.03, CHCl3); IR: (neat) 3493, 2948, 2921, 2856, 1728, 1472, 1391, 1363, 1287, 
1282, 1255, 1157, 1097, 841, 781 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 4.31 (ddd, J = 
10.8, 7.2, 4.8 Hz, 1H), 4.17 (ddd, J = 10.8, 8.2, 6.4 Hz, 1H), 4.12-4.14 (m, 1H), 3.98 
(ddd, J = 8.2, 8.1, 3.8 Hz, 1H), 3.88 (td, J = 9.7, 2.5 Hz, 1H), 3.73 (dd, J = 8.0, 2.9 Hz, 
1H), 3.56-3.65 (m, 3H), 1.88-1.97 (m, 2H), 1.64-1.72 (m, 1H), 1.21 (s, 9H), 1.06 (d, J = 
6.8 Hz, 1H), 0.93 (s, 9H), 0.90 (s, 9H), 0.137 (s, 3H), 0.134 (s, 3H), 0.12 (s, 3H), 0.11 (s, 
3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 178.4, 86.9, 78.9, 74.5, 72.9, 65.9, 62.0, 44.9, 
38.7,  33.6,  27.2,  25.8,  18.3,  9.7,  -4.4,  -4.9,  -5.6  ppm;  HRMS  (ES+)  calcd.  for 
C26H55O6Si2S (M+H) 519.3537, found 519.3512. 
3.37 Minor isomer: [α]D
23 = -28.9 (c = 1.05, CHCl3); IR: (neat) 3504, 2954, 2921, 
2883, 2856, 1734, 1712, 1456, 1282, 1255, 1167, 1075, 835, 781 cm
-1; 
1H NMR (700 
MHz, CDCl3) δ 4.26 (ddd, J = 10.8, 7.0, 4.8 Hz, 1H), 4.15 (ddd, J = 10.9, 8.4, 6.2 Hz, 
1H), 3.68-3.74 (m, 3H), 3.60-3.66 (m, 4H), 1.87-1.96 (m, 2H), 1.76-1.81 (m, 1H), 1.21 
(s, 9H), 1.09 (d, J = 6.6 Hz, 1H), 0.92 (s, 9H), 0.90 (s, 9H), 0.13 (s, 3H), 0.12 (s, 3H), 
0.11 (s, 3H), 0.08 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.4, 85.4, 79.4, 78.6, 
75.0, 65.8, 61.5, 46.1, 38.7, 33.6, 27.2, 25.87, 25.83, 18.29, 18.27, 13.9, -4.5, -4.7, -5.3, -
5.4 ppm;  HRMS (ES+) calcd. for C26H55O6Si2S (M+H) 519.3537, found 519.3511. 
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Thioate 3.38: To a stirred solution of diastereomeric alcohol 3.37 (1.01 g, 1.95 
mmol) in toluene (24.0 mL) was added thiocarbonyldiimidazole (497 mg, 2.78 mmol) at 
rt and heated to 100 ºC. After 24 h, the reaction cooled down to rt and the solvent was 
removed in vacuo. The residue was directly loaded onto column and purified by flash 
chromatography  over  silica  gel,  eluting  with  10-20%  EtOAc  /  hexanes,  to  give 
diastereomeric thioate 3.38 (1.12 g, 1.78 mmol, 91%) as colorless oil. Analytically pure 
samples of the individual diastereomers could be obtained via chromatography over silica 
gel, eluting with 5-15% EtOAc / hexanes, to give sequentially the major diastereomer 
followed by the minor diastereomer. 3.38 Major isomer: [α]D
23 = -18.5 (c = 1.00, CHCl3); 
IR: (neat) 2954, 2927, 2883, 2856, 1761, 1734, 1472, 1358, 1287, 1255, 1157, 1091, 835, 
781 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 8.33 (s, 1H), 7.60 (s. 1H), 7.09 (s, 1H), 6.31 (dd, 
J = 3.4, 3.3 Hz, 1H), 4.29-4.35 (m, 1H), 4.19-4.25 (m, 2H), 3.79-3.88 (m, 2H), 3.59 (dd, 
J = 10.7, 2.4 Hz, 1H), 3.48 (dd, J = 10.7, 4.5 Hz, 1H), 2.29-2.38 (m, 1H), 1.93-2.01 (m, 
1H), 1.74-1.83 (m, 1H), 1.22 (s, 9H), 1.01 (d, J = 6.8 Hz, 3H), 0.90 (s, 9H), 0.84 (s, 9H), 
0.11 (s, 3H), 0.07 (s, 3H), -0.01 (s, 3H), -0.02 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) 
δ 183.4, 178.3, 136.7, 131.2, 117.6, 85.8, 82.2, 79.9, 73.3, 65.9, 61.4, 45.5, 38.7, 33.3, 
    
27.2,  25.9,  25.8,  18.4,  18.3,  10.5,  -4.4,  -4.6,  -5.4  ppm;  HRMS  (ES+)  calcd.  for 
C30H57O6N2Si2S (M+H) 629.3476, found 629.3481. 
3.38 Minor isomer: [α]D
23 = -25.7 (c = 1.05, CHCl3); IR: (neat) 2954, 2927, 2879, 
2856, 1724, 1472, 1461, 1394, 1331, 1280, 1241, 1225, 1150, 1095, 989, 836, 777 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 8.34 (s, 1H), 7.63 (s. 1H), 7.06 (t, J = 0.8 Hz, 1H), 5.96 
(dd, J = 5.5, 3.9 Hz, 1H), 4.30 (dd, J = 11.3, 5.7 Hz, 1H), 4.26 (t, J = 3.3 Hz, 1H), 4.14-
4.20 (m, 1H), 3.99-4.03 (m, 1H), 3.91 (td, J = 8.6, 3.3 Hz, 1H), 3.70 (dd, J = 9.7, 7.7 Hz, 
1H), 3.61 (dd, J = 9.8, 5.0 Hz, 1H), 2.21-2.30 (m, 1H), 1.92-2.00 (m, 1H), 1.81-1.90 (m, 
1H), 1.21 (d, J = 6.7 Hz, 3H), 1.21 (s, 9H), 0.91 (s, 9H), 0.87 (s, 9H), 0.17 (s, 3H), 0.13 
(s, 3H), 0.06 (s, 3H), 0.05 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 183.9, 178.4, 
136.9, 130.9, 117.9, 90.7, 82.1, 81.9, 74.5, 63.9, 61.4, 46.7, 38.7, 33.2, 27.2, 25.9, 18.3, 
18.0, 14.4, -4.1, -4.3, -5.33, -5.34 ppm; HRMS (ES+) calcd. for C30H57O6N2Si2S (M+H) 
629.3476, found 629.3475. 
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Tetrahydrofuran 3.35: To a stirred solution of diastereomeric thioate 3.38 (1.12 
g, 1.78 mmol) in deoxygenated toluene (96.0 mL) at rt was added AIBN (29.3 mg, 0.178 
mmol) and heated to 95 ºC. Bu3SnH (1.04 g, 0.96 mL, 3.56 mmol) was added dropwise 
    
over 45 min. After another 45 min, the reaction was cooled down to rt and the solvent 
was removed in vacuo. The residue was directly loaded onto the column and purified by 
flash  chromatography  over  silica  gel,  eluting  with  3-6%  EtOAc  /  hexanes,  to  give 
tetrahydrofuran 3.35 (859 mg, 1.71 mmol, 96%) as colorless oil. [α]D
23 = -35.0 (c = 1.03, 
CHCl3); IR: (neat) 2958, 2926, 2886, 2854, 1733, 1473, 1457, 1361, 1282, 1250, 1154, 
1106, 1074, 938, 835, 775 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 4.26 (ddd, J = 10.8, 7.1, 
5.1 Hz, 1H), 4.14 (ddd, J = 10.8, 7.7, 6.6 Hz, 1H), 4.00-4.05 (m, 1H), 3.63-3.68 (m, 1H), 
3.53-3.59 (m, 2H), 3.44 (td, J = 8.9, 2.9 Hz, 1H), 2.04 (dt, J = 12.0, 6.6 Hz, 1H), 1.80-
1.94 (m, 2H), 1.64-1.73 (m, 1H), 1.52 (td, J = 11.6, 9.7 Hz, 1H), 1.20 (s, 9H), 1.01 (d, J = 
6.5 Hz, 3H), 0.908 (s, 9H), 0.904 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H), 0.068 (s, 3H), 0.063 
(s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 178.4, 81.6, 78.5, 75.7, 65.1, 62.1, 40.1, 
38.6, 36.7, 33.1, 27.2, 25.9, 18.4, 18.2, 15.9, -4.3, -4.6, -5.3 ppm; HRMS (ES+) calcd. for 
C26H55O5Si2 (M+H) 503.3588, found 503.3586. 
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Alcohol 3.39: To a stirred solution of ketone 3.30 (3.30 g, 6.57 mmol) in MeOH 
(83.0 mL) at rt was added NaBH4 (249 mg, 6.57 mmol). After 1 h, the reaction was 
quenched with sat. aq. NH4Cl (50 mL) and the MeOH was removed in vacuo. EtOAc 
(150 mL) was added to the residue and the aqueous layer was extracted with EtOAc (3 X 
    
150 mL). The dried (MgSO4) extract was concentrated in vacuo and purified by flash 
chromatography  over  silica  gel,  eluting  with  10-20%  EtOAc  /  hexanes,  to  give 
diastereomeric  alcohol  3.39  {3.17  g,  6.27  mmol,  95%  (1.7:  1  dr)}  as  colorless  oil. 
Analytically  pure  samples  of  the  individual  diastereomers  could  be  obtained  via 
chromatography  over  silica  gel,  eluting  with  10-20%  EtOAc  /  hexanes,  to  give 
sequentially  the  major  diastereomer  followed  by  the  minor  diastereomer.  3.39  Major 
isomer: [α]D
23 = -30.8 (c = 1.00, CHCl3); IR: (neat) 3490, 2960, 2929, 2855, 1731, 1470, 
1287, 1260, 1158, 1092, 835, 781 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 4.40 (bs, 1H), 
4.34-4.38 (m, 1H), 4.24 (ddd, J = 10.9, 6.2, 5.4 Hz, 1H), 4.16 (ddd, J = 10.9, 8.3, 6.1 Hz, 
1H), 3.97 (ddd, J = 8.8, 8.3, 3.8 Hz, 1H), 3.70 (dd, J = 8.0, 3.1 Hz, 1H), 3.58-3.65 (m, 
2H), 2.15 (dd, J = 12.9, 5.2 Hz, 1H), 1.81-1.90 (m, 2H), 1.70 (ddt, J = 1.9, 4.6, 11.6 Hz, 
1H), 1.21 (s, 9H), 0.93 (s, 9H), 0.90 (s, 9H), 0.139 (s, 6H), 0.133 (s, 3H), 0.11 (s, 3H) 
ppm; 
13C NMR (176 MHz, CDCl3) δ 178.5, 87.2, 74.0, 72.7, 65.8, 61.9, 41.2, 38.7, 35.0, 
27.2, 25.8, 18.3, 18.2, -4.4, -4.9, -5.68, -5.69 ppm; HRMS (ES+) calcd. for C25H53O6Si2 
(M+H) 505.3381, found 505.3394. 
3.39 Minor isomer: [α]D
23 = -28.7 (c = 1.01, CHCl3); IR: (neat) 3490, 2960, 2925, 
2859, 1734, 1715, 1474, 1256, 1155, 1092, 839, 777 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 
4.24-4.28 (m, 1H), 4.19-4.22 (m, 1H), 4.10-4.17 (m, 2H), 3.68-3.70 (m, 3H), 3.64 (dd, J 
= 12.0, 5.9 Hz, 1H), 3.39 (m, 1H) 2.42 (ddd, J = 12.0, 7.0, 6.2 Hz, 1H), 1.93-1.97 (m, 
1H), 1.87-1.92 (m, 1H), 1.72 (dt, J = 8.8, 12.1 Hz, 1H), 1.21 (s, 9H), 0.92 (s, 9H), 0.90 (s, 
9H), 0.127 (s, 3H), 0.124 (s, 3H), 0.10 (s, 3H), 0.09 (s, 3H) ppm; 
13C NMR (176 MHz, 
CDCl3) δ 178.5, 86.1, 74.7, 74.1, 72.9, 65.5, 61.6, 40.4, 38.7, 35.4, 27.2, 25.8, 18.28, 
    
18.24, -4.5, -4.7, -5.3, -5.4 ppm; HRMS (ES+) calcd. for C25H35O6Si2 (M+H) 505.3381, 
found 505.3394. 
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Thioate 3.40: To a stirred solution of diastereomeric alcohol 3.39 (3.17 g, 6.27 
mmol) in deoxygenated toluene (75.0 mL) at rt was added thiocarbonyldiimidazole (3.36 
g, 18.8 mmol) heated to 100 ºC. After 20 h, the solvent was removed in vacuo. The 
residue was directly loaded onto column and purified by flash chromatography over silica 
gel, eluting with 15-30% EtOAc / hexanes, to give diastereomeric thioate 3.40 (3.82 g, 
6.21  mmol,  99%)  as  colorless  oil.  Analytically  pure  samples  of  the  individual 
diastereomers could be obtained via chromatography over silica gel, eluting with 15-30% 
EtOAc / hexanes, to give sequentially the major diastereomer followed by the minor 
diastereomer. 3.40 Major isomer: [α]D
23 = -14.5 (c = 1.02, CHCl3); IR: (neat) 2953, 2929, 
2894, 2855, 1727, 1474, 1392, 1283, 1244, 1151, 1104, 832, 781 cm
-1; 
1H NMR (700 
MHz, CDCl3) δ 8.31 (s, 1H), 7.60 (s, 1H), 7.09 (dd, J = 1.6, 0.8 Hz, 1H), 5.97 (t, J = 3.3 
Hz, 1H), 4.30-4.34 (m, 1H), 4.25 (ddd, J = 11.0, 6.3, 5.3 Hz, 1H), 4.19 (ddd, J = 11.0, 
8.1, 6.2 Hz, 1H), 4.13 (dd, J = 7.8, 3.1 Hz, 1H), 3.95 (dt, J = 7.8, 4.5 Hz, 1H), 3.57-3.61 
(m, 2H), 2.52 (ddd, J = 14.3, 6.2, 0.9 Hz, 1H), 2.06 (ddd, J = 14.3, 9.1, 4.6 Hz, 1H), 1.87-
    
1.94 (m, 2H), 1.21 (s, 9H), 0.92 (s, 9H), 0.83 (s, 9H), 0.14 (s, 3H), 0.13 (s, 3H), -0.02 (s, 
3H), -0.04 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 182.6, 178.4, 136.6, 131.0, 117.7, 
84.4, 82.2, 73.8, 72.6, 66.0, 61.5, 39.3, 38.7, 35.0, 27.2, 25.9, 25.8, 18.5, 18.3, -4.4, -4.6, -
5.4,  -5.5  ppm;  HRMS  (ES+)  calcd.  for  C29H55O6N2Si2S  (M+H)  615.3319,  found 
615.3309. 
3.40 Minor isomer: [α]D
23 = -21.4 (c = 1.04, CHCl3); IR: (neat) 2956, 2929, 2883, 
2855, 1727, 1470, 1396, 1337, 1287, 1244, 1228, 1158, 1088, 835, 773 cm
-1; 
1H NMR 
(700 MHz, CDCl3) δ 8.36 (s, 1H), 7.64 (t, J = 1.4 Hz, 1H), 7.09 (dd, J = 1.6, 0.8 Hz, 1H), 
6.00 (ddd, J = 7.3, 2.8, 2.1 Hz, 1H), 4.44 (t, J = 2.1 Hz, 1H), 4.38-4.42 (m, 1H), 4.23 
(ddd, J = 11.1, 6.1, 5.6 Hz, 1H), 4.19 (ddd, J = 11.1, 8.1, 5.8 Hz, 1H), 3.93 (ddd, J = 7.7, 
4.8, 2.8 Hz, 1H), 3.71 (dd, J = 9.8, 7.8 Hz, 1H), 3.58 (dd, J = 9.8, 4.9 Hz, 1H), 2.75 (dt, J 
= 14.0, 7.4 Hz, 1H), 1.96-2.01 (m, 1H), 1.89-1.94 (m, 2H), 1.21 (s, 9H), 0.90 (s, 18H), 
0.15 (s, 3H), 0.13 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 
183.5, 178.5, 136.9, 130.9, 117.8, 86.9, 83.2, 74.3, 63.5, 61.6, 38.7, 38.5, 35.4, 27.2, 25.9, 
18.3, 17.9, -4.2, -4.7, -5.32, -5.35 ppm; HRMS (ES+) calcd. for C29H55O6N2Si2S (M+H) 
615.3319, found 615.3298. 
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Tetrahydrofuran 3.41: To a stirred solution of diastereomeric thioate 3.40 (3.82 
g, 6.21 mmol) in deoxygenated toluene (340.0 mL) at rt was added AIBN (102 mg, 0.621 
mmol) and heated to 95 ºC. Bu3SnH (3.61 g, 3.4 mL, 12.4 mmol) was added dropwise 
over 45 min. After additional 1.5 h, the reaction was cooled down to rt and the solvent 
was removed in vacuo. The residue was directly loaded onto the column and purified by 
flash  chromatography  over  silica  gel,  eluting  with  3-6%  EtOAc  /  hexanes,  to  give 
tetrahydrofuran 3.41 (2.76 g, 5.65 mmol, 91%) as colorless oil. [α]D
23 = -21.6 (c = 1.02, 
CHCl3); IR: (neat) 2958, 2931, 2859, 1734, 1474, 1288, 1255, 1156, 1097, 836, 779 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 4.12-4.22 (m, 2H), 3.98-4.10 (m, 2H), 3.67(dd, J = 11.6, 
7.8 Hz, 1H), 3.55-3.59 (m, 2H), 2.02-2.09 (m, 1H), 1.74-1.98 (m, 4H), 1.51 (ddd, J = 
18.2, 11.7, 8.6 Hz, 1H), 1.20 (s, 9H), 0.909 (s, 9H), 0.905 (s, 9H), 0.091 (s, 3H), 0.089 (s, 
3H), 0.07 (s, 3H), 0.06 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.6, 78.9, 76.2, 
75.8, 65.0, 62.1, 38.7, 34.8, 32.5, 27.5, 27.2, 26.0, 25.9, 18.4, 18.2, -4.2, -4.7, -5.3 ppm; 
HRMS (ES+) calcd. for C25H53O5Si2 (M+H) 489.3432, found 489.3418. 
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TBS Ether 3.46: To a stirred solution of alcohol 3.47 (277 mg, 3.37 mmol) in 
DMF (5.0 mL) at 0 
oC were sequentially added imidazole (459 mg, 6.74 mmol), TBS 
chloride (762 mg, 5.06 mmol) and DMAP (102 mg, 0.843 mmol) sequentially. After 1.5 
h, the reaction was quenched with sat. aq. NH4Cl (20 mL) and the aqueous layer was 
extracted with Et2O (2 X 50 mL) and the dried (MgSO4) extract was concentrated in 
vacuo and purified by flash chromatography over silica gel, eluting with 2-10% Et2O / 
pentane, to give TBS ether 3.46
5 (604 mg, 3.07 mmol, 91%) as colorless oil. 
1H NMR 
(700 MHz, CDCl3) δ 6.33 (dtd, J = 15.8, 4.1, 0.55 Hz, 1H), 5.78 (dq, J = 15.8, 2.2 Hz, 
1H), 4.26 (ddd, J = 4.1, 2.2, 0.84 Hz, 1H), 2.89 (dq, J = 2.2, 0.77 Hz, 1H), 0.94 (s, 9H), 
0.10 (s, 6H) ppm; 
13C NMR (176 MHz, CDCl3) δ 144.3, 107.6, 82.1, 77.3, 62.7, 25.8, 
18.3, -5.3 ppm. 
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Propargyl Benzoate 3.43: To a stirred solution of (+)-N-methylephedrine (752 
mg, 4.19 mmol) and Zn(OTf)2 (1.45 g, 3.99 mmol) in toluene (3.4 mL) at rt was added 
Et3N (0.59 mL, 424 mg, 4.19 mmol). After 2 h, alkyne 3.46 (824 mg, 4.19 mmol) was 
added in one portion. After 15 min, a solution of aldehyde 3.45
6 (316 mg, 1.99 mmol) in 
    
toluene (4.9 mL) was added dropwise over 15 h via syringe pump. After another 5 h, 
CH2Cl2 (7.5 mL) was added and the reaction was cooled down to 0 ºC. Then, benzoyl 
chloride (1.26 g, 1.1 mL, 8.99 mmol), Et3N (908 mg, 1.3 mL, 8.99 mmol) and DMAP 
(121 mg, 0.998 mmol) were sequentially added to the reaction. After 2.5 h, the reaction 
was quenched with sat. aq. NH4Cl (30 mL) and the aqueous layer was extracted with 
Et2O (3 X 60 mL). The dried (MgSO4) extract was concentrated in vacuo and purified by 
flash  chromatography  over  silica  gel,  eluting  with  10-15%  EtOAc  /  hexanes,  to  give 
enyne 3.43 (321 mg, 0.699 mmol, 35%) as colorless oil.  
 
                                                 
1. (a) Flögel, O.; Amombo, M. G. O.; Reißig, H.-U.; Zahn, G.; Brüdgam, I.; Hartl, H. 
Chem. Eur. J. 2003, 9, 1405-1415. (b) Herradon, B. Tetrahedron: Asymmetry 1991, 2, 
191-194.  
2. (a) Ohira, S. Synth. Commun. 1989, 19, 561-564. (b) S. Müller, S.; Liepold, B.; Roth, 
G. J.; Bestmann, J. Synlett 1996, 521-522. See also: (c) Goundry, W. R. F.; Baldwin, J. 
E.; Lee, V. Tetrehedron 2003, 59, 1719-1729. (d) Kitamura, M.; Tokynaga, M.; Noyori, 
R. J. Am. Chem. Soc. 1995, 117, 2931-2932.  
3. (a) Dixon, D. J.; Ley, S. V.; Longbottom, D. A. Org. Synth. 2003, 80, 129-132. (b) 
Wang, Q.; Wei, H-x.; Schlosser, M. Eur. J. Org. Chem. 1999, 3263-3268.  
4. Preparation of LDA Solution: To a solution of diisopropylamine (0.14 mL / mmol) 
in THF (0.46 mL / mmol) at -78 °C was added n-BuLi (0.40 mL / mmol, 2.5 M in 
hexanes).  After  5  min,  the  white  slurry  was  warmed  to  -10  °C  and  stirred  for  an 
additional 15 min. 
5. Mapp, A. K.; Heathcock, C. H. J. Org. Chem. 1999, 64, 23-27. 
6. Judd, W. R.; Ban, S.; Aubé, J. J. Am. Chem. Soc. 2006, 128, 13736-13741. 
    
 CHAPTER IV: ASSEMBLY OF C1-C25 FRAMEWORK:  
A NEW STRATEGY TO C9-C11 DIENE 
 
4.1 Preparation of the C1-C14 Iodide Subunit  
 
  After  successful  gram-scale  synthesis  of  the  southern  C1-C8  tetrahydrofuran 
precursor 3.35, our focus shifted to elaborate it to the entire C1-C14 iodide subunit 4.1 
(Scheme 4.1). As mentioned earlier, this extended portion comprised a unique s-cis-1,3-
diene  that  is  present  in  several  amphidinolide  natural  products  as  well.  We  were 
interested in developing practical method to build such kind of diene motif. As part of 
this  effort,  we  established  an  efficient  vinyl  lithium  -  Weinreb  amide  coupling  / 
methylenation sequence during our model study (see Chapter II) to construct the western 
diene segment of amphidinolides C / F.
1 We intended to employ our optimized strategy 
for assembly of full carbon skeleton present in the iodide segment 4.1. The immediate 
target  was  homologation  of  the  tetrahydrofuran  intermediate  3.35  to  the  requisite 
Weinreb-amide 4.2. 
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Scheme 4.1. Strategy for the Diene Construction 
    
4.1.1 Utilization of Cyanosilylation Strategy 
 
  The  synthesis  resumed  with  selective  removal  of  the  primary  silyl  ether  from 
tetrahydrofuran precursor 3.35 to furnish intermediate alcohol, which was subsequently 
oxidized  to  aldehyde  4.3  (Scheme  4.2).  We  planned  to  exploit  the  Verkade  cyano-
silylation protocol
2 to add one carbon to the aldehyde scaffold 4.3 in a stereoselective 
manner - Felkin-controlled addition would furnish the desired alcohol stereochemistry 
(8R). While the Verkade trisaminophosphine-catalyzed cyanosilylation proceeded in an 
excellent yield (98%), the diastereoselectivity of the addition was unsatisfactory (1.1:1 
dr). Lower temperature (up to -60 ºC) and different solvents (e.g. ether, toluene) could 
not improve the stereoselectivity of the transformation. The nitrile diastereomers 4.5 was 
chromatographically inseparable. With the hope of separating the diastereomers in next 
step, the cyanide 4.5 was subjected to different hydrolysis conditions. Unfortunately, the 
cyanide 4.5 was inert under several hydrolysis conditions. Reduction of the cyanide 4.5 
by hydride donors (e.g. DIBAL-H, L-selectride) did not result into the corresponding 
aldehyde. Our alternate approach to directly trap the vinyl iodide 2.21 derived organo-
lithium species 4.7 also failed to provide any desired enone 4.9.  
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Scheme 4.2. A Cynanosilylation Strategy  
 
4.1.2 Homologation Employing Nemoto Protocol 
 
  Our unexpected difficulty in synthesis of the amide 4.2 through traditional three-
step method led us to uncover a one-step protocol for Weinreb amide generation (Scheme 
4.3).  Recently,  Nemoto  and  co-workers  described  a  direct  one-flask  homologation 
technique on aldehyde for synthesis of the α-siloxy Weinreb amide.
3 Our need perfectly 
fitted to this strategy, as we required adding one carbon to aldehyde 4.3 to generate the 
Weinreb amide 4.2. Accordingly, the masked acyl cyanide (MAC) reagent was prepared 
    
in  three  steps  and  then  subjected  to  the  aldehyde  precursor  4.3.  To  our  delight,  the 
reaction proceeded smoothly to furnish the homologated amide 4.12 in good yield and 
reasonable  diastereoselectivity.  A  proposed  mechanism  illustrating  the  formation  of 
Weinreb  amide  4.12  has  been  shown.
4 The  MAC-derived  carbanion  nucleophilically 
attacked the aldehyde to form the oxyanionic intermediate 4.10. The anionic oxygen then 
underwent a Brook rearrangement triggering the elimination of cyanide. The developed 
acyl cyanide 4.11 was then trapped by the free amine to generate Weinreb amide 4.12. 
The stereochemistry of the C8-center was not confirmed at this point.  
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Scheme 4.3. Homologation to Weinreb Amide 4.12 
 
4.1.3 Attempted Vinyl Lithium / Weinreb Amide Coupling 
 
With  the  Weinreb  amide  4.12  in  hand,  we  set  out  to  explore  our  previously 
developed coupling / olefination sequence to construct the 1,3-diene motif (Scheme 4.4).
1 
    
Unfortunately,  our  initial  attempt  to  combine  the  two  subunits  under  our  optimized 
conditions failed to provide the coupled material 4.13. In fact, our all efforts to adjoin the 
vinyl  iodide  2.21  to  Weinreb  amide  4.12  were  unsuccessful.  Different  halogen-metal 
exchange  reagents  (e.g.  n-BuLi,  t-BuLi),  solvents  (e.g.  THF,  Et2O,  THF  /  hexanes), 
temperature  and  vinyl  iodide  to  Weinreb  amide  ratios  could  not  facilitate  this 
transformation to the desired enone 4.13. We attributed the inertness of the Weinreb 
amide 4.12 to extreme steric demand exerted by two bulky vicinal silyl ethers. Failure to 
exploit the optimized strategy led us to revise our approach to diene. 
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Scheme 4.4. Attempted Vinyl Lithium / Weinreb Amide Coupling 
 
 
 
    
4.1.4 A Shapiro Olefination Approach 
 
  Alternately,  we  planned  to  build  the  diene  via  Shapiro  olefination  method 
(Scheme  4.5).
5 The  synthetic  sequence  resumed  with  our  premade  vinyl  iodide  2.21. 
Coupling of 2.21 with another Weinreb amide 4.14 cleanly generated the enone 4.15. The 
enone precursor 4.15 was then treated with 2,4,6-triisopropylbenzensulfonylhydrazide to 
furnish the hydrazone derivative 4.16 in 2:1 diastereomeric ratio (E / Z ratio). The major 
hydrazone  proved  to  be  relatively  unstable  and  readily  equilibrated  during  silica  gel 
column chromatography to other geometrical isomer. The hydrazone derivative 4.16 was 
then treated with t-BuLi (2.0 equiv.) and aldehyde 4.3 was added to it. Disappointingly, 
the  reaction  led  to  complete  decomposition  of  both  the  starting  materials.  Close 
monitoring  of  the  reaction  revealed  that  the  hydrazone  derived  2-metallo-1,3-diene 
species  4.21  probably  formed,  but  was  not  stable  under  the  reaction  conditions.  The 
solution turned deep red immediately after the addition of base (at -78 ºC) indicating the 
first deprotonation of the amine hydrogen. Higher temperature (0 ºC) was required to 
promote the second deprotonation. Evolution of N2-bubble suggested formation of the 2-
metallo-1,3-diene species 4.21. We concluded that the intermediate 4.21 decomposed at 0 
ºC after its formation and gave rise an idea that at lower temperature the 2-metallo-1,3-
diene species could survive.  
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Scheme 4.5. Shapiro Olefination Approach to the C9-C11 Diene 
 
 
    
4.1.5 Synthesis of Dienyl Iodide 4.25 
 
  Difficulty in building the diene motif through conventional methods led us to 
develop a novel coupling strategy for diene installation. The initial target was to prepare 
the dienyl iodide precursor 4.25 as crucial coupling partner (Scheme 4.6). Synthesis of 
the dienyl iodide 4.25 resumed once again with our previously made vinyl iodide 2.21. A 
Sonogashira  coupling
6 between  iodide  2.21  and  TMS-acetylene  4.22  in  presence  of 
palladium (0) catalyst furnished the enyne intermediate in near quantitative yield (98%). 
Use of palladium (II) catalyst {e.g. PdCl2(PPh3)2} resulted in significantly diminished 
yield (78%). Subsequent desilylation cleanly provided the hydrostannylation precursor 
4.23. Regioselective hydrostannylation of enyne 4.23 in presence of PdCl2(PPh3)2 catalyst 
proceeded smoothly to deliver the requisite internal dienyl stannane 4.24 as sole isomer. 
This regiochemistry counter to what is typically observed with most palladium-catalyzed 
hydrostannylation reactions. In fact, this reactivity was initially noted by Smith and co-
workers as an unwanted product in their synthesis of rapamycin.
7 Finally, iodination of 
stannane  4.24  smoothly  delivered  the  required  dienyl  iodide  4.25.  Preparation  of  an 
analogous dienyl iodide 4.27 was reported by Crews and co-workers over three steps 
from enyne 4.26 with a modest 33% overall yield.
8  
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Scheme 4.6. Synthesis of the Dienyl Iodide 
 
4.1.6 Successful Diene Installation 
 
  Successful construction of dienyl iodide 4.25 set the stage for key coupling event 
(Scheme 4.7). After some experimentation, we discovered that treatment of iodide 4.25 
with n-BuLi followed by addition to aldehyde 4.3 generated the C8-C9 coupled material 
4.17 in good yield and reasonable diastereoselectivity at C8 (3:1 dr). Use of sec-BuLi or t-
BuLi  for  the  halogen-metal  exchange  event  resulted  in  either  lower  yield  or  poorer 
    
diastereoselectivity during the coupling. This approach allowed us to construct the C9-C11 
s-cis-diene  and  set  the  C8  alcohol  stereochemistry  in  single  operation.  To  our  best 
knowledge, this is the first example of stereoselective addition of a 2-metallo-1,3-diene 
species to an α-oxy aldehyde. We had been concerned that the dienyl lithium species 
4.28 might undergo 1,3-metallotropic shifts
9 to generate allenyl-metallo species 4.29 as 
well as scramble the C10-C11 E / Z olefin geometry; however, we did not observe any 4.29 
or 4.30 addition product under the reaction conditions. Stereochemical outcome for this 
transformation  was  governed  by  the  adjacent  α-stereocenter  (C7)  and  the  Felkin-
controlled  alcohol  4.17  was  obtained  as  the  predominant  product.  The  diene 
configuration was confirmed by the observed nOe (2.6%) between C32 and C33 protons 
(amphidinolide  F  numbering).  Stereochemical  assignment  of  the  newly  formed  C8 
stereocenter would be provided at the end of this chapter.  
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Scheme 4.7. Regio- and Stereoselective Diene Installation 
 
4.1.7 Completion of the Synthesis of C1-C14 Iodide Subunit 
 
Conversion of the alcohol 4.17 to iodide fragment 4.1 is shown in Scheme 4.8. 
First, the secondary alcohol in 4.17 was protected as TBS ether. The primary silyl ether 
from 4.32 was subsequently removed in presence of three secondary ethers to furnish the 
    
primary  alcohol  4.33  in  good  yield.  Iodination  at  C14  under  Mitsunobu  conditions 
completed synthesis of the C1-C14 iodide fragment 4.1. The alkyl iodide 4.1 proved to be 
reasonably stable and could be saved in -30 ºC freezer over 2 months.  
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Scheme 4.8. Preparation of the Iodide Subunit 
 
4.2 Synthesis of the Northern Sulfone Fragment 
 
  After devising an efficient route to the iodide subunit 4.1, our focus shifted to 
building of the sulfone counterpart 2.2 for alkylation (Scheme 4.9). The diene of 2.2 was 
envisioned to incorporate on sulfone 4.34 during the advance stage of synthesis. The plan 
was to exploit a Julia-Kocienski olefination
10 for stereoselective generation of the diene 
    
sidearm of amphidinolide F (1.16). The C15-C25 sulfone fragment 4.34 was intended to 
prepare  via  coupling  between  aldehyde  4.36  and  the  known  alkyl  iodide  4.35
11.  The 
aldehyde 4.36 would come from the northern tetrahydrofuran precursor 3.41. 
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Scheme 4.9. Retrosynthetic Strategy for the Northern Sulfone Subunit 
 
4.2.1 Preparation of Ketone 4.40 
 
Synthesis of sulfone subunit 2.2 resumed with the common intermediate derived 
northern tetrahydrofuran precursor 3.41 (Scheme 4.10). Removal of the pivolate from 
C18-alcohol followed by Swern oxidation cleanly generated aldehyde 4.36. Coupling of 
aldehyde  4.36  with  the  known  iodide  4.35
11  proved  to  be  problematic,  resulting  in 
decomposition of both the starting materials. The inherent acidity of the protons next to 
sulfur atom in iodide 4.35 was probably responsible for this outcome. Alternately, the O-
    
benzylated iodide 2.42 was prepared in three steps from commercially available Roche’s 
ester.
12 To  our  pleasure,  addition  of  the  iodide  2.42  derived  organolithium  species  to 
aldehyde 4.36 smoothly furnished the C18 alcohols (4.38 / 4.39) as an inseparable mixture 
of diastereomers. TPAP oxidation
13 of the diastereomeric alcohols 4.38 / 4.39 delivered 
ketone 4.40 in excellent yield (94%).  
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Scheme 4.10. Elaboration to Ketone 4.40 
    
4.2.2 Attempt to Protect Ketone 4.40 as Ketal 
 
  We next faced an unanticipated problem in apparently simple ketone protection 
(Scheme 4.11). Masking of the C18 ketone was necessary to circumvent any undesirable 
furan formation between C15 and C18 ketones in later stage of synthesis. Again, we would 
have  to  take  the  protecting  group  off  in  presence  of  sensitive  diene  moieties  in  the 
advanced phase of synthesis. Accordingly, we decided to protect ketone 4.40 as acyclic 
ketal (e.g. dimethyl or diethyl ketal) as they are easier to remove than the cyclic version.
14 
Unfortunately,  installation  of  the  dimethyl  ketal  on  C18  ketone  under  our  previously 
optimized Noyori conditions was unsuccessful (see table, Entry 1).
1,15 Disappointingly, 
all our attempts to mask the ketone as acyclic ketal failed to provide any of the desired 
product (Entry 2-4). Trials to ketalize 4.40 as cyclic ketal also were ineffective (Entry 5-
7). We reasoned that the tetrahydrofuran oxygen was interfering under acidic conditions 
required for ketalization. Protonation of the tetrahydrofuran oxygen could promote retro-
Michael event on β-oxy ketone 4.40. In contrast, the β-oxygen in model ketone 2.46 was 
unavailable for this kind of activation (due to the TIPS moiety).  
 
    
4.33 4.1
OTBS
O H
H
OBn
OTBS
18
OTBS
O H
H
OBn
OTBS
18
4.40 4.41
OP
O
OBn
18
OBn
18
2.46 2.47
OMe
O
OTIPS OTIPS
MeOTMS
TMSOTf, CH2Cl2
83%
OH
OH
HO
O H H
O
H
O
O
O
O H
amphidinolide F (1.16)
1,4-diketone - 
susceptible to 
furan formation
X
OTBS
O
OBn
OTBS
O
H
H
H
Retro-Michael
precursor
4.42
18
15
15 15
15 15
Ketalization on Model Ketone (Ref.1)
OP
OMe
 
 
Entry  Ketalizing agent  Catalyzing acid  Observations 
1  MeOTMS  TMSOTf  Decomposition 
2  MeOH  PPTS  No reaction 
3  MeOH  CSA  Decomposition 
4  EtOH  p-TSA  Decomposition 
5  TMSOCH2CH2OTMS  TMSOTf  Decomposition 
6  HOCH2CH2OH  PPTS  No reaction 
7  HOCH2CH2CH2OH  CSA  Decomposition 
 
Scheme 4.11. Attempted Ketalization 
 
    
4.2.3 Masking the Ketone as Silyl Enol Ether 
 
  In order to avoid the protection issue, one logical alternative would be masking 
the  C18  ketone  as  silyl  enol  ether  (Scheme  4.12).  The  immediate  concern  was  the 
selectivity of the enol ether formation as four possible isomeric products could be formed 
from ketone 4.40. Nevertheless, this approach would save one extra deprotection step as 
the silyl enol ether would fall apart during the final global deprotection (desilylation) 
event to regenerate the C18 ketone. To demonstrate this strategy, sulfone 4.44 was readily 
prepared  in  three  steps  from  ketone  4.40.  Treatment  of  the  keto-sulfone  4.44  with 
TBSOTf  in  presence  of  2,6-lutidine  furnished  the  silyl  enol  ethers  in  excellent  yield 
(95%). Interestingly, only two regioisomeric enol ethers (4.45 and 4.46, 2.5:1 rr) were 
generated under the reaction conditions and they were seperable over regular silica gel 
column  chromatography.  The  structure  of  the  major  isomer  4.45  was  confirmed  by 
extensive 1D and 2D NMR analysis. A convincing 2.8% nOe enhancement between C17 
and C19 protons was observed to confirm the olefinic geometry in 4.45. The double bond 
geometry in the regioisomeric enol ether 4.46 was tentatively assigned by a negative nOe 
but a positive 4-bond COSY interaction between C19 and C17 protons. 
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Scheme 4.12. Masking the C18 Ketone as Silyl Enol Ethers 
 
4.3 Sulfone / Iodide Alkylation  
 
  We anticipated that putting a different protecting group at C18 could effect the 
subsequent  alkylation  /  oxidative  desulfurization  events.  Therefore,  we  decided  to 
evaluate the sequence with this new protecting group before mounting the diene side 
chain present in amphidinolide F (1.16) (Scheme 4.13). As mentioned earlier during our 
model  study  (see  Chapter  II),
1  the  alkylation  was  again  highly  contingent  upon  the 
reaction conditions. Only modest yield (<10%) was obtained when 1.0 equivalent of base 
was used to promote the union. It was necessary to adjust the amount of base with respect 
to sulfone (from 1.0 equiv. to 2.2 equiv.) in order to effect the coupling reaction. Both the 
    
regioisomeric sulfones (4.45 and 4.46) were subjected to coupling with our previously 
made iodide 4.1 and moderate yields were obtained in both occasions (52% and 45% 
respectively). Thus, the successful sulfone / iodide alkylation assembled the entire C1-C25 
skeleton of the amphidinolides C / F. 
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Scheme 4.13. Assembly of the C1-C25 Framework of Amphidinolides C / F 
 
 
 
 
    
4.4 Attempted Oxidation 
 
  With sufficient quantity of coupled materials (4.47 and 4.48) in hand, our focus 
shifted to the key oxidative desulfurization reaction to install the C15 ketone (Scheme 
4.14). Initially, we attempted to employ our previously optimized oxidation conditions 
(LDA, TMSOOTMS)
1 to serve this purpose. Unfortunately, this reaction conditions did 
not  provide  any  of  the  requisite  ketone  4.49.  Disappointingly,  all  our  attempts  to 
incorporate the C15 ketone failed to deliver the desired product 4.49. Different bases (e.g. 
n-BuLi,  NaHMDS,  KHMDS)  and  different  oxidants  (e.g.  MoOPH,  MoOPD,  Davis’ 
oxaziridine)  could  not  promote  the  reaction  to  desired  ketone.  In  stead,  significant 
decomposition of the sulfone 4.47 was observed when LDA or n-BuLi was used as base. 
The other sulfone 4.48 behaved in similar fashion under the oxidation conditions.  
We reasoned that the C18 protecting group was responsible for these observations. 
A chelating protecting group at C18 could help with the deprotonations in both coupling 
and  oxidation  events.  Absence  of  a  chelating  group  could  make  the  deprotonations 
difficult (more base needed during sulfone / iodide alkylation) and once the deprotonation 
occurred the carbanion could undergo retro-Brook rearrangement
16 and that in turn could 
lead to decomposition.  
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Scheme 4.14. Unsuccessful Oxidative Desulfurization 
 
 
 
 
    
4.5 Improved Sulfone / Iodide Alkylation and Successful Oxidation 
 
  Being unable to install any reasonable protecting group on C18 ketone, we set 
back to protect it in the alcohol stage. At this crucial juncture of synthesis, we needed to 
keep two things in mind - 1) the protecting group on C18 alcohol should be a chelating 
group to help deprotonations and 2) it should be easily removed in presence of sensitive 
dienes at the final stage of synthesis. Therefore, we decided to mount a tetrahydropyranyl 
(THP) moiety on C18 alcohol. We expected that the chelating nature of tetrahydropyranyl 
ether  (due  presence  of  two  acetal  oxygens)  would  help  the  deprotonations  during 
alkylation / oxidative desulfurization events and could be easily removed under mild 
acidic conditions (e.g. aq. acetic acid).  Since the tetrahydropyranyl (THP) unit would 
introduce an additional stereocenter that would complicate analysis, we wanted to move 
forward  with  only  one  diastereomeric  C18  alcohol  (either  4.38  or  4.39)  for  practical 
reasons.  
With the hope of stereoselective reduction of C18 ketone, the inseparable mixture 
of alcohols (4.38 and 4.39) was first oxidized to ketone 4.40 (Scheme 4.15). Fortunately, 
reduction  of  the  C18  ketone  under  L-selectride  conditions  (see  the  table,  Entry  3) 
predominantly  delivered  18S  alcohol  4.38  in  excellent  diastereoselectivity  (15:1  dr). 
Interestingly, reduction of ketone 4.40 with DIBAL-H resulted in slight preference for the 
opposite  18R  isomer  (1:1.3  dr).  The  absolute  configuration  at  C18  was  confirmed  by 
advanced Mosher ester analysis.
17 
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Scheme 4.15. Stereoselective Reduction of C18 Ketone 
 
4.5.1 Preparation of Sulfone 4.57 
 
  With  the  18R  alcohol  4.38  in  hand,  we  sought  to  transform  that  into  C15-C25 
sulfone subunit 4.57 with the new tetrahydropyranyl (THP) protecting group (Scheme 
4.16). First, the tetrahydropyranyl unit was introduced on the C18 alcohol to furnish THP 
ether 4.55 in excellent yield (99%). The C15 sulfide 4.56 was installed after debenzylation 
by the treatment of diphenyl disulfide under Mitsunobu-type conditions. TPAP oxidation 
    
of the phenyl sulfide 4.56 smoothly delivered sulfone 4.57 and set the stage for next 
crucial alkylation / oxidative desulfurization sequence.  
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Scheme 4.16. Preparation of the Sulfone Subunit 
 
4.5.2 Sulfone / Iodide Alkylation and Oxidative Desulfurization 
 
  Our focus immediately shifted to demonstrate the sulfone / iodide alkylation and 
oxidative desulfurization sequence on these new systems (Scheme 4.17). To our pleasure, 
the combination of the two subunits (4.1 and 4.57) progressed much more efficiently to 
furnish the C14-C15 coupled material 4.58 in excellent yield (85%). Only one equivalent 
base was required to effect the transformation. This outcome justified necessity of the 
chelating effect of the C18 protecting group during this imperative alkylation reaction. We 
    
believed that the chelating unit (THP moiety) not only helped with deprotonation, but 
also led to an organized array around the reacting centers, making feasible the reaction 
between an α-branched sulfone and α-silyloxy iodide. 
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Scheme 4.17. Improved Sulfone / Iodide Alkylation 
 
The next crucial task in hand was the installation of the C15 ketone via oxidative 
desulfurization reaction (Scheme 4.18). Excitingly, oxidation of the coupled sulfone 4.58 
under our previously optimized conditions (LDA, DMPU, TMSOOTMS)
1 produced the 
desired ketone 4.59 although in modest yield (see the table, Entry 1). Fortunately, we 
were able to improve isolated yield of the transformation up to 74% (combined yield of 
4.59 and 4.60) using Davis’ oxaziridine
18 as oxidant. Some pivaloyl-deprotected product 
4.60 was obtained under the reaction conditions. We believed that excess n-BuLi from 
LDA and the hydroxide generated from contaminated moisture (H2O) were responsible 
for the pivolate removal. Use of molybdenum oxodiperoxy complexes (e.g. MoOPH, 
MoOPD)
19 as oxidants were unproductive. Successful installation of the C15 ketone set 
the stage to enter in the final lap of the synthesis. 
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Entry  Oxidants  Ketone 4.59   Keto-ol 4.60  Borsm 
1  TMSOOTMS  >20%  Not observed  89% 
2  MoOPH  0%  0%  X 
3  MoOPD  0%  0%  X 
4  Davis’ oxaziridine  46%  28%  99% 
 
Scheme 4.18. Successful Oxidative Desulfurization 
 
4.6 Proof of Stereochemistry 
 
  As  mentioned  earlier,  the  stereochemistry  of  amphidinolide  F  (1.16)  was  not 
unambiguously assigned. The natural product 1.16 reported to be an amorphous solid and 
no crystal data was produced to confirm its stereochemistry.
20 The form of amphidinolide 
C  (1.14),  a  congener  of  amphidinolide  F,  was  also  non-crystalline.  The  relative  and 
absolute configuration of amphidinolide C was established by extensive 1D and 2D NMR 
studies,  degradation  techniques  and  Mosher  ester  analysis.
21  The  stereochemical 
assignment of amphidinolide F was based on analogy to amphidinolide C and the fact 
    
that  both  were  isolated  from  the  same  microorganism.  While  these  studies  could 
tentatively assign the structure of amphidinolide F, it definitely stipulated more extensive 
effort for unequivocal stereochemical assignment. Consequently, we sought to establish 
the absolute configuration of all the stereogenic centers have been created so far. 
 
4.6.1 Assignment of C3, C4, C6, C7, C20, C23 and C24 Stereochemistry 
 
In  their  most  recent  isolation  paper  for  amphidinolide  C,  Kobayashi  and  co-
workers performed a degradation study to establish the absolute configuration at C3, C4 
and C6 centers (Scheme 4.19).
21b The naturally occurring amphidinolide C (1.14) was 
sequentially treated with DIBAL-H, NaIO4 and NaBH4 to produce diol 4.62, which was 
subsequently converted to the bis-Mosher ester 4.61. The bis-Mosher ester 4.61 was also 
prepared in laboratory by stepwise synthesis. The absolute configuration at C3, C4 and C6 
was confirmed by comparing 
1H NMR spectra of the synthetic and naturally derived bis-
Mosher  esters.  We  performed  similar  degradation  operation  on  our  synthetic 
tetrahydrofuran intermediate 3.35. The bis-silyl ether 3.35 was transformed to diol 4.62 in 
three steps, which was subsequently converted to bis-Mosher ester 4.61. The 
1H NMR 
spectrum of the naturally derived bis-Mosher ester was in perfect agreement with our 
synthetic bis-Mosher ester (Figure 4.1). Thus, this study explicitly confirmed the C3, C4 
and C6 stereochemistry in our southern tetrahydrofuran segment 3.35. The C6 and C7 
stereochemistry was generated via Sharpless asymmetric dihydroxylation in single step 
(see Chapter III, Scheme 3.2). Therefore, confirmation of C6 configuration in turn proved 
    
the configuration at C7. Since C20, C23 and C24 stereochemistry came from the common 
intermediate 3.30, proof of C3, C6 and C7 configuration justified the stereochemistry at 
C20, C23 and C24 (Scheme 4.20). 
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Scheme 4.19. Preparation of Bis-Mosher Ester 4.61 
 
    
 
 
Figure 4.1. 
1H NMR Comparison between Synthetic and Naturally Derived  
Bis-Mosher Ester 4.61 
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Scheme 4.20. Establishment of C7, C20, C23 and C24 Stereochemistry 
 
 
 
    
4.6.2 Confirmation C8 Alcohol Configuration 
 
  Extensive 1D and 2D NMR studies established the bond connectivity in alcohol 
4.17  (Scheme  4.21).  The  C32  and  C33  protons  exhibited  a  convincing  2.6%  nOe 
enhancement,  hence  verified  the  s-cis  conformation  of  the  C9-C11  diene.  The  major 
alcohol 4.17 was converted to (S)- and (R)-Mosher esters by the treatment of (R)- and (S)-
Mosher acid chlorides respectively. The chemical shift differences (∆δ) from (S)-Mosher 
ester to (R)-Mosher ester were calculated in Hertz. The ∆δ values on the right were all 
negative (except one) and those on the left were all positive. This suggests that the C8 
alcohol is pointing down (8R).
17 The minor alcohol 4.65 was also treated in the similar 
way and the C8 configuration was proved to be S.  
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Scheme 4.21. Proof of the Diene Conformation and the C8 Alcohol Stereochemistry 
    
4.6.3 Establishment of C12, C13 Stereochemistry 
 
  The absolute configuration at C12 and C13 was confirmed via degradation of the 
vinyl iodide intermediate 2.39 to known alcohol 4.69 (Scheme 4.22). First, the acetonide 
was introduced on alcohol 2.39 and subsequently degraded to ketone 4.68. The ketone 
4.68 was then quickly transformed to the known alcohol 4.69. The NMR spectra and the 
optical rotation data of 4.69 were in good agreement with the Nicolaou’s intermediate 
(see  experimental  section  for  details).
22 This  study  evidently  confirmed  the  absolute 
configuration  at  C12  and  C13.  The  C16  stereochemistry  directly  appeared  from  the 
commercially  available  Roche’s  ester  3.70.  It  should  be  mentioned  that  our  several 
attempts to crystalize various intermediates were unsuccessful. Derivatization of several 
intermediate compounds also failed to provide any crystalline solid.  
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Scheme 4.22. Assignment of C12, C13 and C16 Absolute Stereochemistry 
    
4.7 Conclusion 
 
  The  common  intermediate  3.30-derived  C1-C8  southern  and  C18-C25  northern 
tetrahydrofuran fragments were elaborated to the C1-C14 iodide 4.1 and C15-C25 sulfone 
4.57 subunits respectively. During our endeavor toward the western diene segment, we 
have utilized a direct palladium-catalyzed hydrostannylation on enyne 4.23 to furnish the 
internal dienyl stannane 4.24 regioselectively. A stereoselective addition of the dienyl 
iodide 4.25 derived 2-litho-1,3-dienyl species 4.28 to an α-oxy aldehyde installed the C9-
C11 diene and secured the C8 stereochemistry in single operation. Combination of the 
iodide  /  sulfone  subunits  and  subsequent  oxidative  desulfurization  encountered 
unanticipated protecting group issues. A protecting group modification and utilization of 
Davis’ oxaziridine as oxidant provided an efficient avenue to couple the subunits and to 
install the C15-ketone. All the stereochemistry in C1-C25 scaffold 4.59 was unambiguously 
assigned by chemical degradation, comparison study and Mosher ester analysis. Given 
the fact that the stereochemical assignment of amphidinolide F (1.16) was tentative, clear 
assignment of all the stereochemistry was a major boost toward the total synthesis of the 
natural product 1.16.  
 
4.8 References 
 
                                                 
1. Mahapatra, S.; Carter, R. G. Org. Biomol. Chem. 2009, 7, 4582-4585. 
    
                                                                                                                                               
2. Brandon M.; Fetterly, B. M.; Verkade, J. G. Tetrahedron Lett. 2005, 46, 8061-8066. 
3. Nemoto, H.; Ma, R.; Moriguchi, H.; Kawamura, T.; Kamiya, M.; Shibuya, M. J. Org. 
Chem. 2007, 72, 9850-9853. 
4. Nemoto, H.; Kawamura, T.; Miyoshi, N. J. Am. Chem. Soc. 2005, 127, 14546-14547. 
5. For reviews, see: (a) Shapiro, R. H. Org. React. 1976, 23, 405-507. (b) Adlington, R. 
M.; Barrett, A. G. M. Acc. Chem. Res. 1983, 16, 55-59. (c) Chamberlin, A. R.; Bloom, S. 
H. Org. React. 1990, 39, 1-83. 
6. For initial report, see: Sonogashira, K.; Tohda, Y.; Hagihara, N. Tetrahedron Lett. 
1975, 16, 4467-4470.  
7.  This  reactivity  was  initially  noted  by  Smith  and  co-workers  as  an  unwanted  side 
reaction in their synthesis of rapamycin. (a) Smith, A. B., III,; Condon, S. M.; McCauley, 
J. A.; Leazer, J. L., Jr.; Leahy, J. W.; Maleczka, R. E., Jr. J. Am. Chem. Soc. 1997, 119, 
962-973.  For  alternative  routes  to  similar  stannane,  see:    (b)  Oehlschager,  A.  C.; 
Hutzinger, M. W.; Aksela, R.; Sharma, S.; Singh, S. M. Tetrahedron Lett. 1990, 31, 165-
168. (c) Suzenet, F.; Blart, E.; Quintard, J.-P. Synlett 1998, 879-881.  
8. Mandal, A. K.; Schneekloth, J. S., Jr.; Kuramochi, K.; Crews, C. M.  Org. Lett. 2006, 
8, 427-430. 
9. Hoffmann, R. W.; Polachowski, A. Chem. Eur. J. 1998, 4, 1724-1730. 
10. (a) Kocienski, P. J.; Bell, A.; Blakemore, P. R. Synlett 2000, 365-366. (b) Blakemore, 
P. R. J. Chem. Soc., Perkin Trans. 1 2002, 2563-2585. 
11. Kabalka, G. W.; Gooch, E. E.; Sastry, K. A. R. J. Nuc. Med. 1981, 22, 908-912. 
12. (a) White, J. D.; Kawaski, M. J. Org. Chem. 1992, 57, 5292-5300. (b) Vong, B. G.; 
Abraham,  S.;  Xiang,  A.  X.;  Theodorakis,  E.  A.  Org.  Lett.  2003,  5,  1617-1620.  (c) 
Kopecky, D. J.; Rychnovsky, S. D. J. Am. Chem. Soc. 2001, 123, 8420-8421. 
13. Ley, S. V.; Norman, J.; Griffith, W. P.; Marsden, S. P. Synthesis 1994, 639-666. 
14. Greene, T. W.; Wuts, P. G. M. Protective Groups in Organic Synthesis, 3rd ed.; John 
Wiley & Sons, Inc.: New York, 1999; chapter 4. 
    
                                                                                                                                               
15. Tsunoda, T.; Suzuki, M.; Noyori, R. Tetrahedron Lett. 1980, 21, 1357-1358. 
16. Brook, A. G. Acc. Chem. Res. 1974, 7, 77-84. 
17. Ohtani, I.; Kusumi, T.; Kashman, Y.; Kakisawa, H. J. Am. Chem. Soc. 1991, 113, 
4092-4096. 
18. For a review, see: Davis, F. A.; Sheppard, A. C. Tetrahedron 1989, 45, 5703-5742. 
19. (a) Vedejs, E.; Engler, D. A.; Telchow, J. E. J. Org. Chem. 1978, 43, 188-196. (b) 
Anderson, J. C.; Smith, S. C. Synlett 1990, 107-108. 
20.  Kobayashi,  J.;  Tsuda,  M.;  Ishibashi,  M.;  Shigemori,  H.;  Yamasu,  T.;  Hirota,  H.; 
Sasaki, T. J. Antibiot. 1991, 44, 1259-1261. 
21. (a) Kobayashi, J.; Ishibashi, M.; Wälchli, N. R.; Nakamura, H.; Yamasu, T.; Hirata, 
Y.;  Sasaki,  T.;  Ohizumi,  Y.  J. Am. Chem. Soc.  1988,  110,  490-494.  (b)  Kubota,  T.; 
Tsuda, M.; Kobayashi, J. Org. Lett. 2001, 3, 1363-1366. 
22. (a) Nicolaou, K. C.; Papahatjis, D. P.; Claremon, D. A.; Magolda, R. L.; Dolle, R. E. 
J. Org. Chem. 1985, 50, 1440-1456. (b) Shiina, I.; Hashizume, M; Yama, Y.; Oshiumi, 
H.; Shimazaki, T.; Takarauma, Y.; Ibuka, R. Chem. Eur. J. 2005, 11, 6601-6608. (c) 
Larcheveque, M.; Henrot, S. Tetrahedron 1987, 43, 2303-2310. 
 
    
4.9 Experimental 
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Alcohol 4.71: To a stirred solution of bis-TBS ether 3.35 (501 mg, 0.997 mmol) 
in THF (10.0 mL) at 0 ºC was added a stock solution of HF•Pyr.
1 (5.5 mL) over 1 h. 
After 24 h, the reaction quenched with sat. aq. NaHCO3 (30 mL) and the aqueous layer 
was extracted with EtOAc / Et2O (2:1, 3 X 60 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
10-30% EtOAc / hexanes, to give alcohol 4.71 (322 mg, 0.828 mmol, 83%) as colorless 
oil. [α]D
23 = -31.3 (c = 1.04, CHCl3); IR: (neat) 3494, 2957, 2930, 2882, 2855, 1730, 
1477, 1461, 1284, 1252, 1153, 1102, 1055, 940, 838, 778 cm
-1; 
1H NMR (700 MHz, 
CDCl3) δ 4.27 (ddd, J = 10.9, 7.1, 4.9 Hz, 1H), 4.14 (ddd, J = 10.9, 8.2, 6.3 Hz, 1H), 4.06 
(dt, J = 9.7, 6.0 Hz, 1H), 3.65-3.69 (m, 2H), 3.53-3.57 (m, 1H), 3.48 (td, J = 6.3, 2.8 Hz, 
1H), 2.37-2.39 (m, 1H), 2.09 (dt, J = 12.1, 6.5 Hz, 1H), 1.91-1.96 (m, 1H), 1.86-1.91 (m, 
1H), 1.68-1.72 (m, 1H), 1.43 (td, J = 11.5, 10.1 Hz, 1H), 1.21 (s, 9H), 1.04 (d, J = 6.5 Hz, 
3H), 0.92 (s, 9H), 0.13 (s, 3H), 0.12 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 178.4, 
81.8, 79.8, 74.7, 64.2, 61.8, 39.9, 38.6, 36.8, 33.0, 27.1, 25.9, 18.2, 15.9, -4.4, -4.8 ppm; 
HRMS (ES+) calcd. for C20H40O5Si2Na (M+Na) 411.2543, found 411.2542. 
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Aldehyde 4.3: To a stirred solution of oxalyl chloride (262 mg, 0.18 mL, 2.06 
mmol) in CH2Cl2 (10.0 mL) at -78 ºC was cannulated a solution of DMSO (341 mg, 0.31 
mL, 4.31 mmol) in CH2Cl2 (2.7 mL). After 15 min, a solution of alcohol 4.71 (670 mg, 
1.72 mmol) in CH2Cl2 (6.0 mL and 2 X 0.75 mL wash) was cannulated to it. After 45 
min, Et3N (936 mg, 1.30 mL, 8.62 mmol) was added. After 20 min, the cooling bath was 
removed  and  the  reaction  was  quenched  with  H2O  (30  mL).  The  aqueous  layer  was 
extracted with CH2Cl2 (3 X 50 mL). The dried (MgSO4) extract was concentrated in 
vacuo and purified by flash chromatography over silica gel, eluting with 10-20% EtOAc / 
hexanes, to give aldehyde 4.3 (650 mg, 1.67 mmol, 97%) as colorless oil. [α]D
23 = -72.6 
(c = 1.04, CHCl3); IR: (neat) 2953, 2925, 2859, 1731, 1478, 1454, 1283, 1252, 1155, 
1112, 940, 839, 777 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 9.69 (d, J = 1.4 Hz, 1H), 4.29 
(ddd, J = 9.2, 6.6, 4.0 Hz, 1H), 4.23 (ddd, J = 10.9, 7.1, 5.2 Hz, 1H), 4.13 (ddd, J = 10.9, 
7.8, 6.5 Hz, 1H), 3.95 (dd, J = 4.0, 1.4 Hz, 1H), 3.53 (td, J = 9.0, 3.0 Hz, 1H), 2.13 (dt, J 
= 12.1, 6.8 Hz, 1H), 1.83-1.96 (m, 2H), 1.59-1.73 (m, 2H), 1.20 (s, 9H), 1.04 (d, J = 6.5 
Hz, 3H), 0.95 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 
203.8, 178.5, 82.6, 80.0, 78.5, 61.8, 39.7, 38.7, 36.1, 32.8, 27.2, 25.8, 18.3, 15.7, -4.6, -
4.9 ppm; HRMS (CI+) calcd. for C20H39O5Si (M+H) 387.2567, found 387.2560. 
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Cyanide 4.5: To a stirred solution of aldehyde 4.3 (24.0 mg, 0.062 mmol) in THF 
(0.36 mL) at 0°C was added TBSCN (11.1 g, 0.078 mmol) followed by Verkade amino-
phosphine catalyst
2 (2.1 mg, 7.3 µmol). After 1 h, the reaction was directly loaded onto 
column  and  purified  by  chromatography  over  silica  gel,  eluting  with  2-6%  EtOAc  / 
hexanes, to give diastereomeric cyanide 4.5 {32.5 mg, 0.061 mmol, 98% (1.1:1 dr)} as 
colorless oil. [α]D
23 = -31.6 (c = 1.00, CHCl3); IR (neat) 2957, 2931, 2858, 1730, 1472, 
1464,  1255,  1157,  1115,  837,  780  cm
-1; 
1H  NMR  {700  MHz,  CDCl3  (two 
diastereomers)} δ 4.53 (d, J = 4.7 Hz, 1H (1 diastereomer)), 4.46 (d, J = 4.3 Hz, 1H (1 
diastereomer)), 4.29 (ddd, J = 10.9, 7.3, 4.7 Hz, 1H (1 diastereomer)), 4.26 (ddd, J = 
10.9, 7.1, 4.9 Hz, 1H (1 diastereomer)), 4.12-4.20 (m, 2H (1H of 1 diastereomer and 1H 
of 2 diastereomers)), 4.07 (ddd, J = 10.1, 6.1, 4.4 Hz, 1H (1 diastereomer)), 3.73 (t, J = 
4.5 Hz, 1H (1 diastereomer)), 3.55 (dd, J = 6.1, 4.3 Hz, 1H (1 diastereomer)), 3.46-3.50 
(m, 1H (2 diastereomers)), 2.17 (dt, J = 12.2, 6.5 Hz, 1H (1 diastereomer)), 2.06 (dt, J = 
12.0, 6.4 Hz, 1H (1 diastereomer)), 1.88-1.95 (m, 2H (2 diastereomers)), 1.61-1.72 (m, 
2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 1.49 (td, J = 11.7, 10.1 Hz, 1H (1 
diastereomer)), 1.21 (s, 9H (2 diastereomers)), 1.05 (d, J = 6.5 Hz, 3H (1 diastereomer)), 
1.03 (d, J = 6.5 Hz, 3H (1 diastereomer)), 0.93-0.95 (m, 18H (2 diastereomers)), 0.11-
0.23 (m, 12H (2 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.4, 119.3, 
118.5, 82.0, 81.5, 78.3, 77.3, 76.6, 76.0, 65.1, 64.9, 62.0, 61.8, 40.33, 40.31, 38.7, 37.3, 
    
36.2, 33.17, 33.16, 27.2, 25.9, 25.7, 25.6, 25.5, 18.2, 18.1, 18.0, 15.8, 15.6, -4.0, -4.1, -
4.3, -4.8, -5.1, -5.20, -5.29, -5.4 ppm; HRMS (ES+) calcd. for C27H54O5NSi2 (M+H) 
528.3541, found 528.3530.  
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Weinreb  Amide  4.12:  To  a  stirred  solution  of  aldehyde  4.3  (82.3  mg,  0.212 
mmol) and CH(CN)2OTBS (125 mg, 0.636 mmol) in Et2O (2.5 mL) at 0 ºC was added 
NH(OMe)Me (0.43 mL, 0.851 mmol, 2 M in Et2O) followed by DMAP (71.5 mg, 0.585 
mmol). After 2 d, the reaction was concentrated in vacuo and purified by chromatography 
over silica gel, eluting with 5-10% EtOAc / hexanes, to give Weinreb amide 4.12 {81.5 
mg, 0.168 mmol, 79% (2.5:1 dr)} as colorless oil. [α]D
23 = -10.0 (c = 1.00, CHCl3); IR: 
(neat) 2957, 2930, 2857, 1730, 1680, 1463, 1253, 1158, 1106, 1005, 836, 778 cm
-1; 
1H 
NMR (700 MHz, CDCl3) δ 4.76 (br s, 1H), 4.26 (ddd, J = 11.0, 7.2, 4.9 Hz, 1H), 4.16-
4.20 (m, 2H), 3.85 (br s, 1H), 3.75 (s, 3H), 3.47 (td, J = 9.1, 2.6 Hz, 1H), 3.19 (br s, 3H), 
1.86-1.96 (m, 3H), 1.63-1.68 (m, 2H), 1.20 (s, 9H), 1.02 (d, J = 6.5 Hz, 3H), 0.89 (s, 
18H), 0.10 (s, 3H), 0.09 (s, 3H),  0.07 (s, 3H), 0.01 (s, 3H) ppm; 
13C NMR (176 MHz, 
CDCl3) δ 178.5, 173.2, 81.3, 77.8, 75.1, 69.2, 62.1, 61.6, 40.5, 38.6, 36.6, 33.4, 32.4, 
27.2, 26.3, 25.8, 18.4, 18.3, 15.5, -4.1, -4.7, -5.0, -5.1 ppm; HRMS (ES+) calcd. for 
C29H60NO7Si2 (M+H) 590.3908, found 590.3921. 
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Enone 4.15. To a stirred solution of vinyl iodide 2.21
3 (407 mg, 0.839 mmol) in 
THF (7.0 mL) at -78 °C was n-BuLi (0.40 mL, 1.00 mmol, 2.5 M in hexanes). After 1.5 
h, a solution of Weinreb amide 4.14 (136 mg, 0.14 mL, 1.31 mmol) in THF (7.0 mL) was 
cannulated to it. After 1.5 h, the reaction was quenched with sat. aq. NH4Cl (20 mL) and 
the aqueous layer was extracted with Et2O (3 X 40 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by chromatography over silica gel, eluting with 2-6% 
EtOAc / hexanes, to give enone 4.15 (289 mg, 0.721 mmol, 86%) as colorless oil. [α]D
23 
= +17.0 (c = 1.03, CHCl3); IR (neat) 2959, 2943, 2856, 1685, 1609, 1472, 1249, 1091, 
835, 770 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 6.19 (br s, 1H), 3.68 (dt, J = 6.5, 4.9 Hz, 
1H), 3.52 (dd, J = 10.1, 4.8 Hz, 1H), 3.45 (dd, J = 10.1, 6.6 Hz, 1H), 2.52 (qd, J = 7.1, 
5.0 Hz, 1H), 2.18 (s, 3H), 2.15 (d, J = 1.2 Hz, 3H), 1.12 (d, J = 7.1 Hz, 3H), 0.92 (s, 9H), 
0.90 (s, 9H), 0.08 (s, 3H), 0.07 (s, 3H), 0.06 (s, 6H) ppm; 
13C NMR (100 MHz, CDCl3) δ 
198.8, 160.2, 125.2, 75.9, 65.2, 46.0, 31.9, 25.9, 25.8, 18.2, 18.0, 17.8, 15.8, -4.2, -4.9, -
5.40, -5.44 ppm; HRMS (ES+) calcd. for C21H45O3Si2 (M+H) 401.2907, found 401.2907.  
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Hydrazone 4.16. To a stirred solution of enone 4.15 (206 mg, 0.514 mmol) in 
Et2O (4.0 mL) at rt was added 2,4,6-triisopropyl benzenesulfonylhydrazide (307 mg, 1.02 
mmol). After 17 h, MgSO4 (100 mg) was added to the reaction. The reaction was filtered 
through a celite plug and the plug was washed with Et2O (20 mL). The solvent was 
removed in vacuo and purified by flash chromatography over silica gel, eluting with 2-
10% EtOAc / hexanes, to give hydrazone 4.16 {326 mg, 0.478 mmol, 93% (2:1 dr)} as 
colorless oil. The major isomer was readily equilibrated to minor isomer and analytically 
pure  major  isomer  was  not  obtained.  4.16  Minor  isomer:  [α]D
23  =  +15.5  (c  =  1.00, 
CHCl3); IR (neat) 3222, 2956, 2929, 2858, 1603, 1463, 1382, 1255, 1166, 1100, 835, 776 
cm
-1; 
1H NMR (700 MHz, CDCl3) δ 7.49 (s, 1H), 7.18 (s, 2H), 5.51 (s, 1H), 4.24 (sep, J 
= 6.8 Hz, 2H), 3.66 (ddd, J = 7.6, 5.1, 3.8 Hz, 1H), 3.54 (dd, J = 10.1, 5.1 Hz, 1H), 3.40 
(dd, J = 10.1, 7.6 Hz, 1H), 2.92 (sep, J = 6.9 Hz, 1H), 2.61 (qd, J = 7.1, 3.8 Hz, 1H), 1.95 
(s, 3H), 1.65 (d, J = 1.0 Hz, 3H), 1.27-1.29 (m, 18H), 1.15 (d, J = 7.1 Hz, 3H), 0.91 (s, 
9H), 0.90 (s, 9H), 0.099 (s, 3H), 0.095 (s, 3H), 0.079 (s, 3H), 0.078 (s, 3H) ppm; 
13C 
NMR (176 MHz, CDCl3) δ 152.9, 152.5, 151.3, 148.2, 131.6, 123.7, 118.5, 75.9, 64.9, 
    
43.5, 34.1, 29.9, 25.9, 25.8, 24.8, 23.5, 18.2, 18.0, 17.9, 16.9, -4.2, -4.8, -5.33, -5.35 ppm; 
HRMS (ES+) calcd. for C36H69O4N2SSi2 (M+H) 681.4517, found 681.4484.  
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TMS Enyne 4.72: To a stirred solution of Pd(PPh3)4 (116 mg, 0.100 mmol) and 
CuI (38.0 mg, 0.199 mmol) in diisopropylamine (6.5 mL) at 0 ºC was cannulated a pre-
cooled solution of vinyl iodide 2.21
3 (967 mg, 1.99 mmol) in diisopropylamine (2.6 mL). 
TMS acetylene 4.22 (299 mg, 0.43 mL, 2.99 mmol) was added immediately. After 20 
min, the reaction was quenched with sat. aq. NH4Cl (30 mL) and the aqueous layer was 
extracted with Et2O (3 X 50 mL). The dried (MgSO4) extract was concentrated in vacuo 
and purified by flash chromatography over silica gel, eluting with 2-6% Et2O / pentane, 
to give TMS enyne 4.72 (890 mg, 1.95 mmol, 98%) as colorless oil. [α]D
23 = +27.5 (c = 
1.04, CHCl3); IR: (neat) 2956, 2925, 2898, 2851, 2135, 1478, 1260, 1088, 832, 777 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 5.40 (br s, 1H), 3.64 (ddd, J = 6.7, 5.2, 4.2 Hz, 1H), 3.46 
(dd, J = 10.0, 5.2 Hz, 1H), 3.42 (dd, J = 10.0, 6.8 Hz, 1H), 2.50 (qd, J = 7.0, 4.2 Hz, 1H), 
1.94 (d, J = 1.1 Hz, 3H), 1.07 (d, J = 7.1 Hz, 3H), 0.91 (s, 9H), 0.90 (S, 9H), 0.21 (s, 9H), 
0.08 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 
155.4, 106.7, 103.8, 96.7, 76.3, 65.2, 44.0, 26.0, 25.9, 18.3, 18.2, 18.1, 15.8, 0.19, -4.1, -
    
4.9,  -5.3,  -5.4  ppm;  HRMS  (ES+)  calcd.  for  C24H51O2Si3  (M+H)  455.3197,  found 
455.3187. 
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Enyne 4.23: To a stirred solution of TMS enyne 4.72 (718 mg, 1.57 mmol) in 
MeOH (8.0 mL) at rt was added finely powdered K2CO3 (165 mg, 1.19 mmol). After 2 h, 
the solvent was removed in vacuo and the residue was dissolved in Et2O / H2O (3:1, 100 
mL).  The  aqueous  layer  was  extracted  with  Et2O  (3  X  50  mL).  The  dried  (MgSO4) 
extract was concentrated in vacuo and purified by flash chromatography over silica gel, 
eluting with 0-2% EtOAc / hexanes, to give enyne 4.23 (574 mg, 1.49 mmol, 95%) as 
colorless oil. [α]D
23 = +11.4 (c = 1.01, CHCl3); IR: (neat) 3312, 2952, 2925, 2885, 2857, 
1474, 1466, 1387, 1356, 1253, 1119, 1099, 1063, 1012, 834, 810, 779 cm
-1; 
1H NMR 
(400 MHz, CDCl3) δ 5.37 (bs, 1H), 3.64 (dt, J = 6.5, 4.5 Hz, 1H), 3.48 (dd, J = 10.0, 5.1 
Hz, 1H), 3.41 (dd, J = 10.0, 6.8 Hz, 1H), 3.05 (d, J = 2.0 Hz, 1H), 2.50-2.56 (m, 1H), 
1.94 (d, J = 0.6 Hz, 3H), 1.08 (d, J = 7.1 Hz, 3H), 0.91 (s, 9H), 0.90 (s, 9H), 0.077 (s, 
3H), 0.070 (s, 3H), 0.059 (s, 3H), 0.056 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 
155.7, 105.5, 82.0, 79.7, 76.2, 65.2, 43.9, 25.9, 25.8, 18.2, 18.0, 15.8, -4.2, -4.9, -5.3, -5.4 
ppm; HRMS (ES+) calcd. for C21H43O2Si2 (M+H) 383.2802, found 383.2819. 
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Dienyl Stannane 4.24: To a stirred solution of enyne 4.23 (889 mg, 2.32 mmol) 
in degassed THF (100.0 mL) at 0 ºC was added PdCl2(PPh3)2 (81.5 mg, 0.116 mmol) 
followed by Bu3SnH (1.35 g, 1.45 mL, 4.64 mmol) over 2 min. After 25 min, the reaction 
was passed through a plug of silica gel eluting with hexanes (200 mL) buffered with 1% 
Et3N.  The  solvent  was  removed  in  vacuo  and  the  residue  was  purified  by  flash 
chromatography over silica gel, eluting with 0-6% Et2O / pentane, to sequentially give 
dienyl stannane 4.24 {1.22 g, 1.81 mmol, 78% (89% borsm)} as colorless oil followed by 
recovered enyne 4.23 (98.3 mg, 0.257 mmol, 11%). [α]D
23 = +11.8 (c = 1.00, CHCl3); IR: 
(neat) 2954, 2923, 2885, 2855, 1472, 1466, 1365, 1254, 1119, 1095, 1063, 1003, 956, 
833, 777 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 5.95 (s, 1H), 5.65 (dd, J = 3.5, 1.8 Hz, 1H), 
5.32 (dd, J = 3.5, 1.2 Hz, 1H), 3.69 (td, J = 5.8, 3.8 Hz, 1H), 3.53 (dd, J = 10.0, 5.8 Hz, 
1H), 3.47 (dd, J = 10.0, 5.8 Hz, 1H), 2.42 (qd, J = 7.2, 3.8 Hz, 1H), 1.71 (d, J = 1.1 Hz, 
3H), 1.46-1.56 (m, 6H), 1.29-1.38 (m, 6H), 1.09 (d, J = 7.2 Hz, 3H), 0.90-0.95 (m, 33H), 
0.098 (s, 3H), 0.094 (s, 3H), 0.06 (s, 6H) ppm; 
13C NMR (100 MHz, CDCl3) δ 151.9, 
135.2, 131.8, 126.6, 76.8, 65.6, 45.0, 29.0, 27.3, 26.0, 25.9, 18.3, 18.1, 16.0, 15.9, 13.6, 
9.9, -4.1, -4.8, -5.3 ppm; HRMS (ES+) calcd. for C33H70O2Si2SnNa (M+Na) 697.3834, 
found 697.3802. 
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Dienyl Iodide 4.25: To a stirred solution of dienyl stannane 4.24 (1.22 g, 1.81 
mmol) in CH2Cl2 (86.0 mL) at 0 ºC was cannulated a solution of I2 (688 mg, 2.71 mmol) 
in CH2Cl2 (43.0 mL). After 20 min, the reaction was quenched with 10% aq. Na2S2O3 (50 
mL) and the aqueous layer was extracted with CH2Cl2 (2 X 60 mL). The dried (MgSO4) 
extract was concentrated in vacuo and purified by flash chromatography over silica gel, 
eluting with 2-10% Et2O / pentane, to give dienyl iodide 4.25 (871 mg, 1.70 mmol, 94%) 
as colorless oil. [α]D
23 = +7.5 (c = 1.01, CHCl3); IR: (neat) 2954, 2927, 2883, 2855, 1603, 
1472, 1254, 1123, 1095, 1063, 833, 773 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 5.98 (s, 
1H), 5.93 (s, 1H), 5.92 (t, J = 1.3 Hz, 1H), 3.68 (td, J = 5.8, 4.3 Hz, 1H), 3.42-3.49 (m, 
2H), 2.43 (qd, J = 7.1, 4.3 Hz, 1H), 1.81 (d, J = 1.3 Hz, 3H), 1.08 (d, J = 7.1 Hz, 3H), 
0.91 (s, 9H), 0.90 (s, 9H), 0.08 (s, 3H), 0.079 (s, 3H), 0.071 (s, 3H), 0.06 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 142.2, 131.1, 127.4, 104.0, 76.5, 65.2, 44.1, 26.0, 25.9, 
18.3, 18.1, 16.2, 15.7, -4.1, -4.8, -5.2, -5.3 ppm; HRMS (ES+) calcd. for C21H44IO2Si2 
(M+H) 511.1925, found 511.1914. 
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Alcohols 4.17 and 4.65: To a stirred solution of dienyl iodide 4.25 (442 mg, 0.865 
mmol) in THF (7.5 mL) at -78 ºC was added n-BuLi (0.90 mL, 1.44 mmol, 2.5 M in 
hexane). After 45 min, a solution of aldehyde 4.3 (279 mg, 0.721 mmol) in THF (7.5 mL, 
pre-cooled to -78 ºC) was cannulated to it. After 1 h, the reaction was quenched with sat. 
aq. NH4Cl (25 mL) and the aqueous layer was extracted with Et2O (3 X 50 mL). The 
dried (MgSO4) extract was concentrated in vacuo and purified by flash chromatography 
over silica gel, eluting with 4-10% EtOAc / hexanes, to sequentially give diastereomeric 
alcohols 4.17 and 4.65 {345 mg, 0.447 mmol, 62% (81% borsm; 3:1 dr)} as colorless oils 
followed  by  recovered  aldehyde  4.3  (53.1  mg,  0.137  mmol,  19%).  Analytically  pure 
samples of the individual diastereomers could be obtained via chromatography over silica 
gel, eluting with 4-10% EtOAc / hexanes, to give sequentially the major diastereomer 
4.17 followed by the minor diastereomer 4.65. Major isomer 4.17: [α]D
23 = +28.3 (c = 
1.03, CHCl3); IR: (neat) 3478, 2956, 2925, 2883, 2859, 1727, 1474, 1462, 1287, 1158, 
1092, 835, 773 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 5.66 (s, 1H), 5.52 (s, 1H), 5.04 (s, 
1H), 4.25-4.29 (m, 1H), 4.22 (br d, J = 5.88 Hz, 1H), 4.13-4.17 (m, 2H), 4.09 (d, J = 7.0 
Hz, 1H), 3.67 (td, J = 6.0, 4.0 Hz, 1H), 3.61 (t, J = 2.8 Hz, 1H), 3.58 (td, J = 9.1, 2.8 Hz, 
1H), 3.45-3.49 (m, 2H), 2.49 (qd, J = 7.1, 4.0 Hz, 1H), 1.98 (dt, J = 11.8, 6.8 Hz, 1H), 
    
1.90-1.95 (m, 1H), 1.78 (s, 3H), 1.66-1.72 (m, 1H), 1.64 (td, J = 11.4, 9.5 Hz, 1H), 1.22 
(s, 9H), 1.08 (d, J = 7.1 Hz, 3H), 1.02 (d, J = 6.4 Hz, 3H), 0.95 (s, 9H), 0.914 (s, 9H), 
0.910 (s, 9H), 0.14 (s, 3H), 0.11 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.05 (s, 3H), 0.04 (s, 
3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.5, 145.4, 141.5, 124.8, 113.8, 82.7, 78.1, 
78.0, 76.6, 74.1, 65.4, 61.8, 45.3, 39.4, 38.7, 37.0, 32.8, 27.2, 26.0, 25.98, 25.94, 18.3, 
18.2, 18.1, 16.3, 16.1, 15.6, -4.1, -4.3, 4.5, -4.8, -5.31, -5.37 ppm; HRMS (ES+) calcd. for 
C41H82O7Si3Na (M+Na) 793.5266, found 793.5294. 
Minor isomer 4.65: 
1H NMR (400 MHz, CDCl3) δ 5.65 (s, 1H), 5.34 (t, J = 1.6 
Hz, 1H), 5.02 (s, 1H), 4.27(ddd, J = 10.8, 7.2, 4.9 Hz, 1H), 4.13 (ddd, J = 10.8, 8.0, 6.5 
Hz, 1H), 4.04 (ddd, J = 9.8, 7.3, 6.0 Hz, 1H), 3.91 (d, J = 9.3 Hz, 1H), 3.69 (td, J = 5.7, 
4.1 Hz, 1H), 3.57 (dd, J = 7.4, 1.3 Hz, 1H), 3.44-3.53 (m, 3H), 2.91 (d, J = 9.3 Hz, 1H), 
2.46 (qd, J = 7.1, 4.0 Hz, 1H), 2.15 (dt, J = 11.9, 6.2 Hz, 1H), 1.87-1.96 (m, 2H), 1.82 (d, 
J = 1.2 Hz, 3H), 1.66-1.75 (m, 1H), 1.27-1.37 (m, 1H), 1.21 (s, 9H), 1.10 (d, J = 7.1 Hz, 
3H), 1.03 (d, J = 6.4 Hz, 3H), 0.90 (s, 18H), 0.89 (s, 9H), 0.12 (s, 3H), 0.08 (s, 6H), 0.05 
(s, 6H), 0.03 (s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 178.3, 145.8, 142.2, 123.7, 
112.9, 81.6, 80.2, 76.0, 73.2, 65.5, 61.8, 45.3, 39.9, 38.6, 37.9, 33.2, 27.2, 26.06, 26.01, 
25.9, 18.4, 18.3, 18.1, 17.6, 16.1, 16.0, -3.9, -4.1, -4.7, -4.8, -5.2, -5.3 ppm. 
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TBS Ether 4.32: To a stirred solution of alcohol 4.17 (195 mg, 0.252 mmol) in 
CH2Cl2  (6.5  mL)  at  -78  ºC  were  added  2,6-lutidine  (103  mg,  118  µL,  1.01  mmol) 
followed  by  TBSOTf  (133  mg,  117  µL,  0.505  mmol).  After  3  h,  the  reaction  was 
quenched with sat. aq. NaHCO3 (15 mL) and the aqueous layer was extracted with Et2O 
(3 X 40 mL). The dried (MgSO4) extract was concentrated in vacuo and purified by flash 
chromatography over silica gel, eluting with 2-5% EtOAc / hexanes, to give tetra-TBS 
ether 4.32 (195 mg, 0.220 mmol, 87%) as colorless oil. [α]D
23 = +34.6 (c = 1.04, CHCl3); 
IR: (neat) 2956, 2925, 2883, 2859, 1731, 1470, 1462, 1256, 1158, 1100, 1081, 832, 773 
cm
-1; 
1H NMR (700 MHz, CDCl3) δ 5.66 (s, 1H), 5.33 (t, J = 2.0 Hz, 1H), 4.96 (s, 1H), 
4.27 (ddd, J = 10.8, 7.2, 4.8 Hz, 1H), 4.11-4.15 (m, 2H), 3.97 (ddd, J = 9.8, 7.2, 6.2 Hz, 
1H), 3.65-3.67 (m, 1H), 3.54 (dd, J = 7.3, 2.3 Hz, 1H), 3.43-3.47 (m, 2H), 3.31 (td, J = 
9.2, 2.6 Hz, 1H), 2.51 (qd, J = 7.1, 4.0 Hz, 1H), 2.07 (dt, J = 12.3, 6.4 Hz, 1H), 1.87-1.92 
(m, 1H), 1.76-1.83 (m, 1H), 1.79 (d, J = 1.2 Hz, 3H), 1.64-1.69 (m, 1H), 1.21-1.27 (m, 
1H), 1.20 (s, 9H), 1.09 (d, J = 7.2 Hz, 3H), 0.97 (d, J = 6.4 Hz, 3H), 0.92 (s, 9H), 0.917 
(s, 9H), 0.915 (s, 9H), 0.90 (s, 9H), 0.10 (s, 3H), 0.09 (s, 3H), 0.085 (s, 3H), 0.081 (s, 
3H), 0.05 (s, 3H), 0.04 (s, 6H), 0.02 (s, 3H), 0.03 (s, 3H) ppm; 
13C NMR (176 MHz, 
CDCl3) δ 178.4, 145.2, 140.9, 125.7, 114.3, 80.2, 79.5, 79.0, 78.5, 65.4, 62.1, 45.6, 40.3, 
    
38.7, 37.9, 33.0, 27.2, 26.1, 26.0, 25.9, 18.43, 18.40, 18.3, 18.1, 16.06, 16.00, 15.9, -4.1, -
4.2, -4.3, -4.7, -4.83, -4.85, -5.3, -5.4 ppm; HRMS (TOF+) calcd. for C47H96O7Si4Na 
(M+Na) 907.6125, found 907.6106. 
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  Alcohol 4.33: To a stirred solution of tetra-TBS ether 4.32 (264 mg, 0.298 mmol) 
in THF (3.3 mL) at 0 ºC was added a stock solution of HF•Pyr. (1.2 mL).
1 After 32 h, the 
reaction  was  quenched  with  sat.  aq.  NaHCO3  (20  mL)  and  the  aqueous  layer  was 
extracted  with  EtOAc  /  Et2O  (1:1,  4  X  30  mL).  The  dried  (MgSO4)  extract  was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
6-12% EtOAc / hexanes, to give alcohol 4.33 (186 mg, 0.241 mmol, 81%) as colorless 
oil. [α]D
23 = +22.5 (c = 1.01, CHCl3); IR: (neat) 3420, 2956, 2925, 2879, 2855, 1727, 
1470, 1454, 1283, 1248, 1162, 1069, 839, 773 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 5.73 
(s, 1H), 5.31 (t, J = 1.7 Hz, 1H), 4.97 (s, 1H), 4.26 (ddd, J = 10.8, 7.2, 4.8 Hz, 1H), 4.10-
4.16 (m, 2H), 3.95 (ddd, J = 9.9, 7.0, 6.1 Hz, 1H), 3.78 (dt, J = 5.5, 4.8 Hz, 1H), 3.53-
3.57 (m, 3H), 3.35 (td, J = 9.0, 2.8 Hz, 1H), 2.46-2.53 (m, 1H), 2.06 (dt, J = 12.1, 6.3 Hz, 
1H), 1.85-1.93 (m, 1H), 1.80 (d, J = 1.1 Hz, 3H), 1.62-1.75 (m, 2H), 1.21-1.30 (m, 1H), 
1.20 (s, 9H), 1.07 (d, J = 7.1 Hz, 3H), 0.98 (d, J = 6.4 Hz, 3H), 0.92 (s, 9H), 0.918 (s, 
    
9H), 0.915 (s, 9H), 0.11 (s, 3H), 0.10 (s, 3H), 0.09 (s, 3H), 0.08 (s, 3H), 0.05 (s, 3H), 0.02 
(s, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 178.4, 145.1, 140.6, 125.4, 114.8, 80.5, 
79.4, 78.9, 78.6, 75.2, 64.4, 62.0, 46.4, 40.3, 38.6, 38.1, 33.1, 27.2, 26.1, 25.9, 25.8, 18.4, 
18.3, 18.1, 16.0, 14.7, -4.2, -4.3, -4.6, -4.7 ppm; HRMS (ES+) calcd. for C41H82O7Si3Na 
(M+Na) 793.5266, found 793.5232. 
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  Iodide 4.1: To a stirred solution of alcohol 4.33 (186 mg, 0.241 mmol) in benzene 
(6.0 mL) at 5 ºC were sequentially added imidazole (82.1 mg, 1.20 mmol), PPh3 (190 mg, 
0.723 mmol) and I2 (153 mg, 0.602 mmol). After 10 min, the reaction was warmed to rt 
and wrapped with aluminum foil. After 1 h, the reaction was quenched with sat. aq. 
Na2S2O3 (20 mL) and the aqueous layer was extracted with Et2O (3 X 40 mL). The dried 
(MgSO4) extract was concentrated in vacuo and purified by flash chromatography over 
silica gel, eluting with 2-5% EtOAc / hexanes, to give iodide 4.1 (191 mg, 0.216 mmol, 
90%) as colorless oil. [α]D
23 = +27.6 (c = 1.02, CHCl3); IR: (neat) 2955, 2923, 2853, 
1730, 1472, 1460, 1253, 1159, 1073, 1037, 834, 775 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 
5.82 (s, 1H), 5.34 (dd, J = 2.1, 1.4 Hz, 1H), 4.99 (s, 1H), 4.27 (ddd, J = 10.8, 7.2, 4.8 Hz, 
1H), 4.12-4.16 (m, 2H), 3.98 (ddd, J = 9.9, 6.8, 6.1 Hz, 1H), 3.69 (dt, J = 6.7, 4.4 Hz, 
    
1H), 3.56 (dd, J = 6.9, 3.1 Hz, 1H), 3.37 (td, J = 9.1, 2.8 Hz, 1H), 3.18 (dd, J = 10.0, 4.3 
Hz, 1H), 3.15 (dd, J = 10.0, 6.8 Hz, 1H), 2.67 (qd, J = 6.9, 4.7 Hz, 1H), 2.06 (dt, J = 12.2, 
6.2 Hz, 1H), 1.88-1.92 (m, 1H), 1.80-1.85 (m, 1H), 1.81 (d, J = 1.3 Hz, 3H), 1.65-1.70 
(m, 1H), 1.27-1.32 (m, 1H), 1.21 (s, 9H), 1.06 (d, J = 7.0 Hz, 3H), 0.99 (d, J = 6.4 Hz, 
3H), 0.93 (s, 9H), 0.92 (s, 18H), 0.14 (s, 3H), 0.108 (s, 3H), 0.106 (s, 3H), 0.09 (s, 3H), 
0.06 (s, 3H), 0.03 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.4, 145.0, 139.5, 
126.3, 115.2, 80.5, 79.2, 78.6, 78.5, 74.9, 62.1, 47.1, 40.3, 38.7, 38.1, 33.2, 27.2, 26.2, 
26.0, 25.8, 18.4, 18.3, 18.0, 16.1, 16.0, 15.0, 11.4, -4.0, -4.1, -4.2, -4.73, -4.75 ppm; 
HRMS (ES+) calcd. for C41H81O6Si3INa (M+Na) 903.4283, found 903.4263. 
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  Alcohol 4.73: To a stirred solution of pivaloyl ester 3.41 (1.51 g, 3.08 mmol) in 
Et2O (58.0 mL) at 0 ºC was added LiAlH4 (235 mg, 6.17 mmol) in one portion. After 30 
min, the reaction was quenched with dropwise addition of H2O (3.0 mL) and the organic 
layer was decanted. The solid formed was washed with Et2O (3 X 50 mL). The dried 
(MgSO4) extract was concentrated in vacuo and purified by flash chromatography over 
silica gel, eluting with 15-20% EtOAc/ hexanes, to give alcohol 4.73 (1.20 g, 2.96 mmol, 
96%) as colorless oil. [α]D
23 = -20.8 (c = 1.01, CHCl3); IR: (neat) 3443, 2953, 2921, 
2879, 2851, 1470, 1458, 1260, 1081, 1003, 835, 777cm
-1; 
1H NMR (400 MHz, CDCl3) δ 
4.12-4.19 (m, 2H), 3.78-3.82 (m, 2H), 3.65 (dd, J = 11.2, 8.1 Hz, 1H), 3.54-3.59 (m, 2H), 
    
3.01-3.04 (m, 1H), 2.02-2.09 (m, 1H), 1.92-2.00 (m, 1H), 1.68-1.87 (m, 3H), 1.58 (ddd, J 
= 18.2, 11.8, 8.6 Hz, 1H), 0.98 (t, J = 7.9 Hz, 9H), 0.91 (s, 9H), 0.90 (s, 9H), 0.09 (s, 6H), 
0.07 (s, 3H), 0.06 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 80.2, 79.3, 75.5, 64.8, 
62.0, 37.0, 32.6, 27.2, 25.99, 25.90, 18.3, 18.1, -4.2, -4.7, -5.4 ppm; HRMS (ES+) calcd. 
for C20H45O4Si2 (M+H) 405.2856, found 405.2871. 
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Alcohols 4.38 and 4.39: To a stirred solution of oxalyl chloride (453 mg, 0.31 
mL, 3.56 mmol) in CH2Cl2 (21.5 mL) at -78 ºC was cannulated a solution of DMSO (580 
mg, 0.53 mL, 7.43 mmol) in CH2Cl2 (3.5 mL). After 10 min, a solution of alcohol 4.73 
(1.20 g, 2.96 mmol) in CH2Cl2 (6.0 mL) was cannulated to it. After 40 min, Et3N (1. 50 g, 
2.2 mL, 14.84 mmol) was added and the cooling bath was removed. After 15 min, the 
reaction  was  quenched  with  H2O (40  mL)  and the  aqueous  layer  was  extracted  with 
CH2Cl2 (3 X 100 mL). The dried (MgSO4) extract was concentrated in vacuo and purified 
by flash chromatography over silica gel, eluting with 10-20% EtOAc/ hexanes, to give 
aldehyde 4.36 (1.16 g, 2.88 mmol, 97%) as colorless oil.  
    
To a stirred solution of Iodide 2.42
4 (860 mg, 2.96 mmol) in Et2O (50.0 mL) at -
78 ºC was added t-BuLi (3.5 mL, 5.93 mmol, 1.7 M in pentane). After 10 min, the 
reaction was warmed to rt for 25 min and then cooled back down to -78 ºC. A solution of 
aldehyde  4.36  (995  mg,  2.47  mmol)  in  Et2O  (35.0  mL  and  2  X  2.5  mL  wash)  was 
cannulated to it. After 30 min, the reaction was quenched with sat. aq. NH4Cl (35 mL) 
and the aqueous layer was extracted with Et2O (3 X 100 mL). The dried (MgSO4) extract 
was concentrated in vacuo and purified by flash chromatography over silica gel, eluting 
with 5-10% EtOAc / hexanes, to give diastereomeric alcohols 4.38 and 4.39 {1.00 g, 1.78 
mmol, 72% (91% borsm; 1.5:1 dr)} as colorless oil along with recovered aldehyde 4.36 
(190 mg, 0.471 mmol, 19%). Major alcohol 4.38: [α]D
23 = -14.4 (c = 1.01, CHCl3); IR: 
(neat) 3490, 2957, 2929, 2872, 2858, 1458, 1253, 1095, 835, 776, cm
-1; 
1H NMR (700 
MHz, CDCl3) δ 7.35-7.36 (m, 4H), 7.28-7.30 (m, 1H), 4.53 (s, 2H), 4.13-4.17 (m, 2H), 
3.93 (t, J = 9.0 Hz, 2H), 3.88 (s, 1H), 3.66 (dd, J = 11.7, 8.1 Hz, 1H), 3.56-3.58 (m, 2H), 
3.39 (dd, J = 9.1, 6.1 Hz, 1H), 3.31 (dd, J = 9.1, 6.5 Hz, 1H), 2.05-2.09 (m, 2H), 1.92-
1.96 (m, 1H), 1.79-1.85 (m, 1H), 1.63-1.65 (m, 1H), 1.59 (ddd, J = 13.7, 9.0, 5.2 Hz, 1H), 
1.48-1.56 (m, 2H), 1.25 (ddd, J = 13.7, 8.2, 3.7 Hz, 1H), 1.00 (d, J = 6.7 Hz, 3H), 0.914 
(s, 9H), 0.910 (s, 9H), 0.10 (s, 3H), 0.09 (s, 3H), 0.073 (s, 3H), 0.070 (s, 3H) ppm; 
13C 
NMR (176 MHz, CDCl3) δ 138.7, 128.2, 127.5, 127.3, 80.0, 79.4, 76.4, 75.7, 72.8, 69.4, 
65.0, 43.3, 42.1, 33.0, 30.2, 26.9, 25.98, 25.90, 18.3, 18.1, 17.3, -4.2, -4.7, -5.3, -5.4 ppm; 
HRMS (ES+) calcd. for C31H59O5Si2 (M+H) 567.3901, found 567.3882. 
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  Ketone 4.40: To a stirred solution of diastereomeric alcohols 4.38 and 4.39 (747 
mg, 1.31 mmol) in CH2Cl2 (26.0 mL) with 4Å mol. sieves (500 mg) were added NMO 
(463  mg,  3.95  mmol)  followed  by  TPAP  (46.3  mg,  0.131  mmol).  After  30  min,  the 
reaction was directly loaded onto column and purified by flash chromatography over 
silica gel, eluting with 10-15% EtOAc / hexanes, to give ketone 4.40 (708 mg, 1.25 
mmol, 95%) as colorless oil. [α]D
23 = -12.6 (c = 1.03, CHCl3); IR: (neat) 2954, 2929, 
2856, 1713, 1471, 1361, 1253, 1096, 835, 777, 735 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 
7.33-7.37 (m, 4H), 7.28-7.31 (m, 1H), 4.49 (s, 2H), 4.32 (ddd, J = 12.3, 8.6, 6.2 Hz, 1H), 
4.08 (td, J = 7.4, 3.4 Hz, 1H), 3.66 (dd, J = 11.7, 7.9 Hz, 1H), 3.55-3.57 (m, 2H), 3.35 
(dd, J = 9.2, 5.6 Hz, 1H), 3.28 (dd, J = 9.2, 6.8 Hz, 1H), 2.72 (dd, J = 15.5, 6.8 Hz, 1H), 
2.62 (dd, J = 16.3, 5.4 Hz, 1H), 2.51 (dd, J = 15.5, 6.1 Hz, 1H), 2.38-2.42 (m, 1H), 2.34 
(dd, J = 16.3, 7.6 Hz, 1H), 2.10-2.14 (m, 1H), 1.91-1.95 (m , 1H), 1.81-1.87 (m, 1H), 
1.44-1.49 (m, 1H), 0.96 (d, J = 6.7 Hz, 3H), 0.90 (s, 18H), 0.09 (s, 3H), 0.08 (s, 3H), 
0.068 (s, 3H), 0.065 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 209.0, 138.5, 128.3, 
127.59, 127.53, 78.9, 75.7, 75.5, 75.0, 72.9, 65.0, 49.3, 47.5, 32.5, 29.5, 27.4, 26.0, 25.9, 
18.4, 18.2, 17.2, -4.2, -4.7, -5.32, -5.34 ppm; HRMS (ES+) calcd. for C31H56O5Si2Na 
(M+Na) 587.3564, found 587.3553. 
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Sulfide 4.43: To a stirred solution of benzyl ether 4.40 (139 mg, 0.246 mmol) in 
i-PrOH (10.0 mL) was added Pd/C (105 mg, 10 mol% by weight). The flask was fitted 
with a H2 balloon and purged with H2. After 20 h, the reaction was passed through a 
small plug of celite and washed with EtOAc (20 mL). The solvent was removed in vacuo 
to give the crude alcohol 4.74.  
To a stirred solution of crude alcohol 4.74 (101 mg, 0.212 mmol) in THF (2.0 
mL) at 0 ºC was added Ph2S2 (93 mg, 0.425 mmol) followed by n-Bu3P (112 µL, 0.446 
mmol) and the reaction was warmed to rt. After 15 h, the reaction was directly loaded 
onto column and purified by flash chromatography over silica gel, eluting with 5-10% 
EtOAc / hexanes, to give sulfide 4.43 (96.2 mg, 0.169 mmol, 69%) as colorless oil. [α]D
23 
= -22.8 (c = 1.00, CHCl3); IR: (neat) 2954, 2928, 2884, 2856, 1712, 1471, 1360, 1253, 
1088, 835, 777 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 7.34-7.37 (m, 2H), 7.26-7.31 (m, 
2H), 7.15-7.20 (m, 1H), 4.31 (tdd, J = 8.5, 6.9, 5.7 Hz, 1H), 4.08 (td, J = 7.4, 3.4 Hz, 1H), 
3.66 (dd, J = 11.5, 8.0 Hz, 1H), 3.54-3.58 (m, 2H), 2.93 (dd, J = 13.0, 6.4 Hz, 1H), 2.84 
    
(dd, J = 13.0, 6.7 Hz, 1H), 2.73 (dd, J = 17.0, 5.6 Hz, 1H), 2.65 (dd, J = 15.3, 7.0 Hz, 
1H), 2.40-2.48 (m, 2H), 2.29-2.37 (m, 1H), 2.07-2.15 (m, 1H), 1.89-1.97 (m, 1H), 1.80- 
1.87 (m, 1H), 1.42-1.51 (m, 1H), 1.05 (d, J = 6.6 Hz, 3H), 0.907 (s, 9H), 0.905 (s, 9H), 
0.089 (s, 3H), 0.081 (s, 3H), 0.065 (s, 3H), 0.061 (s, 3H) ppm; 
13C NMR (176 MHz, 
CDCl3) δ 208.6, 136.7, 129.0, 128.9, 125.8, 78.9, 75.7, 75.5, 64.9, 49.4, 49.0, 40.4, 32.5, 
28.7, 27.3, 26.0, 25.9, 19.6, 18.4, 18.2, -4.2, -4.7, -5.33, -5.34 ppm; HRMS (ES+) calcd. 
for C30H55O4SSi2 (M+H) 567.3360, found 567.3348.  
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  Sulfone  4.44:  To  a  stirred  solution  of  sulfide  4.43  (117  mg,  0.206  mmol)  in 
CH3CN (3.2 mL) at rt was added NMO (72.5 mg, 0.619 mmol) followed by TPAP (36.2 
mg, 0.103 mmol). After 14 h, the reaction was directly loaded onto column and purified 
by flash chromatography over silica gel, eluting with 10-15% EtOAc / hexanes, to give 
sulfone  4.44  (104  mg,  0.173  mmol,  84%)  as  colorless  oil.  [α]D
23 =  -21.3  (c  =  1.01, 
CHCl3); IR: (neat) 2955, 2929, 2884, 2856, 1712, 1471, 1306, 1253, 1149, 1086, 835, 
777 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 7.92-7.94 (m, 2H), 7.67 (tt, J = 7.4, 1.2 Hz, 1H), 
7.58-7.60 (m, 2H), 4.29 (tdd, J =8.5, 7.6, 5.7 Hz, 1H), 4.08 ( td, J = 7.4, 3.3 Hz, 1H), 3.63 
(dd, J = 11.6, 8.1 Hz, 1H), 3.53-3.56 (m, 2H), 3.25 (dd, J = 14.2, 6.0 Hz, 1H), 3.01 (dd, J 
    
= 14.2, 6.6 Hz, 1H), 2.77 (dd, J = 17.7, 5.7 Hz, 1H), 2.62 (dd, J = 15.2, 7.4 Hz, 1H), 2.61 
(dd, J = 17.7, 6.7 Hz, 1H), 2.52-2.57 (m, 1H), 2.46 (dd, J = 15.2, 5.4 Hz, 1H), 2.08-2.12 
(m, 1H), 1.91-1.96 (m, 1H), 1.81-1.87 (m, 1H), 1.44-1.50 (m, 1H), 1.13 (d, J = 6.8 Hz, 
3H), 0.90 (s, 18H), 0.08 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H) ppm; 
13C NMR 
(176 MHz, CDCl3) δ 207.7, 139.7, 133.6, 129.3, 127.9, 78.9, 75.7, 75.5, 64.9, 60.9, 49.3, 
48.6, 32.5, 27.3, 26.0, 25.9, 24.6, 20.2, 18.4, 18.1, -4.2, -4.7, -5.3 ppm; HRMS (ES+) 
calcd. for C30H54O6SSi2Na (M+Na) 621.3077, found 621.3065.  
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TBS Enol Ethers 4.45 and 4.46: To a stirred solution of keto sulfone 4.44 (104 
mg, 0.173 mmol) in CH2Cl2 (2.5 mL) at -78 ºC were added 2,6-lutidine (149 mg, 0.16 
mL, 1.39 mmol) followed by TBSOTf (184 mg, 0.16 mL, 0.695 mmol). After 15 min, the 
reaction was warmed to 0 ºC. After additional 4 h, by the time the reaction warmed to rt, 
was quenched with sat. aq. NaHCO3 (15 mL) and the aqueous layer was extracted with 
Et2O (3 X 30 mL). The dried (MgSO4) extract was concentrated in vacuo and purified by 
flash  chromatography  over  silica  gel,  eluting  with  5-10%  EtOAc  /  hexanes,  to 
sequentially give isomeric enol ethers 4.45 and 4.46 {145 mg, 0.164 mmol, 95% (2.5:1 
    
rr)} as colorless oils. Major isomer 4.45: [α]D
23 = +4.5 (c = 1.00, CHCl3); IR: (neat) 
2955, 2929, 2885, 2857, 1670, 1472, 1306, 1254, 1151, 1086, 1003, 836 cm
-1; 
1H NMR 
(700 MHz, CDCl3) δ 7.91-7.93 (m, 2H), 7.64 (tt, J = 7.4, 1.2 Hz, 1H), 7.54-7.57 (m, 2H), 
4.28 (d, J = 8.7 Hz, 1H), 4.05 ( td, J = 7.4, 3.4 Hz, 1H), 4.00 (ddd, J = 8.4, 6.2, 6.1 Hz, 
1H), 3.65 (dd, J = 11.8, 8.0 Hz, 1H), 3.53-3.56 (m, 2H), 3.14-3.19 (m, 1H), 3.11 (dd, J = 
14.0, 5.3 Hz, 1H), 3.00 (dd, J = 14.0, 8.3 Hz, 1H), 2.28 (dd, J = 14.8, 6.0 Hz, 1H), 1.95-
1.99 (m, 1H), 1.93 (dd, J = 14.7, 6.7 Hz, 1H), 1.88-1.92 (m, 1H), 1.76-1.82 (m, 1H), 
1.41-1.46 (m, 1H), 1.15 (d, J = 6.7 Hz, 3H), 0.92 (s, 9H), 0.90 (s, 9H), 0.88 (s, 9H), 0.13 
(s, 3H), 0.11 (s, 3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.057 (s, 3H), 0.054 (s, 3H) ppm; 
13C 
NMR (176 MHz, CDCl3) δ 148.3, 140.3, 133.3, 129.1, 127.9, 112.0, 79.0, 75.9, 65.0, 
62.3, 42.4, 32.1, 27.2, 26.0, 25.9, 25.86, 25.80, 25.6, 20.6, 18.4, 18.2, 18.1, -3.7, -3.8, -
4.2,  -4.6,  -5.32,  -5.34  ppm;  HRMS  (ES+)  calcd.  for  C36H69O6SSi3 (M+H)  713.4123, 
found 713.4148. 
  Minor isomer 4.46: [α]D
23 = -9.9 (c = 1.17, CHCl3); IR: (neat) 2955, 2929, 2885, 
2857, 1671, 1472, 1318, 1307, 1255, 1144, 1087, 836 cm
-1; 
1H NMR (700 MHz, CDCl3) 
δ 7.92-7.94 (m, 2H), 7.64 (tt, J = 7.4, 1.2 Hz, 1H), 7.57-7.60 (m, 2H), 4.63 (td, J = 8.8, 
5.7 Hz, 1H), 4.51 ( d, J = 8.8 Hz, 1H), 4.07 (ddd, J = 8.1, 7.0, 3.0 Hz, 1H), 3.73 (dd, J = 
12.4, 7.6 Hz, 1H), 3.59-3.62 (m, 2H), 3.29 (dd, J = 14.3, 3.3 Hz, 1H), 2.90 (dd, J = 14.3, 
9.1 Hz, 1H), 2.18-2.25 (m, 1H), 1.99-2.05 (m, 2H), 1.85-1.94 (m, 3H), 1.44-1.50 (m, 1H), 
1.14 (d, J = 6.6 Hz, 3H), 0.92 (s, 9H), 0.90 (s, 9H), 0.85 (s, 9H), 0.10 (s, 6H), 0.08 (s, 
3H), 0.07 (s, 3H), 0.06 (s, 3H), 0.05 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 149.1, 
139.6, 133.5, 129.3, 127.9, 113.5, 79.2, 75.5, 73.9, 65.3, 61.1, 44.2, 33.5, 27.8, 26.4, 26.0, 
    
25.7, 19.6, 18.4, 18.3, 18.1, -4.0, -4.1, -4.2, -4.7, -5.2 ppm; HRMS (ES+) calcd. for 
C36H69O6SSi3 (M+H) 713.4123, found 713.4094.  
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  Coupled Sulfone 4.47: To a stirred solution of sulfone 4.45 (35.9 mg, 50.3 µmol) 
in THF (0.20 mL) at -78 ºC was added LHMDS (111 µL, 0.111 mmol, 1M in THF). 
After 30 min, the reaction was warmed to 0 ºC and HMPA (77.2 mg, 75 µL, 0.431 mmol) 
was added to it. A solution of iodide 4.1 (15.9 mg, 18.0 µmol) in THF (0.20 mL) was 
cannulated to it and the reaction was slowly warmed to rt over 2 h. After 6 h, the reaction 
was quenched with sat. aq. NH4Cl (5.0 mL) and the aqueous layer was extracted with 
Et2O (3 X 15 mL). The dried (MgSO4) extract was concentrated in vacuo and purified by 
flash  chromatography  over  silica  gel,  eluting  with  5-10%  EtOAc  /  hexanes,  to  give 
coupled sulfone 4.47 (13.8 mg, 9.38 µmol, 52%) as colorless oil. [α]D
23 = -12.5 (c = 1.12, 
CHCl3); IR: (neat) 2956, 2929, 2885, 2857, 1731, 1667, 1472, 1388, 1254, 1146, 1076, 
836  cm
-1; 
1H  NMR  {700  MHz,  CDCl3  (two  diastereomers)}  δ  7.87-7.88  (m,  2H  (1 
diastereomer)),  7.83-7.84  (m,  2H  (1  diastereomer)),  7.62  (tt,  J  =  7.4,  1.2  Hz,  1H  (1 
diastereomer)),  7.59  (tt,  J  =  7.4,  1.2  Hz,  1H  (1  diastereomer)),  7.48-7.50  (m,  2H  (2 
    
diastereomers)), 5.78 (s, 1H (1 diastereomer)), 5.71 (s, 1H (1 diastereomer)), 5.36 (br s, 
1H (1 diastereomer)), 5.33 (br s, 1H (1 diastereomer)), 5.03 (s, 1H (1 diastereomer)), 4.89 
(s, 1H (1 diastereomer)), 4.61 (d, J = 9.2 Hz, 1H (1 diastereomer)), 4.25-4.29 (m, 2H (2 
diastereomers)), 4.21 (d, J = 8.6 Hz, 1H (major)), 4.08-4.16 (m, 2H (2 diastereomers)), 
3.65-3.68 (m, 1H (2 diastereomers)), 3.53-3.60 (m, 3H (2 diastereomers)), 3.37 (td, J = 
9.1, 2.7 Hz, 1H (1 diastereomer)), 3.33 (td, J = 9.1, 2.7 Hz, 1H (1 diastereomer)), 3.19 
(ddd, J = 8.0, 4.7, 2.8 Hz, 1H (1 diastereomer)), 3.12 (ddd, J = 8.5, 5.0, 1.5 Hz, 1H (1 
diastereomer)), 2.99-3.03 (m, 1H (1 diastereomer)), 2.39-2.43 (m, 1H (2 diastereomers)), 
2.36  (dd,  J  =  14.2,  4.2  Hz,  1H  (1  diastereomer)),  2.23  (qd,  J  =  6.8,  3.2  Hz,  1H  (1 
diastereomer)), 2.11 (dt, J = 12.2, 6.4 Hz, 1H (1 diastereomer)), 2.07 (dt, J = 12.2, 6.1 
Hz,  1H  (1  diastereomer)),  1.94-1.99  (m  ,1H  (2  diastereomers)),  1.77-1.93  (m,  7H  (2 
diastereomers)), 1.86 (d, J = 0.9 Hz, 3H (1 diastereomer)), 1.75 (d, J = 1.0 Hz, 3H (1 
diastereomer)),  1.66-1.73  (m,  2H  (2  diastereomers)),  1.35-1.40  (m,  1H  (2 
diastereomers)), 1.23-1.28 (m, 1H (2 diastereomers)), 1.216 (s, 9H (1 diastereomer)), 
1.213 (s, 9H (1 diastereomer)), 1.09 (d, J = 6.9 Hz, 3H (2 diastereomers)), 1.04 (d, J = 7.0 
Hz,  3H  (1  diastereomer)),  1.00  (d,  J  =  6.5  Hz,  3H),  0.99  (d,  J  =  6.9  Hz,  3H  (1 
diastereomer)),  0.88-0.95  (m,  54H  (2  diastereomers)),  0.05-0.19  (m,  36H  (2 
diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.4, 148.6, 148.2, 145.7, 145.5, 
140.3, 139.8, 139.7, 138.6, 133.1, 129.3, 129.0, 128.8, 128.4, 125.8, 124.7, 114.8, 114.4, 
110.1, 109.7, 80.5, 80.4, 79.6, 79.4, 79.3, 79.2, 79.1, 78.9, 78.8, 75.9, 72.3, 71.5, 65.7, 
65.1, 64.7, 62.1, 48.5, 47.9, 42.9, 42.7, 40.3, 38.6, 38.2, 38.0, 34.6, 34.5, 33.17, 33.12, 
31.9, 31.8, 30.7, 29.7, 29.3, 28.4, 27.4, 27.3, 27.2, 26.1, 26.03, 26.00, 25.9, 25.7, 20.1, 
    
18.45, 18.41, 18.3, 18.2, 18.16, 18.11, 17.5, 17.4, 16.0, 15.9, 11.2, -3.51, -3.59, -3.7, -3.8, 
-3.9, -4.0, -4.24, -4.26, -4.30, -4.38, -4.60, -4.64, -4.67, -4.7, -5.3 ppm; HRMS (ES+) 
calcd. for C77H148O12Si6SNa (M+Na) 1487.9205, found 1487.9250.  
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Coupled Sulfone 4.48: To a stirred solution of sulfone 4.46 (58.2 mg, 81.6 µmol) 
in THF (0.33 mL) at -78 ºC was added LHMDS (180 µL, 0.180 mmol, 1M in THF). 
After 30 min, the reaction was warmed to 0 ºC and HMPA (125 mg, 122 µL, 0.698 
mmol) was added to it. A solution of iodide 4.1 (25.8 mg, 29.3 µmol) in THF (0.33 mL) 
was cannulated to it and the reaction was slowly warmed to rt over 2 h. After 7.5 h, the 
reaction was quenched with sat. aq. NH4Cl (5.0 mL) and the aqueous layer was extracted 
with  Et2O  (3  X  15  mL).  The  dried  (MgSO4)  extract  was  concentrated  in vacuo  and 
purified by flash chromatography over silica gel, eluting with 5-10% EtOAc / hexanes, to 
give coupled sulfone 4.48 (19.3 mg, 13.1 µmol, 45%) as colorless oil. [α]D
23 =
 +0.5 (c = 
1.00, CHCl3); IR: (neat) 2956, 2930, 2886, 2857, 1731, 1671, 1472, 1463, 1388, 1305, 
1254, 1147, 1076, 836, 777 cm
-1, 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 
7.87-7.89 (m, 2H (2 diastereomers)), 7.62-7.64 (m, 1H (2 diastereomers)), 7.54-7.58 (m, 
    
2H (2 diastereomers)), 5.76 (s, 1H (1 diastereomer)), 5.74 (s, 1H (1 diastereomer)), 5.33 
(br s, 1H (2 diastereomers)), 4.99 (s, 1H (1 diastereomer)), 4.88 (s, 1H (1 diastereomer)), 
4.71  (td,  J  =  8.6,  5.8  Hz,  1H  (1  diastereomer)),  4.62  (td,  J  =  8.6,  5.6  Hz,  1H  (1 
diastereomer)), 4.52 (d, J = 8.5 Hz, 1H (1 diastereomer)), 4.49 (d, J = 8.6 Hz, 1H (1 
diastereomer)),  4.26-4.30  (m,  1H  (2  diastereomers)),  4.12-4.16  (m,  2H  (2 
diastereomers)), 4.05-4.11 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 
4.00 (dt, J = 9.7, 3.2 Hz, 1H (1 diastereomer)), 3.96 (ddd, J = 9.8, 7.5, 6.0 Hz, 1H (1 
diastereomer)), 3.92 (ddd, J = 9.7, 7.8, 6.2 Hz, 1H (1 diastereomer)), 3.74 (dd, J = 9.2, 
4.6 Hz, 1H (1 diastereomer)), 3.72 (dd, J = 9.5, 4.6 Hz, 1H (1 diastereomer)), 3.58-3.63 
(m, 2H (2 diastereomers)), 3.55-3.57 (m, 1H (2 diastereomers)), 3.37 (td, J = 9.1, 2.7 Hz, 
1H (1 diastereomer)), 3.32 (td, J = 9.1, 2.6 Hz, 1H (1 diastereomer)), 3.19 (dt, J = 8.0, 2.3 
Hz, 1H (1 diastereomer)), 3.11-3.13 (m, 1H (1 diastereomer)), 2.59 (dd, J = 14.5, 3.2 Hz, 
1H (1 diastereomer)), 2.40 (qd, J = 6.9, 3.1 Hz, 1H (1 diastereomer)), 2.28-2.35 (m, 2H 
(1H  of  1  diastereomer  and  1H  of  2  diastereomers)),  1.99-2.12  (m,  4H  (1H  of  1 
diastereomer and 3H of 2 diastereomers)), 1.82-1.95 (m, 4H (2 diastereomers)), 1.81 (d, J 
= 1.1 Hz, 3H (1 diastereomer)), 1.77 (d, J = 1.0 Hz, 3H (1 diastereomer)), 1.63-1.75 (m, 
3H  (2  diastereomers)),  1.45-1.54  (m,  1H  (2  diastereomers)),  1.23-1.30  (m,  1H  (2 
diastereomers)), 1.216 (s, 9H (1 diastereomer)), 1.214 (s, 9H (1 diastereomer)), 1.05 (d, J 
= 7.0 Hz, 3H (1 diastereomer)), 1.03 (d, J = 7.0 Hz, 3H (1 diastereomer)), 0.96-1.00 (m, 
6H  (2  diastereomers)),  0.89-0.95  (m,  54H  (2  diastereomers)),  -0.05-0.18  (m,  36H  (2 
diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.4, 150.3, 149.1, 145.4, 145.2, 
140.6, 139.6, 139.5, 139.1, 133.4, 129.2, 128.5, 128.4, 126.4, 125.4, 115.1, 114.6, 113.6, 
    
112.1, 80.4, 80.3, 79.67, 79.63, 79.3, 79.2, 79.1, 78.8, 75.7, 75.6, 74.1, 72.3, 65.2, 64.7, 
64.4, 62.15, 62.10, 48.1, 47.0, 42.8, 40.3, 38.6, 38.2, 38.1, 38.0, 36.0, 34.6, 34.5, 33.6, 
33.1, 33.0, 31.6, 30.9, 29.7, 29.5, 29.0, 28.6, 27.79, 27.73, 27.4, 27.2, 26.1, 26.05, 26.04, 
26.01, 25.9, 25.8, 25.7, 25.2, 20.7, 18.4, 18.3, 18.2, 18.1, 18.09, 18.04, 17.9, 17.3, 17.0, 
16.0, 15.9, 14.1, 13.6, 12.0, 11.4, -3.8, -3.91, -3.96, -4.1, -4.2, -4.30, -4.34, -4.4, -4.51, -
4.58, -4.63, 4.66, -4.71, -4.73, -5.3 ppm; HRMS (ES+) calcd. for C77H149O12SSi6 (M+H) 
1465.9385, found 1465.9435. 
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Alcohol 4.38: To a stirred solution of ketone 4.40 (708 mg, 1.25 mmol) in THF 
(100.0 mL) was added L-Selectride (3.8 mL, 3.80 mmol, 1 M in THF) and warmed to -30 
ºC over 1 h. After 5 h, the reaction was quenched with sat. aq. NH4Cl (30 mL) and the 
aqueous layer was extracted with Et2O (3 X 60 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
5-10% EtOAc / hexanes, to give alcohol 4.38 {638 mg, 1.12 mmol, 90% (15:1 dr)} as 
colorless oil. 
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  THP Ether 4.55: To a stirred solution of alcohol 4.38 (473 mg, 0.834 mmol) in 
CH2Cl2 (6.2 mL) were added dihydropyran (1.75 g, 1.9 mL, 20.8 mmol) followed by 
PPTS (6.1 mg, 24.2 µmol). After 15 h, the reaction was quenched with Et3N (864 mg, 1.2 
mL,  8.52  mmol)  and  was  concentrated  in vacuo.  The  residue  was  purified  by  flash 
chromatography over silica gel, eluting with 4-10% EtOAc / hexanes, to give THP ether 
4.55 (538 g, 0.826 mmol, 99%) as colorless oil. [α]D
23 = -17.8 (c = 1.00, CHCl3); IR: 
(neat) 2952, 2929, 2856, 1471, 1462, 1360, 1253, 1094, 1077, 1024, 835, 776 cm
-1; 
1H 
NMR {700 MHz, CDCl3 (two diastereomers)} δ 7.34-7.37 (m, 4H (2 diastereomers)), 
7.27-7.30 (m, 1H (2 diastereomers)), 4.61-4.65 (m, 1H (2 diastereomers)), 4.53 (s, 2H (1 
diastereomer)), 4.52 (s, 2H ( 1 diastereomer)), 4.03-4.10 (m, 2H ( 1H of 1 diastereomer 
and 1H of 2 diastereomers)), 3.90-3.99 (m, 2H (2 diastereomers)), 3.85-3.89 (m, 1H (1 
diastereomer)),  3.67-3.70  (m,  1H  (2  diastereomers)),  3.55-3.59  (m,  2H  (2 
diastereomers)), 3.46-3.50 (m, 1H (2 diastereomers)), 3.39 (dd, J = 9.1, 5.7 Hz, 1H (1 
diastereomer)), 3.37 (dd, J = 9.0, 5.4 Hz, 1H (1 diastereomer)), 3.27 (dd, J = 9.1, 7.0 Hz, 
1H (1 diastereomer)), 3.24 (dd, J = 9.0, 7.2 Hz, 1H (1 diastereomer)), 2.10-2.17 (m, 1H 
(1  diastereomer)),  1.96-2.05  (m,  2H  (2  diastereomers)),  1.89-1.94  (m,  1H  (2 
diastereomers)), 1.78-1.85 (m, 3H (2H of 2 diastereomers and 1H of 1 diastereomer)), 
    
1.65-1.72 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 1.50-1.63 (m, 6H 
(1H of 1 diastereomer and 5H of 2 diastereomers)), 1.41-1.48 (m, 1H (2 diastereomers)), 
1.32-1.37 (m, 1H (2 diastereomers)), 1.01 (d, J = 6.6 Hz, 3H (1 diastereomer)), 1.00 (d, J 
=  6.7  Hz,  3H  (1  diastereomer)),  0.921  (s,  9H  (1  diastereomer)),  0.920  (s,  9H  (1 
diastereomer)), 0.909 (s, 9H (1 diastereomer)), 0.908 (s, 9H (1 diastereomer)), 0.908 (s, 
3H (2 diastereomers)), 0.905 (s, 3H (2 diastereomers)), 0.08 (s, 3H (2 diastereomers)), 
0.07 (s, 3H (2 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 138.9, 138.8, 128.3, 
128.2, 127.56, 127.55, 127.4, 127.3, 99.3, 97.0, 78.66, 78.61, 76.5, 76.4, 76.36, 76.30, 
76.1, 74.2, 72.9, 72.8, 72.2, 65.2, 65.1, 63.1, 63.0, 42.0, 40.7, 39.1, 38.3, 33.2, 32.8, 
31.39, 31.35, 30.0, 29.9, 27.4, 27.3, 26.0, 25.9, 25.56, 25.52, 20.3, 20.2, 18.4, 18.2, 18.1, 
17.5, 17.0, -4.2, -4.70, -4.72, -5.33, -5.36 ppm; HRMS (ES+) calcd. for C36H66O6Si2Na 
(M+Na) 673.4296, found 673.4268.  
 
 
 
    
OTBS
O H
H
BnO
OTBS
OTHP
OTBS
O H
H
HO
OTBS
OTHP
4.55 4.75
OTBS
O H
H
PhS
OTBS
OTHP
4.56  
 
Sulfide 4.56: To a stirred solution of benzyl ether 4.55 (538 mg, 0.826 mmol) in 
i-PrOH (34.0 mL) was added Pd/C (354 mg, 10 mol% by weight). The flask was fitted 
with a H2 balloon and purged with H2. After 20 h, the reaction was passed through a plug 
of celite and the celite plug was washed with EtOAc (50 mL). The solvent was removed 
in vacuo to give crude alcohol 4.75.  
To a stirred solution of crude alcohol 4.75 in THF (5.5 mL) at 0 ºC were added 
Ph2S2 (361 mg, 1.65 mmol) followed by n-Bu3P (351 mg, 0.44 mL, 1.73 mmol) and the 
reaction was warmed to rt. After 15 h, the solvent was removed in vacuo and the residue 
was  purified  by  flash  chromatography  over  silica  gel,  eluting  with  5-10%  EtOAc  / 
hexanes, to give sulfide 4.56 (480 mg, 0.735 mmol, 89%) as colorless oil. [α]D
23 = -28.5 
(c = 1.01, CHCl3); IR: (neat) 2953, 2933, 2855, 1478, 1439, 1376, 1256, 1112, 1073, 
1022, 835, 777 cm
-1; 
1H NMR {400 MHz, CDCl3 (two diastereomers)} δ 7.33-7.37 (m, 
2H  (2  diastereomers)),  7.25-7.29  (m,  2H  (2  diastereomers)),  7.13-7.18  (m,  1H  (2 
diastereomers)),  4.55-4.64  (m,  1H  (2  diastereomers)),  4.03-4.10  (m,  1H  (2 
    
diastereomers)),  3.75-4.01  (m,  3H  (2  diastereomers)),  3.66-3.71  (m,  1H  (2 
diastereomers)),  3.53-3.59  (m,  2H  (2  diastereomers)),  3.40-3.48  (m,  1H  (2 
diastereomers)),  2.92-3.02  (m,  1H  (2  diastereomers)),  2.73-2.81  (m,  1H  (2 
diastereomers)),  2.06-2.14  (m,  1H  (1  diastereomer)),  1.96-2.05  (m,  1H  (2 
diastereomers)), 1.87-1.95 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 
1.68-1.85 (m, 4H (2 diastereomers)), 1.55-1.67 (m, 2H (2 diastereomers)), 1.39-1.54 (m, 
6H (2 diastereomers)), 1.08 (d, J = 7.0 Hz, 3H (1 diastereomer)), 1.07 (d, J = 7.1 Hz, 3H 
(1 diastereomer)), 0.91 (s, 18H (2 diastereomers)), 0.09 (s, 6H (2 diastereomers)), 0.075 
(s, 3H (2 diastereomers)), 0.071 (s, 3H (2 diastereomers)) ppm; 
13C NMR (100 MHz, 
CDCl3) δ 137.5, 137.2, 129.1, 129.0, 128.77, 128.71, 125.6, 125.6, 125.4, 99.6, 96.7, 
78.6, 78.5, 77.2, 76.3, 76.2, 76.1, 76.0, 74.6, 72.1, 65.2, 65.1, 63.1, 62.8, 42.0, 41.9, 41.7, 
41.0, 40.6, 33.2, 32.9, 31.3, 31.2, 29.53, 29.50, 27.37, 27.32, 26.0, 25.9, 25.5, 25.4, 20.2, 
20.0, 19.5, 19.1, 18.4, 18.2, 18.1, -4.1, -4.70, -4.74, -5.34, -5.36 ppm; HRMS (ES+) 
calcd. for C35H64O5SSi2Na (M+Na) 675.3911, found 675.3931.  
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Sulfone  4.57:  To  a  stirred  solution  of  sulfide  4.56  (480  mg,  0.735  mmol)  in 
freshly distilled CH3CN (12.0 mL) at rt were sequentially added 4Å mol. sieves (450 
mg), NMO (258 mg, 2.20 mmol) followed by TPAP (129 mg, 0.367 mmol). After 15 h, 
the reaction was directly loaded onto column and purified by flash chromatography over 
silica gel, eluting with 10-30% EtOAc / hexanes, to give sulfone 4.57 (468 mg, 0.683 
mmol, 93%) as colorless oil. [α]D
23 = -16.6 (c = 1.01, CHCl3); IR: (neat) 2952, 2929, 
2856, 1471, 1307, 1253, 1148, 1086, 1024, 835, 776 cm
-1; 
1H NMR {700 MHz, CDCl3 
(two  diastereomers)}  δ  7.93-7.96  (m,  2H  (2  diastereomers)),  7.64-7.68  (m,  1H  (2 
diastereomers)), 7.56-7.59 (m, 2H (2 diastereomers)), 4.56 (dd, J = 5.6, 2.7 Hz, 1H (1 
diastereomer)), 4.53 (dd, J = 5.4, 2.8 Hz, 1H (1 diastereomer)), 4.05-4.09 (m, 1H (2 
diastereomers)), 3.95 (ddd, J = 13.6, 9.0, 4.8 Hz, 1H (1 diastereomer)), 3.90 (ddd, J = 
13.6, 9.1, 4.7 Hz, 1H (1 diastereomer)), 3.85-3.89 (m, 1H (2 diastereomers)), 3.75-3.80 
(m, 1H (2 diastereomers)), 3.64-3.67 (m, 1H (2 diastereomers)), 3.52-3.56 (m, 2H (2 
diastereomers)), 3.41-3.48 (m, 1H (2 diastereomers)), 3.30 (dd, J = 14.2, 4.5 Hz, 1H (1 
diastereomer)), 3.18 (dd, J = 14.2, 4.2 Hz, 1H (1 diastereomer)), 2.97 (t, J = 8.4 Hz, 1H 
(1  diastereomer)),  2.95  (t,  J  =  8.4  Hz,  1H  (1  diastereomer)),  2.32-2.37  (m,  1H  (1 
diastereomer)),  2.20-2.25  (m,  1H  (1  diastereomer)),  1.94-2.00  (m,  2H  (1H  of  2 
    
diastereomers and 1H of 1 diastereomer)), 1.88-1.93 (m, 1H (2 diastereomers)), 1.71-1.83 
(m, 3H (2H of 2 diastereomers and 1H of 1 diastereomer)), 1.60-1.68 (m, 2H (1H of 1 
diastereomers and 1H of 2 diastereomers)), 1.40-1.58 (m, 8H (1H of 1 diastereomer and 
7H of 2 diastereomers)), 1.15 (d, J = 6.4 Hz, 3H (1 diastereomer)), 1.14 (d, J = 6.5 Hz, 
3H (1 diastereomer)), 0.910 (s, 9H (1 diastereomer)), 0.908 (s, 9H (1 diastereomer)), 
0.898  (s,  9H  (1  diastereomer)),  0.896  (s,  9H  (1  diastereomer)),  0.085  (s,  3H  (2 
diastereomers)), 0.081 (s, 3H (2 diastereomers)), 0.07 (s, 3H (2 diastereomers)), 0.06 (s, 
3H (2 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 140.09, 140.01, 133.5, 133.3, 
129.2, 129.1, 128.0, 127.9, 100.0, 96.9, 78.49, 78.46, 76.1, 76.06, 76.02, 76.00, 74.8, 
71.6, 65.1, 65.0, 63.2, 63.1, 63.0, 41.9, 41.8, 41.3, 40.3, 33.2, 32.9, 31.3, 31.2, 27.3, 27.2, 
26.08, 26.04, 25.9, 25.48, 25.40, 20.3, 20.2, 20.0, 19.6, 18.47, 18.45, 18.1, -4.1, -4.70, -
4.73,  -5.3  ppm;  HRMS  (ES+)  calcd.  for  C35H64O7SSi2Na  (M+Na)  707.3809,  found 
707.3815.  
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Coupled Sulfone 4.58: To a stirred solution of sulfone 4.57 (56.0 mg, 81.7 µmol) 
in THF (0.32 mL) at -78 ºC was added LHMDS (82 µL, 82.0 µmol, 1M in THF). After 
    
15 min, the reaction was warmed to 0 ºC and HMPA (77.2 mg, 75 µL, 0.431 mmol) was 
added to it. A solution of iodide 4.1 (27.5 mg, 31.2 µmol) in THF (0.25 mL and 1 X 0.10 
mL wash) was cannulated to it and the reaction was slowly warmed to rt over 1 h. After 
12 h, the reaction was quenched with sat. aq. NH4Cl (10 mL) and the aqueous layer was 
extracted with Et2O (3 X 25 mL). The dried (MgSO4) extract was concentrated in vacuo 
and  purified  by  flash  chromatography  over  silica  gel,  eluting  with  10-30%  EtOAc  / 
hexanes,  to  give  diastereomeric  coupled  sulfone  4.58  (38.4  mg,  26.6  µmol,  85%)  as 
colorless oil. [α]D
23 = -8.8 (c = 1.00, C6H6); IR: (neat) 2955, 2929, 2857, 1731, 1472, 
1463, 1388, 1306, 1253, 1145, 1076, 835, 776 cm
-1, 
1H NMR {700 MHz, CDCl3 (four 
diastereomers)}  δ  7.89-7.95  (m,  2H  (4  diastereomers)),  7.60-7.65  (m,  1H  (4 
diastereomers)), 7.52-7.58 (m, 2H (4 diastereomers)), 5.80 (s, 1H (1 diastereomer)), 5.78 
(s, 1H (1 diastereomer)), 5.70 (s, 1H (2 diastereomers)), 5.34 (br s, 1H (1 diastereomer)), 
5.32  (br  s,  1H  (1  diastereomer)),  5.31  (br  s,  1H  (2  diastereomers)),  5.06  (s,  1H  (1 
diastereomer)), 5.02 (s, 1H (1 diastereomer)), 4.86 (s, 1H (1 diastereomer)), 4.85 (s, 1H 
(1 diastereomer)), 4.51-4.53 (m, 1H (2 diastereomers)), 4.46 (dd, J = 5.9, 2.6 Hz, 1H (1 
diastereomer)), 4.34-4.38 (m, 1H (1H of 1 diastereomer and 1 H of 2 diastereomers)), 
4.32 (dt, J = 10.0, 2.8 Hz, 1H (1 diastereomer)), 4.25-4.30 (m, 1H (4 diastereomers)), 
4.10-4.18 (m, 3H (1H of 2 diastereomers and 2H of 4 diastereomers)), 3.96-4.06 (m, 2H 
(1H  of  2  diastereomers  and  1H  of  4  diastereomers)),  3.81-3.95  (m,  3H  (1H  of  2 
diastereomers and 2H of 4 diastereomers)), 3.63-3.72 (m, 2H (4 diastereomers)), 3.53-
3.57 (m, 3H (4 diastereomers)), 3.46-3.49 (m, 1H (1 diastereomer)), 3.36-3.42 (m, 2H 
(1H of 1 diastereomer and 1H of 4 diastereomers)), 3.32 (td, J = 9.1, 2.7 Hz, 1H (2 
    
diastereomers)), 3.20 (td, J = 7.5, 1.9 Hz, 1H (1 diastereomer)), 3.11-3.16 (m, 1H (3 
diastereomers)), 2.37-2.42 (m, 2H (1H of 1 diastereomer and 1H of 4 diastereomers)), 
2.19-2.24 (m, 1H (2 diastereomers)), 2.13-2.17 (m, 1H (1 diastereomer)), 1.94-2.12 (m, 
4H  (4  diastereomers)),  1.88-1.93  (m,  4H  (4  diastereomers)),  1.74-1.85  (m,  5H  (4 
diastereomers)),  1.62-1.73  (m,  3H  (4  diastereomers)),  1.35-1.55  (m,  7H  (4 
diastereomers)), 1.26-1.31 (m, 1H (4 diastereomers)), 1.216 (s, 9H (2 diastereomers)), 
1.211 (s, 9H (2 diastereomers)), 1.06-1.09 (m, 3H (4 diastereomers)), 0.98-1.01 (m, 6H (4 
diastereomers)),  0.90-0.94  (m,  45H  (4  diastereomers)),  0.04-0.17  (m,  30H  (4 
diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.4, 145.4, 145.3, 140.8, 139.9, 
139.8,  139.7,  139.2,  139.1,  133.2,  133.0,  129.1,  129.07,  129.02,  128.9,  128.3,  126.3, 
124.7, 115.3, 114.5, 100.6, 100.3, 97.3, 96.8, 80.55, 80.50, 80.3, 79.7, 79.55, 79.51, 79.4, 
79.2, 79.0, 78.88, 78.81, 78.6, 76.3, 76.19, 76.17, 76.11, 76.0, 74.99, 74.94, 72.4, 72.3, 
71.9, 71.6, 66.4, 65.8, 65.2, 65.1, 63.7, 63.2, 63.1, 62.1, 62.0, 48.5, 48.4, 46.7, 42.7, 42.6, 
41.7, 40.39, 40.35, 40.32, 38.6, 38.18, 38.10, 36.0, 35.2, 34.6, 34.5, 33.1, 33.0, 32.78, 
32.74, 31.5, 31.3, 31.2, 29.7, 29.3, 29.2, 29.0, 28.9, 28.7, 27.5, 27.4, 27.3, 27.2, 26.1, 
26.0, 25.9, 25.4, 25.3, 25.2, 20.9, 20.7, 20.4, 20.3, 18.47, 18.43, 18.3, 18.24, 18.20, 18.0, 
17.5, 16.7, 16.0, 15.9, 15.0, 14.5, 14.1, 11.8, 11.45, 11.40, -3.8, -3.9, -4.1, -4.23, -4.26, -
4.30, -4.4, -4.54, -4.57, -4.60, -4.65, -4.7, -5.34, -5.36 ppm; HRMS (ES+) calcd. for 
C76H144O13Si5SNa (M+Na) 1459.9072, found 1459.9037. 
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Ketone 4.59 and Keto-ol 4.60: To a stirred solution of sulfone 4.58 (16.5 mg, 
11.5 µmol) in THF (0.20 mL) at -50 ºC was added LDA
5 (29 µL, 29.0 µmol, 1 M in THF 
/ hexanes). After 5 min, DMPU (106 mg, 100 µL, 82.7 µmol) was added and was slowly 
warmed to -30 ºC over 15 min. The reaction was cooled back down to -50 ºC and a 
solution of Davis’ oxaziridine
6 (7.5 mg, 28.7 µmol) in THF (100 µL) was cannulated to 
it. The reaction was warmed to -35 ºC over 20 min and then quenched with sat. aq. 
NH4Cl (5.0 mL) and the aqueous layer was extracted with Et2O (3 X 10 mL). The dried 
(MgSO4) extract was concentrated in vacuo and purified by flash chromatography over 
silica gel, eluting with 5-20% EtOAc / hexanes, to give ketone 4.59 (7.0 mg, 5.33 µmol, 
46%) and keto-ol 4.60 (3.9 mg, 3.17 µmol, 28%) as colorless oil along with recovered 
sulfone 4.58 (4.1 mg, 2.85 µmol, 25%). Ketone 4.59: [α]D
23 = +9.4 (c = 1.00, CHCl3); IR: 
(neat) 2955, 2929, 2885, 2857, 1714, 1732, 1472, 1462, 1361, 1253, 1155, 1077, 835 cm
-
1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 5.60 (s, 1H (2 diastereomers)), 
5.32 (br s, 1H (2 diastereomers)), 4.96 (s, 1H (2 diastereomers)), 4.54-4.59 (m, 1H (2 
diastereomers)),  4.37-4.39  (m,  1H  (2  diastereomers)),  4.25-4.28  (m,  1H  (2 
diastereomers)), 4.13 (ddd, J = 10.8, 8.1, 6.7 Hz, 1H (2 diastereomers)), 4.09 (s, 1H (2 
    
diastereomers)), 4.06 (td, J = 7.5, 3.6 Hz, 1H (2 diastereomer)), 3.98-4.02 (m, 1H (1 
diastereomer)), 3.89-3.95 (m, 3H (1H of 1 diastereomer and 2H of 2 diastereomers)), 
3.84-3.88 (m, 1H (1 diastereomer)), 3.74-3.77 (m, 1H (1 diastereomer)), 3.65-3.68 (m, 
1H (2 diastereomers)), 3.55-3.58 (m, 2H (2 diastereomers)), 3.52 (dd, J = 7.2, 2.6 Hz, 1H 
(2 diastereomers)), 3.47-3.50 (m, 1H (2 diastereomers)), 3.34 (td, J = 9.0, 2.7 Hz, 1H (2 
diastereomers)), 2.81 (qd, J = 6.8, 4.1 Hz, 1H (1 diastereomer)), 2.59-2.68 (m, 2H (1H of 
1  diastereomer  and  1H  of  2  diastereomers)),  2.52  (dd,  J  =  17.4,  5.4  Hz,  1H  (1 
diastereomer)), 2.50 (dd, J = 17.4, 5.5 Hz, 1H (1 diastereomer)), 2.39 (qd, J = 7.0, 3.6 Hz, 
1H  (2  diastereomers)),  2.00-2.08  (m,  3H  (2  diastereomers)),  1.87-1.95  (m,  2H  (2 
diastereomers)),  1.77-1.86  (m,  4H  (2  diastereomers)),  1.82  (d,  J  =  1.2  Hz,  3H  (2 
diastereomers)),  1.64-1.71  (m,  2H  (2  diastereomers)),  1.43-1.56  (m,  7H  (2 
diastereomers)), 1.23-1.28 (m, 1H (2 diastereomers)), 1.21 (s, 9H (2 diastereomers)), 1.08 
(d, J = 7.0 Hz, 3H (2 diastereomers)), 1.06 (d, J = 6.9 Hz, 3H (1 diastereomer)), 1.04 (d, J 
= 6.9 Hz, 3H (1 diastereomer)), 0.98 (d, J = 6.5 Hz, 3H (2 diastereomers)), 0.917 (s, 18H 
(2 diastereomers)), 0.912 (s, 9H (2 diastereomers)), 0.910 (s, 9H (2 diastereomers)), 0.90 
(s, 9H (2 diastereomers)), 0.01-0.12 (m, 30H (2 diastereomers)) ppm; 
13C NMR (176 
MHz, CDCl3) δ 213.1, 212.5, 178.4, 145.1, 140.9, 125.4, 125.3, 114.9, 99.7, 97.8, 80.5, 
79.4, 78.9, 78.8, 78.6, 76.2, 76.0, 74.4, 72.2, 70.4, 65.19, 65.12, 63.9, 63.5, 62.1, 48.0, 
47.9, 45.3, 45.2, 43.4, 43.0, 42.0, 41.2, 40.3, 38.6, 38.1, 37.2, 36.8, 33.2, 33.1, 32.8, 31.4, 
31.3, 29.7, 27.5, 27.4, 27.2, 26.1, 26.0, 25.97, 25.91, 25.4, 20.8, 20.5, 18.4, 18.3, 18.2, 
18.0, 17.1, 17.0, 16.1, 16.0, 15.6, 14.0, 13.9, -4.21, -4.22, -4.27, -4.40, -4.45, -4.6, -4.7, -
    
4.8,  -5.3  ppm;  HRMS  (ES+)  calcd.  for  C70H138O12Si5Na  (M+Na)  1333.8932,  found 
1333.8961. 
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  Bis-Mosher Ester 4.61: To a stirred solution of bis-TBS ether 3.35 (63.4 mg, 
0.126 mmol) in THF (1.4 mL) was added TBAF (0.50 mL, 0.500 mmol, 1 M in THF) at 
rt. After 6 h, the reaction was quenched with H2O (7.5 mL). The aqueous layer was 
extracted with EtOAc (3 X 15 mL) and the combined organic layer was washed with H2O 
and brine (10 mL each). The dried (MgSO4) extract was concentrated in vacuo to give 
crude diol 4.76. 
  To a stirred solution of crude diol 4.76 in THF / H2O (2.8 mL, 1:1) at 0 ºC was 
added NaIO4 (81.0 mg, 0.378 mmol). After 1 h, the reaction was quenched with sat. aq. 
NaHCO3 (5 mL) and sat. aq. Na2S2O3 (5 mL). The aqueous layer was extracted with Et2O 
    
(3 X 15 mL) and the dried (MgSO4) extract was concentrated in vacuo to give the crude 
aldehyde 4.77.  
  To a stirred solution of crude aldehyde 4.77 in Et2O (2.0 mL) at 0 ºC was added 
LiAlH4 (14.4 mg, 0.378 mmol) in one portion. After 30 min, the reaction was quenched 
with dropwise addition of H2O (0.10 mL) and the organic layer was decanted. The solid 
formed was washed with Et2O (3 X 10 mL). The dried (MgSO4) extract was concentrated 
in vacuo and purified by flash chromatography over silica gel, eluting with 50-100% 
EtOAc/ hexanes, to give diol 4.62 (16.1 mg, 0.100 mmol, 79%) as colorless oil. 
  To a stirred solution of diol 4.62 (6.6 mg, 41.2 µmol) in CH2Cl2 (0.75 mL) at rt 
was added DMAP (30.2 mg, 0.247 mmol) followed by (R)-(-)-Mosher acid chloride (31.2 
mg, 23.0 µL, 0.123 mmol). After 1 h, the reaction was directly loaded onto column and 
purified by flash chromatography over silica gel, eluting with 5-20% EtOAc/ hexanes, to 
give bis-Mosher ester 4.61
7 (22.7 mg, 38.3 µmol, 93%) as colorless oil. 
1H NMR (700 
MHz, CDCl3) δ 7.71 (d, J = 7.7 Hz, 2H), 7.68 (d, J = 7.7 Hz, 2H), 7.14-7.17 (m, 2H), 
7.02-7.10 (m, 4H), 4.34 (ddd, J = 10.8, 7.8, 5.2 Hz, 1H), 4.22 (dt, J = 10.8, 7.4 Hz, 1H), 
4.02 (dd, J = 11.4, 3.6 Hz, 1H), 3.92 (dd, J = 11.4, 5.4 Hz, 1H), 3.76-3.80 (m, 1H), 3.46 
(d, J = 0.6 Hz, 3H), 3.40 (d, J = 0.7 Hz, 3H), 3.14 (td, J = 9.1, 2.6 Hz, 1H), 1.59 (dtd, J = 
13.9, 7.6, 2.7 Hz, 1H), 1.47 (dt, J = 12.2, 6.8 Hz, 1H), 1.37-1.42 (m, 1H), 1.26-1.32 (m, 
1H), 0.87 (ddd, J = 12.2, 10.9, 9.3 Hz, 1H), 0.52 (d, J = 6.6 Hz, 3H) ppm; 
13C NMR (176 
MHz, CDCl3) δ 166.28, 166.24, 132.7, 132.6, 129.5, 129.4, 128.3, 128.2, 127.99, 127.94, 
126.4, 124.7, 123.1, 121.4, 85.1, 85.06, 85.00, 84.9, 84.8, 84.7, 84.6, 84.5, 81.4, 74.7, 
67.3, 63.7, 54.99, 54.96, 39.6, 36.4, 32.5, 15.2 ppm. 
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Acetonide 4.67: To a stirred solution of alcohol 2.39 (996 mg, 2.69 mmol) in 
THF (30.0 mL) was added TBAF (5.4 mL, 5.40 mmol, 1 M in THF) at rt. After 1 h, the 
reaction was quenched with H2O (15 mL). The aqueous layer was extracted with EtOAc 
(4 X 50 mL) and the combined organic layer was washed with H2O and brine (20 mL 
each). The dried (MgSO4) extract was concentrated in vacuo to give crude diol 4.78. 
To a stirred solution of crude diol 4.78 in CH2Cl2 (24.0 mL) at rt were added 
dimethoxypropane  (1.40  g,  1.65  mL,  13.4  mmol)  followed  by  TsOH•H2O  (52.1  mg, 
0.269 mmol). After 12 h, the reaction was quenched with sat. aq. NaHCO3 (15 mL) and 
the aqueous layer was extracted with Et2O (3 X 50 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
5-10% EtOAc / hexanes, to give acetonide 4.67 (685 mg, 2.31 mmol, 86%) as colorless 
oil. [α]D
23 = +7.8 (c = 1.00, CHCl3); IR: (neat) 2981, 2932, 2878, 1451, 1380, 1364, 1260, 
1211, 1157, 1059, 862 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 6.04 (s, 1H), 4.00-4.07 (m, 
2H), 3.60-3.65 (m, 1H), 2.53-2.60 (m, 1H), 1.87 (s, 3H), 1.40 (s, 3H), 1.35 (s, 3H), 1.01 
(d, J = 7.0 Hz, 3H) ppm; 
13C NMR (100 MHz, CDCl3) δ 148.9, 109.2, 77.8, 76.9, 67.7, 
    
46.6, 26.7, 25.5, 21.6, 15.3 ppm; HRMS (EI+) calcd. for C10H17O2I (M+) 296.02736, 
found 296.02680. 
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Methyl Ketone 4.68: To a stirred solution of vinyl iodide 4.67 (764 mg, 2.58 
mmol) in THF (16.0 mL) at -78 ºC was added n-BuLi (1.2 mL, 3.00 mmol, 2.5 M in 
hexanes) dropwise. After 2 h, the reaction was quenched with sat. aq. NH4Cl (10 mL) and 
the aqueous layer was extracted with Et2O (3 X 50 mL).  The combined organic layer 
was dried over MgSO4 and concentrated in vacuo to give crude alkene 4.79.  
To a stirred solution of crude alkene 4.79 in CH2Cl2 (20.0 ml) at -78 
oC was 
bubbled ozone gas until a pale blue color persisted. Argon gas was bubbled through until 
the solution became colorless and PPh3 (2.03 g, 7.74 mmol) was added to it and the 
cooling bath was removed. After 3 h, the solvent was evaporated in vacuo and the crude 
mixture was loaded directly onto silica gel and was purified by flash chromatography, 
eluting with 20-25% Et2O / pentane, to give ketone 4.68 (302 mg, 1.75 mmol, 68%) as 
colorless oil. [α]D
23 = +5.6 (c = 1.10, CHCl3); IR: (neat) 2986, 2932, 1712, 1456, 1369, 
1249, 1211, 1151, 1053, 852 cm
-1; 
1H NMR (400 MHz, CDCl3) δ 4.21 (dt, J = 8.3, 6.5 
    
Hz, 1H), 4.08 (dd, J = 8.3, 6.2 Hz, 1H), 3.65 (dd, J = 8.3, 6.8 Hz, 1H), 2.76 (dq, J = 7.6, 
7.0 Hz, 1H), 2.23 (s, 3H), 1.42 (s, 3H), 1.34 (s, 3H), 1.05 (d, J = 7.0 Hz, 3H) ppm; 
13C 
NMR (100 MHz, CDCl3) δ 210.6, 109.2, 76.9, 67.4, 50.3, 29.7, 26.6, 25.3, 12.3 ppm; 
HRMS (CI+) calcd. for C9H17O3 (M+H) 173.1178, found 173.1162. 
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TBS Enol Ether 4.80: To a stirred solution of ketone 4.68 (200 mg, 1.16 mmol) 
in CH2Cl2 (7.0 mL) at 0 ºC were added 2,6-lutidine (498 mg, 0.54 mL, 4.64 mmol) 
followed  by  TBSOTf  (614  mg,  0.53  mL,  2.32  mmol).  After  1.5  h,  the  reaction  was 
quenched with sat. aq. NaHCO3 (5 mL) and diluted with Et2O (20 mL) and H2O (5 mL). 
The aqueous layer was extracted with Et2O (2 X 30 mL) and the dried (MgSO4) extract 
was concentrated in vacuo and purified by flash chromatography over silica gel, eluting 
with 3-5% EtOAc / hexanes, to give TBS enol ether 4.80 (315 mg, 1.10 mmol, 95%) as 
colorless oil. [α]D
23 = -12.8 (c = 1.03, CHCl3); IR: (neat) 2986, 2959, 2932, 2850, 1630, 
1478, 1363, 1255, 1064, 999, 841, 781cm
-1; 
1H NMR (400 MHz, CDCl3) δ 4.21 (dd, J = 
13.6, 7.2 Hz, 1H), 4.11 (d, J = 0.8 Hz, 1H), 4.07 (s, 1H), 3.97 (dd, J = 8.0, 6.2 Hz, 1H), 
3.66 (t, J = 8.0 Hz, 1H), 2.41 (dq, J = 7.2, 6.9 Hz, 1H), 1.43 (s, 3H), 1.36 (s, 3H), 1.01 (d, 
J = 6.9 Hz, 3H), 0.95 (s, 9H), 0.21 (s, 3H), 0.19 (s, 3H) ppm; 
13C NMR (100 MHz, 
    
CDCl3) δ 160.1, 108.6, 89.5, 77.1, 66.8, 43.4, 26.6, 25.7, 25.5, 18.1, 13.2, -4.6, -4.7 ppm; 
HRMS (CI+) calcd. for C15H31O3Si (M+H) 287.2043, found 287.2044. 
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Alcohol 4.69: To a stirred solution of TBS enol ether 4.80 (141 mg, 0.492 mmol) 
in CH2Cl2 (10.0 ml) at -78 ºC was bubbled ozone gas until a pale blue color persisted. 
Argon  gas  was  bubbled  until  the  solution  became  colorless  and  PPh3  (386  mg,  1.47 
mmol) was added to it and the cooling bath was removed. After 3 h at rt, the solvent was 
evaporated in vacuo to give crude 4.81. 
The crude 4.81 was redissolved in dry THF (2.0 mL). This solution was added 
dropwise to a mixture of LiAlH4 (112 mg, 2.95 mmol) in dry THF (2 mL) at 0 ºC over 15 
min and stirred at that temperature for 3 h. The reaction was quenched with minimal 
amount of methanol (15 drops) and diluted with EtOAc (20 mL) and water (5 mL) and 
the aqueous layer was extracted with EtOAc (3 X 15 mL). The dried (MgSO4) extract 
was concentrated in vacuo and purified by flash chromatography over silica gel, eluting 
with 30-35% EtOAc / hexanes, to give known alcohol 4.69
8 (42 mg, 0.262 mmol, 53%) 
as colorless oil. [α]D
23 = -10.9 (c = 1.04, C6H6), -18.7 (c = 0.90, CHCl3); 
1H NMR (400 
    
MHz, CDCl3) δ 4.11 (dd, J = 8.0, 6.0 Hz, 1H), 3.96 (q, J = 7.6 Hz, 1H), 3.60-3.70 (m, 
3H), 2.77 (dd, J = 8.0, 2.8 Hz, 1H), 1.87 (m, 1H), 1.44 (s, 3H), 1.39 (s, 3H), 0.85 (d, J = 
6.9 Hz, 3H) ppm; 
13C NMR (100 MHz, C6D6) δ 108.9, 79.9, 68.4, 66.5, 39.3, 26.5, 25.6, 
12.7 ppm. 
 
                                                 
1.  Preparation  of  HF•Pyr.  Solution:  The  stock  solution  was  prepared  by  mixing 
HF•Pyr. (1.0 mL, 70% HF in pyridine), pyridine (2.0 mL) and THF (5.0 mL). 
2. Fetterly, B. M.; Verkade, J. G. Tetrahedron Lett. 2005, 46, 8061-8066. 
3. Mahapatra, S.; Carter, R. G. Org. Biomol. Chem. 2009, 7, 4582-4585. 
4. a) White, J. D.; Kawaski, M. J. Org. Chem. 1992, 57, 5292-5300. (b) Vong, B. G.; 
Abraham, S.; Xiang, A. X.; Theodorakis, E. A. Org. Lett. 2003, 5, 1617-1620. 
5. Preparation of LDA Solution: To a solution of diisopropylamine (0.14 mL / mmol) 
in THF (0.46 mL / mmol) at -78 °C was added n-BuLi (0.40 mL / mmol, 2.5 M in 
hexanes).  After  5  min,  the  white  slurry  was  warmed  to  -10  °C  and  stirred  for  an 
additional 15 min. 
6. Davis, F. A.; Stringer, O. D. J. Org. Chem. 1982, 47, 1774-1775. 
7. Kubota, T.; Tsuda, M.; Kobayashi, J. Org. Lett. 2001, 3, 1363-1366. 
8. (a) Nicolaou, K. C.; Papahatjis, D. P.; Claremon, D. A.; Magolda, R. L.; Dolle, R. E. J. 
Org. Chem. 1985, 50, 1440-1456. (b) Shiina, I.; Hashizume, M.; Yama, Y.; Oshiumi, H.; 
Shimazaki,  T.;  Takarauma,  Y.;  Ibuka,  R.  Eur.  J.  Chem.  2005,  11,  6601-6608.  (c) 
Larcheveque, M.; Henrot, S. Tetrahedron 1987, 43, 2303-2310. 
    
CHAPTER V: COMPLETION OF THE TOTAL SYNTHESIS OF 
AMPHIDINOLIDE F 
 
5.1 Preparation of the Sulfone Subunit with Amphidinolide F Sidearm 
 
5.1.1 Attempt to Install the Diene via Julia Olefination  
 
  After devising an efficient coupling / oxidative desulfurization sequence, the next 
task in hand was installation of the diene side chain of amphidinolide F (1.16) (Scheme 
5.1). Incorporation of sidearm diene would provide the entire C15-C29 northern sulfone 
subunit 5.6 required for the natural product. The synthesis commenced with our premade 
C15-C25 sulfone fragment 4.57. First, the primary silyl ether was selectively removed 
under HF•Pyr. conditions and the exposed alcohol was oxidized to corresponding α-oxy 
aldehyde 5.1. We initially planned to exploit Julia-Kocienski-Blakemore olefination
1 on 
this aldehyde with the known PT-sulfone 5.2;
2 however, this reaction displayed a slight 
preference  for  the  undesired  cis-alkene  5.3.  Optimization  with  different  bases  and 
solvents could not reverse the preference to desired trans-isomer (see the table).  
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Scheme 5.1. Attempt to Install Diene Side Chain 
 
5.1.2 Incorporation of the Diene via Tamura / Vedejs Olefination 
 
While  alternate  multi-step  solutions  have  been  developed  to  circumvent  this 
problem, e.g. alkene isomerization,
3 Takai olefination / cross coupling
4 etc.; we continued 
to look for a direct solution (Scheme 5.2). During this search, it was interesting to find 
that  while  triphenylphosphonium  salt  showed  a  preference  for  cis-alkene,  trialkyl-
phosphorus ylide produced the trans-isomer selectively.
5 Although this Tamura protocol 
worked effectively on simple aldehydes, there was no example of its application on an α-
oxy  aldehyde.  We  decided  to  test  this  methodology  on  our  α-oxy  aldehyde  5.1. 
Accordingly, the Vedejs type tributyl phosphonium salt 5.4 was prepared in two steps 
    
from commercially available allylic alcohol.
6 To our delight, treatment of aldehyde 5.1 
with the phosphonium salt 5.4 in presence of n-BuLi cleanly generated the desired E-
alkene 5.5 in good selectivity and in excellent yield (11:1 E:Z, 96% yield). The alkene 
isomers  were  inseparable  under  column  chromatography;  however,  the  minor  isomer 
could be removed during purification in subsequent transformations. Finally, exchange of 
the C24 silyl protecting groups provided the C15-C29 sulfone coupling partner 5.6. 
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Scheme 5.2. Efficient Diene Installation 
    
5.2 Sulfone-iodide Alkylation / Oxidative Desulfurization: Construction 
of the All-carbon Framework of Amphidinolide F 
 
  After the efficient preparation of northern sulfone subunit, our focus shifted to the 
crucial coupling event (Scheme 5.3). To our pleasure, the sulfone / iodide alkylation 
proceeded smoothly under our optimized conditions in model study (see Chapter IV, 
Scheme 4.17) to generate the all-carbon framework 5.7 of amphidinolide F. Next, the 
oxidative  desulfurization  in  presence  of  Davis’  oxaziridine
7 cleanly  installed  the  C15 
ketone (5.8 and 5.9). Some pivaloyl-deprotected product 5.9 (22%) was obtained under 
the reaction conditions. We believe that the excess n-BuLi from LDA and the hydroxide 
generated from contaminated moisture (H2O) were responsible for the pivolate removal. 
Fortunately, the keto-ol 5.9 was a useful intermediate to push forward in the synthesis. 
Oxidation  of  the  primary  alcohol  in  5.9  with  Dess-Martin  Periodinane
8 delivered  the 
aldehyde 5.10 in moderate yield (65%). We suspected that presence of the excess base 
(pyridine) at higher temperature (rt) could promote retro-Michael on the β-oxy aldehyde 
5.10 resulting in the lower chemical yield. An improved yield (85%) was achieved by 
switching to Swern oxidation conditions,
9 which was operated at much lower temperature 
(-78  ºC).  Pinnick  oxidation  on  aldehyde  5.10  cleanly  generated  the  corresponding 
carboxylic acid 5.11.
10 The major product from oxidative desulfurization 5.8 was also 
converted to the keto-aldehyde 5.10 in two steps (pivolate removal and oxidation). 
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Scheme 5.3. Generation of the Carboxylic Acid 
 
 
 
    
5.3 End Game of the Total Synthesis of Amphidinolide F 
 
5.3.1 Construction of the 25-Membered Macrolactone  
 
  The stage was all set for the final push to finish amphidinolide F (1.16). The 
immediate task in hand was locking of the C1 and C24 terminus to construct the 25-
membered macrocycle (Scheme 5.4). It is well known that the macro-lactonizations for 
the  formation  of  large  ring  systems  are  highly  conformation  dependent.  During  the 
synthetic effort toward amphidinolide B series in our laboratory, construction of the 26-
membered ring via traditional macrolactonization protocols failed to provide the desired 
cyclized  material  5.16.
11  We  were  curious  to  see  if  the  25-membered  ring  in 
amphidinolide F could be formed via macrolactonization technique. Accordingly, the C24 
secondary  TES  ether  on  5.11  was  first  selectively  removed  under  PPTS  /  MeOH 
conditions to smoothly deliver the seco-acid 5.12. To our delight, macrolactonization on 
seco-acid 5.12 with the bulky acid anhydride 5.13 developed by Shina and co-workers
12 
provided  the  25-membered  macrolactone  5.14  in  excellent  yield  (69%  over  2  steps). 
Yamaguchi variant of macrolactonization
13 also delivered the desired product 5.14, but in 
slightly lowered yield (65%).  
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Scheme 5.4. Successful Formation of the 25-Membered Macrolactone 
 
 
 
 
 
    
5.3.2 Studies on C18 Tetrahydropyranyl Ether Removal 
 
With successful preparation of the macrocyclic structure 5.14, we were eventually 
three  steps  away  from  completion  of  the  total  synthesis  of  the  natural  product  1.16 
(Scheme  5.5).  Since  the  C15,  C18  1,4-dicarbonyl  is  a  sensitive  functional  group;  we 
wanted to install it as late as possible in the synthetic sequence. Thus, all we required was 
the removal of the C18 tetrahydropyranyl (THP) ether and oxidation of the free alcohol to 
generate the diketone. Final global deprotection would furnish amphidinolide F. 
 Therefore, the macrocyclic precursor 5.14 was first subjected to aqueous acetic 
acid in THF (See the table, Entry 1). No tetrahydropyranyl-deprotected product 5.17 was 
detected  under  these  conditions.  Increase  the  ratio  of  acetic  acid  led  to  slow 
decomposition of the macrolactone 5.14 over extended period (Entry 2). Treatment of the 
macrocycle 5.14 with catalytic PPTS in MeOH
14 was also ineffective (Entry 3 and 4). 
Various Lewis acids e.g. MgBr2,
15 Me2AlCl
16 could not promote the reaction to desired γ-
hydroxy ketone 5.17 (Entry 5 and 6). Treatment of 5.14 with BF3•OEt2 in presence of 
1,2-ethanedithiol ligand
17 also failed to remove the tetrahydropyranyl ether (Entry 7). We 
reasoned that coordination of Lewis acids (LA) to allyl ester unit occurred preferentially - 
leading to decomposition via the stabilized allyl carbocation. Given the fact that the C18 
THP  protecting  group  was  incompatible  with  our  synthetic  aspirations,  an  alternate 
chelating protecting group needed to be select that was compatible with our endgame 
sequence.  
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Entry  Conditions  Observation 
1  AcOH / THF / H2O (4:2:1)  No reaction 
2  AcOH / THF / H2O (5:1:1)  Slow decomposition 
3  PPTS, MeOH, rt  No reaction 
4  PPTS, MeOH, 50 ºC  Decomposition 
5   MgBr2, Et2O, 0 ºC to rt  Decomposition 
6   Me2AlCl, CH2Cl2, -25 ºC  Decomposition 
7   BF3•OEt2, HSCH2CH2SH, CH2Cl2  Decomposition 
 
Scheme 5.5. Attempts to Remove the Tetrahydropyranyl Ether  
 
    
5.4 Protecting Group Manipulation: Completion of the Total Synthesis 
of Amphidinolide F 
 
  Deprotection complicacy guided us to search a protecting group that should be 
less  robust  than  tetrahydropyranyl  (THP)  moiety,  but  still  could  chelate  to  help 
deprotonations. Additionally, since this protecting group would be removed only in very 
advanced stage of the synthetic sequence, it must survive the reaction conditions to reach 
that point. In this quest, we identified two analogous protecting groups, i) 1-methyl-1-
methoxyethyl  (MIP)  and  ii)  ethoxyethyl  (EE)  ether  moieties  (Scheme  5.6).  Both  the 
protecting groups are significantly fragile than a tetrahydropyranyl (THP) ether, but still 
have ability to chelate. Among these three, 1-Methyl-1-methoxyethyl (MIP) is the most 
fragile one and could be cleaved in presence of tetrahydropyranyl (THP) or ethoxyethyl 
(EE) ethers. Therefore, we went back to our pre-made alcohol 4.38 and attempted to 
install  the  1-Methyl-1-methoxyethyl  (MIP)  protecting  group  on  it.  The  new  plan 
immediately faced an unforeseen problem and all our efforts to install the MIP ether were 
ineffective  on  this  substrate.  We  reasoned  that  the  isopropenyl  methyl  ether  (5.21) 
derived tertiary carbocation was too hindered to be attacked by the bulky C18 alcohol. 
Next, we quickly moved to our second choice to mount the ethoxyethyl (EE) 
moiety on alcohol 4.38. During a literature search, we uncovered that this relatively less 
known  ethoxyethyl  (EE)  ether  could  be  cleaved  at  270  times  faster  rate  than 
tetrahydropyranyl (THP) ether under mild acidic conditions (see the table).
18 Ethoxyethyl 
(EE) ether is an acyclic variant of tetrahydropyranyl (THP) ether that also has the similar 
chelating  ability  as  tetrahydropyranyl  (THP)  ether.  To  our  delight,  installation  of  the 
    
ethoxyethyl (EE) ether on alcohol 4.38 proceeded smoothly to furnish the desired product 
5.23 in 94% yield. 
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Scheme 5.6. Choice of Protecting Group  
 
 
    
5.4.1 Debenzylation Problem: A Protecting Group Issue 
 
Our concern about fragileness of the protecting group was immediately confirmed 
when we tried to debenzylate the ether under hydrogenation conditions (Scheme 5.7). A 
notable amount of the cyclic acetal 5.26 was obtained along with some ethoxyethyl (EE)-
deprotected  diol  5.24  during  debenzylation.  This  transformation  proved  to  be  highly 
dependent on the quality of the palladium catalyst - different product ratio (5.24, 5.25 and 
5.26) was observed with different batch of the reagent. Up to 50% of cyclic acetal 5.26 
formed under hydrogenation conditions and it was difficult to suppress its formation. 
This complicacy was not experienced for the tetrahydropyranyl (THP) series.  
A plausible mechanism for formation of the cyclic acetal 5.26 has been proposed. 
First,  the  ethoxyethyl  unit  was  coordinated  by  the  palladium  catalyst  promoting  the 
formation of the oxonium ion 5.28. The oxonium species 5.28 was then intramolecularly 
trapped by the primary alcohol, which after deprotonation delivered the acetal 5.26. The 
problem was circumvented by using LiDBB as debenzylating agent
19 and the requisite 
primary alcohol 5.25 was obtained in excellent yield.  
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Scheme 5.7. Game of Debenzylation 
 
 
 
    
5.4.2 Preparation of the Dienyl Sulfone 
 
Conversion  of  alcohol  5.25  to  dienyl  sulfone  5.32  proceeded  uneventfully 
(Scheme 5.8). First, installation of the sulfone moiety on alcohol 5.25 cleanly generated 
the C15-C25 sulfone fragment 5.29. The primary silyl ether was selectively removed and 
then oxidized to corresponding aldehyde 5.30. The Tamura / Vedejs olefination
5,6 with 
the tributyl phosphonium salt 5.4 once again efficiently incorporated the diene side chain 
of the natural product 1.16. Finally, exchange of the C24 silyl protecting group (TBS to 
TES)  furnished  the  C15-C29  sulfone  coupling  partner  5.32.  Thus,  this  efficient  8-step 
sequence delivered the entire northern subunit 5.32 in 53% overall yield. 
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Scheme 5.8. Synthesis of the Sulfone Subunit 
    
5.4.3 Sulfone-iodide Alkylation / Oxidative Desulfurization 
 
After successful preparation of the dienyl sulfone 5.32 with ethoxyethyl moiety 
on  C18  alcohol,  our  priority  shifted  to  test  the  sulfone-iodide  alkylation  /  oxidation 
sequence on this new system (Scheme 5.9). To our pleasure, the sulfone-iodide coupling 
behaved in similar way under our previously optimized conditions to generate the all-
carbon  framework  5.33  of  amphidinolide  F  in  an  impressive  74%  yield.  Next,  the 
oxidative desulfurization with Davis’ oxaziridine
7 installed the C15 ketone (5.34 and 5.35) 
in 67% combined yield. As before, some pivaloyl-deprotected product 5.35 (22%) was 
also obtained under the reaction conditions. Thus, the ethoxyethyl (EE) and the tetra-
hydropyranyl (THP) moieties worked analogously during the coupling / oxidation events.  
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Scheme 5.9. Construction of the All-carbon Framework of Amphidinolide F 
    
5.4.4 Formation of the Macrolactone 
 
  With sufficient quantity of the C15 ketone precursors (5.34 and 5.35) in hand, we 
set out to elaborate them to the macrolactone 5.40 (Scheme 5.10). Both the ketone 5.34 
and keto-ol 5.35 were useful intermediates to push forward in the synthetic sequence. The 
alcohol 5.35 was first oxidized to keto-aldehyde 5.36 and then converted to carboxylic 
acid 5.37 under Pinnick conditions.
10 The major product from oxidative desulfurization 
5.34  was  also  transformed  to  aldehyde  5.36  after  removal  of  the  pivaloyl  moiety. 
Selective removal of the C24 TES ether under our previously optimized conditions (PPTS, 
MeOH) smoothly furnished the seco-acid 5.38 without affecting the ethoxyethyl (EE) 
moiety. Yamaguchi macrolactonization proved to be superior way for construction of the 
cyclized material 5.40, furnishing the 25-membered macrocycle in an impressive 65% 
yield over two steps. Successful preparation of the macrolactone 5.40 set the stage for 
completion of the total synthesis of amphidinolide F (1.16). 
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Scheme 5.10. Generation of the Macrocyclic Precursor 
 
 
 
 
    
5.4.5 Completion of the Total Synthesis of Amphidinolide F 
 
  After  devising  an  efficient  route  to  macrocycle  5.40,  the  final  challenge  that 
remained was the deprotection of the ethoxyethyl (EE) ether for installation of the C18 
ketone (Scheme 5.11). In our previous attempt, we were unable to take off the tetrahydro-
pyranyl (THP) ether from C18 alcohol and that led us to mount the less robust ethoxyethyl 
(EE) ether on it (see Scheme 5.5). With the hope to remove the ethoxyethyl (EE) ether 
under mild conditions, macrolactone 5.40 was subjected to the aqueous acetic acid in 
THF. To our delight, removal of the ethoxyethyl ether under aqueous acidic conditions 
furnished the free C18 alcohol 5.41 over 20 h. As evidenced by NMR, the γ-hydroxy 
ketone exists both in acyclic and cyclic forms (5.41 and 5.43 respectively) in solutions. 
Dess-Martin oxidation of the intermediate keto-ol 5.41 provided access to the desired 1,4-
diketone 5.42. The final task in hand was global deprotection of three silyl ethers to 
complete total synthesis of the natural product 1.16. After some experimentation, we 
were pleased to find that treatment of 5.42 with Et3N•3HF in acetonitrile slowly delivered 
amphidinolide  F  (1.16)  over  7  days.
20 Close  monitoring  of  the  reaction  revealed  that 
removal of one TBS moiety (among three) was much faster than the other two silyl ethers 
and once the second TBS ether was removed, the third one collapsed quickly (monitored 
by TLC mass spectroscopy). We reasoned that deprotection of the first TBS unit probably 
promoted conformational change within the macrocyclic scaffold making the second TBS 
removal difficult. Other common desilylatig agents e.g. HF•pyr., TASF
21 were ineffective 
to promote this transformation. 
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Scheme 5.11. Completion of the Total Synthesis of Amphidinolide F 
 
Interestingly, the synthesized amphidinolide F exhibited concentration dependent 
1H NMR spectrum (Figure 5.1). The 
1H NMR of the synthesized material was in better 
agreement  with  the  naturally  occurring  amphidinolide  F when  recorded  as  0.0036  M 
solution (0.4 mg 1.16 in 0.18 mL CDCl3). The 
13C NMR of synthetic amphidinolide F 
    
was  also  in  good  agreement  with  the  natural  one  (see  the  comparison  table  in 
experimental section). The absolute configuration of the natural product was confirmed 
by  comparing  the  optical  rotation  data  {Synthetic:  [α]D
23  =  49º  (c  =  0.10,  CHCl3); 
Natural:
22 [α]D
30 = 57º (c = 0.10, CHCl3)}. Thus, the first total synthesis of amphidinolide 
F was accomplished in 34 longest linear steps that unambiguously assigned the relative 
and absolute configuration of the natural product. 
 
 
 
Figure 5.1. Comparison of the 
1H NMR Spectrum of Synthetic  
and Natural Amphidinolide F  
 
    
5.5 Conclusion 
 
  In summary, we have efficiently installed the amphidinolide F (1.16) side chain 
by exploring a E-selective Tamura / Vedejs olefination. The 25-membered macrocyclic 
scaffold of the natural product 1.16 was constructed via Yamaguchi macrolactonization 
protocol. The deprotection complications were successfully resolved by switching to a 
less common ethoxyethyl (EE) protecting group on C18 hydroxyl and by employing a less 
known desilylatig agent (Et3N•3HF) for the global deprotection. The first total synthesis 
of  amphidinolide  F  was  accomplished  in  28  steps  (longest  linear  sequence).  By 
comparing the NMR and optical rotation data of the natural and synthetic amphidinolide 
F, we have confirmed the relative and absolute stereochemistry of the natural product, 
which was assigned based on analogy to amphidinolide C (1.14) and the fact that both 
were isolated from same microorganism. 
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Alcohol 5.44: To a stirred solution of bis-TBS ether 4.57 (311 mg, 0.454 mmol) 
in THF (4.4 mL) at 0 ºC was added a stock solution of HF•Pyr.
1 (2.5 mL) over 3 h. After 
24 h, the reaction quenched with sat. aq. NaHCO3 (25 mL) and the aqueous layer was 
extracted  with  EtOAc  /  Et2O  (1:1,  3  X  40  mL).  The  dried  (MgSO4)  extract  was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
20-60% EtOAc / hexanes, to give alcohol 5.44 (215 mg, 0.376 mmol, 83%) as colorless 
oil. [α]D
23 = -26.3 (c = 1.00, C6H6); IR: (neat) 3467, 2931, 2855, 1463, 1447, 1377, 1306, 
1253,  1146,  1085,  1024,  836,  777  cm
-1; 
1H  NMR  {700  MHz,  CDCl3  (two 
diastereomers)}  δ  7.93-7.96  (m,  2H  (2  diastereomers)),  7.64-7.67  (m,  1H  (2 
diastereomers)), 7.56-7.59 (m, 2H (2 diastereomers)), 4.56 (dd, J = 5.3, 2.8 Hz, 1H (1 
diastereomer)), 4.54 (dd, J = 5.4, 2.8 Hz, 1H (1 diastereomer)), 4.06-4.10 (m, 1H (2 
diastereomers)),  4.01-4.05  (m,  1H  (1  diastereomer)),  3.93-3.97  (m,  1H  (1 
diastereomers)),  3.84-3.89  (m,  1H  (2  diastereomers)),  3.74-3.79  (m,  1H  (2 
diastereomers)),  3.65-3.70  (m,  2H  (  2  diastereomer  )),  3.56-3.60  (m,  1H  (2 
diastereomers)), 3.42-3.49 (m, 1H (2 diastereomers)), 3.29 (dd, J = 14.2, 4.8 Hz, 1H (1 
    
diastereomer)), 3.17 (dd, J = 14.2, 4.5 Hz, 1H (1 diastereomer)), 2.99 (dd, J = 9.9, 8.0 Hz, 
1H (1 diastereomer)), 2.97 (dd, J = 9.9, 8.1 Hz, 1H (1 diastereomer)), 2.53 (t, J = 5.7 Hz, 
1H (1 diastereomer)), 2.45 (t, J = 5.8 Hz, 1H (1 diastereomer)), 2.34-2.39 (m, 1H (1 
diastereomer)), 2.22-2.29 (m, 1H (1 diastereomer)), 2.00-2.06 (m, 1H (2 diastereomers)), 
1.90-1.99 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 1.72-1.80 (m, 3H 
(1H of 1 diastereomer and 2H of 2 diastereomers)), 1.61-1.71 (m, 2H (2 diastereomers)), 
1.43-1.59 (m, 7H (2 diastereomers)), 1.14 (d, J = 6.6 Hz, 3H (1 diastereomer)), 1.12 (d, J 
= 6.7 Hz, 3H (1 diastereomer)), 0.92 (s, 9H (2 diastereomers)), 0.110-0.118 (m, 6H (2 
diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 140.2, 140.1, 133.4, 133.3, 129.2, 
129.1, 128.0, 127.9, 100.0, 96.8, 80.39, 80.32, 76.5, 76.2, 74.4, 74.3, 71.3, 64.6, 63.29, 
63.23, 63.0, 62.9, 41.97, 41.90, 41.5, 40.2, 32.9, 32.5, 31.2, 27.5, 27.4, 26.0, 25.8, 25.4, 
25.3, 20.26, 20.23, 20.1, 19.7, -4.5, -4.6 ppm; HRMS (ES+) calcd. for C29H50O7SSiNa 
(M+Na) 593.2944, found 593.2949.  
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  Phosphonium Bromide 5.4:To a stirred solution of allyl bromide 5.45
2 (1.68 g, 
11.2 mmol) in Et2O (45.0 mL) at 0 ºC was added PBu3 (5.74 g, 7.0 mL, 28.1 mmol). 
After 15 min, the reaction was warmed to rt. After 15 h, the reaction filtered through a 
sintered  glass  funnel  and  the  residue  was  washed  with  hexanes  (75  mL)  to  give  the 
phosphonium bromide 5.4
3 (3.68 g, 10.4 mmol, 93%) as white needle-shaped solid. 
1H 
    
NMR (700 MHz, CDCl3) δ 5.00-5.04 (m, 1H), 3.39 (dd, J = 15.2, 7.9 Hz, 2H), 2.40-2.44 
(m, 6H), 1.77-1.78 (m, 6H), 1.47-1.57 (m, 12H), 0.95 (t, J = 7.1 Hz, 9H) ppm; 
13C NMR 
(176 MHz, CDCl3) δ 141.88, 141.81, 109.09, 109.04, 25.9, 24.0, 23.9, 23.84, 23.82, 20.7, 
20.4, 19.1, 19.0, 18.8, 13.4 ppm. 
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Diene  5.5:  To  a  stirred  solution  of  oxalyl  chloride  (55.1  mg,  39.0  µL,  0.441 
mmol) in CH2Cl2 (2.2 mL) at -78 ºC was cannulated a solution of DMSO (73.2 mg, 66.0 
µL, 0.919 mmol) in CH2Cl2 (0.60 mL). After 15 min, a solution of alcohol 5.44 (210 mg, 
0.367 mmol) in CH2Cl2 (1.6 mL and 2 X 0.25 mL wash) was cannulated to it. After 45 
min, Et3N (188 mg, 0.26 mL, 1.84 mmol) was added. After 20 min, the cooling bath was 
removed  and  the  reaction  was  quenched  with  H2O  (25  mL).  The  aqueous  layer  was 
extracted with CH2Cl2 (3 X 50 mL). The dried (MgSO4) extract was concentrated in 
vacuo and purified by flash chromatography over silica gel, eluting with 20-40% EtOAc / 
hexanes, to give aldehyde 5.1 (201 mg, 0.353 mmol, 96%) as colorless oil. 
    
To a stirred solution of tributyl phosphonium salt 5.4 (175 mg, 0.498 mmol) in 
THF (3.9 mL) at -45 ºC was added n-BuLi (0.20 mL, 0.500 mmol, 2.5 M in hexane) and 
was warmed to rt over 45 min. After 2 h, the reaction was cooled back down to -78 ºC 
and a solution of aldehyde 5.1 (189 mg, 0.332 mmol) in THF (3.9 mL) was cannulated to 
it. The reaction was slowly warmed to rt over 2.5 h. After another 3 h, the reaction was 
quenched with H2O (8 drops) and the solvent was removed in vacuo. The residue was 
purified by flash chromatography over silica gel, eluting with 10-30% EtOAc / hexanes, 
to  give  diene  5.5  {197  mg,  0.317  mmol,  96%  (11:1  E:Z  inseparable  mixture)}  as 
colorless oil. [α]D
23 = +20.4 (c = 1.00, CHCl3); IR: (neat) 2949, 2925, 2859, 1458, 1450, 
1302,  1260,  1147,  1069,  1022,  835,  781  cm
-1; 
1H  NMR  {400  MHz,  CDCl3  (two 
diastereomers)}  δ  7.92-7.96  (m,  2H  (2  diastereomers)),  7.62-7.67  (m,  1H  (2 
diastereomers)), 7.54-7.59 (m, 2H (2 diastereomers)), 6.45 (dd, J = 15.1, 11.0 Hz, 1H (2 
diastereomers of E isomer)), 6.20 (t, J = 11.4 Hz, 1H (2 diastereomers of Z isomer), 6.06 
(dt, J = 11.5, 1.2 Hz, 1H (2 diastereomers of Z isomer)), 5.83 (d, J = 11.0 Hz, 1H (2 
diastereomers of E isomer)), 5.53 (dd, J = 15.1, 5.7 Hz, 1H (1 diastereomer of E isomer)), 
5.52 (dd, J = 15.1, 5.8 Hz, 1H (1 diastereomer of E isomer)), 5.30 (t, J = 10.1 Hz, 1H (2 
diastereomers of Z isomer)), 4.53-4.56 (m, 1H (2 diastereomers)), 4.16 (t, J = 5.6 Hz, 1H 
(2 diastereomers)), 3.90-3.97 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 
3.82-3.89 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 3.72-3.80 (m, 1H (2 
diastereomer)), 3.40-3.48 (m, 1H (2 diastereomers)), 3.31 (dd, J = 14.2, 4.5 Hz, 1H (1 
diastereomer)), 3.18 (dd, J = 14.1, 4.2 Hz, 1H (1 diastereomer)), 2.97 (dd, J = 14.2, 8.3 
Hz, 1H (1 diastereomer)), 2.95 (dd, J = 14.2, 8.4 Hz, 1H (1 diastereomer)), 2.30-2.38 (m, 
    
1H (1 diastereomer)), 2.19-2.27 (m, 1H (1 diastereomer)), 1.82-1.99 (m, 3H (1H of 1 
diastereomer and 2H of 2 diastereomers)), 1.84-1.89 (m, 1H (2 diastereomers)), 1.78 (s, 
3H  (2  diastereomers)),  1.76  (s,  3H  (2  diastereomers)),  1.71-1.76  (m,  1H  (1 
diastereomer)),  1.59-1.70  (m,  3H  (2  diastereomers)),  1.38-1.58  (m,  7H  (2 
diastereomers)), 1.14 (d, J = 6.6 Hz, 3H (1 diastereomer)), 1.13 (d, J = 6.6 Hz, 3H (1 
diastereomer)), 0.91 (s, 9H (2 diastereomers)), 0.07 (s, 3H (2 diastereomers)), 0.04 (s, 3H 
(2  diastereomers))  ppm; 
13C  NMR  (100  MHz,  CDCl3)  δ  140.2,  140.1,  134.9,  134.8, 
133.4, 133.3, 130.0, 129.9, 129.2, 129.1, 128.0, 127.9, 127.4, 127.3, 124.73, 124.71, 99.7, 
97.0, 82.0, 81.9, 76.1, 76.0, 75.6, 74.5, 71.7, 63.29, 63.23, 63.1, 62.9, 42.0, 41.8, 41.4, 
40.4, 32.9, 32.6, 31.3, 31.2, 27.1, 27.0, 26.1, 25.9, 25.8, 25.46, 25.40, 20.3, 20.2, 20.0, 
19.7, 18.28, 18.26, -4.4, -4.6, -4.7 ppm; HRMS (ES+) calcd. for C34H56O6SSiNa (M+Na) 
643.3465, found 643.3471.  
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Dienyl Sulfone 5.6: To a stirred solution of TBS ether 5.5 (187 mg, 0.301 mmol) 
in THF (3.0 mL) at 0 ºC was added TBAF (0.90 mL, 0.900 mmol, 1 M in THF). The 
reaction was slowly warmed to rt over 3 h. After another 12 h, the reaction quenched with 
H2O (15 mL) and the aqueous layer was extracted with EtOAc / Et2O (1:1, 3 X 30 mL). 
The dried (MgSO4) extract was concentrated in vacuo to give crude alcohol 5.46. 
To a stirred solution of crude alcohol 5.46 in CH2Cl2 (4.0 mL) at 0 ºC were 
sequentially added Et3N (244 mg, 0.34 mL, 2.40 mmol), DMAP (18.3 mg, 0.151 mmol) 
and TESCl (162 mg, 0.18 mL, 1.05 mmol). After 8 h, the reaction was quenched with 
half-saturated aq. NH4Cl (15 mL) and the aqueous layer was extracted with Et2O (3 X 30 
mL).  The  dried  (MgSO4)  extract  was  concentrated  in  vacuo  and  purified  by  flash 
chromatography over silica gel, eluting with 10-30% EtOAc / hexanes, to give dienyl 
sulfone  5.6  (177  mg,  0.285  mmol,  95%)  as  colorless  oil.  [α]D
23  =  +10.4  (c  =  1.00, 
CHCl3); IR: (neat) 2951, 2915, 2875, 1446, 1378, 1306, 1148, 1075, 1023, 843, 740 cm
-1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 7.93-7.96 (m, 2H (2 diastereomers)), 
    
7.64-7.67 (m, 1H (2 diastereomers)), 7.56-7.59 (m, 2H (2 diastereomers)), 6.43-6.47 (m, 
1H  (2  diastereomers  of  E  isomer)),  6.22  (t,  J  =  11.4  Hz,  1H  (2  diastereomers  of  Z 
isomer), 6.07-6.10 (m, 1H (2 diastereomers of Z isomer)), 5.83 (d, J = 11.0 Hz, 1H (2 
diastereomers of E isomer)), 5.51-5.55 (m, 1H (2 diastereomers of E isomer)), 5.30 (t, J = 
10.3  Hz,  1H  (2  diastereomers  of  Z  isomer)),  4.55  (dd,  J  =  5.5,  2.8  Hz,  1H  (1 
diastereomer)), 4.54 (dd, J = 5.5, 2.8 Hz, 1H (1 diastereomer)), 4.16 (t, J = 5.8 Hz, 1H (2 
diastereomers)), 3.92-3.97 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 
3.82-3.89 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 3.73-3.80 (m, 1H (2 
diastereomer)), 3.42-3.48 (m, 1H (2 diastereomers)), 3.31 (dd, J = 14.2, 4.5 Hz, 1H (1 
diastereomer)), 3.18 (dd, J = 14.2, 4.2 Hz, 1H (1 diastereomer)), 2.97 (dd, J = 14.2, 8.3 
Hz, 1H (1 diastereomer)), 2.96 (dd, J = 14.2, 8.4 Hz, 1H (1 diastereomer)), 2.31-2.38 (m, 
1H (1 diastereomer)), 2.20-2.26 (m, 1H (1 diastereomer)), 1.92-1.99 (m, 2H (1H of 1 
diastereomer and 1H of 2 diastereomers)), 1.84-1.89 (m, 1H (2 diastereomers)), 1.79 (s, 
3H  (2  diastereomers)),  1.77  (s,  3H  (2  diastereomers)),  1.72-1.77  (m,  2H  (1H  of  1 
diastereomer and 1H of 2 diastereomers)), 1.58-1.71 (m, 3H (2 diastereomers)), 1.38-1.55 
(m, 7H (2 diastereomers)), 1.15 (d, J = 6.6 Hz, 3H (1 diastereomer)), 1.14 (d, J = 6.6 Hz, 
3H (1 diastereomer)), 0.96 (t, J = 8.0 Hz, 9H (2 diastereomers)), 0.61 (q, J = 7.9 Hz, 6H 
(2  diastereomers))  ppm; 
13C  NMR  (176  MHz,  CDCl3)  δ  140.2,  140.1,  135.0,  134.9, 
133.4, 133.3, 130.0, 129.9, 129.2, 129.1, 128.0, 127.9, 127.5, 127.4, 124.74, 124.71, 99.7, 
97.1, 82.0, 81.9, 76.1, 76.0, 75.6, 75.5, 74.5, 71.7, 63.3, 63.2, 63.1, 62.9, 42.1, 41.8, 41.4, 
40.4, 32.9, 32.5, 31.3, 31.2, 27.2, 27.1, 26.1, 25.9, 25.47, 25.41, 20.3, 20.2, 20.0, 19.6, 
    
18.2, 6.8, 5.0 ppm; HRMS (ES+) calcd. for C34H56O6SSiNa (M+Na) 643.3465, found 
643.3464. 
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  Coupled Sulfone 5.7: To a stirred solution of sulfone 5.6 (216 mg, 0.348 mmol) 
in THF (1.5 mL) at -78 ºC was added LHMDS (0.35 mL, 0.350 mmol, 1 M in THF). 
After 15 min, the reaction was warmed to 0 ºC. After 15 min, HMPA (361 mg, 0.35 mL, 
2.01 mmol) was added. After another 25 min, a solution of iodide 4.1 (122 mg, 0.138 
mmol) in THF (1.8 mL and 2 X 0.10 mL wash) was cannulated to it. The reaction was 
slowly warmed to rt over 2 h. After 16 h, the reaction was quenched with sat. aq. NH4Cl 
(15 mL) and the aqueous layer was extracted with Et2O (3 X 30 mL). The dried (MgSO4) 
extract was concentrated in vacuo and purified by flash chromatography over silica gel, 
eluting with 5-30% EtOAc / hexanes, to give diastereomeric coupled sulfone 5.7 (137.3 
mg, 99.9 µmol, 72%) as colorless oil along with recovered sulfone 5.6 (108 mg, 0.174 
mmol). [α]D
23 = -7.9 (c = 1.00, C6H6); IR: (neat) 2955, 2930, 2856, 1730, 1462, 1379, 
1305,  1252,  1145,  1076,  1034,  835,  776  cm
-1; 
1H  NMR  {(700  MHz,  CDCl3  (four 
diastereomers)}  δ  7.88-7.94  (m,  2H  (4  diastereomers)),  7.60-7.65  (m,  1H  (4 
    
diastereomers)),  7.52-7.57  (m,  2H  (4  diastereomers)),  6.44-6.49  (m,  1H  (4 
diastereomers)),  5.84  (d,  J  =  11.0  Hz,  1H  (4  diastereomers)),  5.80  (s,  1H  (1 
diastereomer)), 5.78 (s, 1H (1 diastereomer)), 5.71 (s, 1H (2 diastereomers)), 5.52-5.55 
(m, 1H (4 diastereomers)), 5.33 (s, 1H (2 diastereomers)), 5.31 (s, 1H (2 diastereomers)), 
5.05  (s,  1H  (1  diastereomer)),  5.00  (s,  1H  (1  diastereomer)),  4.87  (s,  1H  (1 
diastereomer)),  4.86  (s,  1H  (  1  diastereomer)),  4.52  (dd,  J  =  5.6,  2.6  Hz,  1H  (2 
diastereomers)), 4.47 (dd, J = 5.7, 2.6 Hz, 1H (1 diastereomer)), 4.38 (dd, J = 5.6, 2.6 Hz, 
1H (1 diastereomer)), 4.35 (dt, J = 9.6, 3.1 Hz, 1H (1 diastereomer)), 4.32 (dt, J = 10.3, 
2.9 Hz, 1H (1 diastereomer)), 4.25-4.29 (m, 1H (4 diastereomers)), 4.10-4.16 (m, 4H (1H 
of 2 diastereomers and 3H of 4 diastereomers)), 3.95-3.99 (m, 1H (2 diastereomers)), 
3.87-3.95 (m, 3H (4 diastereomers)), 3.81-3.86 (m, 1H (2 diastereomers)), 3.76-3.80 (m, 
1H  (1  diastereomer)),  3.65-3.71  (m,  1H  (3  diastereomers)),  3.53-3.56  (m,  1H  (4 
diastereomers)),  3.46-3.49  (m,  1H  (1  diastereomer)),  3.36-3.43  (m,  2H  (1H  of  1 
diastereomer  and  1H  of  4  diastereomers)),  3.32  (td,  J  =  9.2,  2.6  Hz,  1H  (2 
diastereomers)), 3.20 (td, J = 9.0, 2.0 Hz, 1H (1 diastereomer)), 3.12-3.16 (m, 1H (3 
diastereomers)), 2.37-2.41 (m, 2H (1H of 2 diastereomers and 1H of 4 diastereomers)), 
2.16-2.21 (m, 1H (2 diastereomers)), 2.04-2.12 (m, 1H (4 diastereomers)), 1.95-2.03 (m, 
2H  (4  diastereomers)),  1.74-1.95  (m,  6H  (4  diastereomers)),  1.88  (s,  3H  (2 
diastereomers)), 1.87 (s, 3H (2 diastereomers)), 1.78 (s, 3H (4 diastereomers)), 1.77 (s, 
3H  (4  diastereomers)),  1.58-1.73  (m,  6H  (4  diastereomers)),  1.34-1.56  (m,  8H  (4 
diastereomers)),  1.16-1.32  (m,  16H  (4  diastereomers)),  1.07-1.11  (m,  3H  (4 
diastereomers)),  0.86-1.00  (m,  36H  (4  diastereomers)),  0.61  (q,  J  =  8.0  Hz,  6H  (4 
    
diastereomers)), 0.04-0.17 (m, 18H (4 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) 
δ 178.4, 145.5, 145.4, 140.5, 139.9, 139.69, 139.66, 139.1, 139.0, 135.1, 135.0, 133.3, 
133.1, 130.0, 129.8, 129.09, 129.05, 129.03, 128.9, 128.3, 127.4, 127.3, 126.1, 124.8, 
124.79, 124.72, 115.3, 125.2, 114.6, 100.6, 100.3, 97.3, 82.1, 81.9, 80.5, 80.4, 80.3, 79.6, 
79.5, 79.4, 79.3, 79.2, 78.8, 78.6, 77.2, 77.0, 76.8, 76.3, 76.2, 75.67, 75.61, 74.7, 72.37, 
72.33, 71.7, 71.4, 66.3, 65.78, 65.75, 63.6, 63.3, 63.2, 62.17, 62.11, 48.5, 48.3, 46.9, 41.6, 
41.5, 40.37, 40.34, 40.0, 38.7, 38.1, 38.0, 36.6, 36.0, 35.2, 34.6, 33.1, 33.0, 32.9, 32.4, 
31.5, 31.3, 31.2, 29.7, 29.2, 29.1, 28.9, 28.6, 27.5, 27.4, 27.3, 27.2, 26.7, 26.3, 26.1, 26.0, 
25.97, 25.94, 25.4, 25.3, 24.7, 23.3, 20.8, 20.7, 20.6, 20.4, 20.3, 18.4, 18.38, 18.31, 18.2, 
18.07, 18.02, 17.3, 17.0, 16.0, 15.9, 14.9, 11.9, 11.4, 6.9, 4.9, -3.8, -4.1, -4.20, -4.28, -4.3, 
-4.4,  -4.5,  -4.65,  -4.69  ppm;  HRMS  (ES+)  calcd.  for  C75H136O12SSi4Na  (M+Na) 
1395.8727, found 1395.8761. 
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  Ketone 5.8 and Keto-ol 5.9: To a stirred solution of sulfone 5.7 (113.6 mg, 82.6 
µmol) in THF (1.4 mL) at -50 ºC was added LDA
4 (0.21 mL, 0.210 mmol, 1 M in THF / 
hexanes). After 5 min, DMPU (794 mg, 0.75 mL, 6.17 mmol) was added and was slowly 
    
warmed to -25 ºC over 30 min. The reaction was cooled back down to -50 ºC and a 
solution of Davis’ oxaziridine
5 (59.4 mg, 0.227 mmol) in THF (0.50 mL) was cannulated 
to it. The reaction was allowed to warm to -35 ºC over 20 min and then quenched with 
sat. aq. NH4Cl (15 mL). The aqueous layer was extracted with Et2O (3 X 30 mL). The 
dried (MgSO4) extract was concentrated in vacuo and purified by flash chromatography 
over silica gel, eluting with 6-20% EtOAc / hexanes, to give ketone 5.8 (46.3 mg, 37.1 
µmol,  45%)  and  keto-ol  5.9  (20.7  mg,  17.8  µmol,  22%)  as  colorless  oil  along  with 
recovered sulfone 5.7 (30.4 mg, 22.1 µmol, 27%). Ketone 5.8: [α]D
23 = +27.4 (c = 1.00, 
C6H6); IR: (neat) 2955, 2930, 2856, 1731, 1461, 1376, 1252, 1156, 1076, 1034, 835, 776 
cm
-1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 6.47 (dd, J = 15.1, 11.0 Hz, 1H 
(2  diastereomers)),  5.84  (d,  J  =  11.0  Hz,  1H  (2  diastereomers)),  5.60  (s,  1H  (2 
diastereomers)), 5.52-5.56 (m, 1H (2 diastereomers)), 5.32 (s, 1H (2 diastereomers)), 4.96 
(s,  1H  (2  diastereomers)),  4.54-4.59  (m,  1H  (2  diastereomers)),  4.36-4.40  (m,  1H  (2 
diastereomers)),  4.25-4.28  (m,  1H  (2  diastereomers)),  4.16-4.19  (m,  1H  (2 
diastereomers)), 4.11-4.14 (m, 1H (2 diastereomers)), 4.08 (s, 1H (2 diastereomers)), 4.00 
(ddd, J = 13.5, 8.1, 5.5 Hz, 1H (1 diastereomer)), 3.89-3.97 (m, 4H (1H of 1 diastereomer 
and 3H of 2 diastereomers)), 3.82-3.86 (m, 1H (1 diastereomer)), 3.71-3.75 (m, 1H (1 
diastereomer)), 3.47-3.53 (m, 2H (2 diastereomers)), 3.33 (td, J = 9.1, 2.6 Hz, 1H (2 
diastereomers)), 2.81 (qd, J = 6.9, 4.3 Hz, 1H (1 diastereomer)), 2.58-2.69 (m, 2H (1H of 
1  diastereomer  and  1H  of  2  diastereomers)),  2.52  (dd,  J  =  12.1,  5.3  Hz,  1H  (1 
diastereomer)), 2.49 (dd, J = 12.1, 5.4 Hz, 1H (1 diastereomer)), 2.37-2.41 (m, 1H (2 
diastereomers)),  2.04-2.09  (m,  1H  (2  diastereomers)),  1.95-2.02  (m,  1H  (2 
    
diastereomers)),  1.84-1.92  (m,  4H  (2  diastereomers)),  1.80-1.84  (m,  1H  (1 
diastereomer)), 1.82 (s, 3H (2 diastereomers)), 1.79 (s, 3H (2 diastereomers)), 1.78 (s, 3H 
(2  diastereomers)),  1.64-1.71  (m,  3H  (2  diastereomers)),  1.49-1.56  (m,  5H  (2 
diastereomers)),  1.40-1.47  (m,  2H  (  2  diastereomers)),  1.22-1.28  (m,  1H  (2 
diastereomers)),  1.21  (s,  9H  (2  diastereomers)),  1.08  (d,  J  =  7.0  Hz,  3H  (2 
diastereomers)), 1.06 (d, J = 6.9 Hz, 3H (1 diastereomer)), 1.04 (d, J = 6.9 Hz, 3H (1 
diastereomer)), 0.98 (d, J = 6.4 Hz, 3H (2 diastereomers)), 0.97 (t, J = 7.9 Hz, 9H (2 
diastereomers)), 0.915 (s, 9H (2 diastereomers)), 0.910 (s, 9H (2 diastereomers)), 0.89 (s, 
9H  (2  diastereomers)),  0.62  (q,  J  =  7.9  Hz,  6H  (2  diastereomers)),  0.12  (s,  3H  (2 
diastereomers)), 0.08 (s, 3H (2 diastereomers)), 0.07 (s, 3H (2 diastereomers)), 0.047 (s, 
3H (1 diastereomer)), 0.043 (s, 3H (1 diastereomer)), 0.03 (s, 3H (1 diastereomer)), 0.02 
(s, 3H (1 diastereomer)), 0.015 (s, 3H (1 diastereomer)), 0.012 (s, 3H (1 diastereomer)) 
ppm; 
13C NMR (176 MHz, CDCl3) δ 213.1, 212.5, 178.4, 145.2, 140.8, 135.0, 134.9, 
130.0, 129.8, 127.5, 127.4, 125.46, 125.40, 124.75, 124.72, 114.9, 99.5, 97.9, 82.1, 82.0, 
80.5, 79.4, 78.9, 78.6, 77.4, 76.28, 76.24, 75.58, 75.54, 74.1, 72.1, 70.49, 70.44, 63.8, 
63.4, 62.0, 48.1, 48.0, 45.3, 43.3, 43.0, 41.8, 41.1, 40.3, 38.6, 38.1, 37.3, 36.8, 33.1, 32.9, 
32.5, 31.4, 31.3, 29.7, 27.4, 27.28, 27.20, 26.1, 25.97, 25.92, 25.90, 25.4, 20.8, 20.4, 18.4, 
18.3, 18.2, 17.9, 17.16, 17.10, 16.1, 16.0, 15.6, 13.97, 13.93, 6.8, 5.0, -4.23, -4.27, -4.43, 
-4.47,  -4.77,  -4.79,  -4.8  ppm;  HRMS  (ES+)  calcd.  for  C69H130O11Si4Na  (M+Na) 
1269.8588, found 1269.8671.  
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  Aldehyde 5.10: To a stirred solution of pivaloyl ester 5.8 (37.0 mg, 29.6 
µmol)  in  Et2O  (2.2  mL)  at  -20  ºC  was  added  LiAlH4  (5.6  mg,  0.148  mmol)  in  one 
portion. After 25 min, the reaction was quenched with H2O (5 drops) and the organic 
layer was decanted. The solid formed was washed with Et2O (3 X 10 mL). The dried 
(MgSO4) combined solution was concentrated in vacuo to give crude diol 5.47. 
To a stirred solution of oxalyl chloride (18.6 mg, 13.0 µL, 0.148 mmol) in CH2Cl2 
(0.80 mL) at -78 ºC was cannulated a solution of DMSO (22.7 mg, 21.0 µL, 0.296 mmol) 
in CH2Cl2 (0.40 mL). After 15 min, a solution of crude diol 5.47 in CH2Cl2 (0.95 mL and 
2 X 0.10 mL wash) was cannulated to it. After 45 min, Et3N (29.7 mg, 41.7 µL, 0.296 
mmol) was added. After 10 min, the reaction was quenched with H2O (10 mL) and the 
aqueous layer was extracted with CH2Cl2 (3 X 20 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
5-15% EtOAc / hexanes, to give aldehyde 5.10 (27.2 mg, 23.4 µmol, 79%) as colorless 
    
oil. [α]D
23 = +17.8 (c = 0.45, C6H6); IR: (neat) 2953, 2928, 2855, 1728, 1641, 1461, 1377, 
1252, 1075, 1033, 835, 776 cm
-1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 
9.82 (dd, J = 2.9, 2.3 Hz, 1H (2 diastereomers)), 6.47 (dd, J = 15.1, 11.0 Hz, 1H (2 
diastereomers)),  5.84  (d,  J  =  11.0  Hz,  1H  (2  diastereomers)),  5.60  (s,  1H  (2 
diastereomers)),  5.54  (dt,  J  =  15.1,  6.6  Hz,  1H  (2  diastereomers)),  5.32  (s,  1H  (2 
diastereomers)),  4.97  (s,  1H  (2  diastereomers)),  4.54-4.59  (m,  1H  (2  diastereomers)). 
4.38-4.41 (m, 1H (2 diastereomers)), 4.17 (dd, J = 12.3, 6.1 Hz, 1H (2 diastereomers)), 
4.08 (s, 1H (2 diastereomers)), 3.98-4.03 (m, 2H (1H of 1 diastereomer and 1H of 2 
diastereomers)),  3.93-3.97  (m,  1H  (2  diastereomers)),  3.88-3.92  (m,  2H  (1H  of  1 
diastereomer and 1H of 2 diastereomers)), 3.83-3.86 (m, 1H (1 diastereomer)), 3.73-3.76 
(m, 1H (1 diastereomer)), 3.73 (td, J = 8.9, 3.4 Hz, 1H (2 diastereomers)), 3.54 (ddd, J = 
7.1, 4.3, 2.8 Hz, 1H (2 diastereomers)), 3.47-3.51 (m, 1H (2 diastereomers)), 2.82 (qd, J = 
6.8, 4.2 Hz, 1H (1 diastereomer)), 2.68 (dd, J = 17.3, 6.7 Hz, 1H (1 diastereomer)), 2.60-
2.64 (m, 1H (1 diastereomer)), 2.62 (dd, J = 17.4, 6.7 Hz, 1H (1 diastereomer)), 2.58 (dd, 
J = 3.3, 2.3 Hz, 1H (1 diastereomer)), 2.56 (dd, J = 3.3, 2.3 Hz, 1H (1 diastereomer)), 
2.45-2.51 (m, 2H (2 diastereomers)), 2.38-2.42 (m, 1H (2 diastereomers)), 2.05-2.10 (m, 
2H  (1H  of  1  diastereomer  and  1H  of  2  diastereomers)),  1.95-2.02  (m,  2H  (1H  of  1 
diastereomer and 1H of 2 diastereomers)), 1.84-1.90 (m, 3H (2 diastereomers)), 1.83 (d, J 
=  1.0  Hz,  3H  (2  diastereomers)),  1.79  (s,  3H  (2  diastereomers)),  1.78  (s,  3H  (2 
diastereomers)),  1.66-1.72  (m,  2H  (2  diastereomers)),  1.49-1.56  (m,  5H  (2 
diastereomers)),  1.39-1.47  (m,  2H  (2  diastereomers)),  1.23-1.31  (m,  2H  (2 
diastereomers)), 1.09 (d, J = 7.0 Hz, 3H (2 diastereomers)), 1.06 (d, J = 6.9 Hz, 3H (1 
    
diastereomer)), 1.04 (d, J = 6.9 Hz, 3H (1 diastereomer)), 1.02 (d, J = 6.4 Hz, 3H (2 
diastereomers)),  0.97  (t,  J  =  7.9  Hz,  9H  (2  diastereomers)),  0.91  (s,  9H  (2 
diastereomers)), 0.89 (s, 18H (2 diastereomers)), 0.62 (q, J = 7.9 Hz, 6H), 0.12 (s, 3H (1 
diastereomer)),  0.08  (s,  3H  (2  diastereomers)),  0.01-0.04  (m,  12H  (2  diastereomers)) 
ppm; 
13C  NMR  (176  MHz,  CDCl3)  212.5,  202.0,  145.1,  141.0,  135.0,  134.9,  130.0, 
129.8, 127.5, 127.4, 125.1, 124.7, 115.0, 99.5, 97.9, 82.1, 82.0, 79.9, 79.4, 78.69, 78.65, 
77.4, 76.2, 75.5, 74.2, 72.1, 70.3, 63.5, 48.0, 47.6, 45.1, 43.4, 43.0, 41.9, 41.1, 40.6, 37.6, 
37.2, 36.8, 32.9, 32.5, 31.4, 31.3, 29.7, 27.4, 27.2, 26.1, 25.96, 25.90, 25.4, 20.8, 20.4, 
18.4, 18.3, 18.2, 17.9, 17.3, 17.2, 16.0, 15.6, 15.5, 13.8, 6.9, 5.0, -4.1, -4.3, -4.4, -4.7, -4.8 
ppm; HRMS (ES+) calcd. for C64H120O10Si4Na (M+Na) 1183.7856, found 1183.7847.  
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  Aldehyde 5.10: To a stirred solution of oxalyl chloride (10.6 mg, 7.3 µL, 83.7 
µmol) in CH2Cl2 (0.50 mL) at -78 ºC was cannulated a solution of DMSO (13.1 mg, 11.9 
µL, 0.167 mmol) in CH2Cl2 (0.25 mL). After 15 min, a solution of alcohol 5.9 (19.5 mg, 
16.7 µmol) in CH2Cl2 (0.50 mL and 2 X 0.10 mL wash) was cannulated to it. After 45 
min, Et3N (16.9 mg, 23.4 µL, 0.167 mmol) was added. After 10 min, the reaction was 
quenched with H2O (5 mL) and the aqueous layer was extracted with CH2Cl2 (3 X 15 
    
mL).  The  dried  (MgSO4)  extract  was  concentrated  in  vacuo  and  purified  by  flash 
chromatography over silica gel, eluting with 5-15% EtOAc / hexanes, to give aldehyde 
5.10 (16.5 mg, 14.2 µmol, 85%) as colorless oil.  
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  Carboxylic Acid 5.11: To a stirred solution of aldehyde 5.10 (27.2 mg, 23.4 
µmol) in t-BuOH / H2O (1:1, 2.3 mL) at 0 ºC were sequentially added 2-methyl-2-butene 
(82.1 mg, 124 µL, 1.17 mmol), NaH2PO4•H2O (32.3 mg, 0.234 mmol) and NaClO2 (10.7 
mg, 0.117 mmol). After 15 min, the reaction was warmed to rt. After another 2 h, the 
reaction was diluted with H2O (7.5 mL) and the aqueous layer was extracted with EtOAc 
/ Et2O (1:1, 3 X 20 mL). The dried (MgSO4) extract was concentrated in vacuo and 
purified by flash chromatography over silica gel, eluting with 10-30 % EtOAc / hexanes, 
to give carboxylic acid 5.11 (24.1 mg, 20.4 µmol, 87%) as light yellow oil. [α]D
23 = +14.3 
(c = 1.00, CHCl3); IR: (neat) 3376, 2953, 2927, 2855, 1713, 1654, 1461, 1377, 1252, 
1076, 1034, 835 cm
-1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 9.79 (br s, 1H 
(2 diastereomers)), 6.45-6.49 (m, 1H (2 diastereomers)), 5.84 (d, J = 11.0 Hz, 1H (2 
diastereomers)), 5.60 (s, 1H (1 diastereomer)), 5.58 (s, 1H (1 diastereomer)), 5.54 (ddd, J 
= 15.1, 10.6, 5.9 Hz, 1H (2 diastereomers)), 5.39 (s, 1H (1 diastereomer)), 5.35 (s, 1H (1 
    
diastereomer)), 5.02 (s, 1H (1 diastereomer)), 5.00 (s, 1H (1 diastereomer)), 4.52-4.60 (m, 
2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 4.38 (td, J = 5.8, 3.6 Hz, 1H (1 
diastereomer)), 4.11-4.19 (m, 3H (1H of 1 diastereomer and 2H of 2 diastereomers)), 
4.10 (s, 1H (1 diastereomer)), 3.99-4.06 (m, 1H (2 diastereomers)), 3.93-3.98 (m, 2H (1H 
of 1 diastereomer and 1H of 2 diastereomers)), 3.86-3.92 (m, 2H (1H of 1 diastereomer 
and 1H of 2 diastereomers)), 3.72-3.76 (m, 1H (1 diastereomer)), 3.66 (ddd, J = 9.6, 6.9, 
3.7 Hz, 1H (1 diastereomer)), 3.59 (dd, J = 7.0, 1.9 Hz, 1H (1 diastereomer)), 3.57 (dd, J 
= 6.6, 2.5 Hz, 1H (1 diastereomer)), 3.48-3.56 (m, 1H (2 diastereomers)), 2.88 (qd, J = 
6.7, 3.5 Hz, 1H (1 diastereomer)), 2.69-2.75 (m, 1H (2 diastereomers)), 2.59-2.66 (m, 2H 
(1H  of  1  diastereomer  and  1H  of  2  diastereomers)),  2.48  (dd,  J =  15.9  Hz,  1H  (2 
diastereomers)),  2.37-2.46  (m,  2H  (2  diastereomers)),  2.05-2.15  (m,  2H  (2 
diastereomers)),  1.91-2.03  (m,  3H  (2  diastereomers)),  1.84-1.89  (m,  1H  (2 
diastereomers)), 1.85 (s, 3H (1 diastereomer)), 1.83 (s, 3H (1 diastereomer)), 1.79 (s, 3H 
(2 diastereomers)), 1.78 (s, 3H (2 diastereomers)), 1.65-1.73 (m, 3H (2 diastereomers)), 
1.50-1.56 (m, 5H (2 diastereomers)), 1.42-1.48 (m, 2H (2 diastereomers)), 1.32-1.38 (m, 
1H (2 diastereomers)), 1.11 (d, J = 7.0 Hz, 3H (1 diastereomer)), 1.10 (d, J = 7.0 Hz, 3H 
(1 diastereomer)), 1.05 (d, J = 6.9 Hz, 3H (2 diastereomers)), 1.03 (d, J = 6.4 Hz, 3H (2 
diastereomers)), 0.97 (t, J = 7.9 Hz, 9H), 0.93 (s, 9H, (1 diastereomer)), 0.925 (s, 9H (1 
diastereomer)), 0.922 (s, 9H (1 diastereomer)), 0.91 (s, 9H (1 diastereomer)), 0.899 (s, 9H 
(1 diastereomer)), 0.892 (s, 9H (1 diastereomer)), 0.62 (q, J = 7.9 Hz, 6H), 0.02-0.13 (m, 
18H (2 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 213.0, 212.5, 171.7, 144.9, 
141.5, 141.3, 135.1, 134.9, 129.9, 129.8, 127.5, 127.4, 125.0, 124.7, 124.6, 124.4, 115.0, 
    
114.4, 99.5, 98.5, 82.2, 82.0, 80.25, 80.20, 80.1, 79.1, 78.8, 78.0, 77.4, 76.3, 76.1, 75.6, 
75.5, 74.1, 72.2, 70.4, 69.8, 64.6, 63.5, 47.9, 47.6, 45.2, 44.6, 43.4, 42.8, 41.8, 41.2, 39.8, 
38.0, 37.7, 37.6, 37.5, 37.2, 36.8, 33.0, 32.5, 31.6, 31.3, 29.7, 27.4, 27.2, 26.0, 25.98, 
25.95, 25.8, 25.4, 25.2, 21.2, 20.4, 18.3, 18.2, 17.9, 17.3, 17.1, 16.1, 15.6, 15.5, 15.1, 
14.0, 13.3, 6.8, 5.0, -3.9, -4.3, -4.43, -4.48, -4.5, -4.6, -4.74, -4.77, -4.8 ppm; HRMS 
(ES+) calcd. for C64H120O11Si4Na (M+Na) 1199.7805, found 1199.7843.  
 
OTBS
OTBS
TBSO
O H H OTES
O H
H
O
OTHP
CO2H
OTBS
OTBS
TBSO
O H H
O
O H
H
O
O
OTHP
5.14
OTBS
OTBS
TBSO
O H H OH
O H
H
O
OTHP
CO2H
5.11 5.12
 
 
Macrolactone 5.14: To a stirred solution of TES ether 5.11 (20.9 mg, 17.7 µmol) 
in dry MeOH (1.7 mL) at 0 ºC was added methanolic PPTS solution (34 µL).
6 After 15 
min, the reaction was warmed to rt. After another 35 min, the reaction was quenched with 
sat. aq. NaHCO3 (6.0 mL) and the aqueous layer was extracted with EtOAc (3 X 15 mL). 
The dried (MgSO4) extract was concentrated in vacuo to give crude seco-acid 5.12.  
    
To a stirred solution of Shina anhydride 5.13
7 (7.3 mg, 21.3 mmol) and DMAP 
(5.2 mg, 42.6 mmol) in DCE (12.0 mL) was slowly added a solution of crude seco acid 
5.12 in DCE (1.3 mL) over 24 h. After another 12 h, the solvent was removed in vacuo. 
The residue was purified by flash chromatography over silica gel, eluting with 5-15% 
EtOAc / hexanes, to give macrolactone 5.14 (12.9 mg, 12.3 µmol, 69%) as colorless oil. 
[α]D
23 = +3.1 (c = 0.71, CHCl3); IR: (neat) 2953, 2927, 2855, 1740, 1710, 1553, 1462, 
1385, 1252, 1076, 1034, 835 cm
-1; 
1H NMR {700 MHz, CDCl3 (Note: NMR analysis 
indicated that compound 5.14 exists as a mixture of conformational isomers)} δ 6.5 (dd, J 
= 14.8, 11.1 Hz, 1H (2 diastereomers)), 6.15 (s, 1H (1 diastereomer)), 6.13 (s, 1H (1 
diastereomer)),  5.78  (d,  J  =  11.0  Hz,  1H  (2  diastereomers)),  5.36-5.40  (m,  1H  (2 
diastereomers)), 4.95-5.03 (m, 2H (2 diastereomer)), 4.91 (s, 1H (2 diastereomers)), 4.59-
4.62  (m,  1H  (2  diastereomers)),  4.22  (s,  1H  (1  diastereomer)),  4.20  (s,  1H  (1 
diastereomer)),  3.84-4.05  (br  m,  6H  (2  diastereomers)),  3.49-3.65  (br  m,  3H  (2 
diastereomers)), 3.00 (dd, J = 18.4, 10.4 Hz, 1H (1 diastereomer)), 2.96 (dd, J = 18.2, 
10.2  Hz,  1H  (1  diastereomer)),  2.76  (br  s,  1H  (2  diastereomers)),  2.56  (br  s,  1H  (2 
diastereomers)),  2.39-2.50  (m,  3H  (2  diastereomers)),  2.28-2.33  (m,  1H  (2 
diastereomers)),  2.02-2.11  (br  m,  3H  (2  diastereomers)),  1.84-1.99  (m,  5H  (2 
diastereomers)), 1.78 (s, 6H (2 diastereomers)), 1.77 (s, 3H (2 diastereomers)), 1.68-1.76 
(m, 3H (2 diastereomers)), 1.48-1.60 (m, 9H (2 diastereomers)), 1.22-1.31 (m, 2H (2 
diastereomers)),  1.10  (br  s,  3H  (2  diastereomers)),  1.04  (t,  J  =  6.5  Hz,  3H  (2 
diastereomers)), 0.91 (s, 18H (2 diastereomers)), 0.86 (s, 9H (2 diastereomers)), -0.01-
0.11 (m, 18H (2 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 212.2, 211.7, 
    
170.5, 170.4, 146.5, 146.4, 140.6, 137.5, 131.2, 128.9, 128.3, 128.1, 125.1, 125.0, 124.2, 
114.4, 114.3, 101.1, 97.3, 81.8, 81.7, 80.0, 79.2, 79.0, 78.7, 78.2, 77.9, 75.7, 75.4, 75.3, 
71.7, 64.1, 63.7, 56.0, 47.0, 46.3, 42.7, 42.2, 42.0, 41.8, 40.7, 39.9, 39.8, 38.6, 36.6, 34.8, 
34.6, 34.5, 34.2, 32.7, 32.6, 31.9, 31.7, 31.5, 31.0, 30.3, 29.4, 28.9, 26.4, 26.9, 25.9, 25.8, 
25.4, 25.3, 24.7, 22.7, 21.0, 20.7, 18.7, 18.5, 18.4, 17.9, 16.7, 16.4, 16.4, 15.3, 14.1, -4.1, 
-4.5, -4.6, -4.7, -4.8, -5.2. -5.3 ppm; HRMS (ES+) calcd. for C58H104O10Si3Na (M+Na) 
1067.6835, found 1067.6857. 
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  EE Ether 5.23: To a stirred solution of alcohol 4.38 (946 mg, 1.67 mmol) in 
CH2Cl2 (26.0 mL) were added ethyl vinyl ether (3.00 g, 4.0 mL, 41.7 mmol) followed by 
PPTS (1.5 mg, 41.7 µmol). After 14 h, the reaction was quenched with Et3N (1.44 g, 2.0 
mL,  14.2  mmol)  and  was  concentrated  in vacuo.  The  residue  was  purified  by  flash 
chromatography over silica gel, eluting with 3-6% EtOAc / hexanes, to give EE ether 
5.23 (1.00 g, 1.57 mmol, 94%) as colorless oil. [α]D
23 = -21.0 (c = 1.00, C6H6); IR: (neat) 
2954, 2929, 2857, 1471, 1361, 1253, 1091, 960, 835, 777 cm
-1; 
1H NMR {700 MHz, 
CDCl3 (two diastereomers)} δ 7.35-7.36 (m, 4H (2 diastereomers)), 7.29-7.30 (m, 1H (1 
diastereomer)), 4.72 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.68 (q, J = 5.2 Hz, 1H (1 
    
diastereomer)), 4.52 (s, 2H (2 diastereomers)), 4.06-4.10 (m, 1H (2 diastereomers)), 3.94-
4.01 (m, 1H (2 diastereomers)), 3.87 (ddd, J = 13.0, 8.1, 4.0 Hz, 1H (1 diastereomer)), 
3.78  (ddd,  J  =  12.6,  8.4,  4.4  Hz,  1H  (1  diastereomer)),  3.61-3.69  (m,  2H  (2 
diastereomers)),  3.54-3.58  (m  ,  2H  (2  diastereomers)),  3.45-3.53  (m,  1H  (2 
diastereomers)),  3.35-3.38  (m,  1H  (2  diastereomers)),  3.23-3.28  (m,  1H  (2 
diastereomers)),  2.08-2.13  (m,  1H  (1  diastereomer)),    1.98-2.04  (m,  2H  (1H  of  1 
diastereomer and 1H of 2 diastereomers)), 1.90-1.96 (m, 2H (2 diastereomers)), 1.77-1.85 
(m, 1H (2 diastereomers)), 1.54-1.63 (m, 2H (2 diastereomers)), 1.42-1.48 (m, 1H (2 
diastereomers)),  1.31-1.37  (m,  1H  (2  diastereomers)),  1.30  (d,  J  =  5.2  Hz,  3H  (2 
diastereomers)), 1.21 (t, J = 7.0 Hz, 3H (2 diastereomers)), 1.01 (d, J = 6.6 Hz, 3H (1 
diastereomer)), 1.00 (d, J = 6.6 Hz, 3H (1 diastereomer)), 0.91 (s, 9H (2 diastereomers)), 
0.90 (s, 9H (2 diastereomers)), 0.094 (s, 3H), 0.090 (s, 3H), 0.08 (s, 3H)), 0.07 (s, 3H)) 
ppm; 
13C NMR (176 MHz, CDCl3) δ 138.8, 138.7, 128.3, 128.2, 127.5, 127.4, 127.3, 
99.6, 98.3, 78.6, 78.5, 76.4, 76.3, 76.2, 76.0, 72.9, 72.87, 72.84, 71.9, 65.1, 60.7, 60.5, 
41.8, 41.2, 39.0, 38.6, 33.2, 32.9, 29.8, 29.7, 27.39, 27.36, 26.0, 25.9, 20.9, 20.7, 18.4, 
18.1,  17.3,  17.0,  15.4,  15.3,  -4.1,  -4.2,  -4.6,  -4.7  ppm;  HRMS  (ES+)  calcd.  for 
C35H66O6Si2Na (M+Na) 661.4296, found 661.4295. 
 
    
OTBS
O H
H
BnO
OTBS
OEE
5.23
5.25
O
O
OTBS
O H
H OTBS
OTBS
O H
H
HO
OTBS
OH
+
5.24 5.26
OTBS
O H
H
HO
OTBS
OEE
+
 
 
  Pd / C-mediated Debenzylation: To a stirred solution of benzyl ether 5.23 (333 
mg, 0.521 mmol) in i-PrOH (22.0 mL) was added Pd / C (225 mg, 10 mol% by weight). 
The flask was fitted with a H2 balloon and purged with H2. After 15 h, the reaction was 
passed through a plug of celite and the celite plug was washed with EtOAc (50 mL). The 
solvent  was  removed  in vacuo  and  purified  by  flash  chromatography  over  silica  gel, 
eluting with 10-50% EtOAc / hexanes, to sequentially give cyclic acetal 5.26 (52.4 mg, 
0.104 mmol, 20 %), alcohol 5.25 (202 mg, 0.368 mmol, 71%) and diol 5.24 (17.4 mg, 
36.5 µmol, 7%) as colorless oils. Cyclic acetal 5.26: [α]D
23 = -18.7 (c = 1.00, CHCl3); IR 
(neat) 2953, 2930, 2858, 1464, 1387, 1253, 1146, 1094, 835, 776 cm
-1; 
1H NMR (700 
MHz, CDCl3) δ 4.94 (q, J = 5.2 Hz, 1H), 4.08 (td, J = 7.5, 3.5 Hz, 1H), 4.00-4.04 (m, 
1H), 3.78-3.82 (m, 1H), 3.67-3.70 (m, 1H), 3.55-3.62 (m, 3H), 3.46 (ddd, J = 11.8, 3.4, 
1.6 Hz, 1H), 2.00-2.04 (m, 1H), 1.80-1.97 (m, 5H), 1.47-1.51 (m, 1H), 1.26 (d, J = 5.2 
Hz, 3H), 1.18 (dt, J = 13.7, 11.2 Hz, 1H), 0.914 (s, 9H), 0.912 (s, 9H), 0.86 (d, J = 6.8 
    
Hz, 3H), 0.09 (s, 6H), 0.078 (s, 3H), 0.074 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 
98.4, 78.7, 76.5, 76.1, 74.9, 67.3, 65.1, 43.3, 42.3, 34.3, 32.5, 27.4, 26.0, 25.9, 20.5, 18.4, 
18.2, 17.6, -4.1, -4.7, -5.33, -5.34 ppm; HRMS (ES+) calcd. for C26H54O5Si2Na (M+Na) 
525.3408, found 525.3388.  
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  Sulfide 5.48: To a stirred solution of benzyl ether 5.23 (616 mg, 0.964 
mmol) in THF (10.0 mL) at -78 ºC was added freshly prepared LiDBB solution
8 (7.0 mL, 
2.80 mmol, 0.4 M in THF) in one portion. After 10 min, the reaction was quenched with 
sat. aq. NH4Cl (30 mL) and the aqueous layer was extracted with EtOAc / Et2O (1:1, 3 X 
50  mL).  The  dried  extract  was  concentrated  in  vacuo  and  purified  by  flash 
chromatography over silica gel, eluting with 20-40% EtOAc / hexanes, to give alcohol 
5.25 (506 mg, 0.922 mmol, 96%) as colorless oil.  
To a stirred solution of alcohol 5.25 (506 mg, 0.922 mmol) in THF (6.8 mL) at 0 
ºC were added Ph2S2 (426 mg, 1.95 mmol) followed by n-Bu3P (413 mg, 0.52 mL, 2.04 
    
mmol) and the reaction was warmed to rt. After 16 h, the solvent was removed in vacuo 
and the residue was purified by flash chromatography over silica gel, eluting with 5-10% 
EtOAc / hexanes, to give sulfide 5.48 (576 mg, 0.898 mmol, 97%) as colorless oil. [α]D
23 
= -36.9 (c = 1.03, C6H6); IR: (neat) 2955, 2929, 2857, 1472, 1376, 1253, 1091, 959, 835, 
776, 736, 690 cm
-1; 
1H NMR {400 MHz, CDCl3 (two diastereomers)} δ 7.33-7.36 (m, 2H 
(2  diastereomers)),  7.25-7.29  (m,  2H  (2  diastereomers)),  7.13-7.18  (m,  1H  (2 
diastereomers)), 4.70 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.64 (q, J = 5.2 Hz, 1H (1 
diastereomer)),  4.05-4.11  (m,  1H  (2  diastereomers)),  3.92-4.01  (m,  1H  (2 
diastereomers)), 3.82-3.88 (m, 1H (1 diastereomer)), 3.72-3.79 (m, 1H (1 diastereomer)), 
3.64-3.71 (m, 1H (2 diastereomers)), 3.50-3.62 (m, 3H (2 diastereomers)), 3.37-3.47 (m, 
1H  (1  diastereomer)),  2.93-2.99  (m,  1H  (2  diastereomers)),  2.74-2.81  (m,  1H  (2 
diastereomers)),  1.87-2.10  (m,  3H  (2  diastereomers)),  1.68-1.85  (m,  3H  (2 
diastereomers)),  1.51-1.58  (m,  1H  (2  diastereomers)),  1.39-1.48  (m,  2H  (2 
diastereomers)),  1.27  (d,  J  =  5.2  Hz,  3H  (1  diastereomer)),  1.23  (d,  J  =  5.2  Hz  (1 
diastereomer)), 1.19 (t, J = 7.0 Hz, 3H (1 diastereomer)), 1.14 (t, J = 7.0 Hz, 3H (1 
diastereomer)), 1.08 (d, J = 6.5 Hz, 3H (1 diastereomer)), 1.07 (d, J = 6.5 Hz, 3H (1 
diastereomer)), 0.91 (s, 18H (2 diastereomers)), 0.09 (s, 6H (2 diastereomers)), 0.073 (s, 
3H  (2  diastereomers)),  0.070  (s,  3H  (2  diastereomers))  ppm; 
13C  NMR  (100  MHz, 
CDCl3) δ 137.4, 129.1, 129.0, 128.79, 128.73, 125.6, 125.5, 99.8, 98.1, 78.6, 78.5, 77.2, 
76.24, 76.20, 76.1, 73.1, 71.8, 65.0, 60.7, 60.3, 41.99, 41.91, 41.6, 41.3, 41.1, 33.2, 33.0, 
29.3, 27.3, 26.0, 25.9, 20.8, 20.6, 19.3, 19.1, 18.4, 18.1, 15.3, -4.1, -4.2, -4.7, -5.3 ppm; 
HRMS (ES+) calcd. for C34H64O5SSi2Na (M+Na) 663.3911, found 663.3882.  
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  Sulfone  5.29:  To  a  stirred  solution  of  sulfide  5.48  (592  mg,  0.923  mmol)  in 
CH3CN (16.0 mL) at rt were added NMO (325 mg, 2.77 mmol) followed by TPAP (163 
mg, 0.461 mmol). After 12 h, the reaction was directly loaded onto column and purified 
by flash chromatography over silica gel, eluting with 10-30% EtOAc / hexanes, to give 
sulfone 5.29 (574 mg, 0.852 mmol, 92%) as colorless oil. [α]D
23 = -27.8 (c = 1.00, C6H6); 
IR: (neat) 2955, 2929, 2856, 1471, 1446, 1377, 1307, 1253, 1147, 1086, 835, 776, 689 
cm
-1; 
1H  NMR  {700  MHz,  CDCl3  (two  diastereomers)}  δ  7.93-7.96  (m,  2H  (2 
diastereomers)),  7.64-7.67  (m,  1H  (2  diastereomers)),  7.56-7.59  (m,  2H  (2 
diastereomers)), 4.67 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.62 (q, J = 5.2 Hz, 1H (1 
diastereomer)),  4.05-4.09  (m,  1H  (2  diastereomers)),  3.88-3.94  (m,  1H  (2 
diastereomers)), 3.81-3.85 (m, 1H (1 diastereomer)), 3.69-3.72 (m, 1H (1 diastereomer)), 
3.63-3.66 (m, 1H (2 diastereomers)), 3.59-3.63 (m, 1H (1 diastereomer)), 3.50-3.56 (m, 
3H  (1H  of  1  diastereomer  and  2H  of  2  diastereomers)),  3.40-3.47  (m,  1H  (2 
diastereomers)), 3.23 (dd, J = 14.2, 4.7 Hz, 1H (1 diastereomer)), 3.17 (dd, J = 14.2, 4.3 
Hz, 1H (1 diastereomer)), 2.97 (dd, J = 8.2, 5.5 Hz, 1H (1 diastereomer)), 2.95 (dd, J = 
8.3, 5.7 Hz, 1H (1 diastereomer)), 2.32-2.37 (m, 1H (1 diastereomer)), 2.21-2.26 (m, 1H 
(1  diastereomer)),  1.96-2.01  (m,  1H  (2  diastereomers)),  1.86-1.94  (m,  2H  (1H  of  1 
    
diastereomer and 1H of 2 diastereomers)), 1.78-1.84 (m, 1H (2 diastereomers)), 1.72-1.76 
(m, 1H (1 diastereomer)), 1.39-1.62 (m, 4H (2 diastereomers)), 1.23 (d, J = 5.2 Hz, 3H (1 
diastereomer)), 1.21 (d, J = 5.2 Hz, 3H (1 diastereomer)), 1.19 (t, J = 7.1 Hz, 3H (1 
diastereomer)), 1.17 (t, J = 7.1 Hz, 3H (1 diastereomer)), 1.148 (d, J = 6.6 Hz, 3H (1 
diastereomer)),  1.145  (d,  J  =  6.6  Hz,  3H  (1  diastereomer)),  0.909  (s,  9H  (1 
diastereomer)), 0.907 (s, 9H (1 diastereomer)), 0.89 (s, 9H (2 diastereomers)), 0.06-0.08 
(m, 12H (2 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 141.2, 141.0, 133.5, 
133.3, 129.2, 129.1, 128.04, 128.0, 99.9, 97.9, 78.6, 78.5, 76.0, 75.9, 72.9, 71.1, 65.0, 
63.26, 63.20, 60.7, 60.6, 41.8, 41.7, 41.5, 40.7, 33.2, 33.0, 27.3, 27.2, 26.0, 25.9, 25.86, 
25.83, 20.7, 20.6, 19.8, 19.7, 18.4, 18.1, 15.4, 15.3, -4.20, -4.22, -4.6, -4.7, -5.3 ppm; 
HRMS (ES+) calcd. for C34H64O7SSi2Na (M+Na) 695.3809, found 695.3818. 
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  Alcohol 5.49: To a stirred solution of bis-TBS ether 5.29 (574 mg, 0.852 mmol) 
in THF (8.0 mL) at 0 ºC was added a stock solution of HF•Pyr.
1 (4.8 mL) over 30 min. 
After 24 h, the reaction quenched with sat. aq. NaHCO3 (50 mL) and the aqueous layer 
was extracted with EtOAc / Et2O (2:1, 3 X 100 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
    
20-60% EtOAc / hexanes, to give alcohol 5.49 (380 mg, 0.679 mmol, 80%) as colorless 
oil. [α]D
23 = -30.2 (c = 1.01, C6H6); IR: (neat) 3468, 2957, 2930, 2857, 1462, 1447, 1377, 
1306, 1253, 1145, 1086, 1056, 836, 777, 689 cm
-1; 
1H NMR {700 MHz, CDCl3 (two 
diastereomers)}  δ  7.93-7.95  (m,  2H  (2  diastereomers)),  7.64-7.67  (m,  1H  (2 
diastereomers)),  7.56-7.59  (m,  2H  (2  diastereomers)),  4.67  (q,  J  =  5.2  Hz,  1H  (1 
diastereomer)),  4.63  (q,  J  =  5.2  Hz,  1H  (1  diastereomer)),  4.06-4.10  (m,  1H  (2 
diastereomers)),  3.94-4.01  (m,  1H  (2  diastereomers)),  3.80-3.83  (m,  1H  (1 
diastereomer)), 3.65-3.71 (m, 3H (1H of 1 diastereomer and 2H of 2 diastereomers)), 
3.56-3.61 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 3.52 (ddd, J = 14.0, 
9.2, 7.0 Hz, 1H (1 diastereomer)), 3.46 (ddd, J = 14.0, 9.2, 7.0 Hz, 1H (1 diastereomer)), 
3.42 (ddd, J = 14.0, 9.2, 7.0 Hz, 1H (1 diastereomer)), 3.22 (dd, J = 14.2, 5.0 Hz, 1H (1 
diastereomer)), 3.16 (dd, J = 14.2, 4.6 Hz, 1H (1 diastereomer)), 2.95-2.99 (m, 1H (2 
diastereomers)),  2,45-2.47  (m,  1H  (2  diastereomers)),  2.32-2.38  (m,  1H  (1 
diastereomer)), 2.21-2.28 (m, 1H (1 diastereomer)), 2.01-2.06 (m, 1H (2 diastereomers)), 
1.88-1.97 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 1.72-1.79 (m, 2H 
(1H of 1 diastereomer and 1H of 2 diastereomers)), 1.61-1.69 (m, 1H (2 diastereomers)), 
1.49-1.57 (m, 1H (2 diastereomers)), 1.42-1.48 (m, 2H (2 diastereomers)), 1.24 (d, J = 
5.2 Hz, 3H (1 diastereomer)), 1.23 (d, J = 5.2 Hz, 3H (1 diastereomer)), 1.19 (t, J = 7.0 
Hz, 3H (1 diastereomer)), 1.17 (t, J = 7.0 Hz, 3H (1 diastereomer)), 1.13 (d, J = 6.6 Hz, 
3H  (1  diastereomer)),  1.12  (d,  J  =  6.7  Hz,  3H  (1  diastereomer)),  0.92  (s,  9H  (2 
diastereomers)),  0.112-0.117  (m,  6H  (2  diastereomers))  ppm; 
13C  NMR  (176  MHz, 
CDCl3) δ 140.1, 140.0, 133.5, 133.4, 129.2, 129.1, 128.0, 127.9, 99.9, 97.7, 80.4, 80.3, 
    
76.3, 76.2, 74.47, 74.42, 72.8, 70.7, 64.6, 63.13, 63.10, 60.5, 60.3, 41.7, 41.5, 40.6, 32.9, 
32.7, 27.5, 25.88, 25.81, 25.78, 20.59, 20.50, 20.0, 19.7, 18.1, 15.4, 15.3, -4.5, -4.6 ppm; 
HRMS (ES+) calcd. for C28H50O7SSiNa (M+Na) 581.2944, found 581.2930. 
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Diene 5.31: To a stirred solution of oxalyl chloride (103 mg, 72 µL, 0.814 mmol) 
in CH2Cl2 (4.2 mL) at -78 ºC was cannulated a solution of DMSO (133 mg, 0.12 mL, 
1.70 mmol) in CH2Cl2 (1.2 mL). After 15 min, a solution of alcohol 5.49 (380 mg, 0.679 
mmol) in CH2Cl2 (2.0 mL and 2 X 0.5 mL wash) was cannulated to it. After 45 min, Et3N 
(346 mg, 0.48 mL, 3.39 mmol) was added. After 10 min, the cooling bath was removed 
and the reaction was quenched with H2O (20 mL).  The aqueous layer was extracted with 
CH2Cl2 (3 X 50 mL) and the dried (MgSO4) extract was concentrated in vacuo and was 
quickly passed through a short plug of silica gel to give crude aldehyde 5.30. 
To a stirred solution of tributyl phosphonium salt 5.4 (341 mg, 0.970 mmol) in 
THF (7.6 mL) at -45 ºC was added n-BuLi (0.40 mL, 1.00 mmol, 2.5 M in hexane) and 
    
was warmed to rt over 45 min. After 2 h, the reaction was cooled back down to -78 ºC 
and a solution of crude aldehyde 5.30 in THF (7.6 mL) was cannulated to it. The reaction 
was slowly warmed to rt over 2.5 h. After another 3 h, the reaction was quenched with 
H2O (15 drops) and the solvent was removed in vacuo. The residue was purified by flash 
chromatography over silica gel, eluting with 10-30% EtOAc / hexanes, to give diene 5.31 
{401 mg, 0.658 mmol, 97% (11:1 E:Z; inseparable mixture)} as colorless oil. [α]D
23 = 
+12.7 (c = 1.02, C6H6); IR: (neat) 2956, 2928, 2856, 1446, 1378, 1308, 1253, 1148, 1086, 
959, 836, 776, 689 cm
-1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 7.93-796 
(m, 2H (2 diastereomers)), 7.64-7.67 (m, 1H (2 diastereomers)), 7.56-7.59 (m, 2H (2 
diastereomers)), 6.43-6.47 (m, 1H (2 diastereomers of E isomer)), 6.21 (t, J = 11.2 Hz, 
1H  of  Z  isomer),  6.06-6.09  (m,  1H  of  Z  isomer)),  5.83  (d,  J  =  11.0  Hz,  1H  (2 
diastereomers of E isomer)), 5.53 (ddd, J = 14.1, 5.7, 3.1 Hz, 1H (2 diastereomers of E 
isomer)), 5.29 (q, J = 10.1 Hz, 1H of Z isomer), 4.67 (q, J = 5.2 Hz, 1H (1 diastereomer)), 
4.63 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.46 (dd, J = 9.0, 5.2 Hz, 1H of Z isomer), 4.16 
(t, J = 5.6 Hz, 1H (2 diastereomers)), 3.86-3.94 (m, 2H (2 diastereomers)), 3.79-3.83 (m, 
1H (1 diastereomer)), 3.67-3.71 (m, 1H (1 diastereomer)), 3.60 (ddd, J = 14.1, 9.2, 7.0 
Hz, 1H (1 diastereomer)), 3.53 (ddd, J = 14.1, 9.2, 7.0 Hz, 1H (1 diastereomer)), 3.41-
3.47 (m, 1H (2 diastereomers)), 3.25 (dd, J = 14.2, 4.7 Hz, 1H (1 diastereomer)), 3.18 
(dd, J = 14.2, 4.4 Hz, 1H (1 diastereomer)), 2.95-2.99 (m, 1H (2 diastereomers)), 2.32-
2.37 (m, 1H (1 diastereomer)), 2.21-2.26 (m, 1H (1 diastereomer)), 1.92-1.98 (m, 1H (2 
diastereomers)), 1.84-1.91 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 
1.79 (s, 3H (2 diastereomers)), 1.77 (s, 3H (2 diastereomers)), 1.67-1.75 (m, 2H (1H of 1 
    
diastereomer and 1H of 2 diastereomers)), 1.57-1.66 (m, 1H (2 diastereomers)), 1.39-1.54 
(m, 3H (2 diastereomers)), 1.24 (d, J = 5.2 Hz, 3H (1 diastereomer)), 1.22 (d, J = 5.2 Hz, 
3H (1 diastereomer)), 1.19 (t, J = 7.0 Hz, 3H (1 diastereomer)), 1.18 (t, J = 7.0 Hz, 3H (1 
diastereomer)), 1.154 (d, J = 6.6 Hz, 3H (1 diastereomer)), 1.152 (d, J = 6.6 Hz, 3H (1 
diastereomer)), 0.921 (s, 9H (1 diastereomer)), 0.920 (s, 9H (1 diastereomer)) ppm, 0.05-
0.08  (m,  6H  (2  diastereomers))  ppm; 
13C  NMR  (176  MHz,  CDCl3)  δ  140.2,  140.0, 
135.04, 135.02, 133.5, 133.3, 129.97, 129.95, 129.2, 129.1, 128.0, 127.9, 127.45, 127.43, 
124.7, 99.9, 98.0, 82.1, 82.0, 76.0, 75.7, 75.6, 72.8, 71.1, 63.19, 63.12, 60.6, 60.5, 41.8, 
41.7, 41.6, 40.7, 32.9, 32.7, 27.24, 27.21, 25.9, 25.8, 20.7, 20.5, 20.0, 19.7, 18.2, 15.4, 
15.3, -4.4, -4.6 ppm; HRMS (ES+) calcd. for C33H56O6SSiNa (M+Na) 631.3465, found 
631.3459. 
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Dienyl Sulfone 5.32: To a stirred solution of TBS ether 5.31 (401 mg, 0.658 
mmol) in THF (6.7 mL) at rt was added TBAF (2.0 mL, 2.00 mmol, 1 M in THF). After 
    
12 h, the reaction quenched with H2O (25 mL) and the aqueous layer was extracted with 
EtOAc / Et2O (1:1, 3 X 50 mL). The dried (MgSO4) extract was concentrated in vacuo to 
give crude alcohol 5.50. 
To a stirred solution of crude alcohol 5.50 in CH2Cl2 (8.7 mL) at 0 ºC were 
sequentially added Et3N (523 mg, 0.73 mL, 5.17 mmol), DMAP (39.1 mg, 0.323 mmol) 
and TESCl (341 mg, 0.38 mL, 2.26 mmol). The reaction was slowly warmed to rt over 2 
h. After another 3 h, the reaction was quenched with sat. aq. NH4Cl (25 mL) and the 
aqueous layer was extracted with Et2O (3 X 50 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
10-30% EtOAc / hexanes, to give dienyl sulfone 5.32 (379 mg, 0.622 mmol, 95%) as 
colorless oil. [α]D
23 = +18.0 (c = 1.00, C6H6); IR: (neat) 2957, 2913, 2876, 1446, 1377, 
1308, 1148, 1086, 1018, 959, 841, 741, 689 cm
-1; 
1H NMR {700 MHz, CDCl3 (two 
diastereomers)}  δ  7.93-796  (m,  2H  (2  diastereomers)),  7.64-7.67  (m,  1H  (2 
diastereomers)), 7.56-7.59 (m, 2H (2 diastereomers)), 6.42-6.46 (m, 1H (2 diastereomers 
of E isomer)), 6.21 (t, J = 11.3 Hz, 1H of Z isomer), 6.07-6.09 (m, 1H of Z isomer)), 5.82 
(d, J = 11.0 Hz, 1H (2 diastereomers of E isomer)), 5.52 (ddd, J = 15.0, 6.1, 3.0 Hz, 1H 
(2 diastereomers of E isomer)), 5.29 (q, J = 10.2 Hz, 1H of Z isomer), 4.66 (q, J = 5.2 Hz, 
1H (1 diastereomer)), 4.63 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.46-4.48 (m, 1H of Z 
isomer), 4.15 (t, J = 5.6 Hz, 1H (2 diastereomers)), 3.86-3.94 (m, 2H (2 diastereomers)), 
3.78-3.82 (m, 1H (1 diastereomer)), 3.67-3.70 (m, 1H (1 diastereomer)), 3.60 (ddd, J = 
14.1,  9.2,  7.0  Hz,  1H  (1  diastereomer)),  3.53  (ddd,  J  =  14.1,  9.2,  7.0  Hz,  1H  (1 
diastereomer)), 3.41-3.47 (m, 1H (2 diastereomers)), 3.25 (dd, J = 14.2, 4.7 Hz, 1H (1 
    
diastereomer)), 3.17 (dd, J = 14.2, 4.4 Hz, 1H (1 diastereomer)), 2.94-2.98 (m, 1H (2 
diastereomers)), 2.31-2.36 (m, 1H (1 diastereomer)), 2.20-2.26 (m, 1H (1 diastereomer)), 
1.92-1.98 (m, 1H (2 diastereomers)), 1.84-1.91 (m, 2H (1H of 1 diastereomer and 1H of 2 
diastereomers)), 1.79 (s, 3H (2 diastereomers)), 1.77 (s, 3H (2 diastereomers)), 1.68-1.75 
(m,  2H  (1H  of  1  diastereomer  and  1H  of  2  diastereomers)),  1.57-1.65  (m,  1H  (2 
diastereomers)),  1.38-1.53  (m,  3H  (2  diastereomers)),  1.24  (d,  J  =  5.2  Hz,  3H  (1 
diastereomer)), 1.22 (d, J = 5.2 Hz, 3H (1 diastereomer)), 1.19 (t, J = 7.0 Hz, 3H (1 
diastereomer)), 1.17 (t, J = 7.0 Hz, 3H (1 diastereomer)), 1.148 (d, J = 6.6 Hz, 3H (1 
diastereomer)), 1.147 (d, J = 6.6 Hz, 3H (1 diastereomer)), 0.96 (t, J = 8.0 Hz, 9H (2 
diastereomers)), 0.61 (q, J = 7.9 Hz, 6H (2 diastereomers)) ppm; 
13C NMR (176 MHz, 
CDCl3) δ 140.2, 140.0, 135.13, 135.11, 133.5, 133.3, 129.96, 129.95, 129.2, 129.1, 128.0, 
127.9, 127.54, 127.53, 124.6, 99.8, 98.0, 82.1, 82.0, 76.0, 75.68, 75.63, 72.8, 71.1, 63.17, 
63.10, 60.6, 60.5, 41.9, 41.7, 41.6, 40.7, 32.9, 32.7, 27.32, 27.30, 25.9, 25.8, 20.6, 20.5, 
19.9,  19.7,  18.2,  15.4,  15.3,  6.8,  5.0  ppm;  HRMS  (ES+)  calcd.  for  C33H56O6SSiNa 
(M+Na) 631.3465, found 631.3466. 
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Coupled  Sulfone  5.33:  To  a  stirred  solution  of  sulfone  5.32  (325  mg,  0.533 
mmol) in THF (2.2 mL) at -60 ºC was added LHMDS (0.54 mL, 0.540 mmol, 1 M in 
THF) and warmed to -10 ºC over 1 h. HMPA (515 mg, 0.50 mL, 2.87 mmol) was added 
and the reaction was warmed to 0 ºC over 15 min. The reaction was cooled back down to 
-10 ºC and a solution of iodide 4.1 (188 mg, 0.213 mmol) in THF (2.0 mL and 2 X 0.35 
mL wash) was cannulated to it and warmed to 0 ºC. After 1.5 h, the cooling bath was 
removed. After another 1 h, the reaction was quenched with sat. aq. NH4Cl (20 mL) and 
the aqueous layer was extracted with Et2O (3 X 30 mL). The dried (MgSO4) extract was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
5-20% EtOAc / hexanes, to give diastereomeric coupled sulfone 5.33 (215 mg, 0.157 
mmol, 74%) as colorless oil along with recovered sulfone 5.32 (191 mg, 0.313 mmol). 
Coupled sulfone 5.33: [α]D
23 = -10.0 (c = 1.00, C6H6); IR (neat): 2956, 2935, 2886, 2862, 
1730, 1467, 1382, 1304, 1252, 1148, 1081, 1007, 835, 776 cm
-1 ; 
1H NMR {700 MHz, 
CDCl3 (four diastereomers)} δ 7.89-7.94 (m, 2H (4 diastereomers)), 7.60-7.65 (m, 1H (4 
diastereomers)),  7.52-7.57  (m,  2H  (4  diastereomers)),  6.43-6.48  (m,  1H  (4 
diastereomers)), 5.79 (m, 2H (1H of 2 diastereomers and 1H of 4 diastereomers)), 5.69 (s, 
    
1H (1 diastereomer)), 5.68 (s, 1H (1 diastereomer)), 5.52 (dt, J = 15.1, 6.4 Hz, 1H (4 
diastereomers)), 5.30-5.33 (m, 1H (4 diastereomers)), 5.05 (s, 1H (1 diastereomer)), 5.01 
(s, 1H (1 diastereomer)), 4.88 (s, 1H (1 diastereomer)), 4.86 (s, 1H (2 diastereomers)), 
4.66 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.61 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.59 
(q, J = 5.1 Hz, 1H (1 diastereomer)), 4.49 (q, J = 5.1 Hz, 1H (1 diastereomer)), 4.36-4.39 
(m, 1H (2 diastereomers)), 4.25-4.29 (m, 1H (4 diastereomers)), 4.07-4.16 (m, 4H (1H of 
2 diastereomers and 3H of 4 diastereomers)), 3.96-4.00 (m, 1H (2 diastereomers)), 8.84-
3.94 (m, 3H (1H of 2 diastereomers and 2H of 4 diastereomers)), 3.71-3.76 (m, 1H (1 
diastereomer)),  3.65-3.69  (m,  1H  (1  diastereomer)),  3.52-3.62  (m,  2H  (1H  of  2 
diastereomers + 2H of 4 diastereomers)), 3.43-3.48 (m, 1H (2 diastereomers)), 3.36-3.42 
(m,  2H  (1H  of  2  diastereomers  and  1H  of  4  diastereomers)),  3.27-3.35  (m,  1H  of  2 
diastereomers)),  3.10-3.21  (m,  1H  (2  diastereomers)),  2.40-2.44  (m,  1H  (2 
diastereomers)),  2.31-2.34  (m,  1H  (2  diastereomers)),  2.14-2.30  (m,  1H  (4 
diastereomers)),  2.00-2.12  (m,  2H  (4  diastereomers)),  1.76-1.99  (m,  6H  (4 
diastereomers)), 1.90 (s, 3H (2 diastereomers)), 1.88 (s, 3H (2 diastereomers)), 1.79 (s, 
3H (4 diastereomers)), 1.777 (s, 3H (2 diastereomers)), 1.771 (s, 3H (2 diastereomers)), 
1.62-1.71 (m, 3H (4 diastereomers)), 1.36-1.46 (m, 2H (4 diastereomers)), 1.26-1.33 (m, 
4H  (4  diastereomers)),  1.19-1.23  (m,  13H  (4  diastereomers)),  1.13-1.18  (m,  4H  (4 
diastereomers)), 1.06-1.10 (m, 3H (4 diastereomers)), 0.98-1.01 (m, 3H), 0.95-0.98 (m, 
9H  (4  diastereomers)),  0.85-0.93  (m,  27H  (4  diastereomers)),  0.59-0.63  (m,  6H  (4 
diastereomers)), 0.03-0.18 (m, 18H (4 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) 
δ 178.4, 145.56, 145.50, 145.4, 140.5, 140.2, 140.1, 139.8, 139.6, 139.0, 138.8, 135.1, 
    
135.0, 133.3, 133.2, 133.1, 129.99, 129.97, 129.92, 129.91, 129.2, 129.1, 129.09, 129.06, 
128.98, 128.94, 128.3, 125.8, 125.7, 124.79, 124.74, 124.6, 115.33, 115.30, 114.6, 114.5, 
100.0, 99.5, 97.8, 97.7, 82.2, 82.19, 82.11, 80.54, 80.50, 80.3, 79.6, 79.53, 79.51, 79.2, 
78.8, 78.7, 78.6, 76.28, 76.23, 76.18, 76.10, 75.8, 75.79, 75.75, 75.6, 72.4, 72.3, 72.0, 
71.4, 71.1, 70.8, 70.6, 66.3, 65.6, 65.5, 62.15, 62.10, 61.1, 60.78, 60.75, 48.5, 48.4, 47.3, 
47.0, 42.4, 42.1, 41.7, 41.4, 40.35, 40.32, 39.6, 39.2, 38.6, 38.1, 38.0, 35.8, 35.2, 33.1, 
33.0, 32.8, 32.68, 32.63, 31.9, 29.7, 29.4, 29.3, 29.2, 28.8, 28.78, 28.71, 28.6, 27.6, 27.59, 
27.54, 27.4, 27.2, 26.1, 26.0, 25.97, 25.91, 20.9, 20.7, 20.6, 20.5, 18.4, 18.3, 18.2, 18.1, 
18.0, 17.9, 17.5, 17.2, 16.0, 15.9, 15.5, 15.4, 15.2, 11.7, 11.3, 6.93, 6.91, 4.9, -3.8, -4.15, -
4.18, -4.2, -4.3, -4.4, -4.5, -4.6, -4.7 ppm; HRMS (ES+) calcd. for C74H136O12SSi4Na 
(M+Na) 1383.8727, found 1383.8776. 
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Ketone 5.34 and Alcohol 5.35: To a stirred solution of sulfone 5.33 (173.4 mg, 
0.127 mmol) in THF (2.2 mL) at -50 ºC was added LDA
4 (0.32 mL, 0.320 mmol, 1 M in 
THF / hexanes). After 5 min, DMPU (1.27 g, 1.2 mL, 9.88 mmol) was added and was 
slowly warmed to -25 ºC over 20 min. The reaction was cooled back down to -50 ºC and 
    
a solution of Davis’ oxaziridine
5 (91.4 mg, 0.350 mmol) in THF (1.0 mL) was cannulated 
to it. The reaction was warmed to -35 ºC over 20 min and then quenched with sat. aq. 
NH4Cl (20 mL) and the aqueous layer was extracted with Et2O (3 X 50 mL). The dried 
(MgSO4) extract was concentrated in vacuo and purified by flash chromatography over 
silica gel, eluting with 6-20% EtOAc / hexanes, to give the ketone 5.34 (66.0 mg, 53.4 
µmol, 42%) and keto-ol 5.35 (33.6 mg, 29.2 µmol, 23%) as colorless oil along with the 
recovered sulfone 5.33 (49.9 mg, 36.6 µmol, 29%). Ketone 5.34: [α]D
23 = +30.0 (c = 1.03, 
C6H6); IR (neat): 2956, 2932, 2859, 1731, 1719, 1461, 1377, 1251, 1078, 835, 776 cm
-1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 6.43-6.48 (m, 1H (2 diastereomers)), 
5.83 (d, J = 11.0 Hz, 1H (2 diastereomers)), 5.59 (s, 1H (2 diastereomers)), 5.53 (ddd, J = 
15.1, 6.0, 3.2 Hz, 1H (2 diastereomers)), 5.32 (s, 1H (2 diastereomers)), 4.96 (s, 1H (2 
diastereomers)),  4.65-4.68  (m,  1H  (2  diastereomers)),  4.35-4.37  (m,  1H  (2 
diastereomers)),  4.24-4.28  (m,  1H  (2  diastereomers)),  4.10-4.16  (m,  2H  (2 
diastereomers)),  4.08  (s,  1H  (2  diastereomers)),  3.89-3.97  (m,  3H  (2  diastereomers)), 
3.74-3.78 (m, 1H (1 diastereomer)), 3.57-3.67 (m, 2H (1H of 1 diastereomer and 1H of 2 
diastereomers)), 3.45-3.53 (m, 2H (2 diastereomers)), 3.33 (dt, J = 9.2, 2.7 Hz, 1H (2 
diastereomers)), 2.77 (qd, J = 7.4, 4.3 Hz , 1H (1 diastereomer)), 2.57-2.66 (m, 2H (1H of 
1  diastereomer  and  1H  of  2  diastereomers)),  2.54  (dd,  J  =  5.6,  3.5  Hz,  1H  (1 
diastereomer)), 2.51 (dd, J = 5.6, 3.5 Hz, 1H (1 diastereomer)), 2.36-2.41 (m, 1H (2 
diastereomers)),  2.03-2.07  (m,  1H  (2  diastereomers)),  1.94-2.01  (m,  2H  (2 
diastereomers)), 1.80-1.91 (m, 3H (2 diastereomers)), 1.81 (s, 3H (2 diastereomers)), 1.79 
(s,  3H  (2  diastereomers)),  1.77  (s,  3H  (2  diastereomers)),  1.63-1.71  (m,  2H  (2 
    
diastereomers)),  1.48-1.52  (m,  1H  (2  diastereomers)),  1.37-1.46  (m,  2H  (2 
diastereomers)),  1.26-1.30  (m,  4H  (2  diastereomers)),  1.19-1.22  (m,  12H  (2 
diastereomers)), 1.08 (d, J = 7.0 Hz, 3H (2 diastereomers)), 1.05 (d, J = 6.9 Hz, 3H (1 
diastereomer)), 1.04 (d, J = 6.9 Hz, 3H (1 diastereomer)), 0.98 (d, J = 6.4 Hz, 3H (2 
diastereomers)),  0.97  (t,  J  =  7.9  Hz,  3H  (2  diastereomers)),  0.907  (s,  9H  (2 
diastereomers)), 0.905 (s, 9H (1 diastereomer)), 0.904 (s, 9H (1 diastereomer)), 0.892 (s, 
9H  (1  diastereomer)),  0.890  (s,  9H  (1  diastereomer)),  0.61  (q,  J  =  7.9  Hz,  6H  (2 
diastereomers)), 0.113 (s, 3H (1 diastereomer)), 0.111 (s, 3H (1 diastereomer)), 0.08 (s, 
3H (2 diastereomers)), 0.06 (s, 3H (2 diastereomers)), 0.04 (s, 3H (1 diastereomer)), 0.03 
(s, 3H (1 diastereomer)), 0.02 (s, 3H (2 diastereomers)), 0.007 (s, 3H (1 diastereomer)), 
0.004 (s, 3H (1 diastereomer)) ppm; 
13C NMR (176 MHz, CDCl3) δ 213.1, 212.7, 178.4, 
145.1,  140.93,  140.91,  135.16,  135.13,  129.87,  129.83,  127.4,  125.4,  124.6,  115.04, 
115.00, 99.8, 98.8, 98.4, 82.19, 82.14, 80.45, 80.43, 79.4, 78.8, 78.5, 76.1, 76.0, 75.6, 
72.5, 71.3, 70.47, 70.40, 62.1, 61.3, 61.1, 47.9, 47.8, 45.5, 45.4, 43.0, 42.8, 41.8, 41.2, 
40.3, 38.6, 38.0, 37.0, 36.9, 33.1, 32.9, 32.7, 29.7, 27.4, 27.2, 26.1, 26.0, 25.97, 25.90, 
20.8, 20.7, 18.4, 18.36, 18.30, 17.9, 17.1, 17.0, 16.1, 16.0, 15.7, 15.4, 15.3, 14.1, 14.0, 
6.9,  4.9,  -4.23,  -4.26,  -4.44,  -4.46,  -4.7,  4.8  ppm;  HRMS  (ES+)  calcd.  for 
C68H130O11Si4Na (M+Na) 1257.8588, found 1257.8564. 
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Aldehyde 5.36: To a stirred solution of pivaloyl ester 5.34 (46.2 mg, 37.3 µmol) 
in Et2O (2.7 mL) at -20 ºC was added LiAlH4 (3.6 mg, 93.4 µmol) in one portion. After 
25  min,  the  reaction  was  quenched  with  H2O  (10  drops)  and  the  organic  layer  was 
decanted. The solid formed was washed with Et2O (3 X 20 mL). The dried (MgSO4) 
extract was concentrated in vacuo to give crude diol 5.51. 
To a stirred solution of oxalyl chloride (23.7 mg, 16.5 µL, 0.187 mmol) in CH2Cl2 
(1.0 mL) at -78 ºC was cannulated a solution of DMSO (29.2 mg, 27 µL, 0.374 mmol) in 
CH2Cl2 (0.50 mL). After 20 min, a solution of crude diol 5.51 in CH2Cl2 (1.2 mL and 2 X 
0.25 mL wash) was cannulated to it. After 45 min, Et3N (37.8 mg, 53 µL, 0.374 mmol) 
was added. After 10 min, the reaction was quenched with H2O (10 mL) and the aqueous 
layer  was  extracted  with  CH2Cl2  (3  X  20  mL).  The  dried  (MgSO4)  extract  was 
concentrated in vacuo and purified by flash chromatography over silica gel, eluting with 
5-15% EtOAc / hexanes, to give aldehyde 5.36 (35.6 mg, 30.9 µmol, 83%) as colorless 
    
oil. [α]D
23 = +14.9 (c = 0.35, C6H6); IR: (neat) 2959, 2927, 2857, 1732, 1710, 1662, 1635, 
1465, 1380, 1078, 835, 781 cm
-1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 
9.82 (dd, J = 2.9, 2.3 Hz, 1H (2 diastereomers)), 6.44-6.48 (m, 1H (2 diastereomers)), 
5.83 (d, J = 11.0 Hz, 1H (2 diastereomers)), 5.60 (s, 1H (2 diastereomers)), 5.53 (ddd, J = 
15.1, 6.0, 3.2 Hz, 1H (2 diastereomers)), 5.32 (t, J = 1.7 Hz, 1H (2 diastereomers)), 4.97 
(s, 1H (2 diastereomers)), 4.68 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.66 (q, J = 5.2 Hz, 
1H (1 diastereomer)), 4.37-4.39 (m, 1H (2 diastereomers)), 4.16 (t, J = 5.9 Hz, 1H (2 
diastereomers)),  4.08  (s,  1H  (2  diastereomers)),  3.99-4.02  (m,  1H  (2  diastereomers)), 
3.89-3.97 (m, 1H (2 diastereomers)), 3.75-3.78 (m, 1H (1 diastereomer)), 3.73 (td, J = 3.5 
Hz,  1H  (2  diastereomers)),  3.58-3.67  (m,  2H  (1H  of  1  diastereomer  and  1H  of  2 
diastereomers)), 3.54 (dt, J = 7.1, 2.5 Hz, 1H (2 diastereomers)), 3.45-3.52 (m, 1H (2 
diastereomers)),  2.76-2.81  (m,  1H  (1  diastereomer)),  2.59-2.68  (m,  2H  (1H  of  1 
diastereomer  and  1H  of  2  diastereomers)),  2.57  (dd,  J  =  3.4,  2.3  Hz,  1H  (1 
diastereomer)), 2.55 (dd, J = 3.4, 2.3 Hz, 1H (1 diastereomer)), 2.47-2.52 (m, 2H (2 
diastereomers)),  2.38-2.42  (m,  1H  (2  diastereomers)),  2.06-2.10  (m,  1H  (2 
diastereomers)), 1.95-2.01 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 
1.84-1.90 (m, 3H (1H of 1 diastereomer and 2H of 2 diastereomers)), 1.83 (s, 3H (2 
diastereomers)), 1.79 (s, 3H (2 diastereomers)), 1.77 (s, 3H (2 diastereomers)), 1.65-1.72 
(m, 1H (2 diastereomers)), 1.48-1.53 (m, 1H (2 diastereomers)), 1.38-1.46 (m, 2H (2 
diastereomers)), 1.296 (d, J = 5.2 Hz, 3H (1 diastereomer)), 1.291 (d, J = 5.2 Hz, 3H (1 
diastereomer)), 1.22 (t, J = 7.0 Hz, 3H (1 diastereomer)), 1.21 (t, J = 7.0 Hz, 3H (1 
diastereomer)), 1.09 (d, J = 7.0 Hz, 3H (2 diastereomers)), 1.06 (d, J = 6.9 Hz, 3H (1 
    
diastereomer)), 1.05 (d, J = 6.9 Hz, 3H (1 diastereomer)), 1.02 (d, J = 6.5 Hz, 3H (2 
diastereomers)),  0.97  (t,  J  =  7.9  Hz,  3H  (2  diastereomers)),  0.913  (s,  9H  (1 
diastereomer)), 0.912 (s, 9H (1 diastereomer)), 0.897 (s, 9H (2 diastereomers)), 0.896 (s, 
9H  (2  diastereomers)),  0.62  (q,  J  =  7.9  Hz,  6H  (2  diastereomers)),  0.12  (s,  3H  (1 
diastereomer)), 0.11 (s, 3H (1 diastereomer)), 0.08 (s, 3H (2 diastereomers)), 0.04 (s, 6H 
(2 diastereomers)), 0.028 (s, 3H (2 diastereomers)), 0.025 (s, 3H (2 diastereomers)), 0.01 
(s,  3H  (1  diastereomer)),  0.007  (s,  3H  (1  diastereomer))  ppm; 
13C  NMR  (176  MHz, 
CDCl3) δ 213.0, 212.6, 202.1, 145.0, 141.1, 141.0, 135.1, 135.0, 129.9, 129.8, 127.5, 
127.4, 125.2, 124.6, 115.1, 115.0, 99.8, 98.4, 82.2, 82.1, 79.9, 79.8, 79.3, 78.66, 78.60, 
76.1, 76.0, 75.6, 72.6, 71.3, 70.4, 70.3, 61.3, 61.1, 48.0, 47.9, 47.6, 45.4, 45.3, 43.1, 42.8, 
41.8, 41.2, 40.6, 37.5, 37.1, 36.9, 32.9, 32.7, 29.7, 27.4, 26.1, 26.0, 25.95, 25.91, 25.89, 
20.8, 20.7, 18.4, 18.3, 18.2, 17.9, 17.26, 17.24, 16.1, 15.7, 15.6, 15.4, 15.3, 14.0, 13.9, 
6.9, 4.9, -4.1, -4.2, -4.45, -4.46, -4.7, -4.8 ppm; HRMS (ES+) calcd. for C63H120O10Si4Na 
(M+Na) 1171.7856, found 1171.7769. 
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Aldehyde 5.36: To a stirred solution of oxalyl chloride (10.4 mg, 7.2 µL, 82.4 
µmol) in CH2Cl2 (0.50 mL) at -78 ºC was cannulated a solution of DMSO (12.9 mg, 11.8 
µL, 0.165 mmol) in CH2Cl2 (0.25 mL). After 15 min, a solution of alcohol 5.35 (19.0 mg, 
16.5 µmol) in CH2Cl2 (0.50 mL and 2 X 0.10 mL wash) was cannulated to it. After 45 
min, Et3N (16.7 mg, 24 µL, 0.165 mmol) was added. After 10 min, the reaction was 
quenched with H2O (5 mL) and the aqueous layer was extracted with CH2Cl2 (3 X 15 
mL).  The  dried  (MgSO4)  extract  was  concentrated  in  vacuo  and  purified  by  flash 
chromatography over silica gel, eluting with 5-15% EtOAc / hexanes, to give aldehyde 
5.36 (15.8 mg, 13.7 µmol, 83%) as colorless oil. 
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Carboxylic Acid 5.37: To a stirred solution of aldehyde 5.36 (35.6 mg, 30.9 
µmol) in t-BuOH / H2O (1:1, 3.0 mL) at 0 ºC were sequentially added 2-methyl-2-butene 
(108 mg, 0.16 mL, 1.54 mmol), NaH2PO4•H2O (42.7 mg, 0.309 mmol) and NaClO2 (14.1 
mg, 0.154 mmol). After 15 min, the reaction was warmed to rt. After another 1.5 h, the 
reaction was diluted with H2O (7.5 mL) and the aqueous layer was extracted with EtOAc 
/ Et2O (1:1, 3 X 20 mL). The dried (MgSO4) extract was concentrated in vacuo and 
purified by flash chromatography over silica gel, eluting with 10-30 % EtOAc / hexanes, 
to give carboxylic acid 5.37 (30.7 mg, 26.3 µmol, 85%) as light yellow oil. [α]D
23 = +23.4 
(c = 0.87, C6H6); IR (neat): 3385, 2959, 2930, 2886, 2862, 1713, 1465, 1382, 1252, 1084, 
1005, 835, 776 cm
-1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 10.00 (bs, 1H 
(2 diastereomers)), 6.43-6.48 (m, 1H (2 diastereomers)), 5.83 (d, J = 10.9 Hz, 1H (2 
diastereomers)), 5.60 (s, 1H (1 diastereomer)), 5.59 (s, 1H (1 diastereomer)), 5.53 (ddd, J 
= 15.1, 6.0, 2.8 Hz, 1H (2 diastereomers)), 5.36 (t, J = 1.8 Hz, 1H (1 diastereomer)), 5.35 
(t, J = 1.7 Hz, 1H (1 diastereomer)), 5.00 (s, 1H (2 diastereomers)), 4.68 (q, J = 5.2 Hz, 
1H (1 diastereomer)), 4.66 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.41-4.44 (m, 1H (1 
diastereomer)),  4.36-4.38  (m,  1H  (1  diastereomer)),  4.17  (t,  J  =  5.4  Hz,  1H  (1 
diastereomer)),  4.16  (t,  J  =  5.3  Hz,  1H  (1  diastereomer)),  4.10-4.13  (m,  2H  (2 
    
diastereomers)),  3.89-3.98  (m,  2H  (2  diastereomers)),  3.76-3.80  (m,  1H  (1 
diastereomer)),  3.61-3.68  (m,  2H  (2  diastereomers)),  3.52-3.60  (m,  2H  (2 
diastereomers)), 3.46-3.50 (m, 1H (1 diastereomer)), 2.78-2.83 (m, 1H (1 diastereomer)), 
2.58-2.70 (m, 3H (1H of 1 diastereomer and 2H of 2 diastereomers)), 2.39-2.54 (m, 3H (2 
diastereomers)),  2.10-2.14  (m,  1H  (2  diastereomers)),  1.94-2.01  (m,  2H  (2 
diastereomers)),  1.81-1.93  (m,  3H  (2  diastereomers)),  1.83  (d,  J  =  1.0  Hz,  3H  (1 
diastereomer)), 1.82 (d, J = 1.0 Hz, 3H (1 diastereomer)), 1.79 (s, 3H (2 diastereomers)), 
1.77 (s, 3H (2 diastereomers)), 1.66-1.73 (m, 1H (2 diastereomers)), 1.48-1.53 (m, 1H (2 
diastereomers)),  1.36-1.47  (m,  2H  (2  diastereomers)),  1.27-1.34  (m,  4H  (2 
diastereomers)), 1.22 (t, J = 7.0 Hz, 3H (1 diastereomer)), 1.21 (t, J = 7.0 Hz, 3H (1 
diastereomer)), 1.104 (d, J = 7.0 Hz, 3H (1 diastereomer)), 1.102 (d, J = 7.0 Hz, 3H (1 
diastereomer)), 1.05 (d, J = 6.9 Hz, 3H (2 diastereomers)), 1.03 (d, J = 6.5 Hz, 3H (1 
diastereomer)), 1.01 (d, J = 6.5 Hz, 3H (1 diastereomer)), 0.97 (t, J = 7.9 Hz, 3H (2 
diastereomers)),  0.89-0.92  (m,  27H  (4  diastereomers)),  0.62  (q,  J  =  7.9  Hz,  6H  (2 
diastereomers)), 0.01-0.12 (m, 18H) ppm; 
13C NMR (176 MHz, CDCl3) δ 213.0, 212.6, 
172.0, 144.9, 141.5, 141.4, 135.16, 135.10, 129.88, 129.82, 127.5, 125.1, 124.8, 124.6, 
115.1, 114.7,  99.7, 98.5, 82.2, 82.1, 80.2, 80.16, 80.11, 78.9, 78.7, 78.0, 76.17, 76.12, 
75.6, 75.5, 72.5, 71.2, 70.4, 70.2, 61.7, 61.1, 47.8, 47.7, 45.4, 45.1, 43.1, 42.7, 41.8, 41.2, 
39.8, 37.9, 37.7, 37.58, 37.55, 37.1, 36.9, 32.9, 32.6, 29.7, 27.4, 26.09, 26.01, 25.9, 25.8, 
20.8, 20.7, 18.3, 18.2, 17.9, 17.2, 17.1, 16.1, 15.69, 15.65, 15.5, 15.39, 15.34, 14.1, 13.8, 
6.9,  4.9,  -3.9,  -4.40,  -4.43,  -4.47,  -4.71,  -4.74,  -4.78  ppm;  HRMS  (ES+)  calcd.  for 
C63H120O11Si4Na (M+Na) 1187.7805, found 1187.7740. 
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  Macrolactone 5.40: To a stirred solution of carboxylic acid 5.37 (30.7 
mg, 26.3 µmol) in dry MeOH (2.5 mL) at 0 ºC was added methanolic PPTS solution (50 
µL).
6 After 15 min, the reaction was warmed to rt. After another 35 min, the reaction was 
quenched with sat. aq. NaHCO3 (8 mL) and the aqueous layer was extracted with EtOAc 
(3 X 20 mL). The dried (MgSO4) extract was concentrated in vacuo to give crude seco-
acid 5.38.  
To a stirred solution of crude seco-acid 5.38 in THF (1.0 mL) at 0 ºC were added 
Et3N (4.7 mg, 6.6 µL, 46.7 µmol) followed by 2,4,6-trichlorobenzoylchloride 5.39 (7.6 
mg, 4.9 µL, 31.1 µmol). After 45 min, the reaction was diluted with toluene (1.8 mL). In 
a  separate  flask,  a  solution  of  DMAP  (5.7  mg,  46.7  µmol)  in  toluene  (7.0  mL)  was 
warmed to 70 ºC and the solution of mixed acid anhydride was added dropwise over 6 h 
to it. After another 30 min, the reaction was cooled down to rt and was directly loaded 
onto column and purified by flash chromatography over silica gel, eluting with 5-15% 
    
EtOAc / hexanes, to give macrolactone 5.40 (17.7 mg, 17.1 µmol, 65%) as colorless oil. 
[α]D
23 = +2.0 (c = 1.00, CHCl3); IR: (neat) 2959, 2930, 2859, 1745, 1708, 1465, 1384, 
1255, 1090, 837, 778 cm
-1; 
1H NMR {700 MHz, CDCl3 (Note: NMR analysis indicated 
that compound 5.40 exists as a mixture of conformational isomers)} δ 6.52-6.56 (m, 1H 
(2 diastereomers)), 6.17 (s, 1H (1 diastereomer)), 6.16 (s, 1H (1 diastereomer)), 5.78 (d, J 
= 11.0 Hz, 1H (2 diastereomers)), 5.35-5.38 (m, 1H (2 diastereomers)), 5.00 (s, 1H (1 
diastereomer)), 4.98 (s, 1H (1 diastereomer)), 4.95 (t, J = 8.3 Hz, 1H (2 diastereomers)), 
4.91 (s, 1H (1 diastereomer)), 4.70 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.67 (q, J = 5.2 
Hz, 1H (1 diastereomer)), 4.20 (s, 1H (1 diastereomer)), 4.19 (s, 1H (1 diastereomer)), 
3.96-4.05 (m, 2H (2 diastereomers)), 3.89-3.94 (m, 2H (2 diastereomers)), 3.54-3.76 (m, 
4H  (2  diastereomers)),  2.95-3.05  (m,  1H  (2  diastereomers)),  2.71-2.75  (m,  1H  (1 
diastereomer)), 2.59-2.63 (m, 1H (1 diastereomer)), 2.45-2.51 (m, 2H (2 diastereomers)), 
2.27-2.38 (m, 2H (2 diastereomers)), 2.11 (br s, 1H (2 diastereomers)), 2.04-2.07 (m, 2H 
(1H of 1 diastereomer and 1H of 2 diastereomers)), 1.91-1.99 (m, 2H (2 diastereomers)), 
1.85-1.89 (m, 1H (1 diastereomer)), 1.70-1.81 (m, 10H (2 diastereomers)), 1.49-1.60 (m, 
4H (2 diastereomers)), 1.28-1.34 (m, 5H (2 diastereomers)), 1.23 (t, J = 7.0 Hz, 3H (2 
diastereomers)),  1.08-1.13  (m,  6H  (2  diastereomers)),  1.03-1.05  (m,  3H  (2 
diastereomers)), 0.91 (s, 18H (2 diastereomers)), 0.85 (s, 9H (2 diastereomers)), 0.02-
0.11 (m, 18H (2 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 212.0, 211.6, 
170.49,  170.45,  146.4,  146.3,  140.83,  140.80,  137.6,  137.5,  131.26,  131.22,  129.0, 
125.05, 125.01, 124.2, 114.36, 114.33, 99.7, 97.8, 81.8, 80.0, 79.2, 79.1, 78.8, 78.20, 
78.17, 77.7, 77.6, 75.5, 75.2, 71.7, 71.6, 70.2, 62.2, 61.7, 56.0, 47.2, 47.1, 46.2, 42.5, 
    
41.8, 41.7, 40.78, 40.74, 39.88, 39.80, 38.79, 38.73, 34.7, 34.5, 32.7, 31.9, 30.3, 30.2, 
29.4, 29.2, 29.0, 26.5, 26.1, 25.9, 25.8, 22.7, 21.2, 21.0, 18.7, 18.58, 18.52, 17.9, 16.6, 
16.4, 16.3, 16.2, 16.0, 15.6, 15.2, 14.1, -3.9, -4.0, -4.4, -4.5, -4.6, -4.7, -4.8, -5.4, -5.5 
ppm; HRMS (ES+) calcd. for C57H104O10Si3Na (M+Na) 1055.6835, found 1055.6757. 
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Diketone 5.42: The macrolactone 5.40 (6.8 mg, 6.57 µmol) in THF / AcOH / H2O 
(0.78 mL, 4:4:1) was stirred at rt. After 20 h, the reaction was quenched with sat. aq. 
NaHCO3 (5 mL) and the aqueous layer was extracted with EtOAc / Et2O (2:1, 3 X 15 
mL). The dried (MgSO4) extract was concentrated in vacuo to give crude alcohol 5.41. 
To a stirred solution of crude alcohol 5.41 in CH2Cl2 (1.0 mL) at 0 ºC were added 
pyridine (10.4 mg, 10.7 µL, 0.131 mmol) followed by Dess-Martin Periodinane (16.7 mg, 
39.5  µmol).  After  15  min,  the  reaction  was  warmed  to  rt.  After  another  2.45  h,  the 
reaction was quenched with sat. aq. NaHCO3 (mL) and the aqueous layer was extracted 
    
with  Et2O  (3  X  15  mL).  The  dried  (MgSO4)  extract  was  concentrated  in vacuo  and 
purified by flash chromatography over silica gel, eluting with 5-15% EtOAc / hexanes, to 
give diketone 5.42 (3.9 mg, 4.06 µmol, 62%) as colorless oil: [α]D
23 = +0.92 (c = 0.55, 
CHCl3); IR: (neat) 2959, 2929, 2860, 1740, 1708, 1662, 1632, 1467, 1387, 1258, 1098, 
1045, 838, 781 cm
-1; 
1H NMR {700 MHz, CDCl3 (Note: NMR analysis indicated that 
compound 5.42 exists as a mixture of conformational isomers)} δ 6.54 (dd, J = 15.2, 11.0 
Hz, 1H), 6.01 (br s, 0.5H), 5.77 (br d, J = 11.0 Hz, 1H), 5.57-5.68 (br m, 0.2H), 5.36-5.47 
(br m, 1.3H), 5.12 (br s, 1H), 5.05 (br s, 1H), 4.95 (br s, 1H), 4.42-4.61 (br m, 1H), 4.25 
(br s, 1H), 3.91-4.06 (br m, 3H), 3.71 (br s, 0.7H), 3.55 (br s, 1.3H), 2.98 (br s 1H), 2.84-
2.87 (br m, 1H), 2.73 (br s, 1H), 2.60 (dd, J = 14.3, 3.3 Hz, 1H), 2.43 (br s, 4H), 2.17 (br 
s, 1H), 2.00 (br s, 2H), 1.86-1.94 (m, 2H), 1.79 (br s, 3H), 1.78 (s, 3H), 1.77 (s, 3H)1.62-
1.65 (m, 1H), 1.52-1.58 (m, 2H), 1.22-1.27 (m, 1H), 1.14 (br s, 3H), 1.11 (d, J = 7.0 Hz, 
3H), 1.03 (br s, 3H), 0.90 (s, 27H), 0.03-0.09 (m, 18H); 
13C NMR (176 MHz, CDCl3) δ 
211.0,  207.5,  170.5,  146.3,  140.7,  140.3,  137.87,  137.80,  131.6,  128.6,  124.7,  124.2, 
114.7, 113.7, 81.4, 80.0, 79.5, 78.7, 75.2, 71.6, 50.4, 46.7, 46.3, 42.8, 41.1, 40.6, 39.8, 
38.3, 36.6, 32.2, 28.5, 26.4, 26.06, 26.01, 25.8, 18.5, 18.4, 17.7, 16.5, 15.9, 15.6, -4.1, -
4.6, -4.8; HRMS (ES+) calcd. for C53H94O9Si3Na (M+Na) 981.6103, found 981.6069. 
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Amphidinolide F (1.16): To a solution of tri-TBS ether 5.42 (3.9 mg, 4.06 µmol) 
in CH3CN (0.60 mL) at rt was added Et3N•3HF (0.48 mL) followed by Et3N (0.41 mL). 
After 7 d, the reaction was diluted with EtOAc (15 mL) and poured into sat. aq. solution 
of NaHCO3 (7 mL) and the aqueous layer was extracted with EtOAc (3 X 15 mL). The 
dried (MgSO4) extract was concentrated in vacuo and purified by flash chromatography 
over silica gel, eluting with 1-5% MeOH / EtOAc, to give amphidinolide F (1.16) (1.4 
mg, 2.27 µmol, 56%) as pale yellow amorphous solid. [α]D
23 = -49.0 (c = 0.10, CHCl3), 
{lit.
9 [α]D
30 = -57 (c = 0.10, CHCl3)}; 
1H NMR {700 MHz, CDCl3 (Note: NMR data is 
concentration  dependent,  data  reported  below  is  for  1.4  mg  of  1.16  in  0.18  mL  of 
CDCl3)} δ 6.55 (dd, J = 14.9, 11.0 Hz, 1H), 6.02 (br s, 1H), 5.79 (br d, J = 11.0 Hz, 1H), 
5.37 (dd, J = 15.0, 8.4 Hz, 1H), 5.22 (t, J = 8.2 Hz, 1H), 5.20 (d, J = 1.3 Hz, 1H), 4.98 (br 
s, 1H), 4.35-4.39 (m, 1H), 4.15 (br s, 1H), 4.11 (dd, J = 14.9, 7.3 Hz, 1H), 4.01 (br s, 1H), 
3.97 (br t, J = 9.0 Hz, 1H), 3.85-3.88 (m, 1H), 3.84 (dt, J = 9.5, 2.6 Hz, 1H), 3.80 (br t, J 
= 7.8 Hz, 1H), 3.56 (br s, 2H), 3.13-3.18 (m, 1H), 3.08 (dd, J = 17.5, 8.9 Hz, 1H), 2.77 
(dd, J = 15.2, 9.1 Hz, 1H), 2.74 (dd, J = 15.8, 8.4 Hz, 1H), 2.49-2.58 (m, 4H), 2.34-2.38 
(m, 1H), 2.28-2.32 (m, 1H), 2.09-2.14 (m, 2H), 1.94-1.98 (m, 1H), 1.81-1.86 (m, 1H), 
1.79 (s, 3H), 1.78 (s, 3H), 1.74 (d, J = 1.1 Hz, 3H), 1.47-1.54 (m, 2H), 1.36-1.40 (m, 1H), 
    
1.12 (d, J = 7.2 Hz, 3H), 1.06 (d, J = 6.9 Hz, 3H), 1.02 (d, J = 6.5 Hz, 3H); 
13C NMR 
(176 MHz, CDCl3) δ 213.77, 207.77, 171.22, 144.45, 140.04, 138.29, 132.06, 124.52, 
124.19,  124.04,  116.11,  81.45,  79.90,  78.94,  77.84,  76.51(2C),  75.01,  70.62,  49.38, 
48.57, 46.03, 45.55, 42.79, 39.79, 38.70, 36.77, 31.98, 28.43, 26.08, 18.51, 16.24, 15.53, 
15.40, 13.77; HRMS (ES+) calcd. for C35H53O9 (M+H) 617.3690, found 617.3685. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
                      Comparison of the 
13C NMR Data of Amphidinolide F (1.16) 
 
No.  Synthetic 1.16
a 
(176 MHz, CDCl3) 
Natural 1.16
9 
(125 MHz, CDCl3) 
1  171.22  171.16 
2  38.70  38.65 
3  81.45  81.26 
4  39.79  39.67 
5  36.77  36.81 
6  78.94  79.08 
7  76.51  76.71 
8  76.51  76.71 
9  144.45  144.37 
10  124.52  124.62 
11  140.04  140.00 
12  49.38  49.46 
13  70.62  70.50 
14  45.55  45.65 
15  213.77  213.58 
16  42.79  42.93 
17  46.03  45.81 
18  207.77  207.47 
19  48.57  48.45 
20  75.01  74.82 
21  31.98  31.84 
22  28.43  28.46 
23  79.90  79.87 
24  77.84  77.93 
25  124.04  123.97 
26  132.06  132.09 
27  124.19  124.06 
28  138.29  138.25 
29  26.08  26.00 
30  18.51  18.43 
31  15.53  15.39 
32  116.11  116.16 
33  13.77  13.94 
34  15.40  15.29 
35  16.24  16.20 
 
(a)
 Concentration: 1.4 mg of 1.16 in 0.18 mL CDCl3.  
    
                                                 
1.  Preparation  of  HF•Pyr.  Solution:  The  stock  solution  was  prepared  by  mixing 
HF•Pyr. (1.0 mL, 70% HF in pyridine), pyridine (2.0 mL) and THF (5.0 mL). 
2. Agrios, K. A.; Srebnik, M. J. Org. Chem. 1994, 59, 5468-5472. 
3. Wang, Y.; Panagabko, C.; Atkinson, J. Bioorg. Med. Chem. 2010, 18, 777-786. 
4. Preparation of LDA Solution: To a solution of diisopropylamine (0.14 mL / mmol) 
in THF (0.46 mL / mmol) at -78 °C was added n-BuLi (0.40 mL / mmol, 2.5 M in 
hexanes).  After  5  min,  the  white  slurry  was  warmed  to  -10  °C  and  stirred  for  an 
additional 15 min. 
5. Davis, F. A.; Stringer, O. D. J. Org. Chem. 1982, 47, 1774-1775. 
6. Preparation of PPTS Solution: The stock solution was prepared by mixing PPTS 
(20.0 mg) in dry MeOH (3.0 mL). 
7. Shiina, I.; Kubota, M.; Oshiumi, H.; Hashizume, M. J. Org. Chem. 2004, 69, 1822-
1830. 
8. (a) To a stirred solution of DBB (1.85 g, 6.8 mmol) in THF (17.0 mL) at 0 ºC was 
added lithium wire (0.65 g, ~34.0 mmol). The reaction was sonicated for 10 min and then 
stirred for additional 2 h. (b) Freeman, P. K.; Hutchinson, L. L. J .Org. Chem. 1980, 45, 
1924-1930. 
9.  Kobayashi,  J.;  Tsuda,  M.;  Ishibashi,  M.;  Shigemori,  H.;  Yamasu,  T.;  Hirota,  H.; 
Sasaki, T. J. Antibiot. 1991, 44, 1259-1261. 
    
CHAPTER VI: STUDIES TOWARD THE TOTAL SYNTHESES 
 OF AMPHIDINOLIDES C, C2 AND C3 
 
6.1 Introduction 
 
  After  accomplishing  the  first  total  synthesis  of  amphidinolide  F  (1.16),
1 we 
targeted the total syntheses of other members of this subfamily, amphidinolides C, C2 and 
C3 (Figure 6.1). Amphidinolide C (1.14) is biologically the most potent affiliate of this 
subgroup possessing the antineoplastic activity against a series of cancer cell lines in 
nanomolar  range  (in  vitro  IC50  values  against  murine  lymphoma  L1210  and  human 
epidermoid carcinoma KB cells are 5.8 and 4.6 ng/mL respectively).
2 In fact, only four 
members  of  this  well-known  natural  product  family  (>35  amphidinolides  have  been 
isolated and bio-tested) displayed cytotoxicity in nanomolar range
3 and amphidinolide C 
is one of them. It has been mentioned in earlier chapters that all the members of this 
subfamily, amphidinolides F, C and C2 (1.14-1.16) share the same macrocyclic core, but 
possess different C24 side chain. Amphidinolide C3 (6.1) is the most recent addition to 
this  subfamily  -  it  has  been  isolated  in  2010  from  Y-56  strain  of  the  dinoflagellate 
Amphidinium  sp.
4 The  natural  product  6.1  contains  exactly  same  carbon  skeleton  as 
amphidinolide C - only the C29 hydroxyl is replaced by a ketone moiety. Interestingly, 
amphidinolide C3 is 1000-2500 times less potent than C, suggesting that the side chain 
has tremendous impact in cytotoxicity. 
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Figure 6.1. Structural Relevance in Amphidinolides C, C2 and C3 
 
6.2 Retrosynthetic Analysis 
 
  Attracted by the impressive biological potency of amphidinolide C (1.14) and 
equipped with the knowledge gained during the total synthesis of amphidinolide F (1.16), 
we resumed the research program targeting the total syntheses of amphidinolides C, C2 
and C3. Our retrosynthetic disconnection for amphidinolide C series was similar to that of 
amphidinolide  F  (Scheme  6.1).  As  before,  the  25-membered  macrocyclic  scaffold  of 
these natural products (1.14, 1.15 and 6.1) was planned to form via macrolactonization 
technique. The key disconnection at C14-C15 would break down the all-carbon skeleton of 
    
amphidinolides C, C2 and C3 in two halves, the iodide subunit 4.1 and the sulfone subunit 
6.3.  This  strategy  would  provide  highly  convergent  nature  to  the  retrosynthetic 
disconnection.  Analogous  to  amphidinolide  F  synthesis,  both  the  iodide  and  sulfone 
fragments  (4.1  and  6.3)  of  amphidinolides  C,  C2  and  C3  would  be  derived  from  the 
common intermediate 3.30. 
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Scheme 6.1. Retrosynthetic Disconnection for Amphidinolides C, C2 and C3 
 
 
 
    
6.3 Synthetic Efforts Toward Amphidinolide C Sidearm 
 
Several groups have described their synthetic efforts toward the side chain of 
amphidinolide C (1.14) (Schemes 6.2 and 6.3). Pagenkopf and co-workers exploited a 
stereoselective alkynylation to adjoin the side chain and Trost asymmetric alkynylation to 
install the C29 bis-allylic alcohol in a stereoselective manner.
5 On the other hand, Spilling 
and co-workers employed a Horner-Wardsworth-Emmons (HWE) olefination to install 
the sidearm diene.
6 The group utilized a classic Nozaki-Hiyama-Kishi (NHK) coupling to 
mount the C29 bis-allylic alcohol. The Mohapatra group also employed the HWE and 
NHK  reactions  for  the  sidearm  synthesis,  but  switched  the  order  of  events  in  their 
synthetic sequence.
7  
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Scheme 6.2. Pagenkopf’s Enantio- and Diastereoselective Alkynylation Pathway 
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Scheme 6.3. Spilling and Mohapatra’s NHK / HWE Sequence 
 
6.4 Preparation of the Sulfone Subunit with Amphidinolide C Sidearm 
 
  It was mentioned that the structural diversities in the amphidinolides F and C 
series arise from the C24 side chain extension. Accordingly, in our synthetic sequence, the 
    
sulfone  subunit  6.3  of  amphidinolide  C  (1.14)  would  be  different  from  that  of 
amphidinolide F (1.16) (Scheme 6.4). Thus, we targeted to construct the sulfone fragment 
6.3 at the beginning of our synthetic endeavor toward amphidinolides C, C2 and C3. We 
envisioned to utilize the Tamura / Vedejs olefination
8 between α-oxy-aldehyde 6.14 and 
tributyl phosphonium salt 6.15 for stereoselective introduction of the sidearm diene. The 
C25-C34 side chain of 1.14 and 1.15 consists of a rare bis-allylic alcohol (at C29) and an 
interesting skipped diene with exo-methylene functionality. The plan was to exploit Trost 
asymmetric alkynylation between methyl propiolate 6.17 and 2-methylenehexanal 6.12 to 
install the C29 alcohol and a stereoselective Michael addition to introduce the C28 methyl 
moiety. 
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Scheme 6.4. Retrosynthetic Strategy for the Sulfone Subunit 
 
 
    
6.4.1 Synthesis of the Phosphonium Bromide 
 
  Synthesis of the tributyl phosphonium salt 6.15 commenced with an asymmetric 
alkynylation  on  2-methylenehexanal  6.12,
9 which  was  prepared  in  one-step  from 
commercially available hexanal (Scheme 6.5). Alkynylation between methyl propiolate 
6.17 and 2-methylenehexanal 6.12 in presence of Trost prolinol ligand 6.18
10 delivered 
the propargyl alcohol 6.19 in good yield and enantiomeric excess. The secondary alcohol 
was protected as silyl ether to furnish the Michael addition precursor 6.16. To our delight, 
the Cu (I)-catalyzed Michael addition on 6.16 proceeded with complete stereoselectivity 
to produce the desired α,β-unsaturated ester 6.20. The regiochemistry of the addition 
adduct was confirmed by a nOe analysis after reduction to alcohol 6.21. The alcohol 6.21 
was first converted to corresponding allyl bromide and subsequently transformed into 
tributyl phosphonium salt 6.15 by the treatment of tributyl phosphine. Thus, this scalable, 
efficient  6-step  sequence  furnished  the  requisite  phosphonium  bromide  6.15  in  68% 
overall yield. The absolute configuration at C29 was established by modified Mosher ester 
analysis
11 on 6.21-derived diol. Absence of adjacent protons on one side of the hydroxyl 
moiety restricted Mosher ester analysis on propargyl alcohol 6.19. 
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Scheme 6.5. Preparation of the Phosphonium Salt 
 
 
 
 
    
6.4.2 Installation of the Sidearm for Amphidinolide C 
 
  A quick gram-scale preparation of phosphonium bromide 6.15 set the stage for 
synthesis of the entire sulfone subunit 6.3 of amphidinolide C (Scheme 6.6). Equipped 
with the knowledge gained from our diene installation during amphidinolide F synthesis, 
we  intended  to  implement  similar  Tamura  /  Vedejs  olefination  strategy
8  for  the 
introduction of amphidinolide C side chain. Thus, the α-oxy-aldehyde 6.24 was prepared 
in three steps from our previously made sulfone fragment 5.29. The bis-TBS ether 5.29 
was first switched to bis-TES ether 6.23 and a one-flask Swern operation furnished the 
requisite aldehyde 6.24 in reasonable yield. Next, following our optimized conditions,
1 
the phosphonium salt 6.15 was treated with n-BuLi at -45 ºC, slowly warmed to rt, cooled 
back  down  to  -78  ºC  and  aldehyde  6.24  was  added  to  it.  To  our  despair,  this 
transformation resulted into complete decomposition of both the starting materials. We 
reasoned that the ylide 6.25 generated after base treatment of salt 6.15 might be unstable 
at higher temperature and could suffer decomposition via an elimination pathway.  
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Scheme 6.6. Attempted Optimized Tamura / Vedejs Olefination 
 
With  the  hope  that  the  ylide  6.25  would  survive  at  lower  temperature,  the 
phosphonium bromide 6.15 was treated with base at -55 ºC and kept at that temperature 
    
over an extended period (2 h) before addition of the aldehyde 6.24 (Scheme 6.7). To our 
delight, this slight modification of reaction conditions furnished the desired triene 6.3 
although in modest yield (55%). We were able to improve the yield of the transformation 
by further optimizing the reaction temperature and the ratio of salt 6.15 with respect to 
aldehyde 6.24. An excellent 96% yield was obtained by adding the base at -78 ºC and by 
using  2.2  equivalent  of  phosphonium  bromide  6.15  with  respect  to  aldehyde  6.24. 
Stereoselectivity of the transformation (10:1 E:Z) was comparable to that was observed 
during our amphidinolide F synthesis, and hence provided a reliable mean for E-selective 
diene construction on α-oxy-aldehyde. 
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Scheme 6.7. Successful Amphidinolide C Side Chain Incorporation 
 
 
 
 
 
 
 
 
 
    
6.5 Sulfone-iodide Alkylation / Oxidative Desulfurization: Formation of 
the All-carbon Framework of Amphidinolides C, C2 and C3 
 
  With efficient preparation of the C15-C34 northern sulfone subunit 6.3, our 
priority shifted to effect the sulfone-iodide alkylation / oxidative desulfurization sequence 
(Scheme 6.8). Accordingly, sulfone 6.3 was first treated with one equivalent of LHMDS 
and subsequent addition of our pre-made iodide 4.1 in presence of HMPA furnished the 
C14-C15 coupled material 6.26 in excellent yield (84%). The reaction was performed in 
reasonably large scale (300 mg) and provided sufficient quantity of the coupled sulfone 
6.26 to push forward in the synthesis. Next, oxidative desulfurization
12 on 6.26 under our 
previously optimized conditions (Davis’ oxaziridine / LDA / DMPU) incorporated the 
C15  ketone  (6.28  and  6.29)  in  respectable  combined  yield  (74%).  Some  pivaloyl-
deprotected  ketone  6.29  was  also  obtained  (15%)  under  the  reaction  conditions,  but 
would be used in the synthetic sequence. With the sufficient quantities of the ketone 
precursors (6.28 and 6.29) in hand, we are now well set for the final lap of the total 
syntheses of amphidinolide C, C2 and C3. The endgame toward the total syntheses of 
these natural products (1.14, 1.15 and 6.1) is currently underway.  
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Scheme 6.8. Construction of the All-carbon Framework of Amphidinolides C, C2 and C3 
 
6.6 Conclusion 
 
  In conclusion, we have devised a short and efficient synthetic course to access the 
phosphonium  bromide  6.15  for  amphidinolides  C,  C2  and  C3  sidearm  (6  steps,  68% 
overall  yield).  The  bis-allylic  alcohol  moiety  in  6.15  was  created  via  asymmetric 
alkynylation / Michael addition sequence. We successfully manipulated the Tamura / 
Vedejs olefination conditions and the side chain of amphidinolide C was incorporated in 
an  excellent  yield.  The  crucial  sulfone-iodide  alkylation  /  oxidative  desulfurization 
sequence  was  effectively  implemented  to  furnish  the  all-carbon  framework  of 
    
amphidinolides C, C2 and C3 (1.14, 1.15 and 6.1). Efficient preparation of C15 ketone 
(6.28 and 6.29) in sufficient quantity has laid a solid platform for the completion of the 
total syntheses of these natural products. 
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6.8 Experimental 
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OH
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O
6.17 6.12 6.19  
 
Alcohol 6.19: To a stirred solution of Me2Zn (14.3 mL, 17.1 mmol, 1.2 M in 
toluene) in toluene (29.5 mL) at rt was added methyl propiolate 6.17 (1.36 g, 1.45 mL, 
16.2 mmol) and then was left without stirring. After 90 min, the reaction was cannulated 
to another flask containing the Trost prolinol ligand 6.18
1 (62.9 mg, 0.098 mmol). After 
10 min, aldehyde 6.12
2 (650 g, 0.78 mL, 5.79 mmol) was added and the reaction was 
cooled down to 5 ºC. After 24 h, the reaction was quenched by sat. aq. NH4Cl (40 mL) 
and extracted with Et2O (3 X 75 mL). The dried (MgSO4) extract was concentrated in 
vacuo and purified by flash chromatography over silica gel, eluting with 5-20% EtOAc / 
hexanes,  to  give  propargyl  alcohol  6.19  (988  mg,  5.03  mmol,  87%)  as  colorless  oil. 
Enatiomeric excess was determined by chiral HPLC {4.6 X 250 mm, Daicel AD column, 
99:1 hexanes / i-PrOH, 0.7 mL min
-1, retention times 57.3 min (major) and 63.6 (minor)} 
to be 92%. [α]D
23 = +3.9 (c = 1.02, CHCl3); IR (neat) 3428, 2963, 2932, 2868, 2239, 
1721, 1439, 1254, 1033, 753 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 5.32 (s, 1H), 5.04 (s, 
1H), 4.96 (d, J = 6.6 Hz, 1H), 3.81 (s, 3H), 2.17-2.25 (m, 2H), 2.11 (br d, J = 6.6 Hz, 
1H), 1.48-1.53 (m, 2H), 1.38 (dq, J = 14.8, 7.4 Hz, 2H), 0.94 (t, J = 7.4 Hz, 3H) ppm; 
13C 
NMR (176 MHz, CDCl3) δ 153.7, 146.3, 112.6, 86.2, 77.1, 65.3, 52.9, 31.5, 29.8, 22.4, 
    
 
13.9 ppm; HRMS (EI+) calcd. for C11H16O3 (M+) 196.10995, found 196.10942. 
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TBS Ether 6.16: To a stirred solution of alcohol 6.19 (843 mg, 4.29 mmol) in 
CH2Cl2 (60.0 mL) at -78 °C was added 2,6-lutidine (2.77 g, 3.0 mL, 25.8 mmol) followed 
by TBSOTf (3.45 g, 3.0 mL, 12.9 mmol). After 2.5 h, the reaction was quenched by sat. 
aq.  NaHCO3  (40  mL)  and  extracted  with  CH2Cl2  (3  X  75  mL).  The  dried  (MgSO4) 
extract was concentrated in vacuo and purified by chromatography over silica gel, eluting 
with  2-6%  EtOAc  /  hexanes,  to  give  TBS  ether  6.16  (1.27  g,  4.09  mmol,  95%)  as 
colorless oil. [α]D
23 = -29.6 (c = 1.03, CHCl3); IR (neat) 2956, 2931, 2859, 2236, 1721, 
1465, 1435, 1250, 1061, 838, 779 cm
-1; 
1H NMR (700 MHz, CDCl3) δ 5.24 (s, 1H), 4.95 
(s, 1H), 4.93 (s, 1H), 3.79 (s, 3H), 2.13-2.22 (m, 2H), 1.49 (dt, J = 14.6, 7.8 Hz, 2H), 1.37 
(dq, J = 15.0, 7.4 Hz, 2H), 0.94 (t, J = 7.4 Hz, 3H), 0.93 (s, 9H), 0.18 (s, 3H), 0.14 (s, 3H) 
ppm; 
13C NMR (176 MHz, CDCl3) δ 153.9, 146.8, 111.4, 87.4, 76.2, 65.9, 52.7, 31.0, 
29.8, 25.7, 22.4, 18.2, 13.9, -4.7, -5.1 ppm; HRMS (EI+) calcd. for C17H30O3Si (M+) 
310.19643, found 310.19794.  
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Alcohol 6.21: To a stirred suspension of CuI (1.01 g, 5.33 mmol) in THF (17.5 
mL) at -40 °C was added methyl magnesium bromide (3.6 mL, 10.7 mmol, 3.0 M in 
Et2O). After 15 min, the reaction was cooled down to -78 ºC. A solution of ester 6.16 
(552 mg, 1.77 mmol) in THF (4.5 ml) was cannulated to it over 15 min. After 3 h, the 
reaction was allowed to warm to 5 ºC over 4 h. The reaction was quenched by half-
saturated  aq.  NH4Cl  (100  mL)  and  extracted  with  Et2O  (3  X  45  mL)  to  give  crude 
addition adduct 6.20.  
To a stirred solution of crude adduct 6.20 in Et2O (32.0 mL) at -10 ºC was added 
LiAlH4 (133 mg, 3.50 mmol) in one portion. After 20 min, the reaction was quenched 
with dropwise addition of H2O (2.0 mL) and the organic layer was decanted. The solid 
formed was washed with Et2O (3 X 25 mL). The dried (MgSO4) extract was concentrated 
in vacuo and purified by chromatography over silica gel, eluting with 5-15% EtOAc / 
hexanes, to give alcohol 6.21 (470 mg, 1.57 mmol, 89%) as colorless oil. [α]D
23 = -23.9 (c 
= 1.00, CHCl3); IR (neat) 3319, 2956, 2929, 2858, 1468, 1252, 1073, 1006, 836, 775 cm
-
    
 
1; 
1H NMR (700 MHz, CDCl3) δ 5.70 (tt, J = 6.7, 1.2 Hz, 1H), 5.14 (br d, J = 0.7 Hz, 
1H), 4.89 (br s, 1H), 4.41 (s, 1H), 4.23 (t, J = 5.6 Hz, 2H), 1.91-1.95 (m, 1H), 1.81-1.86 
(m, 1H), 1.53 (s, 3H), 1.38-1.45 (m, 2H), 1.29-1.35 (m, 2H), 1.19 (t, J = 5.6 Hz, 1H), 
0.92 (s, 9H), 0.91 (t, J = 7.2 Hz, 3H), 0.05 (s, 3H), 0.04 (s, 3H) ppm; 
13C NMR (176 
MHz, CDCl3) δ 149.3, 139.5, 124.7, 109.9, 80.4, 59.4, 30.7, 30.0, 25.8, 22.6, 18.3, 14.0, 
11.5,  -4.9,  -5.0  ppm;  HRMS  (ES+)  calcd.  for  C17H35O2Si  (M+H)  299.2406,  found 
299.2398.  
 
6.30 6.21
OTBS OTBS
HO
6.15
OTBS
Bu3P
Br
Br
 
 
Phosphonium Bromide 6.15: To a stirred solution of alcohol 6.21 (693 mg, 2.32 
mmol) in CH2Cl2 (19.0 mL) at 0 °C was added PPh3 (731 mg, 2.78 mmol) followed by 
CBr4 (924 mg, 2.78 mmol). The reaction was allowed to warm to rt over 2.5 h. The 
reaction quickly passed through a small plug of silica gel, eluting with 2% EtOAc / 
hexanes, to give bromide 6.30 as a colorless oil.  
To a stirred solution of crude bromide 6.30 (822 mg, 2.27 mmol) in Et2O (18.0 
mL) at 0 ºC was added PBu3 (1.14 g, 1.4 mL, 5.63 mmol). After 15 min, the reaction was 
    
 
warmed to rt. After 15 h, the reaction filtered through a sintered glass funnel and the 
residue was washed with hexanes (3 X 25 mL) to give phosphonium bromide 6.15 (1.20 
g, 2.13 mmol, 92%) as white powdered solid. Mp. 52-54 ºC; [α]D
23 = +11.9 (c = 1.03, 
CHCl3); IR (neat) 2956, 2929, 2860, 1464, 1251, 1096, 1075, 877, 836, 776 cm
-1; 
1H 
NMR (700 MHz, CDCl3) δ 5.45-5.49 (m, 1H), 5.10 (s, 1H), 4.94 (br d, J = 1.4 Hz, 1H), 
4.43 (d, J = 3.5 Hz, 1H), 3.54 (ddd, J = 15.5, 15.4, 8.1 Hz, 1H), 3.48 (ddd, J = 15.6, 15.5, 
8.1 Hz, 1H), 2.46-2.51 (m, 6H), 1.91 (dt, J = 15.9, 7.9 Hz, 1H), 1.68-1.71 (m, 4H), 1.51-
1.60 (m, 11H), 1.39-1.44 (m, 2H), 1.29-1.34 (m, 2H), 0.99 (t, J = 7.0 Hz, 9H), 0.92 (t, J = 
7.2 Hz, 3H), 0.91 (s, 9H), 0.05 (s, 3H), 0.04 (s, 3H) ppm; 
13C NMR (176 MHz, CDCl3) δ 
148.5,  145.9,  145.8,  111.8,  109.16,  109.11,  80.5,  29.7,  29.5,  25.7,  24.1,  24.0,  23.95, 
23.92, 22.7, 20.4, 20.1, 19.3, 19.0, 18.2, 14.0, 13.9, 13.5 -4.8, -5.1 ppm. HRMS (ES+) 
calcd. for C29H60OPSi(M-Br) 483.4151, found 483.4127.  
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Bis-TES Ether 6.23: To a stirred solution of bis-TBS ether 5.29 (348 mg, 0.517 
mmol) in THF (6.6 mL) at 0 ºC was added TBAF (2.1 mL, 2.10 mmol, 1 M in THF) and 
allowed to warm to rt. After 12 h, the reaction quenched with H2O (30 mL) and the 
aqueous layer was extracted with EtOAc / Et2O (1:1, 3 X 50 mL). The dried (MgSO4) 
extract was concentrated in vacuo to give crude diol 6.31. 
To a stirred solution of crude alcohol 6.31 in CH2Cl2 (6.6 mL) at 0 ºC were 
sequentially added Et3N (418 mg, 0.58 mL, 4.14 mmol), DMAP (31.3 mg, 0.258 mmol) 
and TESCl (278 mg, 0.31 mL, 1.81 mmol). After 12 h, the reaction was quenched with 
sat. aq. NH4Cl (35 mL) and the aqueous layer was extracted with Et2O (3 X 50 mL). The 
dried (MgSO4) extract was concentrated in vacuo and purified by flash chromatography 
over silica gel, eluting with 5-20% EtOAc / hexanes, to give bis-TES ether 6.23 (346 mg, 
0.514 mmol, 99%) as colorless oil. [α]D
23 = -21.5 (c = 1.00, CHCl3); IR (neat) 2954, 
2916, 2876, 1462, 1447, 1377, 1309, 1238, 1147, 1086, 1008, 740 cm
-1; 
1H NMR {700 
MHz, CDCl3 (two diastereomers)} δ 7.93-7.96 (m, 2H (2 diastereomers)), 7.64-7.67 (m, 
    
 
1H (2 diastereomers)), 7.56-7.59 (m, 2H (2 diastereomers)), 4.67 (q, J = 5.2 Hz, 1H (1 
diastereomer)),  4.62  (q,  J  =  5.2  Hz,  1H  (1  diastereomer)),  4.02-4.06  (m,  1H  (2 
diastereomers)),  3.90-3.96  (m,  1H  (2  diastereomers)),  3.79-3.83  (m,  1H  (1 
diastereomer)),  3.67-3.71  (m,  1H  (1  diastereomer)),  3.60-3.65  (m,  2H  (1H  of  1 
diastereomer and 1H of 2 diastereomers)), 3.51-3.59 (m, 3H (1H of 1 diastereomer and 
2H of 2 diastereomers)), 3.40-3.47 (m, 1H (2 diastereomers)), 3.23 (dd, J = 14.2, 4.7 Hz, 
1H (1 diastereomer)), 3.17 (dd, J = 14.2, 4.3 Hz, 1H (1 diastereomer)), 2.97 (dd, J = 8.2, 
5.7 Hz, 1H (1 diastereomer)), 2.95 (dd, J = 8.5, 5.9 Hz, 1H (1 diastereomer)), 2.31-2.38 
(m,  1H  (1  diastereomer)),  2.21-2.26  (m,  1H  (1  diastereomer)),  1.97-2.02  (m,  1H  (2 
diastereomers)), 1.87-1.94 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 
1.78-1.84 (m, 1H (2 diastereomers)), 1.73-1.77 (m, 1H (1 diastereomer)), 1.59-1.63 (m, 
1H  (1  diastereomer)),  1.54-1.58  (m,  1H  (1  diastereomer)),  1.39-1.52  (m,  3H  (2 
diastereomers)), 1.24 (d, J = 5.2 Hz, 3H (1 diastereomer)), 1.21 (d, J = 5.2 Hz, 3H (1 
diastereomer)), 1.19 (t, J = 7.1 Hz, 3H (1 diastereomer)), 1.17 (t, J = 7.1 Hz, 3H (1 
diastereomer)), 1.148 (d, J = 6.6 Hz, 3H (1 diastereomer)), 1.144 (d, J = 6.6 Hz, 3H (1 
diastereomer)), 0.97 (t, J = 8.0 Hz, 18H (1 diastereomer)), 0.96 (t, J = 8.0 Hz, 18H (1 
diastereomer)), 0.59-0.64 (m, 12H (2 diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) 
δ 140.1, 140.0, 133.5, 133.4, 129.2, 129.1, 128.0, 127.9, 99.9, 98.0, 78.6, 78.5, 76.1, 76.0, 
72.9, 71.2, 64.7, 63.2, 63.1, 60.7, 60.5, 41.8, 41.7, 41.5, 40.8, 33.1, 32.9, 27.4, 25.8, 20.7, 
20.5,  19.8,  19.6,  15.4,  15.3,  6.9,  6.8,  5.1,  4.3  ppm;  HRMS  (ES+)  calcd.  for 
C34H64O7SSi2Na (M+Na) 695.3809, found 695.3795.  
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Dienyl Sulfone 6.3: To a stirred solution of oxalyl chloride (139 mg, 95.5 µL, 
1.09 mmol) in CH2Cl2 (3.0 mL) at -78 ºC was cannulated a solution of DMSO (177 mg, 
0.16 mL, 2.18 mmol) in CH2Cl2 (0.6 mL). The reaction was warmed to -50 ºC over 20 
min. A solution of alcohol bis-TES ether 6.23 (294 mg, 0.437 mmol) in CH2Cl2 (2.0 mL 
and 2 X 0.5 mL wash) was cannulated to it. After 1 h, Et3N (447 mg, 0.62 mL, 4.37 
mmol) was added. After 10 min, the cooling bath was removed and the reaction was 
quenched with H2O (30 mL).  The aqueous layer was extracted with CH2Cl2 (3 X 50 
mL).  The  dried  (MgSO4)  extract  was  concentrated  in  vacuo  and  purified  by  flash 
chromatography over silica gel, eluting with 20-40% EtOAc / hexanes, to give aldehyde 
6.24 (177 mg, 0.318 mmol, 73%) as colorless oil. 
To a stirred solution of tributyl phosphonium salt 6.15 (392 mg, 0.695 mmol) in 
THF (3.7 mL) at -78 ºC was added n-BuLi (0.28 mL, 0.700 mmol, 2.5 M in hexane) and 
was warmed to -60 ºC. After 1.5 h, the reaction was cooled back down to -78 ºC and a 
    
 
solution of aldehyde 6.24 (177 mg, 0.318 mmol) in THF (3.7 mL and 2 X 0.20 mL wash) 
was cannulated to it. After 2 h, the reaction was slowly warmed to -5 ºC over 2.5 h and 
then quenched with H2O (30 mL). The aqueous layer was extracted with Et2O (3 X 50 
mL).  The  dried  (MgSO4)  extract  was  concentrated  in  vacuo  and  purified  by  flash 
chromatography over silica gel, eluting with 10-30% EtOAc / hexanes, to give dienyl 
sulfone 6.3 {251 mg, 0.305 mmol, 96% (10:1 E:Z, inseparable mixture)} as colorless oil. 
[α]D
23 = -6.0 (c = 1.00, CHCl3); IR: (neat) 2955, 2930, 2875, 1462, 1446, 1377, 1307, 
1250, 1148, 1086, 835, 776 cm
-1; 
1H NMR {700 MHz, CDCl3 (two diastereomers)} δ 
7.93-796 (m, 2H (2 diastereomers)), 7.64-7.68 (m, 1H (2 diastereomers)), 7.56-7.60 (m, 
2H (2 diastereomers)), 6.46 (ddd, J = 11.0, 3.3, 1.2 Hz, 1H (1 diastereomer of E isomer)), 
6.44 (ddd, J = 11.0, 3.3, 1.2 Hz, 1H (1 diastereomer of E isomer)), 6.34 (d, J = 11.6 Hz, 2 
diastereomers of Z isomer)), isomer)), 6.22-6.26 (m, 1H (2 diastereomers of Z isomer)), 
6.06 (d, J = 11.0 Hz, 1H (2 diastereomers of E isomer)), 5.66 (dd, J = 6.3, 3.9 Hz, 1H (1 
diastereomer of E isomer)), 5.64 (dd, J = 6.3, 3.9 Hz, 1H (1 diastereomer of E isomer)), 
5.38-5.42  (m,  1H  (2  diastereomers  of  Z  isomer)),  5.13  (s,  1H  (2  diastereomers  of  E 
isomer)), 4.89 (s, 1H (2 diastereomers of Z isomer)), 4.87 (s, 1H (2 diastereomers of E 
isomer)),  4.67  (q,  J  =  5.2  Hz,  1H  (1  diastereomer)),  4.63  (q,  J  =  5.2  Hz,  1H  (1 
diastereomer)), 4.44 (s, 1H (2 diastereomers of Z isomer)), 4.41 (s, 1H (2 diastereomers 
of  E  isomer)),  4.14  (t,  J  =  5.8  Hz,  1H  (2  diastereomers)),  3.89-3.97  (m,  2H  (2 
diastereomers)), 3.79-3.83 (m, 1H (1 diastereomer)), 3.67-3.71 (m, 1H (1 diastereomer)), 
3.60 (ddd, J = 14.1, 9.2, 7.0 Hz, 1H (1 diastereomer)), 3.53 (ddd, J = 14.1, 9.2, 7.0 Hz, 
1H (1 diastereomer)), 3.41-3.48 (m, 1H (2 diastereomers)), 3.25 (dd, J = 14.2, 4.7 Hz, 1H 
    
 
(1 diastereomer)), 3.18 (dd, J = 14.2, 4.3 Hz, 1H (1 diastereomer)), 2.98 (dd, J = 8.1, 6.2 
Hz, 1H (1 diastereomer)), 2.96 (dd, J = 8.3, 6.4 Hz, 1H (1 diastereomer)), 2.32-2.37 (m, 
1H  (1  diastereomer)),  2.21-2.26  (m,  1H  (1  diastereomer)),  1.94-2.00  (m,  1H  (2 
diastereomers)), 1.86-1.92 (m, 3H (1H of 1 diastereomer and 2H of 2 diastereomers)), 
1.74-1.84 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 1.68-1.73 (m, 1H (2 
diastereomers)),  1.62-1.67  (m,  1H  (2  diastereomers)),  1.59  (d,  J  =  1.0  Hz,  3H  (2 
diastereomers)),  1.47-1.53  (m,  1H  (2  diastereomers)),  1.36-1.46  (m,  4H  (2 
diastereomers)),  1.27-1.34  (m,  2H  (2  diastereomers)),  1.24  (d,  J  =  5.2  Hz,  3H  (1 
diastereomer)), 1.22 (d, J = 5.2 Hz, 3H (1 diastereomer)), 1.20 (t, J = 7.0 Hz, 3H (1 
diastereomer)), 1.18 (t, J = 7.0 Hz, 3H (1 diastereomer)), 1.156 (d, J = 6.6 Hz, 3H (1 
diastereomer)), 1.152 (d, J = 6.6 Hz, 3H (1 diastereomer)), 0.960 (t, J = 8.0 Hz, 9H (1 
diastereomers)),  0.958  (t,  J  =  8.0  Hz,  9H  (1  diastereomers)),  0.91  (s,  9H  (2 
diastereomers)),  0.88-0.92  (m,  3H  ((2  diastereomers)),  0.58-0.62  (m,  6H  ((2 
diastereomers)); 
13C NMR (176 MHz, CDCl3) δ 149.6, 140.1, 139.9, 138.56, 138.52, 
133.5, 133.4, 132.2, 132.1, 129.2, 129.1, 128.0, 127.9, 127.25, 127.21, 125.2, 109.6, 99.9, 
98.0, 82.05, 82.01, 80.6, 76.1, 76.0, 75.8, 72.8, 71.1, 63.1, 63.0, 60.7, 60.5, 41.9, 41.7, 
41.6, 40.8, 32.9, 32.6, 30.9, 30.0, 27.4, 25.8, 22.5, 20.6, 20.5, 20.0, 19.7, 18.3, 15.4, 15.3, 
14.0,  11.9,  6.9,  4.9,  -5.01,  -5.04;  HRMS  (ES+)  calcd.  for  C45H80O7SSi2Na  (M+Na) 
843.5061, found 843.5055.  
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  Coupled Sulfone 6.26: To a stirred solution of sulfone 6.3 (297 mg, 0.361 mmol) 
in THF (1.4 mL) at -60 ºC was added LHMDS (0.37 mL, 0.370 mmol, 1 M in THF) and 
warmed to -10 ºC over 1 h. HMPA (361 mg, 0.35 mL, 2.00 mmol) was added and the 
reaction was warmed to 0 ºC over 15 min. The reaction was cooled back down to -10 ºC 
and a solution of iodide 4.1 (122 mg, 0.138 mmol) in THF (1.5 mL and 2 X 0.15 mL 
wash)  was  cannulated  to  it  and  warmed  to  0  ºC.  After  2.5  h,  the  cooling  bath  was 
removed. After another 30 min, the reaction was quenched with sat. aq. NH4Cl (20 mL) 
and the aqueous layer was extracted with Et2O (3 X 30 mL). The dried (MgSO4) extract 
was concentrated in vacuo and purified by flash chromatography over silica gel, eluting 
with  5-20%  EtOAc  /  hexanes,  to  give  diastereomeric  coupled  sulfone  6.26  (183  mg, 
0.116 mmol, 84%) along with recovered sulfone 6.3 (170 mg, 0.207 mmol) as colorless 
oils. [α]D
23 = -3.6 (c = 1.00, CHCl3); IR: (neat) 2956, 2928, 2856, 1731, 1462, 1378, 
1306, 1251, 1146, 1076, 835 cm
-1; 
1H NMR {700 MHz, CDCl3 (four diastereomers)} δ 
7.89-7.94 (m, 2H (4 diastereomers)), 7.60-7.65 (m, 1H (4 diastereomers)), 7.52-7.58 (m, 
2H (4 diastereomers)), 6.43-6.48 (m, 1H (4 diastereomers)), 6.07 (d, J = 10.5 Hz, 1H (2 
diastereomers)),  6.06  (d,  J  =  10.8  Hz,  1H  (2  diastereomers)),  5.81  (s,  1H  (1 
    
 
diastereomer)), 5.79 (s, 1H (1 diastereomer)), 5.68 (s, 1H (1 diastereomer)), 5.67 (s, 1H 
(1  diastereomer)),  5.64  (dd,  J  =  15.1,  6.5  Hz,  1H  (4  diastereomers)),  5.32  (s,  1H  (2 
diastereomers)), 5.31 (s, 1H (2 diastereomers)), 5.13 (s, 1H (4 diastereomers)), 5.06 (s, 
1H (1 diastereomer)), 5.01 (s, 1H (1 diastereomer)), 4.87 (s, 2H (1H of 2 diastereomers 
and 1H of 4 diastereomers)), 4.66 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.62 (q, J = 5.2 
Hz, 1H (1 diastereomer)), 4.59 (q, J = 5.1 Hz, 1H (1 diastereomer)), 4.49 (q, J = 5.1 Hz, 
1H (1 diastereomer)), 4.417 (s, 1H (2 diastereomers)), 4.410 (s, 1H (2 diastereomers)), 
4.36-4.38 (m, 1H (2 diastereomers)), 4.25-4.29 (m, 1H (4 diastereomers)), 4.06-4.16 (m, 
4H  (1H  of  2  diastereomers  and  3H  of  4  diastereomers)),  3.96-4.00  (m,  1H  (2 
diastereomers)), 3.87-3.96 (m, 3H (1H of 2 diastereomers and 2H of 4 diastereomers)), 
3.72-3.77 (m, 1H (1 diastereomer)), 3.65-3.69 (m, 1H (1 diastereomer)), 3.52-3.63 (m, 
2H  (1H  of  2  diastereomers  and  1H  of  4  diastereomers)),  3.44-3.49  (m,  1H  (2 
diastereomers)),  3.36-3.42  (m,  1H  (4  diastereomers)),  3.28-3.35  (m,  1H  of  2 
diastereomers)),  3.10-3.20  (m,  1H  (4  diastereomers)),  2.40-2.44  (m,  1H  (2 
diastereomers)),  2.30-2.33  (m,  1H  (2  diastereomers)),  2.20-2.25  (m,  1H  (2 
diastereomers)),  2.13-2.18  (m,  1H  (2  diastereomers)),  2.05-2.12  (m,  1H  (4 
diastereomers)),  1.98-2.04  (m,  1H  (2  diastereomers)),  1.86-1.97  (m,  7H  (1H  of  2 
diastereomers and 6H of 4 diastereomers)), 1.78-1.85 (m, 4H (4 diastereomers)), 1.72-
1.77  (m,  1H  (4  diastereomers)),  1.62-1.71  (m,  4H  (4  diastereomers)),  1.60  (s,  3H  (2 
diastereomers)),  1.59  (s,  3H  (2  diastereomers)),  1.49-1.56  (m,  1H  (4  diastereomers)), 
1.34-1.48 (m, 5H (4 diastereomers)), 1.26-1.33 (m, 6H (4 diastereomers)), 1.20-1.24 (m, 
1H (4 diastereomers)), 1.21 (s, 9H (2 diastereomers)), 1.20 (s, 9H (2 diastereomers)), 
    
 
1.15-1.19 (m, 3H (1H of 4 diastereomers and 3H of 2 diastereomers)), 1.13 (d, J = 5.1 
Hz, 3H (2 diastereomers)), 1.06-1.10 (m, 3H (4 diastereomers)), 0.98-1.01 (m, 3H (4 
diastereomers)),  0.95  (t,  J  =  7.9  Hz,  9H  (4  diastereomers)),  0.87-0.93  (m,  39H  (4 
diastereomers)),  0.59-0.63  (m,  6H  (4  diastereomers)),  0.01-0.17  (m,  24H  (4 
diastereomers)) ppm; 
13C NMR (176 MHz, CDCl3) δ 178.4, 149.6, 145.58, 145.50, 145.4, 
140.5, 140.2, 140.1, 139.89, 139.83, 139.7, 138.9, 138.7, 138.57, 138.54, 133.37, 133.31, 
133.1,  132.3,  132.2,  129.2,  129.1,  129.09,  129.00,  128.9,  128.3,  127.1,  125.8,  125.7, 
125.26, 125.22, 125.1, 124.7, 115.3, 114.6, 114.4, 109.5, 100.0, 99.5, 97.8, 97.7, 82.19, 
82.12, 80.6, 80.5, 80.3, 79.6, 79.4, 79.2, 78.8, 78.6, 76.4, 76.3, 76.2, 76.18, 76.15, 72.3, 
72.1, 71.3, 71.1, 70.8, 70.6, 66.3, 65.59, 65.53, 62.17, 62.11, 61.3, 61.2, 60.8, 60.7, 48.4, 
47.3, 47.0, 42.5, 42.2, 41.8, 41.5, 41.3, 40.8, 40.37, 40.33, 39.6, 38.7, 38.1, 38.0, 36.6, 
36.0, 35.8, 35.1, 34.6, 34.5, 33.7, 33.1, 33.0, 32.8, 32.6, 32.5, 31.6, 30.93, 30.90, 30.0, 
29.7, 29.3, 29.0, 28.8, 28.77, 28.72, 28.6, 28.4, 27.8, 27.7, 27.2, 25.3, 24.7, 23.8, 23.3, 
22.7, 22.5, 20.9, 20.79, 20.74, 20.6, 20.5, 18.8, 18.4, 18.37, 18.34, 18.28, 18.23, 18.0, 
17.9, 16.0, 15.9, 15.5, 15.4, 15.3, 14.1, 14.0, 11.9, 11.4, 11.3, 6.94, 6.91, 5.0, -3.8, -4.1, -
4.2,  -4.3,  -4.4,  -4.5,  -4.65,  -4.69,  -5.01,  -5.05  ppm;  HRMS  (ES+)  calcd.  for 
C86H160O13SSi5Na (M+Na) 1596.0324, found 1596.0127.  
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  Ketone 6.28 and Keto-ol 6.29: To a stirred solution of sulfone 6.26 (171.6 mg, 
0.109 mmol) in THF (1.9 mL) at -50 ºC was added LDA
3 (0.27 mL, 0.270 mmol, 1 M in 
THF / hexanes). After 5 min, DMPU (1.06 g, 1.0 mL, 8.23 mmol) was added and slowly 
warmed to -35 ºC over 15 min. The reaction was cooled back down to -50 ºC and a 
solution of Davis’ oxaziridine
4 (78.3 mg, 0.299 mmol) in THF (0.85 mL) was cannulated 
to it. The reaction was warmed to -35 ºC over 15 min and then quenched with sat. aq. 
NH4Cl (25 mL). The aqueous layer was extracted with Et2O (3 X 40 mL). The dried 
(MgSO4) extract was concentrated in vacuo and purified by flash chromatography over 
silica gel, eluting with 6-20% EtOAc / hexanes, to give ketone 6.28 (92.5 mg, 63.8 µmol, 
59%) and keto-ol 6.29 (24.2 mg, 17.7 µmol, 16%) as colorless oil along with recovered 
sulfone 6.26 (39.6 mg, 25.1 µmol, 23%). [α]D
23 = +17.0 (c = 1.00, C6H6); IR: (neat) 2956, 
2929, 2856, 1731, 1725, 1462, 1376, 1251, 1155, 1076, 835, 776 cm
-1; 
1H NMR {700 
MHz,  CDCl3  (two  diastereomers)}  δ  6.48  (ddd,  J  =  11.0,  4.5,  1.1  Hz,  1H  (1 
diastereomer)), 6.45 (ddd, J = 11.0, 4.5, 1.1 Hz, 1H (1 diastereomer)), 6.06 (d, J = 10.9 
Hz, 1H (2 diastereomers)), 5.66 (dd, J = 6.1, 4.4 Hz, 1H (1 diastereomer)), 5.64 (dd, J = 
6.2, 4.4 Hz, 1H (1 diastereomer)), 5.59 (s, 1H (2 diastereomers)), 5.53 (ddd, J = 15.1, 6.0, 
    
 
3.2  Hz,  1H  (2  diastereomers)),  5.32  (s,  1H  (2  diastereomers)),  5.14  (s,  1H  (2 
diastereomers)), 4.96 (s, 1H (2 diastereomers)), 4.87 (s, 1H (2 diastereomers)), 4.68 (q, J 
= 5.2 Hz, 1H (1 diastereomer)), 4.66 (q, J = 5.2 Hz, 1H (1 diastereomer)), 4.41 (s, 1H (2 
diastereomers)),  4.35-4.38  (m,  1H  (2  diastereomers)),  4.25-4.28  (m,  1H  (2 
diastereomers)),  4.10-4.15  (m,  2H  (2  diastereomers)),  4.08  (s,  1H  (2  diastereomers)), 
3.91-4.01 (m, 3H (2 diastereomers)), 3.74-3.78 (m, 1H (1 diastereomer)), 3.58-3.67 (m, 
2H  (1H  of  1  diastereomer  and  1H  of  2  diastereomers)),  3.46-3.53  (m,  2H  (2 
diastereomers)), 3.33 (dt, J = 9.1, 2.7 Hz, 1H (2 diastereomers)), 2.78 (qd, J = 6.9, 4.4 Hz 
,  1H  (1  diastereomer)),  2.62-2.67  (m,  1H  (1H  of  1  diastereomer  and  1H  of  1 
diastereomer)), 2.57-2.66 (m, 2H (1H of 1 diastereomer and 1H of 2 diastereomers)), 
2.59  (dd,  J  =  17.5,  6.3  Hz,  1H  (1  diastereomer)),  2.54  (dd,  J  =  5.7,  2.6  Hz,  1H  (1 
diastereomer)), 2.52 (dd, J = 5.7, 2.6 Hz, 1H (1 diastereomer)), 2.37-2.41 (m, 1H (2 
diastereomers)),  2.04-2.08  (m,  1H  (2  diastereomers)),  1.96-2.03  (m,  1H  (2 
diastereomers)),  1.87-1.92  (m,  3H  (2  diastereomers)),  1.78-1.86  (m,  3H  (2 
diastereomers)), 1.82 (s, 3H (2 diastereomers)), 1.64-1.74 (m, 3H (2 diastereomers)), 1.60 
(s,  3H  (2  diastereomers)),  1.48-1.52  (m,  1H  (2  diastereomers)),  1.36-1.46  (m,  4H  (2 
diastereomers)),  1.26-1.33  (m,  6H  (2  diastereomers)),  1.20-1.23  (m,  12H  (2 
diastereomers)), 1.08 (d, J = 7.0 Hz, 3H (2 diastereomers)), 1.06 (d, J = 7.0 Hz, 3H (1 
diastereomer)), 1.05 (d, J = 7.0 Hz, 3H (1 diastereomer)), 0.98 (d, J = 6.4 Hz, 3H (2 
diastereomers)),  0.96  (t,  J  =  7.9  Hz,  3H  (2  diastereomers)),  0.89-0.92  (m,  39H  (2 
diastereomers)), 0.62 (q, J = 7.9 Hz, 6H (1 diastereomers)), 0.61 (q, J = 7.9 Hz, 6H (1 
diastereomers)), 0.116 (s, 3H (1 diastereomer)), 0.114 (s, 3H (1 diastereomer)), 0.08 (s, 
    
 
3H (2 diastereomers)), 0.06 (s, 3H (2 diastereomers)), 0.046 (s, 3H (2 diastereomers)), 
0.043  (s,  3H  (1  diastereomer)),  0.041  (s,  3H  (1  diastereomer)),    0.026  (s,  3H  (2 
diastereomers)), 0.022 (s, 3H (2 diastereomers)), 0.009 (s, 3H (1 diastereomer)), 0.007 (s, 
3H (1 diastereomer)) ppm; 
13C NMR (176 MHz, CDCl3) 213.1, 212.7, 178.4, 149.6, 
145.1,  140.93,  140.90,  138.5,  138.4,  132.18,  132.11,  127.24,  127.20,  125.4,  125.2, 
115.05, 115.00, 109.5, 99.8, 98.5, 82.1, 80.7, 80.46, 80.43, 79.4, 78.8, 78.5, 76.2, 76.1, 
75.9, 75.8, 72.6, 71.3, 70.48, 70.40, 62.1, 61.4, 61.1, 47.96, 47.92, 45.6, 45.4, 43.1, 42.8, 
41.8, 41.3, 40.3, 38.7, 38.0, 37.1, 37.0, 33.1, 32.9, 32.6, 30.9, 30.1, 27.6, 27.2, 26.1, 
25.98, 25.90, 25.8, 22.5, 20.8, 20.7, 18.4, 18.37, 18.34, 18.0, 17.1, 16.2, 16.0, 15.8, 15.4, 
15.3, 14.1, 14.0, 11.9, 6.9, 4.9, -4.2, -4.44. -4.44, -4.77, -4.79, -4.8, -5.00, -5.05 ppm; 
HRMS (ES+) calcd. for C80H154O12Si5Na (M+Na) 1470.0184, found 1470.0157.  
 
                                                 
1. Trost B. M.; Weiss, A. H.; Wangelin A J.-V J. Am. Chem. Soc. 2006, 128, 8-9. 
2. Ragoussis, V.; Giannikopoulos, A.; Skoka, E.; Grivas, P. J. Agric. Food Chem. 2007, 
55, 5050-5052. 
3. Preparation of LDA Solution: To a solution of diisopropylamine (0.14 mL / mmol) 
in THF (0.46 mL / mmol) at -78 °C was added n-BuLi (0.40 mL / mmol, 2.5 M in 
hexanes).  After  5  min,  the  white  slurry  was  warmed  to  -10  °C  and  stirred  for  an 
additional 15 min. 
4. Davis, F. A.; Stringer, O. D. J. Org. Chem. 1982, 47, 1774-1775. 
    
CHAPTER VII: CONCLUSION AND FUTURE WORK 
 
7.1 General Conclusion 
 
In  summary,  the  first  total  synthesis  of  amphidinolide  F  (1.16)  has  been 
accomplished in 28 steps (longest linear steps).
1 We have also generated the all-carbon 
framework of amphidinolide C (1.14), a more complex and the most potent member of 
this subfamily. During our endeavor toward the total syntheses of amphidinolides C / F, 
we have uncovered a “hidden symmetry element” present in the northern and southern 
tetrahydrofuran domains of these natural products (Scheme 7.1). It was noticed that the 
C1-C8 and C18-C25 segments contained nearly identical functionalization, oxidation state 
and  stereochemical  information.  This  observation  led  us  to  design  a  common 
intermediate strategy. Ketone 3.30 provided access to over half the carbon backbone of 
the macrocycle as well as the majority of the stereochemistry present in amphidinolides C 
/ F. This strategy largely simplified the bond disconnections for these targets.  
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Scheme 7.1. Common Intermediate Strategy 
    
During the course of our synthetic effort toward amphidinolides F, C, C2 and C3, 
we  have  developed  or  explored  several  important  protocols.  Two  tactically  different 
reaction sequences have been devised for accessing the key isomerization / cyclization 
precursor 3.19 (Scheme 7.2). In our first-generation approach, a scalable 9-step sequence 
(total steps count 12) delivered the doubly propargyl ester / alcohol 3.19 in multigram 
quantity. Sonogashira cross-coupling
2 and Sharpless asymmetric dihydroxylation
3 were 
utilized as key steps in this approach. An improved second-generation synthesis produced 
the same propargyl-benzoate / diol 3.19 in 5 steps (total steps count 6). The propargyl 
benzoate  moiety  was  incorporated  via  Carreira  asymmetric  alkynylation
4 during  our 
second-generation approach. 
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Scheme 7.2. Preparation of Isomerization / Cyclization Precursor 3.19 
 
We  successfully  executed  the  gold  or  silver-catalyzed  dihydrofuran  formation 
technique  in  our  natural  product  synthesis  (Scheme  7.3).  The  silver-catalyzed 
isomerization / cyclization on propargyl benzoate / diol 3.19 provided an efficient access 
to the 2,5-dihydrofuran precursor 3.20. The stereogenicity of the propargyl benzoate 3.19 
was  completely  transferred  into  product  dihydrofuran  3.20.  This  transformation  was 
routinely performed on 5-gram scale and delivered the common ketone intermediate 3.30 
in multigram quantity. Ketone 3.30 could be diversified to variety of fully substituted 
    
tetrahydrofurans and might serve as a building block for various trans-disposed furan-
containing natural products.
5 
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Scheme 7.3. Construction of the Common Intermediate and Possible Diversification  
 
    
  The common intermediate 3.30 was differentiated into two distinct tetrahydro-
furan domains of amphidinolides C / F (Scheme 7.4). Direct enolate trapping of ketone 
3.30  incorporated  the  C4-methyl  moiety  from  wrong  face  of  the  5-membered  ring. 
Alternately, ketone 3.30 was converted to enone 3.33 and a face selective hydrogenation, 
governed  by  the  intrinsic  substrate  geometry,  generated  the  desired  stereochemical 
combination  3.32.  An  efficient  three-step  deoxygenation  of  ketone  3.32  provided  the 
fully functionalized C1-C8 southern tetrahydrofuran subunit 3.35. Direct deoxygenation 
of ketone 3.30 furnished the C18-C25 northern tetrahydrofuran segment 3.41.  
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Scheme 7.4. Elaboration of Common Intermediate 3.30 to C1-C8 and C18-C25 Fragments 
    
Another highlight of our work is synthesis of the C10-C14 vinyl iodide fragment 
2.21 in multigram quantity (Scheme 7.5). A regio- and stereoselective opening of the 
vinyl iodide / allylic epoxide 2.37 provided access to the C12, C13 anti-stereochemistry. 
To our best knowledge, this is the first example of regio- and stereoselective opening of a 
vinyl iodide / allylic epoxide by alkyl nucleophile. The reaction was optimized for gram-
scale generation of the requisite vinyl iodide in good diastereoselectivity. Incorporation 
of the C12, C13 substituents via traditional anti-aldol protocol failed to generate the vinyl 
iodide precursor 2.21.  
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Scheme 7.5. Me3Al-mediated Diastereoselective Epoxide Ring Opening 
 
    
We have established strategically two different techniques for the C9-C11 non-
thermodynamic diene preparation (Scheme 7.6). An efficient metal catalyst free Weinreb 
amide - vinyl lithium coupling / methylenation sequence was utilized to access the 1,3-
diene motif. While this sequence worked smoothly on our model system, we were unable 
to implement the strategy during the real synthesis. In an alternate approach, a diastereo-
selective addition of the dienyl iodide 4.25 derived 2-lithio-1,3-diene species to α-oxy 
aldehyde  4.3  installed  the  C9-C11  diene  and  secured  the  C8  stereochemistry  in  single 
operation. Major product from this reaction was the Felkin-controlled alcohol 4.17. The 
dienyl iodide 4.25 was prepared via a regioselective hydrostannylation on enyne 4.23. 
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Scheme 7.6. C9-C11 Diene Construction: Two Different Strategies 
    
  We have explored the Tamura / Vedejs olefination
6 for stereoselective installation 
of side chains for both amphidinolides C and F (Scheme 7.7). While the Julia-Kocienski 
olefination
7 displayed  preference  for  the  undesired  cis-isomer  on  our  α-oxy-aldehyde 
5.30, the Vedejs-type tributyl phosphonium salt 5.4 furnished the requisite trans-product 
5.31 in good selectivity. Temperature played a significant role during incorporation of the 
amphidinolide C (1.14) side arm using Tamura protocol, leading to decomposition of the 
phosphonium  bromide  6.15  at  higher  temperature  (above  -25  ºC).  We  were  able  to 
circumvent this problem by lowering the temperature and increasing the aldehyde to salt 
ratio and the conjugated diene 6.3 was obtained in excellent yield. This protocol could be 
generally employed for trans-stereoselective diene formation. 
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Scheme 7.7. Stereoselective Diene Installation via Tamura / Vedejs Protocol 
 
    
We have successfully executed the challenging alkylations between α-branched 
sulfones and α-silyloxy iodide to generate the all-carbon framework of amphidinolides F 
and  C  (Scheme  7.8).  An  efficient  oxidative  desulfurization  on  the  coupled  sulfone 
incorporated the carbonyl moiety at C15. To our best knowledge, this is the most complex 
example of this kind of oxidation in natural product synthesis. This two-step sequence 
(sulfone alkylation / oxidation) led to an overall umpolung process and circumvented any 
problematic furan formation between C15, C18 1,4-diketone present in amphidinolides F / 
C. The strategy could provide access to different unsymmetrical ketones and could be 
viewed as a viable alternative to traditional dithiane chemistry.
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Scheme 7.8. Alkylation / Oxidative Desulfurization: An Overall Umpolung Strategy 
 
  Protection  /  deprotection  has  tremendous  impact  in  poly-oxygenated  natural 
product synthesis. Proper selection of the protecting groups is very imperative in this 
context. In our system, we finally required to take off the protecting groups in presence of 
sensitive dienes and allyl ester moiety. We also needed to tackle the delicate C15, C18 1,4-
    
diketone unit. Utilization of suitable silyl ethers and relatively less known ethoxyethyl 
(EE) ether as protecting groups helped us to solve the deprotection complicacy (Scheme 
7.9).  An  unusual  desilylatig  agent  (Et3N•3HF)  was  employed  for  the  final  global 
deprotection to deliver amphidinolide F (1.16).  
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Scheme 7.9. Game of Protecting Group in Poly-oxygenated Natural Product 
 
Finally, during course of the synthesis, we have unambiguously assigned all the 
stereochemistry present in amphidinolide F (1.16) by Mosher ester analysis,
9 chemical 
degradation and comparison study. By comparing the NMR and optical rotation data of 
natural  and  synthetic  amphidinolide  F,  we  have  confirmed  the  relative  and  absolute 
stereochemistry of the natural product 1.16, which was assigned based on analogy to 
amphidinolide C (1.14) and the fact that both were isolated from same microorganism.  
    
7.2 Proposed Future Work 
 
  We have established an efficient synthetic route for amphidinolide F (1.16). The 
all-carbon  framework  of  amphidinolides  C,  C2  and  C3 ( 1.14,  1.15  and  6.1)  has  been 
prepared in reasonable quantity. The proposed future work would include completion of 
the  total  syntheses  of  amphidinolides  C,  C2  and  C3.  Interestingly,  amphidinolide  C 
containing the same macrocyclic core as amphidinolide F with different side arm displays 
250-700 times stronger cytotoxicity than amphidinolide F (Table 7.1). Another member 
of the family, amphidinolide U (1.17) that possesses the same sidearm as amphidinolide 
C but, differ in the macrocyclic core also exhibited much diminished activity.
10 These 
observations  suggest  that  the  25-membered  macrolactone  ring  may  be  essential  for 
cytotoxicity, and the side chain can affect the potency of cytotoxic activity significantly. 
This opens up a window for structure activity relationship (SAR) study of the analogues 
with same macrocyclic core, but different side chains. We intend to make some such 
analogues with different sidearms and test the bioactivities. 
 
    
O
O
O
OH
Bu O
HO
O
1
8
19
24
amphidinolide U (1.17)
H
H
29
OH
OH
HO
O H H
O
H
O
1
O
amphidinolide C3 (6.1)
24
O
O H
O
Bu
29
24
OH
OH
HO
O H H
O
H
O
1
O
O
O H
amphidinolide F (1.16)
29
OH
OH
HO
O H H
O
H
O
1
O
amphidinolide C  (1.14) R = H
amphidinolide C2 (1.15) R = Ac
24
O
O H
OR
Bu
 
 
Entry  Amphidinolides  L1210 Cells 
(IC50 Value) 
KB Cells 
(IC50 Value) 
1  amphidinolide C (1.14)  5.8 ng/mL  4.6 ng/mL 
2  amphidinolide C2 (1.15)  0.8 µg/mL  3.0 µg/mL 
3  amphidinolide C3 (6.1)  7.6 µg/mL  10.0 µg/mL 
4  amphidinolide F (1.16)  1.5 µg/mL  3.2 µg/mL 
5  amphidinolide U (1.17)  12 µg/ mL  >20 µg/mL 
 
Table 7.1. Structural Similarity and Comparison of Cytotoxicity 
 
  
 
    
Future work might include devising a general strategy to access the analogues 
(Scheme 7.10). Rather than going back several steps to make different sulfone subunits 
with different side chains, we would like to prepare common macrocyclic intermediates 
(7.3 or 7.4) for the analogues. The macrocyclic aldehyde 7.3 or vinyl iodide 7.4 could 
arise from the common dihydrofuran intermediate 3.20. Common advanced intermediates 
(7.3  or  7.4)  could  be  diversified  into  variety  of  analogues  (Scheme  7.11).  Propargyl 
alcohol, allyl alcohol, conjugated aldehyde or truncated arm in the side chain could bring 
variety in the structure activity relationship (SAR) study. 
 
O
TBSO
HO
BzO
OPiv
H H
3.20
Common
intermediate
OTBS
OTBS
TBSO
O H H
OTES
O H
H
SO2Ph
OEE
OTBS
OPiv
I
7.2
4.1
OTBS
OTBS
TBSO
O H H
O
O H
H
O
O
OEE
X
Diversiﬁcation of the
common intermediate
7.3 X = O 
7.4 X = CH2I
Common macrocyclic
aldehyde or vinyl iodide
 
 
Scheme 7.10. Proposed Strategy to Common Macrocyclic Intermediates 
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Scheme 7.11. Diversification of the Common Intermediate to Proposed Analogues 
 
  Beside the analogue study, future work might include improvement of several 
steps, including the silver-catalyzed isomerization / cyclization to access dihydrofuran 
3.20  (Scheme  7.12).  Formation  of  furan  by-product  3.21  suggested  the  competitive 
nucleophilicity between the benzoate ester and the distal hydroxyl moieties in propargyl 
benzoate  /  diol  3.19  during  the  silver-catalyzed  cyclization  event  (for  detailed 
mechanism, see Chapter III). From this finding, we propose that a more nucleophilic ester 
could suppress the formation of furan by-product 3.21. More nucleophilic benzoates (e.g. 
p-alkylbenzoates,  p-methoxybenzoate,  p-bromobenzoate)  could  serve  as  possible 
alternatives.  
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Scheme 7.12. Proposed Modification for Improved Dihydrofuran Formation 
 
Future  work  might  also  include  use  of  chiral  ligands  (e.g.  methylephedrine, 
sparteine)  to  improve  the  diastereoselectivity  of  dienyl  lithium  /  aldehyde  addition 
reaction (Scheme 7.13). Alternately, the dienyl lithium 4.28 could be in situ converted to 
dienyl zinc species 7.12 and then chiral ligand directed addition
11 to aldehyde 4.3 could 
provide an improved selectivity.  
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Scheme 7.13. Proposed Optimization for the Stereoselective Organometallic Addition 
 
  Arylsulfone-mediated carbon-carbon bond formation is a well-established organic 
reaction. After alkylation, the arylsulfone unit could be β-eliminated, reduced or oxidized 
to different functional groups. While β-elimination and reduction of sulfone have found 
much more synthetic applications,
12 proportionally limited utilization has been made for 
oxidative desulfurization of the arylsulfone moiety.
13 Unsymmetrical ketone is a common 
organic building block and its generation via sulfone alkylation / oxidation could serve as 
valuable  alternative  to  traditional  dithiane  chemistry.
8  Unfortunately,  most  oxidative 
desulfurization process provides modest isolated yield with the mass being balanced by 
recovered  starting  material.
1,13  Future  work  might  include  efforts  to  improve  the 
conversion ratio by adjusting the reaction parameters for better isolated yield. The first 
aspect that should be explored would be modification of the electronic nature of the 
    
arylsulfone  moiety  (Scheme  7.14).  We  propose  that  incorporation  of  an  electron-
withdrawing group in aryl unit could assist the transformation in two ways - 1) it would 
help deprotonation and hence should increase the solution concentration of the sulfone 
carbanion, 2) it would work as better leaving group in the desulfurization event.
14 We 
would introduce m- or p-chloro-, m- or p-fluoro-, m- or p-nitro-, m- or p-trifluoromethyl-
phenylsulfone to serve this purpose. We also intend to optimize the oxidizing agents (e.g. 
Davis’ oxaziridine, molecular O2 / P(OEt)3, TMSOOTMS, MoOPH etc.) and bases to 
evaluate the correct combination of reaction conditions. After the optimization, we could 
implement this methodology for one-flask unsymmetrical ketone 7.20 synthesis starting 
from simple arylmethylsulfone 7.17 (Scheme 7.15). Interestingly, no report of one-flask 
unsymmetrical ketone generation from arylalkylsulfone has been documented to date.  
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Scheme 7.14. Proposed Modifications on Oxidative Desulfurization 
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Scheme 7.15. One-flask Unsymmetrical Ketone Synthesis via Oxidative Desulfurization 
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PART II: COMPUTATIONAL STUDY ON PROLINE 
SULFONAMIDE-CATALYZED ALDOL REACTION 
 
CHAPTER VIII. ORIGIN OF STEREOSELECTIVITY IN PROLINE 
SULFONAMIDE-CATALYZED ALDOL REACTION 
 
 
8.1 Introduction 
 
  The aldol reaction has emerged as one of the most powerful carbon-carbon bond 
forming reaction after its initial invention back in 1838.
1 A myriad of advancement has 
been made to control the stereoselectivity of the reaction.
2 Organocatalysis provides a 
practical and user-friendly method for this widely used transformation.
3 Organocatalyzed 
aldol reactions mostly provide the anti-aldol adduct as major product. The mechanism 
and stereoselectivity of the proline-catalyzed aldol reaction has been previously explored 
by Houk and co-workers;
4 however, the divergent nature of the stereoselectivities based 
on catalyst modification and substrate scope is not fully understood. Recently, the Carter 
group has reported a highly enantio- and diastereoselective aldol reaction catalyzed by a 
practical  proline  mimetic  N-(p-dodecylphenylsulfonyl)-2-pyrrolidinecarboxamide  8.3 
(Scheme  8.1).
5 The  Cheong  group  has  conducted  a  detailed  computational  study  to 
explain the enhanced stereoselectivity of proline sulfonamide-catalyzed aldol reactions.
6 
This chapter concerns the experimental and computational study to explain the improved 
stereoselectivity in proline sulfonamide-catalyzed aldol reactions.  
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Scheme 8.1. Proline Sulfonamide-catalyzed Aldol Reaction 
 
8.2 Comparison of Stereoselectivity of Various Organocatalyzed Aldol 
Reactions 
 
  A comparison of stereoselectivity among the proline sulfonamide catalyst 8.3 and 
a range of known organocatalysts under a single set of optimized reaction conditions is 
shown in table 8.1. All of the screened catalysts facilitated the reaction with comparable 
enantioselectivity  (98-99%);  however,  diastereoselectivity  of  the  transformation  was 
sensitive to the catalyst scaffold. While all of the sulfonamide catalysts (8.10, 8.11, 8.12 
and 8.3) displayed excellent diastereoselectivity (65-99:1 dr), the tetrazole 8.9 and proline 
8.8 exhibited diminished diastereomeric ratios (7:1 and 13:1 dr respectively). The reason 
of  enhanced  diastereoselectivity  in  proline  sulfonamide  catalyzed  aldol  reaction  was 
unknown.  Herein,  we  describe  the  quantum  mechanical  prediction  of  the  enhanced 
diastereoselectivity. 
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Entry  Catalyst  ee  dr  Yield 
1  8.8  98%  13:1  22% 
2  8.9  98%  7:1  91% 
3  8.10  99%  65:1  42% 
4  8.11  98%  83:1  49% 
5  8.12  99%  92:1  52% 
6  8.3  99%  >99:1  95% 
 
Table 8.1. Comparison of Stereoselectivity of Selected Proline Mimetics 
 
 
 
 
    
8.3 Houk’s Computational Study on Proline-catalyzed Aldol Reaction 
 
The  mechanism  and  stereoselectivity  of  proline-catalyzed  intermolecular  aldol 
reaction has been described earlier by Houk and coworkers (Scheme 8.2).
4b An organized 
hydrogen-bonding network involving the proline carboxylic hydrogen and the aldehyde 
oxygen  contributes  to  the  electrostatic  stabilization  of  the  transition  state  (TS).  The 
proton transfer from carboxyl to aldehyde in the C-C bond-forming transition state (TS) 
is  key  for  the  stereocontrol  in  the  proline-catalyzed  aldol  reactions.  In  addition  to 
hydrogen-bonding setup, staggered arrangement of the substituents around the forming 
C-C bond diminishes steric repulsions in the transition state. By considering these two 
key  criteria,  four  possible  diastereomeric  enamine  aldol  transition  states  could  be 
identified:  TS-Anti-Re,  TS-Anti-Si,  TS-Syn-Re  and  TS-Syn-Si.  The  catalyst  8.8  and 
cyclohexanone 8.5 could generate anti and syn enamines (8.13 and 8.17 respectively). Re 
or  si  facial  attacks  on  aldehyde  8.14  by  the  enamines  would  give  rise  four  possible 
products 8.15, 8.16, 8.18 and 8.19. Anti / syn signifies the arrangement of the enamine 
with  respect  to  carboxylic  acid  moiety,  while  re  /si  implies  the  facial  attack  on 
electrophilic aldehyde. Houk’s quantum mechanical calculations revealed that due to the 
optimal hydrogen-bonding network, the TS-Anti-Re was the most stable one leading to 
anti-aldol adduct 8.15 as major diastereomer. 
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Scheme 8.2. Houk’s Study on the Mechanism of  
Proline-catalyzed Intermolecular Aldol Reaction 
 
8.4 Results and Discussion 
 
8.4.1 Sulfonamide as Proline Mimetic: pKa Determination of the Amide 
Proton by Experimental Way 
 
  Acidic nature (pKa value) of the catalyst has great impact in catalytic efficiency 
in organocatalyzed aldol reactions. Houk’s model explains that enantio- and diastereo-
selectivity of the proline-catalyzed intermolecular aldol reaction is governed by a strong 
hydrogen-bonding network involving carboxylic acid hydrogen. For better understanding 
of the catalytic machinery in the proline sulfonamide-catalyzed aldol reaction, it was 
    
necessary to recognize the acid / base property of the catalysts. Recently, Shi and co-
workers have performed detailed theoretical studies on the acidities of various proline 
amide  derivatives.
7 However,  none  of  the  pKa  values  of  these  proline  sulfonamide 
catalysts has been experimentally measured to date.  
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Figure 8.1. Unknown Experimental pKa Value of Proline Sulfonamide Catalyst  
 
  We have experimentally determined pKa value of the proline sulfonamide catalyst 
8.10  by  NMR  titration  technique  (Plot  8.1).  Perrin  and  co-workers  have  described  a 
multicomponent NMR titration technique for measurement of the relative pKa values.
8 
The group demonstrated simultaneous measurement of the relative pKas (∆pKas) in up to 
four-component systems. We utilized this method for relative pKa determination of the 
proline sulfonamide 8.10 with respect to parent proline 8.8. A mixture of proline 8.8 and 
sulfonamide 8.10 in CD3OD / D2O (3:1) was titrated with NaOD solution and the change 
in 
1H NMR and 
13C NMR chemical shifts were recorded (see the experimental section). 
From this titration, we found the chemical shift values for - 1) PHº (proline in complete 
protonated form), 2) P
- (proline in complete deprotonated form), 3) PMHº (sulfonamide 
in complete protonated form) and, 4) PM
- (sulfonamide in complete deprotonated form). 
    
A linearized plot of {(δP - δPHº)(δPM
- - δPM)} vs {(δPM - δPMHº)(δP
- - δP)} (from 
1H NMR 
chemical shift value) provided a straight line with slope 3.898. From slope, the difference 
between pKas of proline 8.8 and sulfonamide 8.10 was calculated to be 0.59. Since we 
know the pKa(1) of proline is 1.99, the pKa of the proline sulfonamide 8.10 should be 
(1.99+0.59) = 2.58. This indicates the sulfonamide catalyst 8.10 is less acidic than the 
parent proline 8.8. The calculated pKa value using 
13C NMR chemical shifts was in good 
accord with that of using 
1H NMR chemical shifts (2.57).  
 
 
 
Plot 8.1. Linearized Plot of {(δP - δPHº)(δPM
- - δPM)} vs {(δPM - δPMHº)(δP
- - δP)}  
from 
1H NMR Chemical Shift Values 
 
 
 
 
    
8.4.2 Computational Study: The Method 
 
We have developed a computational model to describe the large improvements in 
diastereoselectivity that is uniquely observed with proline sulfonamide-catalyzed aldol 
reactions  (see  Table  8.1).  For  optimal  computational  efficiency,  we  used  the  proline 
sulfonamide 8.10 as a model catalyst and benzaldehyde 8.14 as a model electrophilic 
component. Intermolecular aldol reaction between the sulfonamide and cyclohexanone 
derived enamine and benzaldehyde was explored computationally using DFT (B3LYP /6-
31G*)  geometries  and  thermochemistries,
9  augmented  with  SCS-MP2  energies 
extrapolated to infinite basis (extrapolated from cc-pVTZ and cc-pVQZ results).
10 Use of 
the two-point extrapolation to infinite basis eliminates the basis set truncation - a major 
source of error in computations. Single point solvation corrections for dichloromethane 
(CH2Cl2) were computed using PCM with the UAKS radii at the B3LYP/6-31+G** level 
of theory.  
 
8.4.3 Origin of Enhanced Diastereoselectivity: Presence of Non-classical 
Hydrogen Bonding 
 
A  detailed  conformational  analysis  has  been  performed  to  find  the  possible 
additional  interactions  in  sulfonamide-catalyzed  aldol  reactions  compared  to  proline 
(Scheme 8.3). Analogous to proline catalysis, the major diastereomer 8.15 from proline 
sulfonamide-catalyzed aldol reaction arose from the TS-Anti-Re, and the minor isomer 
8.16 from the TS-Anti-Si. All the computational methods employed (B3LYP/6-31G*, 
    
B3LYP/6-31G*//MP2/∞ and B3LYP/6-31G*//SCS-MP2/∞) were in agreement with the 
significant energetic preferences for the TS-Anti-Re. The computed result indicated that 
energetic preference for the TS-Anti-Re transition state was >4.5 kcal/mol (or >3.7 with 
solvation corrections) over the TS-anti-si. It should be mentioned that computed energy 
difference  in  the  proline  sulfonamide  series  is  ~3  kcal/mol  more  selective  than  that 
calculated for proline.
4  
We noticed substantial additional stabilizing interactions in proline sulfonamide-
catalyzed C-C bond forming transition states compared to parent proline. Among these, 
two non-classical hydrogen bonding interactions between sulfonamide oxygens and 1) 
hydrogen of the aldehyde electrophile (distance O-HCOPh = 2.9 Å) and 2) the cyclohexyl 
enamine (distance O-Enamine H = 2.6 Å) that stabilized the TS-Anti-Re in C-C bond-
forming event. In the disfavored TS-Anti-Si, these favorable interactions were replaced 
by steric repulsions from the intercalating phenyl ring (analogous O-Enamine H distance 
= 4.0 Å). This loss of stabilizing electrostatic interactions and gain of repulsive steric 
interactions in the TS-Anti-Si caused the proline-sulfonamide catalysts to be ~3 kcal/mol 
more selective than other proline-based catalysts. Thus, the greatly enhanced diastereo-
selectivity of proline sulfonamide catalysts over proline is due to presence of those two 
non-classical hydrogen bonds. 
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Scheme 8.3. Lowest Energy Transition Structures for Proline Sulfonamide-catalyzed 
Aldol Reaction (Distances are in Ångstroms, energies in kcal/mol) 
 
    
We have considered role of the sulfonamide conformation in the catalysis. An 
extensive conformational analysis was conducted in order to find the most stable non-
classical  hydrogen-bonding  setup  by  the  sulfonamide.  Three  such  conformations  by 
rotating the sulfone unit around the nitrogen-sulfur bond for the TS-Anti-Re are shown in 
Figure 8.2. In TS-Anti-Re conformation, both the sulfonamide oxygens were in close 
proximity to the aldehyde hydrogen and the cyclohexyl protons. This rotamer found to be 
significantly stable than TS-Anti-Re’ or TS-Anti-Re” arrangements (1.5 and 3.5 kcal/mol 
respectively). The stabilizing non-classical hydrogen bonding interactions were notably 
disturbed in TS-Anti-Re’ or TS-Anti-Re” rotamers. The preference for TS-Anti-Re was 
somewhat diminished with solvation corrections (DCE solvation corrections shown in 
parenthesis), as expected for any electrostatic interactions. 
 
 
 
Figure 8.2. Role of Sulfonamide Conformation in Most Stable Non-classical Hydrogen-
bonding Setup (Distances are in Ångstroms, energies in kcal/mol) 
 
    
Non-classical  hydrogen  bonds,  or  electrostatic  interactions,  are  prevalent  in 
literature. Corey was one of the pioneers to propose formyl (δ+)CH-O(δ-) non-classical 
hydrogen  bonds  as  stabilizing  interactions.
11 Non-classical  hydrogen  bonds  have  been 
subsequently  invoked  by  other  groups  to  explain  stabilizing  relationships.
12  In 
organocatalysis, Houk pointed out that stabilizing electrostatic interactions between the 
CH vicinal to the forming iminum and the forming alkoxide {referred to as the (δ+)NCH-
O(δ-)
  interactions}  contributes  to  the  stereoselectivity  of  proline-catalyzed  aldol 
reactions.
4a These non-classical hydrogen-bonding interactions were also demonstrated as 
stabilizing interactions in stereoselective additions of chiral alcohols to ketenes.
13 The 
magnitude of these stabilizing interactions has also been quantified and demonstrated to 
be significant even in the solution.
14 
We did consider the possibility that enhanced diastereoselectivity of the proline 
sulfonamide catalysts over proline might be due to increased torsional strain around the 
forming bond that stabilized the TS-Anti-Re over other transition states. Interestingly, 
juxtaposing the proline sulfonamide transition structures with those published for proline, 
we did find no evidence that proline-sulfonamide transition structures exhibit drastically 
different torsional strain than proline transition structures. The torsional differences that 
exist could not explain >3 kcal/mol greater selectivity exhibited by proline sulfonamides 
compared to proline. 
 
 
 
    
8.5 Conclusion 
 
  We have performed detailed analytical and computational investigations for better 
understanding of aldol reactions catalyzed by proline sulfonamides. The pKa value of the 
proline  sulfonamide  catalyst  8.10  was  determined  experimentally  via  NMR  titration 
technique. To our best knowledge, this was the first experimental evaluation of pKa for 
any proline sulfonamide catalyst. This technique could be employed on other organo-
catalysts for estimating their acidic nature. The computational study revealed the origin 
of  enhanced  stereoselectivity  by  the  proline  sulfonamide  catalyst  compared  to  parent 
proline. The non-classical hydrogen bonding interactions was responsible for the greatly 
improved diastereoselectivity. 
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8.7 Experimental  
 
pKa Determination of Proline Sulfonamide 8.10 by NMR Titration  
 
A mixture of proline 8.8 (7.5 mg, 0.065 mmol) and sulfonamide 8.10 (1.6 mg, 
8.32 µmol) in CD3OD / D2O (3:1, 0.4 mL) was taken in a 3 mm NMR tube. A stock 
solution of NaOD was prepared by mixing CD3OD (660 mg, 0.74 mL, 18.3 mmol), D2O 
(90  mg,  90  µL,  4.0  mmol)  and  40%  NaOD  /  D2O  (250  mg).  The  proline  8.8  and 
sulfonamide  8.10  mixture  in  NMR  tube  was  treated  with  one  drop  of  NaOD  stock 
solution each time and the 
1H NMR / 
13C NMR chemical shifts (in ppm) was recorded in 
a 400 MHz instrument. The titration was continued until no more change in chemical 
shifts was observed. The chemical shifts of C2-Hs and carbonyl carbons for both proline 
8.8 and sulfonamide 8.10 are listed in the table. 
 
Titration   Proline C2-H  Prolinamide 
C2-H 
Proline C=O  Prolinamide 
C=O 
0  4.051  4.051  173.35  173.35 
1  4.015  3.939  173.83  174.99 
2  3.973  3.836  174.38  176.28 
3  3.926  3.751  174.99  177.34 
4  3.855  3.660  175.92  178.49 
5  3.779  3.594  176.89  179.34 
6  3.684  3.535  178.12  180.10 
7  3.587  3.493  179.39  180.66 
 
    
   
Titration   Proline C2-H  Prolinamide 
C2-H 
Proline C=O  Prolinamide 
C=O 
8  3.488  3.461  180.67  181.08 
9  3.450  3.450  181.16  181.22 
10  3.450  3.450  181.18  181.18 
 
Value  of  PHº  (Proline  in  complete  protonated  form),  P
- (proline  in  complete 
deprotonated  form),  PMHº  (sulfonamide  in  complete  protonated  form)  and  PM
- 
(sulfonamide in complete deprotonated form) were evaluated from the table. 
 
PHº  P
-  PMHº                PM
- 
4.051  3.450  4.051  3.450 
173.35  181.16  173.35  181.22 
 
Calculation for the Value of (δP - δPHº)(δPM
- - δPM) by 
1H NMR Chemical Shift 
Change the During Titration: 
 
Titration 1: (4.015 – 4.051)(3.450 – 3.939) = 0.01760 ppm = 7.04 Hz 
Titration 2: (3.973 – 4.051) (3.450 – 3.835) = 0.03003 ppm = 12.01 Hz 
Titration 3: (3.926 – 4.051)(3.450 – 3.751) = 0.03762 ppm = 15.04 Hz 
Titration 4: (3.855 – 4.051) (3.450 – 3.660) = 0.04116 ppm = 16.46 Hz 
Titration 5: (3.779 – 4.051)(3.450 – 3.594) = 0.03916 ppm = 15.66 Hz 
Titration 6: (3.684 – 4.051) (3.450 – 3.535) = 0.03119 ppm = 12.47 Hz 
Titration 7: (3.587 – 4.051)(3.450 – 3.493) = 0.01995 ppm = 7.98 Hz 
Titration 8: (3.488 – 4.051) (3.450 – 3.461) = 0.00619 ppm = 2.47 Hz 
    
   
Calculation for the Value of (δPM - δPMHº)(δP
- - δP) by 
1H NMR Chemical Shift 
Change the During Titration: 
 
Titration 1: (3.939 - 4.051)(3.450 – 4.015) = 0.06328 ppm = 25.31 Hz 
Titration 2: (3.835 – 4.051)(3.450 – 3.973) = 0.11296 ppm = 45.18 Hz 
Titration 3: (3.751 - 4.051)(3.450 – 3.926) = 0.14280 ppm = 57.12 Hz 
Titration 4: (3.660 – 4.051)(3.450 – 3.855) = 0.15835 ppm = 63.34 Hz 
Titration 5: (3.594 - 4.051)(3.450 – 3.779) = 0.15035 ppm = 60.14 Hz 
Titration 6: (3.535 – 4.051)(3.450 – 3.684) = 0.12074 ppm = 48.29 Hz 
Titration 7: (3.493 - 4.051)(3.450 – 3.587) = 0.07644 ppm = 30.57 Hz 
Titration 8: (3.461 – 4.051)(3.450 – 3.488) = 0.02242 ppm = 8.96 Hz 
 
Linearized plot of [(δP - δPHº)(δPM
- - δPM) vs (δPM - δPMHº)(δP
- - δP)] from 
1H NMR 
Chemical Shift Values: 
 
 
 
    
   
Calculation for the Value of (δP - δPHº)(δPM
- - δPM) by 
13C NMR Chemical Shift 
Change the During Titration:  
 
Titration 1: (173.83 – 173.35)(181.22 – 174.99) = 2.990 ppm 
Titration 2: (174.38 – 173.35)(181.22 – 176.28) = 5.088 ppm 
Titration 3: (174.99– 173.35)(181.22 – 177.34) = 6.363 ppm 
Titration 4: (175.92 – 173.35)(181.22 – 178.49) = 7.016 ppm 
Titration 5: (176.89 – 173.35)(181.22 – 179.34) = 6.655 ppm 
Titration 6: (178.12 – 173.35)(181.22 – 180.10) = 5.342 ppm 
Titration 7: (179.39 – 173.35)(181.22 – 180.66) = 3.382 ppm 
Titration 2: (180.67 – 173.35)(181.22 – 181.08) = 1.024 ppm 
 
Calculation for the Value of (δPM - δPMHº)(δP
- - δP) by 
13C NMR Chemical Shift 
Change the During Titration: 
 
Titration 1: (174.99 – 173.35)(181.16 – 173.83) = 12.021 ppm 
Titration 2: (176.28 – 173.35)(181.16 – 174.38) = 19.865 ppm 
Titration 3: (177.34 – 173.35)(181.16 – 174.99) = 24.618 ppm 
Titration 4: (178.49 – 173.35)(181.16 – 175.92) = 26.933 ppm 
Titration 5: (179.34 – 173.35)(181.16 – 176.89) = 25.577 ppm 
Titration 6: (180.10 – 173.35)(181.16 – 178.12) = 20.520 ppm 
Titration 7: (180.66 – 173.35)(181.16 – 179.39) = 12.938 ppm 
Titration 8: (181.08 – 173.35)(181.16 – 180.67) = 3.378 PPM 
 
    
   
Linearized plot of [(δP - δPHº)(δPM
- - δPM) vs (δPM - δPMHº)(δP
- - δP)] from 
13C NMR 
Chemical Shift Values: 
 
 
 
Calculated Value of pKa from the Plots: 
 
1. From the Excel plot of the 
1H NMR data the slope of the line is 3.898.  
So the log (3.898) = 0.590 is the difference between the pKa of proline and prolinamide. 
Hence the pKa of the Sulfonamide 8.10 is (1.99+0.590) = 2.580. 
 
2. From the Excel plot of the 
13C NMR data the slope of the line is 3.830.  
So the log (3.830) = 0.583 is the difference between the pKa of proline and prolinamide. 
Hence the pKa of the Sulfonamide 8.10 is (1.99+0.583) = 2.573. 
 
So the pKa value is consistent in both methods. 
 
    
   
Supporting Information for the Computed Transition States 
  
TS-Anti-Re 
------------------------------------------------------------------------------ 
 Using Gaussian 03: AM64L-G03RevC.02 12-Jun-2004 
=============================================== 
 #b3lyp/6-31G* geom=check guess=read freq=noraman scf=(tight, maxcycle=300) 
------------------------------------------------------------------------------ 
 Point group = C1   Stoichiometry= C19H26N2O4S   C1[X(C19H26N2O4S)] #Atoms= 52 
 Charge = 0     Multiplicity = 1 
------------------------------------------------------------------------------ 
 SCF Energy= -1548.18003102     Predicted Change= -1.911237D-08 
=============================================== 
 Optimization incomplete. 
 Item      Max Val.    Criteria    Pass?      RMS Val.    Criteria    Pass? 
 Force      0.00002 ||  0.00045   [ YES ]      0.00000 ||  0.00030   [ YES ]      
 Displ      0.00232 ||  0.00180   [ NO ]       0.00232 ||  0.00180   [ YES ]      
------------------------------------------------------------------------------ 
    Atomic           Coordinates (Ångstroms) 
      Type          X                    Y                  Z 
------------------------------------------------------------------------------ 
       C         1.290423      -0.470026      -0.285804 
       H        -1.730575       4.286185      -1.406021 
       H        -1.836921       1.520675       2.186888 
       C        -0.077845       1.125844       3.399027 
       H        -1.244430       3.638326      -2.982389 
       C        -2.522049       2.296677      -1.785014 
       H        -2.375939       1.504444      -2.528243 
       H        -3.542622       2.672396      -1.886080 
       H        -1.157662      -0.071971       1.950187 
       H         0.006618       2.188003       3.668775 
       C         1.278613       1.366854       0.839156 
       H         1.784759       1.904055       0.042215 
       N        -0.815971       1.925092      -0.173672 
       H         0.907426      -1.096218       0.523830 
       C        -0.887731       0.981959       2.099702 
       C        -0.125046       1.483705       0.889140 
       O         0.502812      -0.268998      -1.302011 
       C         2.085128       1.238158       2.118974 
       H        -2.834553       2.309408       0.368650 
       C        -2.272337       1.729612      -0.372110 
       C        -0.222382       2.730080      -1.270995 
       C        -2.779234       0.274593      -0.238089 
       H         1.882502       0.608914       4.182725 
    
   
       C         2.741613      -0.588646      -0.549537 
       H         1.233623      -0.545407       3.022870 
       O        -3.956057       0.121594       0.082029 
       H        -0.563671      -0.468226      -1.006699 
       H         0.476017       3.460654      -0.851088 
       C        -1.441440       3.373037      -1.939680 
       H         0.320145       2.081315      -1.962421 
       C         1.322180       0.527312       3.243830 
       H         2.370147       2.246041       2.460142 
       H         3.029103       0.722815       1.906106 
       H        -0.626180       0.635004       4.210549 
       C         5.484688      -0.881005      -1.052837 
       C         3.560241      -1.285911       0.351705 
       C         3.310340      -0.051703      -1.715705 
       C         4.672344      -0.195500      -1.962404 
       C         4.925120      -1.430361       0.101469 
       H         3.120449      -1.736729       1.237816 
       H         2.670023       0.458871      -2.428093 
       H         5.103596       0.219662      -2.869372 
       H         5.547503      -1.979255       0.802667 
       H         6.547259      -0.993989      -1.249905 
       N        -1.858194      -0.681883      -0.542657 
       S        -2.137274      -2.265522      -0.068173 
       O        -2.432509      -2.319470       1.373153 
       O        -0.979288      -3.015765      -0.578718 
       C        -3.610610      -2.799292      -0.958496 
       H        -4.421015      -2.122623      -0.685824 
       H        -3.399591      -2.764126      -2.028923 
       H        -3.822225      -3.823561      -0.642924 
------------------------------------------------------------------------------ 
 Statistical Thermodynamic Analysis 
 Temperature= 298.150 Kelvin       Pressure= 1.00000 Atm  
=============================================== 
 SCF Energy=     -1548.18003102 Predicted Change= -1.911237D-08 
 Zero-point correction (ZPE)=        -1547.7469  0.43307 
 Internal Energy (U)=                -1547.7229  0.45711 
 Enthalpy (H)=                      -1547.7219   0.45805 
 Gibbs Free Energy (G)=            -1547.8006    0.37940 
------------------------------------------------------------------------------ 
 Frequencies --  -474.2003                27.9688                36.1039 
 
 
    
   
TS-Anti-Si 
------------------------------------------------------------------------------ 
 Using Gaussian 03:  AM64L-G03RevC.02 12-Jun-2004 
=============================================== 
 #b3lyp/6-31G* geom=check guess=read freq=noraman scf=(tight,maxcycle=300) 
------------------------------------------------------------------------------ 
 Point group= C1   Stoichiometry= C19H26N2O4S   C1[X(C19H26N2O4S)]  #Atoms= 52 
 Charge = 0     Multiplicity = 1 
------------------------------------------------------------------------------ 
 SCF Energy= -1548.16999762     Predicted Change= -5.300717D-09 
=============================================== 
 Optimization completed.            {Found        1        times} 
 Item      Max Val.    Criteria    Pass?      RMS Val.    Criteria    Pass? 
 Force      0.00000 ||  0.00045   [ YES ]      0.00000 ||  0.00030   [ YES ]      
 Displ      0.00110 ||  0.00180   [ YES ]      0.00110 ||  0.00180   [ YES ]      
------------------------------------------------------------------------------ 
     Atomic         Coordinates (Ångstroms) 
      Type           X                   Y                   Z 
------------------------------------------------------------------------------ 
       C        -1.281792      -0.189636      -1.618613 
       H         3.211079      -3.318268      -2.036715 
       H         0.043167      -1.854598       2.379740 
       H        -4.191424      -2.113079       1.617339 
       H         2.956669      -1.566757      -1.924518 
       C         3.136268      -2.515954       0.019427 
       H         4.101543      -2.044972       0.214148 
       H         3.169070      -3.537220       0.418027 
       H        -0.761532      -0.428058       1.760803 
       H        -3.164615      -3.366380      -0.151264 
       C        -1.528630      -2.077241      -0.630687 
       H        -1.299598      -2.616201      -1.545708 
       N         0.808548      -2.083420      -0.112028 
       C        -2.118532       0.785023      -0.876461 
       C        -0.756452      -1.525839       1.711433 
       C        -0.464661      -1.949224       0.286593 
       O        -0.002319      -0.059017      -1.819527 
       C        -3.237339      -1.718636       1.247605 
       H         1.870495      -2.057860       1.730139 
       C         1.995281      -1.732029       0.696360 
       C         1.205934      -2.717387      -1.399585 
       C         2.342105      -0.218022       0.788599 
       H        -2.034402      -3.163316       2.323543 
       H        -3.343203      -0.629759       1.197647 
       H        -1.800748      -0.609495      -2.484466 
    
   
       O         3.206167       0.066211       1.619860 
       H         0.688511       0.297830      -1.018076 
       H         0.924779      -3.778896      -1.361843 
       C         2.724252      -2.529027      -1.457000 
       H         0.702099      -2.239656      -2.236385 
       H        -3.656449      -1.851308      -0.876706 
       C        -2.956311      -2.284915      -0.151082 
       H        -2.301483      -1.665078       3.209911 
       C        -2.104230      -2.072209       2.211774 
       C        -3.809117       2.638444       0.390071 
       C        -1.627018       1.616404       0.144028 
       C        -3.465356       0.910948      -1.262043 
       C        -4.306026       1.825717      -0.631492 
       C        -2.468462       2.534024       0.769202 
       H        -0.591973       1.565001       0.453397 
       H        -3.848720       0.301496      -2.077021 
       H        -5.342459       1.913362      -0.945813 
       H        -2.062669       3.176102       1.545287 
       H        -4.459891       3.358816       0.878206 
       N         1.713443       0.606531      -0.087880 
       S         1.989618       2.270719       0.015512 
       O         1.500224       2.784266       1.305261 
       O         1.426169       2.819538      -1.225806 
       C         3.778482       2.499851      -0.038228 
       H         4.216083       1.976102       0.810287 
       H         4.148951       2.111509      -0.988843 
       H         3.946570       3.577667       0.022327 
------------------------------------------------------------------------------ 
 Statistical Thermodynamic Analysis 
 Temperature= 298.150 Kelvin       Pressure= 1.00000 Atm  
=============================================== 
 SCF Energy=     -1548.16999762 Predicted Change= -5.300717D-09 
 Zero-point correction (ZPE)=        -1547.7369  0.43308 
 Internal Energy (U)=                -1547.7129  0.45704 
 Enthalpy (H)=                      -1547.7120   0.45799 
 Gibbs Free Energy (G)=            -1547.7903    0.37962 
------------------------------------------------------------------------------ 
 Frequencies --  -528.3733                19.6165                32.2832 
 
 
    
   
TS-Syn-Re 
------------------------------------------------------------------------------ 
 Using Gaussian 03:  AM64L-G03RevC.02 12-Jun-2004 
=============================================== 
 #b3lyp/6-31G* opt=(calcfc,maxcycle=250,ts,noeigentest,gdiis) freq=noraman 
 scf=(tight,maxcycle=300) 
 #N Geom=AllCheck Guess=Read SCRF=Check GenChk RB3LYP/6-31G(d) Freq 
------------------------------------------------------------------------------ 
 Point group= C1   Stoichiometry= C19H26N2O4S   C1[X(C19H26N2O4S)]  #Atoms= 52 
 Charge = 0     Multiplicity = 1 
------------------------------------------------------------------------------ 
 SCF Energy= -1548.17012098     Predicted Change= -7.611290D-09 
=============================================== 
 Optimization completed.            {Found        2        times} 
 Item      Max Val.    Criteria    Pass?      RMS Val.    Criteria    Pass? 
 Force      0.00003 ||  0.00045   [ YES ]      0.00000 ||  0.00030   [ YES ]      
 Displ      0.00150 ||  0.00180   [ YES ]      0.00150 ||  0.00180   [ YES ]      
------------------------------------------------------------------------------ 
     Atomic         Coordinates (Ångstroms) 
      Type           X                   Y                    Z 
------------------------------------------------------------------------------ 
       H        -0.814207      -0.465336      -0.976428 
       O        -3.061349       0.083601       1.835136 
       C         0.854290      -0.788864      -0.091036 
       H         2.472521       0.194686       2.383720 
       H        -0.659634       2.219973      -2.339916 
       C         2.140895       1.153513       1.968809 
       O         0.212066      -0.486887      -1.201489 
       H        -4.045269       2.240816       0.187822 
       H        -0.856337       3.762916      -1.475218 
       C        -1.155171       2.706608      -1.496568 
       C         4.285161      -1.391320      -1.555722 
       C        -1.950414       1.777278       0.631844 
       H        -2.966510       1.608294      -1.944606 
       C        -2.436713       0.311149       0.795279 
       C         4.218855      -2.299686       0.686357 
       C         0.498536       1.864870       0.169371 
       C         0.841414       0.964959       1.200222 
       C        -3.050115       2.631097      -0.035790 
       N        -0.765854       2.045286      -0.226806 
       H         5.948327      -2.379725      -0.599497 
       H         0.019939       0.607245       1.817068 
       H        -1.729435       2.121550       1.644663 
       H        -3.145699       3.369606      -2.115989 
    
   
       C        -2.680784       2.576327      -1.523756 
       H        -2.999270       3.662107       0.335790 
       C         2.261541      -1.193086      -0.231857 
       H         2.340652      -2.105274       1.722757 
       H         1.926074       1.791428       2.840628 
       H         2.451941      -0.496255      -2.260192 
       H         0.274893      -1.313782       0.669560 
       H         4.819495      -1.221114      -2.486440 
       C         1.609322       2.519209      -0.617375 
       H         4.698439      -2.834796       1.501061 
       C         3.274252       1.782931       1.145751 
       C         4.918795      -2.048115      -0.496043 
       C         2.896444      -1.879911       0.816416 
       C         2.964116      -0.970166      -1.429417 
       H         1.973163       1.793151      -1.359815 
       C         2.766632       2.953782       0.300734 
       H         1.235297       3.379080      -1.178757 
       H         3.715679       1.029591       0.484796 
       H         2.420222       3.767624       0.952739 
       H         3.575018       3.366284      -0.314256 
       H         4.072503       2.119048       1.818338 
       N        -2.194751      -0.502542      -0.261413 
       S        -2.575887      -2.136806      -0.116896 
       O        -1.758335      -2.744374       0.952886 
       O        -2.468218      -2.682137      -1.477232 
       C        -4.307867      -2.235917       0.380670 
       H        -4.420108      -1.720513       1.333317 
       H        -4.917264      -1.776460      -0.400066 
       H        -4.540461      -3.300041       0.465050 
------------------------------------------------------------------------------ 
 Statistical Thermodynamic Analysis 
 Temperature= 298.150 Kelvin       Pressure= 1.00000 Atm  
=============================================== 
 SCF Energy=     -1548.17012098 Predicted Change= -7.611290D-09 
 Zero-point correction (ZPE)=        -1547.7346  0.43548 
 Internal Energy (U)=                -1547.7107  0.45938 
 Enthalpy (H)=                      -1547.7097   0.46032 
 Gibbs Free Energy (G)=            -1547.7887    0.38140 
------------------------------------------------------------------------------ 
 Frequencies --  -243.2889                18.8267                28.4045 
 
 
    
   
TS-Syn-Si 
------------------------------------------------------------------------------ 
 Using Gaussian 03:  AM64L-G03RevC.02 12-Jun-2004 
=============================================== 
 #b3lyp/6-31G* geom=check guess=read freq=noraman scf=(tight,maxcycle=300) 
------------------------------------------------------------------------------ 
 Point group= C1   Stoichiometry= C19H26N2O4S   C1[X(C19H26N2O4S)]  #Atoms= 52 
 Charge = 0     Multiplicity = 1 
------------------------------------------------------------------------------ 
 SCF Energy= -1548.16440706     Predicted Change= -1.477744D-08 
=============================================== 
 Optimization completed.            {Found        1        times} 
 Item      Max Val.    Criteria    Pass?      RMS Val.    Criteria    Pass? 
 Force      0.00000 ||  0.00045   [ YES ]      0.00000 ||  0.00030   [ YES ]      
 Displ      0.00061 ||  0.00180   [ YES ]      0.00061 ||  0.00180   [ YES ]      
------------------------------------------------------------------------------ 
    Atomic         Coordinates (Ångstroms) 
     Type            X                   Y                    Z 
------------------------------------------------------------------------------ 
       H         0.685657       0.196503      -0.903240 
       O         2.752220      -0.268139       1.852536 
       C        -1.469155       0.362904      -0.960192 
       H        -3.560428       0.111500       1.165487 
       H         0.898744      -2.766737      -1.854374 
       C        -3.196288      -0.914575       1.044140 
       O        -0.321444       0.084288      -1.508199 
       H         2.950107      -2.707223       1.798665 
       H         0.355456      -4.135955      -0.860690 
       C         0.882002      -3.177190      -0.841054 
       H        -0.425305       4.316576       1.334304 
       C         1.087559      -1.778232       1.143473 
       H         2.984899      -2.645404      -0.672944 
       C         1.952142      -0.494434       0.944363 
       C        -1.184539       3.718371       0.839033 
       C        -1.142278      -2.010084       0.029458 
       C        -1.726494      -0.881146       0.648920 
       C         2.045358      -2.980846       1.255665 
       N         0.176443      -2.229808       0.060886 
       H        -3.841343       1.587715      -0.998677 
       H        -1.095039      -0.337771       1.348570 
       H         0.506961      -1.627698       2.056153 
       H         2.663437      -4.357300      -0.359118 
       C         2.276889      -3.344343      -0.217185 
       H         1.549341      -3.803548       1.784908 
    
   
       H        -2.319458      -0.023581      -1.535557 
       C        -2.493037       4.193157       0.716843 
       H        -3.286506      -1.383805       2.035833 
       C        -0.830615       2.476709       0.316057 
       C        -1.786021       1.688124      -0.342555 
       H        -2.762166       5.164468       1.123236 
       C        -2.012063      -2.858562      -0.873145 
       H         0.193772       2.143919       0.421058 
       C        -4.073481      -1.680374       0.044752 
       H        -4.468252       3.784680      -0.052565 
       C        -3.097992       2.176426      -0.465278 
       C        -3.451012       3.419070       0.060033 
       H        -2.039961      -2.376980      -1.862692 
       C        -3.438722      -3.025168      -0.317685 
       H        -1.569472      -3.844753      -1.031070 
       H        -4.211998      -1.087088      -0.868832 
       H        -3.399313      -3.663346       0.575894 
       H        -4.047612      -3.558669      -1.056928 
       H        -5.073198      -1.834679       0.467642 
       N         1.803806       0.186316      -0.220198 
       S         2.765921       1.559823      -0.500364 
       O         2.525517       2.588346       0.522645 
       O         2.546669       1.886771      -1.913401 
       C         4.463200       0.978521      -0.311310 
       H         4.586080       0.604166       0.704216 
       H         4.651784       0.205638      -1.058740 
       H         5.100917       1.846540      -0.494181 
------------------------------------------------------------------------------ 
 Statistical Thermodynamic Analysis 
 Temperature= 298.150 Kelvin       Pressure= 1.00000 Atm  
=============================================== 
 SCF Energy=     -1548.16440706 Predicted Change= -1.477744D-08 
 Zero-point correction (ZPE)=        -1547.7326  0.43177 
 Internal Energy (U)=                -1547.7083  0.45610 
 Enthalpy (H)=                      -1547.7073   0.45704 
 Gibbs Free Energy (G)=            -1547.7872    0.37716 
------------------------------------------------------------------------------ 
 Frequencies --  -964.4262                19.3413                26.6228 
    
   
TS-Anti-Re’ 
------------------------------------------------------------------------------ 
 Using Gaussian 03:  AM64L-G03RevC.02 12-Jun-2004 
=============================================== 
 #b3lyp/6-31G* geom=check guess=read freq=noraman scf=(tight,maxcycle=300) 
------------------------------------------------------------------------------ 
 Point group= C1   Stoichiometry= C19H26N2O4S   C1[X(C19H26N2O4S)]  #Atoms= 52 
 Charge = 0     Multiplicity = 1 
------------------------------------------------------------------------------ 
 SCF Energy= -1548.17643984     Predicted Change= -2.696993D-09 
=============================================== 
 Optimization completed.            {Found        1        times} 
 Item      Max Val.    Criteria    Pass?      RMS Val.    Criteria    Pass? 
 Force      0.00000 ||  0.00045   [ YES ]      0.00000 ||  0.00030   [ YES ]      
 Displ      0.00129 ||  0.00180   [ YES ]      0.00129 ||  0.00180   [ YES ]      
------------------------------------------------------------------------------ 
    Atomic         Coordinates (Ångstroms) 
     Type            X                   Y                    Z 
------------------------------------------------------------------------------ 
       C        -1.319562       0.502807       0.001573 
       H         1.563256      -2.081488      -3.917812 
       H         1.476989      -2.475496       1.725752 
       C        -0.410587      -2.494230       2.781168 
       H         1.657142      -0.512533      -3.098906 
       C         2.725866      -2.079538      -2.040777 
       H         3.694842      -1.629728      -2.263713 
       H         2.829173      -3.169267      -2.107631 
       H         0.839831      -0.876373       2.035335 
       H        -0.513038      -3.573711       2.603254 
       C        -1.436366      -1.630490       0.199682 
       H        -1.843481      -1.772615      -0.796588 
       N         0.781378      -1.788630      -0.706049 
       H        -1.011878       0.694507       1.033527 
       C         0.550267      -1.894822       1.741971 
       C        -0.046413      -1.823684       0.348762 
       O        -0.435828       0.718219      -0.927122 
       C        -2.391367      -2.018244       1.314826 
       H         2.651238      -2.384527       0.112962 
       C         2.256502      -1.685751      -0.628675 
       C         0.328911      -1.909766      -2.119340 
       C         2.815685      -0.291850      -0.210609 
       H        -2.459310      -2.268171       3.467303 
       C        -2.734008       0.815066      -0.306763 
       H        -1.697218      -0.768326       2.949594 
    
   
       O         4.038457      -0.223912      -0.089465 
       H         0.613152       0.699523      -0.500744 
       H        -0.019750      -2.938841      -2.283840 
       C         1.582542      -1.593503      -2.939357 
       H        -0.484187      -1.219105      -2.326243 
       C        -1.790490      -1.837418       2.712921 
       H        -2.683442      -3.072234       1.184228 
       H        -3.318141      -1.441500       1.216219 
       H         0.031306      -2.380991       3.777851 
       C        -5.400833       1.474523      -0.869272 
       C        -3.633204       1.093205       0.733563 
       C        -3.182324       0.886107      -1.635416 
       C        -4.506843       1.210883      -1.912457 
       C        -4.960187       1.420417       0.453744 
       H        -3.284136       1.078033       1.763163 
       H        -2.476553       0.707308      -2.440402 
       H        -4.843852       1.268964      -2.943878 
       H        -5.645089       1.642335       1.267384 
       H        -6.433313       1.731779      -1.089279 
       N         1.885192       0.667690       0.023115 
       S         2.351499       2.231867       0.465216 
       O         1.111866       2.827095       0.991000 
       O         3.070977       2.906689      -0.620612 
       C         3.496430       2.029210       1.846062 
       H         2.976442       1.530325       2.666235 
       H         4.350528       1.448264       1.500425 
       H         3.791652       3.038321       2.142843 
------------------------------------------------------------------------------ 
 Statistical Thermodynamic Analysis 
 Temperature= 298.150 Kelvin       Pressure= 1.00000 Atm  
=============================================== 
 SCF Energy=     -1548.17643984 Predicted Change= -2.696993D-09 
 Zero-point correction (ZPE)=        -1547.7437  0.43269 
 Internal Energy (U)=                -1547.7195  0.45688 
 Enthalpy (H)=                      -1547.7186   0.45782 
 Gibbs Free Energy (G)=            -1547.7981    0.37826 
------------------------------------------------------------------------------ 
 Frequencies --  -555.0827                24.9918                32.3191 
    
   
TS-Anti-Re’’ 
------------------------------------------------------------------------------ 
 Using Gaussian 03:  AM64L-G03RevC.02 12-Jun-2004 
=============================================== 
 #b3lyp/6-31G* scf=(direct,tight,maxcycle=300,xqc) gfinput gfprint 
 opt=(readfc,ts,noeigentest,maxcycle=150,nofreeze) freq=noraman geom=check 
 guess=read 
 #N Geom=AllCheck Guess=Read SCRF=Check GenChk RB3LYP/6-31G(d) Freq 
------------------------------------------------------------------------------ 
 Point group= C1   Stoichiometry= C19H26N2O4S   C1[X(C19H26N2O4S)]  #Atoms= 52 
 Charge = 0     Multiplicity = 1 
------------------------------------------------------------------------------ 
 SCF Energy= -1548.17525969     Predicted Change= -1.380713D-08 
=============================================== 
 Optimization completed.            {Found        2        times} 
 Item      Max Val.    Criteria    Pass?      RMS Val.    Criteria    Pass? 
 Force      0.00001 ||  0.00045   [ YES ]      0.00000 ||  0.00030   [ YES ]      
 Displ      0.00104 ||  0.00180   [ YES ]      0.00104 ||  0.00180   [ YES ]      
------------------------------------------------------------------------------ 
    Atomic         Coordinates (Ångstroms) 
     Type           X                    Y                    Z 
------------------------------------------------------------------------------ 
       C        -1.279631       0.221040      -0.021074 
       H         2.006835      -3.818434      -2.212700 
       H         1.916594      -1.726154       1.944082 
       C         0.068661      -1.857661       3.093426 
       H         1.613919      -2.799546      -3.607854 
       C         2.799746      -1.797420      -2.043735 
       H         2.700078      -0.852502      -2.588257 
       H         3.827168      -2.149525      -2.159804 
       H         0.994408      -0.236052       1.992814 
       H         0.095343      -2.956267       3.101446 
       C        -1.192962      -1.465128       0.448275 
       H        -1.597311      -1.952522      -0.439140 
       N         0.990319      -1.847876      -0.486480 
       H        -1.011185       0.745493       0.914045 
       C         0.898436      -1.329775       1.907370 
       C         0.247420      -1.638632       0.581596 
       O        -0.458513       0.458773      -1.051950 
       C        -2.023789      -1.822863       1.690068 
       H         2.992135      -2.279013       0.079130 
       C         2.453624      -1.571261      -0.557348 
       C         0.476424      -2.333411      -1.801971 
       C         2.853613      -0.156369      -0.061513 
    
   
       H        -1.961856      -1.770283       3.852910 
       C        -2.743907       0.478030      -0.339233 
       H        -1.406805      -0.282544       3.095141 
       O         3.902210      -0.040763       0.550339 
       H         0.858744       0.605688      -0.715584 
       H        -0.248752      -3.133261      -1.632622 
       C         1.742502      -2.800173      -2.521947 
       H        -0.011875      -1.499714      -2.307934 
       C        -1.381790      -1.376647       3.009811 
       H        -2.160611      -2.913765       1.713240 
       H        -3.024085      -1.393002       1.581420 
       H         0.541672      -1.522806       4.022849 
       C        -5.436715       0.983769      -0.966840 
       C        -3.615180       1.001229       0.623866 
       C        -3.234477       0.227725      -1.627419 
       C        -4.570205       0.474176      -1.938664 
       C        -4.954339       1.252424       0.314187 
       H        -3.239110       1.233272       1.618135 
       H        -2.546031      -0.132642      -2.385756 
       H        -4.936537       0.278933      -2.943556 
       H        -5.615607       1.665868       1.071374 
       H        -6.477351       1.180160      -1.211255 
       N         1.966806       0.827565      -0.416724 
       S         2.101277       2.391239       0.257803 
       O         3.474371       2.889424       0.210001 
       O         1.363251       2.386569       1.534442 
       C         1.112688       3.286985      -0.955300 
       H         1.686975       3.361030      -1.880242 
       H         0.178815       2.743346      -1.114751 
       H         0.932834       4.278351      -0.533531 
------------------------------------------------------------------------------ 
 Statistical Thermodynamic Analysis 
 Temperature= 298.150 Kelvin       Pressure= 1.00000 Atm  
=============================================== 
 SCF Energy=     -1548.17525969 Predicted Change= -1.380713D-08 
 Zero-point correction (ZPE)=        -1547.7417  0.43351 
 Internal Energy (U)=                -1547.7179  0.45729 
 Enthalpy (H)=                      -1547.7170   0.45823 
 Gibbs Free Energy (G)=            -1547.7950    0.38022 
------------------------------------------------------------------------------ 
 Frequencies --  -525.9802                30.8059                37.1569 
    
   
 
File Name   HF/cc-pVTZ  HF/cc-pVQZ  HF/∞ 
TS-Anti-Re  -1540.810421  -1540.899140  -1540.952603 
TS-Anti-Si  -1540.796581  -1540.885189  -1540.938585 
TS-Syn-Re  -1540.801265  -1540.889911  -1540.943330 
TS-Syn-Si  -1540.790911  -1540.879732  -1540.933257 
TS-Anti-Re'  -1540.804640  -1540.893520  -1540.947080 
TS-Anti-Re''  -1540.809354  -1540.898000  -1540.951419 
       
       
File Name   MP2/cc-pVTZ             MP2/cc-pVQZ                    MP2/∞  
TS-Anti-Re  -1545.944458  -1546.695401  -1547.498779 
TS-Anti-Si  -1545.937805  -1546.688659  -1547.491996 
TS-Syn-Re  -1545.934456  -1546.685169  -1547.488326 
TS-Syn-Si  -1545.929036  -1546.680135  -1547.483636 
TS-Anti-Re'  -1545.939087  -1546.690463  -1547.494247 
TS-Anti-Re''  -1545.941921  -1546.692363  -1547.495214 
       
       
File Name   SCS-MP2/cc-pVTZ  SCS-MP2/cc-pVQZ  SCS-MP2/∞ 
TS-Anti-Re  -1545.865480  -1546.670619  -1547.535370 
TS-Anti-Si  -1545.857528  -1546.662522  -1547.527168 
TS-Syn-Re  -1545.855923  -1546.660740  -1547.525164 
TS-Syn-Si  -1545.849481  -1546.654834  -1547.519773 
TS-Anti-Re'  -1545.860059  -1546.665694  -1547.530922 
TS-Anti-Re''  -1545.864086  -1546.668785  -1547.533076 
       
       
File Name   DCE PCM UAKS Solv   
TS-Anti-Re  -0.008175174     
TS-Anti-Si  -0.009322567     
TS-Syn-Re  -0.009577543     
TS-Syn-Si  -0.010948040     
TS-Anti-Re'  -0.010246855     
TS-Anti-Re''  -0.010167175     
 
 
   !
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